data_2l83_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l83 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.661 0.267 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -152.15 167.41 28.64 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.795 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.447 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -155.02 166.89 32.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.108 0.48 . . . . 0.0 111.372 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 35.0 mtpt -136.44 156.97 47.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.33 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 16' ' ' ARG . 6.8 tp -146.37 160.48 42.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.262 0.554 . . . . 0.0 112.229 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -97.66 172.96 7.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.332 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.19 -19.1 62.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.741 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.82 -42.33 25.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.807 0.337 . . . . 0.0 111.029 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.411 ' HG ' ' CD2' ' A' ' 42' ' ' LEU . 5.9 mp -108.66 -33.29 7.05 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.645 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.89 -10.76 41.52 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -56.43 -40.31 74.52 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.462 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 11.7 t -97.77 -53.07 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.77 -41.32 97.56 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.508 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.68 -15.15 62.25 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.416 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -116.77 128.68 55.53 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -109.58 -58.54 2.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.804 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 6.0 p -92.86 133.53 35.99 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.817 0.342 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 3' ' ' TRP . 9.6 t -140.34 163.37 23.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -130.52 149.87 51.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.58 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.9 t -101.97 120.22 51.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.939 0.4 . . . . 0.0 110.939 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.38 -50.84 0.75 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.73 154.56 3.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.23 133.06 56.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.067 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.5 -153.69 6.88 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.603 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -33.61 76.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.558 0.179 . . . . 0.0 111.288 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.08 116.15 4.31 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.137 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.82 178.08 8.2 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.781 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -77.98 -38.04 23.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.617 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.574 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -87.74 -27.51 26.56 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.23 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.31 -41.13 68.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.651 0.262 . . . . 0.0 110.768 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.14 -26.45 23.6 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.86 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.7 tp -62.24 -57.46 11.36 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.382 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -56.99 -40.4 76.5 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.982 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.95 -51.87 59.43 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.645 0.259 . . . . 0.0 110.36 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.9 mp -62.52 -35.88 80.81 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.86 -52.27 63.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.59 0.233 . . . . 0.0 110.69 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 158.02 52.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.638 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.35 -61.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.208 0.051 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.412 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 1.3 m-70 172.02 -62.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 123.442 0.464 . . . . 0.0 111.008 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 39' ' ' HIS . 8.0 Cg_endo -50.03 -27.76 17.43 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.626 2.217 . . . . 0.0 112.326 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.54 -31.67 70.76 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 1.6 pt? -136.65 29.76 2.9 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.28 155.77 0.12 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 111.251 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.1 p -78.35 -35.54 47.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.214 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -62.83 98.21 0.12 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.855 0.359 . . . . 0.0 110.994 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -58.03 -40.21 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.613 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.85 87.12 0.1 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 49' ' ' ASP . . . 100.32 -34.22 5.72 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.661 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 1.8 m-20 70.11 139.93 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.956 0.407 . . . . 0.0 111.383 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -111.03 -28.9 8.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.786 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.29 156.74 6.96 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.94 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.3 98.26 3.28 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.832 0.349 . . . . 0.0 111.362 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 54' ' ' TYR . 1.3 pt? -174.1 -42.8 0.01 OUTLIER 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.557 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.414 ' N ' ' HG ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -158.83 141.5 14.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.654 0.264 . . . . 0.0 111.234 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.06 142.05 29.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.176 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.437 ' CD2' ' HG2' ' A' ' 83' ' ' PRO . 2.0 t60 -110.68 135.06 51.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.636 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.5 pt -143.91 115.01 2.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -90.49 138.28 31.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.833 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.89 151.32 27.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.198 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.88 118.9 36.8 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.615 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -121.69 145.52 47.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.909 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -67.9 -13.4 62.12 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.724 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.58 23.57 5.63 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.736 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -103.19 165.49 10.99 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.782 0.325 . . . . 0.0 110.793 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.33 125.08 25.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.54 95.45 0.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.83 149.03 25.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.101 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.574 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 8.1 tt -126.2 -61.13 1.24 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.203 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.11 44.81 3.38 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.129 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -151.11 72.93 1.08 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.761 0.28 . . . . 0.0 111.104 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.05 -28.01 15.76 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.635 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.22 34.78 0.93 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.756 0.313 . . . . 0.0 111.442 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.77 176.72 6.05 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.894 0.378 . . . . 0.0 111.242 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.67 32.05 3.54 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.668 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.63 158.82 10.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.557 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -76.39 0.59 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.743 0.306 . . . . 0.0 111.275 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -145.53 -162.65 1.55 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.972 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.66 -45.12 2.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.487 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -156.61 169.14 25.35 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tt -153.32 122.15 6.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.859 0.361 . . . . 0.0 110.605 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -150.7 135.84 10.11 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.285 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 6' ' ' PHE . 84.4 Cg_endo -78.94 146.55 20.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.671 2.248 . . . . 0.0 112.614 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.437 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 45.6 Cg_exo . . . . . 0 C--N 1.349 0.598 0 C-N-CA 122.808 2.339 . . . . 0.0 112.489 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.817 0.341 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -160.57 172.97 16.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.7 140.84 21.26 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.417 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.408 ' HG2' HG22 ' A' ' 17' ' ' THR . 35.9 mttt -137.62 151.9 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.388 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.45 151.11 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.095 0.474 . . . . 0.0 111.879 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.12 -175.61 5.92 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.049 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.48 -20.18 43.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.939 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.68 -43.14 12.38 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.979 0.418 . . . . 0.0 110.81 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.452 ' HG ' ' CD2' ' A' ' 42' ' ' LEU . 4.7 mp -105.17 -31.37 9.16 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.011 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.08 -4.3 28.11 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -36.67 84.7 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.668 0.27 . . . . 0.0 110.936 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 t -97.21 -46.11 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.813 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.25 -45.17 20.31 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.99 -29.55 7.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.114 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 t -167.49 117.14 0.82 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.669 0.271 . . . . 0.0 110.994 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.57 29.19 7.42 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.043 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 HG22 ' HG2' ' A' ' 4' ' ' LYS . 11.5 p -95.63 114.03 25.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.328 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.7 161.72 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.215 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.81 152.58 46.77 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.744 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.3 120.33 51.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 0.0 110.776 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.33 -50.09 2.13 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.869 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.55 134.23 52.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.158 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -115.95 152.52 33.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.951 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.91 -81.62 0.15 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.963 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -82.71 -46.65 12.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.665 0.269 . . . . 0.0 111.125 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.64 116.16 4.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.66 172.86 11.88 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.439 HG21 ' CB ' ' A' ' 70' ' ' GLU . 39.0 t -76.71 -35.5 25.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.509 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.25 -32.44 9.64 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.353 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.84 -42.8 80.3 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.741 0.305 . . . . 0.0 110.775 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.62 -27.75 26.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.046 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tp -62.45 -57.2 12.08 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.7 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.04 -40.42 76.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.237 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.02 -52.1 61.07 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.794 0.33 . . . . 0.0 110.949 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.88 -34.41 75.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.318 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.4 -48.89 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.603 0.239 . . . . 0.0 111.023 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.87 53.23 0.02 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.646 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.83 -61.78 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.448 0.166 . . . . 0.0 110.744 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.407 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 2.5 m-70 -179.74 -62.92 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 39' ' ' HIS . 9.8 Cg_endo -52.27 -26.68 27.84 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.301 2.001 . . . . 0.0 112.064 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.41 -27.89 69.4 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.452 ' CD2' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -135.4 28.89 3.34 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 71.16 150.34 0.09 Allowed 'General case' 0 C--N 1.342 0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 110.847 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.9 m -60.38 -43.09 96.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.523 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.62 148.33 29.19 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.805 0.335 . . . . 0.0 110.814 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 p -169.02 -43.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.417 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -172.9 106.79 0.16 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.673 0.273 . . . . 0.0 110.755 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.23 92.57 0.11 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.495 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -65.53 -52.15 54.73 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.572 0.225 . . . . 0.0 110.855 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.24 -28.9 69.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.079 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.25 -166.89 14.0 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.707 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.38 179.8 4.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.692 0.282 . . . . 0.0 110.927 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -35.84 59.86 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.134 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.15 128.97 48.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.72 0.295 . . . . 0.0 111.003 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.18 130.02 55.61 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -142.01 108.29 5.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.176 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.9 pp -150.29 127.72 2.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.51 162.56 12.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.063 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -135.62 152.64 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.649 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.86 131.04 54.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.4 145.46 40.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.202 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -3.63 25.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.895 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.77 23.57 5.57 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.902 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.27 157.71 16.01 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.817 0.342 . . . . 0.0 110.684 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.73 102.73 14.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.297 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.03 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.95 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.84 133.71 50.13 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.991 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.8 -69.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.107 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.03 64.26 1.73 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.479 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.439 ' CB ' HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -140.73 47.29 1.75 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.7 -28.15 13.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.782 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.31 33.48 2.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.668 0.27 . . . . 0.0 111.258 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -96.52 174.16 6.99 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.815 0.34 . . . . 0.0 111.461 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.54 -34.09 17.51 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.469 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.68 157.93 27.47 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.429 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -109.32 -72.96 0.7 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.761 0.281 . . . . 0.0 110.644 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.53 -173.16 3.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.308 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.58 -53.22 2.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.611 0.243 . . . . 0.0 110.987 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -164.9 173.71 11.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.1 95.27 3.17 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.214 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -130.32 148.97 72.0 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.245 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.05 148.68 51.21 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.552 2.168 . . . . 0.0 112.545 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.348 0.508 0 C-N-CA 122.656 2.237 . . . . 0.0 112.479 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.838 0.352 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -160.3 173.33 15.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.469 ' CH2' HD13 ' A' ' 32' ' ' LEU . 3.1 t90 -155.85 146.17 21.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.44 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -138.07 144.81 41.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.015 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' HB3' ' CB ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -135.34 164.35 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.042 0.449 . . . . 0.0 111.375 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.402 ' HB2' ' CD ' ' A' ' 82' ' ' PRO . 6.4 t80 -89.5 170.08 10.81 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.816 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.57 -9.24 57.92 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.48 -44.06 65.37 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 111.224 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' A' ' 5' ' ' LEU . 5.0 mp -107.49 -32.84 7.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.177 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.68 -7.06 35.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -40.6 91.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.543 0.211 . . . . 0.0 111.005 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 21.1 t -95.08 -46.89 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.522 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.07 -46.51 80.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.752 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.52 11.81 70.87 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.901 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -139.08 92.96 2.64 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.452 ' CB ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -91.22 -42.79 10.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.181 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.8 p -96.64 145.42 25.78 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 120.718 0.294 . . . . 0.0 111.216 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -142.87 108.58 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.24 152.32 21.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.779 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.84 120.23 51.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.748 0.309 . . . . 0.0 111.032 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.34 -72.79 0.38 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.049 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.0 p -94.88 148.54 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.213 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.27 116.07 22.25 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.04 -139.31 3.89 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.635 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -107.01 36.12 2.78 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.845 0.355 . . . . 0.0 111.193 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.89 123.03 41.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.741 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.03 169.32 8.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.766 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 40.8 t -74.18 -33.55 35.28 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.132 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.72 -36.92 9.87 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.086 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.37 -38.68 74.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 110.666 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.39 -23.21 22.24 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.752 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.469 HD13 ' CH2' ' A' ' 3' ' ' TRP . 23.8 tp -63.53 -52.53 60.79 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.499 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -58.54 -41.87 86.54 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.447 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.68 -49.68 61.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.753 0.311 . . . . 0.0 111.206 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.19 -33.35 74.28 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.466 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.51 -48.89 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-O 120.705 0.288 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.91 54.84 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.612 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -62.49 -61.64 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.465 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . 1.1 m170 155.02 -66.47 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.646 0.778 . . . . 0.0 110.423 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 39' ' ' HIS . 11.0 Cg_endo -54.17 -24.74 34.76 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.511 2.141 . . . . 0.0 111.805 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 12' ' ' VAL . . . -61.45 -28.28 69.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.054 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.47 22.8 2.0 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.89 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 61.97 160.06 0.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.246 0.546 . . . . 0.0 111.875 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -14.15 22.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.515 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 150.74 32.49 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.5 p 45.38 34.33 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.169 0.509 . . . . 0.0 111.981 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.95 -60.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.088 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.3 69.27 1.99 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.565 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -69.77 165.19 21.94 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.574 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -82.15 -20.97 36.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.756 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.14 -152.51 1.99 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.596 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.82 91.49 2.71 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.845 0.355 . . . . 0.0 111.192 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tp -97.59 142.7 29.08 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.626 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.03 127.54 53.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.104 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.94 146.97 48.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.075 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -111.42 152.76 27.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.637 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.401 HG22 ' HB3' ' A' ' 82' ' ' PRO . 1.7 pt -156.55 124.99 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.761 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -90.56 137.42 32.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.02 157.99 30.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.31 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.84 122.21 44.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.075 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 145.45 50.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.743 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.94 -19.42 65.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.663 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.28 23.5 5.74 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.743 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.94 165.74 23.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.603 0.24 . . . . 0.0 111.006 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.15 124.64 29.42 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.289 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.22 146.79 23.43 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.368 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.1 -177.75 6.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.968 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.3 -45.02 0.62 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.225 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.53 31.97 6.38 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.787 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -164.7 91.46 0.57 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.787 0.327 . . . . 0.0 111.221 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.45 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -64.83 -17.63 64.41 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.835 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 t -88.83 33.92 0.78 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 111.246 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.68 168.84 12.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.213 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.65 80.36 8.01 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.64 149.87 3.21 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.985 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -133.3 -49.52 0.85 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.573 0.225 . . . . 0.0 111.335 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.461 ' HG3' ' CD1' ' A' ' 3' ' ' TRP . 0.5 OUTLIER -165.04 -172.43 2.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.56 179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.19 -45.18 2.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.516 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -170.35 174.02 5.43 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.343 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tt -152.93 117.72 5.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.324 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -141.46 138.28 17.34 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.568 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 6' ' ' PHE . 77.8 Cg_endo -77.71 169.55 20.61 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.712 2.274 . . . . 0.0 112.452 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 C--N 1.349 0.59 0 C-N-CA 122.817 2.345 . . . . 0.0 112.038 179.784 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.872 0.368 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.419 ' HG2' ' HG3' ' A' ' 19' ' ' ARG . 6.3 mt-10 -146.95 166.17 27.6 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.89 137.69 18.97 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.025 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -134.92 148.86 50.16 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.066 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 3.1 mm? -130.9 152.44 50.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.742 0.306 . . . . 0.0 111.257 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -174.95 3.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 11' ' ' GLU . . . -57.03 -23.04 43.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.854 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.72 -37.8 19.76 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.715 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 10.3 mt -120.57 -34.96 3.49 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.623 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.06 -2.8 22.71 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -91.14 -29.16 17.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.797 0.332 . . . . 0.0 110.36 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.549 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 97.3 t -93.11 -35.89 7.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.357 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 42' ' ' LEU . . . -94.42 -43.5 8.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.62 0.247 . . . . 0.0 111.1 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.98 -40.34 1.75 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.356 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.34 141.12 2.43 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.47 ' HG3' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -137.57 27.04 2.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.45 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 p -96.45 112.01 23.91 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 110.401 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.97 157.99 41.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.408 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.419 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -129.61 148.91 51.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.584 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.3 120.22 56.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.907 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.35 -52.02 0.82 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.725 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -90.67 153.31 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.32 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.6 142.22 35.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.086 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.19 -111.54 0.27 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.689 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.98 38.25 4.18 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.054 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.03 133.13 56.35 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.981 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.29 167.94 10.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.22 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 t -74.99 -39.18 44.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.943 0.401 . . . . 0.0 110.213 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -83.19 -34.38 20.83 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.221 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.24 -45.83 83.58 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.832 0.349 . . . . 0.0 110.405 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.12 -26.74 53.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.563 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.37 -61.07 2.59 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.258 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.65 -34.25 72.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.114 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -69.05 -50.6 47.06 Favored 'General case' 0 C--N 1.335 -0.046 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.186 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.414 ' N ' HD11 ' A' ' 35' ' ' LEU . 11.1 mp -68.26 -19.5 64.73 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.703 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.78 -44.81 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -133.42 -34.37 0.32 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.273 -0.965 . . . . 0.0 114.476 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.573 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -69.67 -0.94 7.69 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -121.81 64.87 18.11 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 120.738 0.304 . . . . 0.0 110.821 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 86.4 Cg_exo -50.64 -18.9 4.4 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.887 2.392 . . . . 0.0 112.942 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.427 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -49.47 -31.63 10.39 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 4.1 pp -106.68 -6.84 17.62 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -158.95 70.97 0.51 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.868 0.365 . . . . 0.0 110.524 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -31.6 66.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.346 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -134.85 125.03 26.01 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.392 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.22 37.88 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.87 0.367 . . . . 0.0 111.313 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 60.65 99.21 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.394 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.13 -36.03 4.48 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.508 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 70.52 -66.32 0.29 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.622 0.369 . . . . 0.0 111.101 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.27 31.4 3.4 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 111.154 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.85 -75.55 1.22 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.335 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.45 144.56 21.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 0.0 111.034 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tp -92.13 95.68 9.89 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.487 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -124.72 123.75 40.67 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.048 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -111.75 114.71 27.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.72 103.51 5.44 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.027 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 pt -149.35 121.76 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.831 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -82.81 153.32 25.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 p -135.58 145.95 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.577 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.29 120.97 41.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.597 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -132.17 142.47 49.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.717 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -62.74 -20.56 65.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.482 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.72 23.75 5.52 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.76 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.18 163.8 12.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 110.633 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.15 124.55 36.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.26 159.81 36.75 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.78 169.26 9.03 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.231 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -103.68 -35.3 8.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.173 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.45 28.37 8.36 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.077 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -173.44 103.16 0.12 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.826 0.313 . . . . 0.0 110.862 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.2 6.32 17.01 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.93 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.72 1.36 26.81 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.8 -176.2 1.03 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.787 0.327 . . . . 0.0 111.34 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.97 83.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.448 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.34 172.61 43.72 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.663 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.0 -70.22 0.73 Allowed 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.67 -165.83 1.1 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.529 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tp -108.57 -50.83 2.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.782 0.325 . . . . 0.0 110.751 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -155.38 171.57 19.66 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.339 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.5 tp -135.54 110.56 8.85 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.594 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -129.13 124.56 22.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.34 133.61 13.38 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.647 2.231 . . . . 0.0 112.52 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 122.726 2.284 . . . . 0.0 112.53 -179.785 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.738 0.304 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -148.03 167.05 25.93 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.07 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.43 ' O ' ' HA ' ' A' ' 17' ' ' THR . 54.4 m95 -145.96 138.59 25.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.942 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -138.51 136.19 35.86 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.436 ' HB3' ' CB ' ' A' ' 16' ' ' ARG . 4.4 tp -130.91 153.7 48.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 111.23 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.13 173.29 8.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.48 -15.06 62.28 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.925 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.52 -35.38 72.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.933 0.397 . . . . 0.0 110.524 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -112.11 -40.56 4.17 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.763 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 16' ' ' ARG . . . -64.74 -13.94 56.85 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -74.95 -27.12 60.06 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.505 -0.122 . . . . 0.0 111.232 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -90.79 -42.25 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.19 -42.85 9.66 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.76 -26.76 11.21 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.648 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.45 126.96 49.66 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.7 0.286 . . . . 0.0 111.244 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' CB ' ' HB3' ' A' ' 5' ' ' LEU . 1.7 ptt-85 -118.42 -58.4 1.98 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.53 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' TRP . 9.1 p -93.33 136.33 33.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -142.32 124.34 13.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.8 132.83 56.59 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 t -148.68 121.31 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.338 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.61 32.64 2.76 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.07 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.34 150.69 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.104 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -115.71 125.15 52.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.84 88.11 0.14 Allowed Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.397 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.41 26.02 13.64 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.692 0.282 . . . . 0.0 111.592 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.66 116.07 23.91 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.788 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.03 169.01 11.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.558 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.75 -33.53 16.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.642 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.06 -27.49 31.02 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.449 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.34 -42.69 82.44 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.672 0.272 . . . . 0.0 110.975 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -83.16 -38.16 22.74 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 tt -53.23 -54.98 28.15 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -59.32 -41.09 88.27 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.169 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.469 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -59.47 -56.5 21.17 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.58 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.6 mt -62.4 -20.56 64.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.167 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.5 t -88.59 -48.52 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 111.571 0.211 . . . . 0.0 111.571 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.56 -30.64 0.04 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.478 -0.867 . . . . 0.0 114.661 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -69.54 -1.38 8.56 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -133.04 72.8 76.15 Favored Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -51.44 -15.25 2.37 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.32 2.68 . . . . 0.0 113.967 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.63 -28.92 23.45 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -100.07 -13.22 19.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HB2' HD22 ' A' ' 9' ' ' LEU . 4.2 tp10 -140.0 114.71 9.44 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.246 -0.284 . . . . 0.0 111.425 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -8.56 53.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.085 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 60.63 58.64 2.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.998 0.428 . . . . 0.0 111.017 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 m -96.44 34.92 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.553 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -167.15 -56.05 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.74 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.15 60.32 4.81 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.661 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.2 -49.27 11.88 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.708 0.29 . . . . 0.0 110.683 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.76 31.91 2.78 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.7 -100.22 0.19 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.675 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 56.77 -167.74 0.11 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.092 0.157 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 66.22 -75.69 0.05 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.455 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -111.9 125.52 54.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.031 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.67 158.37 31.72 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.179 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -137.21 113.39 9.9 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.414 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -144.83 103.87 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.9 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -85.23 144.85 27.88 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.194 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 p -140.58 140.58 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.939 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -93.61 139.49 30.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.7 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.36 146.14 47.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.102 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.402 ' HB3' HD23 ' A' ' 78' ' ' LEU . 12.2 p-10 -84.96 19.28 2.17 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.181 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.32 23.72 5.65 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.885 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -108.42 155.8 20.16 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.737 0.303 . . . . 0.0 111.032 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 102.81 14.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.242 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.01 109.24 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.821 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.51 133.71 42.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.625 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.26 -68.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.4 49.19 1.14 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.573 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.66 31.35 5.7 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.59 -34.95 62.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.215 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.63 31.25 2.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.527 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.47 150.56 32.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.6 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.14 72.45 2.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 110.783 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.2 147.07 6.77 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.469 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.16 -73.25 0.69 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.689 0.28 . . . . 0.0 110.766 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 2.7 pt-20 -148.9 -169.58 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.543 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.402 HD23 ' HB3' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -112.11 -42.65 3.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.791 179.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.22 166.95 31.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.205 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tt -146.06 99.82 3.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.785 0.326 . . . . 0.0 110.842 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -151.47 143.23 15.91 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.413 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.56 153.47 23.36 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.855 2.37 . . . . 0.0 112.552 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.576 2.184 . . . . 0.0 112.551 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -146.17 164.33 32.56 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.915 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -147.4 118.58 7.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.974 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 23.3 mttm -106.16 141.96 36.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.627 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 11.6 tp -132.49 144.42 50.43 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.889 0.376 . . . . 0.0 111.412 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.489 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -82.57 172.43 12.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.265 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.05 66.36 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.008 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -34.46 53.31 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.573 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 3.9 mp -113.24 -38.05 4.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.978 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 -13.05 45.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -79.28 -27.28 42.26 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HB ' ' C ' ' A' ' 42' ' ' LEU . 16.4 t -87.13 -39.44 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.43 -38.09 10.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.22 27.42 8.19 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.455 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.3 t -140.91 128.99 22.06 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.634 0.255 . . . . 0.0 110.758 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.627 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 3.2 ptm180 -113.79 -75.08 0.6 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.543 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 3.5 p -97.43 134.06 41.19 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.792 0.329 . . . . 0.0 111.409 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -145.27 129.83 12.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.843 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.0 mtm-85 -100.77 139.21 36.77 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.423 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.81 120.35 52.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.815 0.341 . . . . 0.0 111.261 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.57 -36.53 5.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.93 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.59 149.98 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.268 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -108.51 166.27 10.9 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.149 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.01 -124.29 0.87 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.633 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.51 34.52 2.19 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.939 0.399 . . . . 0.0 111.004 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.33 120.12 37.22 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.588 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.66 -176.94 3.89 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.009 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.3 t -75.2 -42.22 44.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.506 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -75.64 -26.7 64.64 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.923 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -50.93 -45.24 60.41 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.489 0.316 . . . . 0.0 110.876 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.91 -32.23 20.28 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tt -56.71 -60.73 3.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 110.098 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -60.87 -40.97 94.97 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.305 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.42 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -53.49 -56.02 20.51 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.228 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.57 -29.84 70.88 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.956 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.62 -53.02 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.585 0.231 . . . . 0.0 110.827 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.02 20.58 0.06 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.248 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -105.15 -1.17 25.81 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.44 0.62 . . . . 0.0 111.579 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.32 72.65 81.96 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.44 -20.6 1.65 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.371 2.714 . . . . 0.0 113.551 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.52 -32.26 17.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.8 OUTLIER -99.7 -15.92 18.34 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.467 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -165.07 95.73 0.69 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.705 0.288 . . . . 0.0 111.161 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.78 -48.92 22.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.282 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -155.46 133.63 11.56 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.718 0.294 . . . . 0.0 110.839 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.49 -44.3 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.733 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -171.95 -67.41 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.964 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.42 99.57 1.01 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.595 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.36 -62.81 1.5 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.618 0.247 . . . . 0.0 111.146 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.87 -26.41 13.76 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.527 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.73 82.07 0.31 Allowed Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.767 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 59.85 80.0 0.21 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.985 0.421 . . . . 0.0 111.253 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.1 tp -96.0 97.5 9.65 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.692 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -147.9 116.99 6.83 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.277 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -147.17 149.7 33.49 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -87.49 157.64 19.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.594 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.5 124.23 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.67 0.272 . . . . 0.0 110.787 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -97.58 136.9 37.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 110.862 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 p -140.4 141.09 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.358 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.8 tp -97.81 134.51 40.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.803 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 145.84 47.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -55.43 -21.26 15.12 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.7 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.81 23.76 5.49 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.41 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.85 165.93 13.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.369 0.267 . . . . 0.0 110.468 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.38 123.62 16.09 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.771 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.37 102.19 0.08 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.338 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.25 160.48 28.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.073 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.506 ' CD2' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -158.15 22.53 0.25 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.499 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.19 14.45 2.33 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.133 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 178.54 96.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.717 0.294 . . . . 0.0 110.41 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.41 -6.66 41.94 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.894 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 t -75.23 1.52 13.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.89 -177.73 0.86 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.357 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 77.91 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.47 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.8 160.94 9.72 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.667 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.43 -78.79 0.59 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.674 0.273 . . . . 0.0 110.27 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -131.76 -177.01 4.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 110.823 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.76 -37.86 6.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.842 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -174.25 166.39 4.09 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.972 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.47 110.36 7.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.895 0.379 . . . . 0.0 110.602 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.44 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 23.3 m-85 -112.73 161.47 26.29 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.101 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 6' ' ' PHE . 96.6 Cg_endo -81.96 169.48 14.69 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.671 2.247 . . . . 0.0 112.584 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 C--N 1.348 0.516 0 C-N-CA 122.819 2.346 . . . . 0.0 112.547 179.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.788 0.328 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -160.68 163.64 32.32 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.166 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -155.36 174.68 14.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.997 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 27.0 mttm -137.13 152.98 50.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.132 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -141.51 132.38 25.91 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.811 0.338 . . . . 0.0 111.528 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.401 ' O ' HD12 ' A' ' 5' ' ' LEU . 1.1 t80 -81.35 175.77 10.3 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.112 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.82 -10.97 60.4 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.41 -46.31 62.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.901 0.381 . . . . 0.0 110.911 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -112.44 -36.03 5.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.121 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.95 -10.46 13.71 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -40.7 74.4 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.485 0.183 . . . . 0.0 111.067 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 4.2 t -94.51 -45.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.532 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.34 -46.75 79.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.09 11.24 61.61 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.546 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.3 m -116.83 129.73 56.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.773 0.32 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.521 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -111.73 -85.91 0.56 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.728 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.7 p -102.66 134.37 46.14 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.571 0.224 . . . . 0.0 111.405 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 t -147.75 154.39 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.031 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 1.3 mtt85 -108.45 152.27 24.93 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.617 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.0 120.32 51.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.072 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.81 -46.43 0.95 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.388 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 m -87.37 122.15 38.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.444 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -116.45 129.36 56.17 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.096 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.21 -125.63 0.77 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.651 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.54 -45.67 91.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.581 0.229 . . . . 0.0 111.173 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.44 122.0 22.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.19 171.05 15.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.289 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG23 ' CB ' ' A' ' 67' ' ' ALA . 8.7 m -74.75 -37.08 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 68' ' ' LEU . . . -80.27 -33.23 32.73 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.937 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -50.98 -47.5 61.38 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.78 0.324 . . . . 0.0 110.831 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.21 -25.8 33.89 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.886 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.1 -60.25 3.69 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.8 -36.57 72.38 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.091 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.61 -52.28 63.99 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.758 0.313 . . . . 0.0 110.267 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 5.6 mp -68.9 -33.26 73.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.984 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.6 t -55.66 -51.15 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.681 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.66 49.73 0.02 OUTLIER Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.959 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.19 -61.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.426 0.155 . . . . 0.0 110.588 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.423 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER 170.87 -58.78 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.78 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 39' ' ' HIS . 54.4 Cg_exo -50.67 -29.25 24.9 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.206 1.937 . . . . 0.0 111.914 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 35' ' ' LEU . . . -61.98 -26.09 68.01 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.492 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.428 ' HB3' ' HA ' ' A' ' 9' ' ' LEU . 1.9 pt? -139.99 27.59 2.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.714 0.292 . . . . 0.0 110.765 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 64.78 165.61 0.16 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.201 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.1 p -69.68 -41.83 74.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.582 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.09 129.1 6.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.731 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.87 -37.87 11.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.995 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -154.05 35.64 0.43 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.204 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.91 97.6 0.38 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.221 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -61.37 142.94 56.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.827 0.346 . . . . 0.0 111.401 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.41 -28.87 65.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.631 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.62 62.76 0.63 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.784 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -123.98 118.23 26.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.564 0.221 . . . . 0.0 110.704 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.5 79.28 5.54 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.596 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.1 134.07 19.17 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.324 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.98 119.27 12.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -143.19 133.14 24.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.187 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.8 tt -169.88 146.9 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.46 155.33 16.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.871 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -140.54 149.02 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.365 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.59 123.11 49.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.814 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -114.16 144.41 43.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.818 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -74.12 -16.35 61.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.521 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.7 23.26 6.0 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.83 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.48 165.92 11.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.717 0.294 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.25 124.91 19.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.971 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.89 87.79 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.964 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.45 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -70.24 142.76 52.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.265 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.432 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -141.61 -59.24 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.005 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.36 36.69 3.66 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.67 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.79 90.81 1.49 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.698 0.285 . . . . 0.0 111.285 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.12 -24.51 63.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.516 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.92 33.56 0.78 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.686 0.279 . . . . 0.0 111.571 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.33 171.18 12.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.859 0.362 . . . . 0.0 111.674 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.1 92.97 3.93 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.023 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.07 122.41 3.81 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.892 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -107.18 -65.27 1.11 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.709 0.29 . . . . 0.0 111.003 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -162.95 -159.37 0.54 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.584 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.8 tp -123.29 -53.11 1.83 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.558 0.218 . . . . 0.0 110.951 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -152.8 153.54 33.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.196 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.93 101.37 5.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.752 0.31 . . . . 0.0 110.73 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -146.81 145.13 21.66 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.469 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.16 150.42 65.9 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.668 2.245 . . . . 0.0 112.103 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--N 1.347 0.491 0 C-N-CA 122.589 2.193 . . . . 0.0 112.074 179.789 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -135.48 153.22 51.82 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 111.635 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.424 ' CD1' ' HG3' ' A' ' 77' ' ' GLU . 1.9 t90 -155.48 148.28 24.29 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.112 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 2.9 mttp -137.98 146.61 43.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.351 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 1.1 tt -135.54 165.1 26.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.974 0.416 . . . . 0.0 111.028 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.79 -178.61 6.89 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.205 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.62 -8.73 50.0 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.29 -40.22 61.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.681 0.276 . . . . 0.0 111.431 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 4.7 mp -100.24 -33.23 10.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.596 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.52 -7.52 48.12 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -79.9 -29.57 39.89 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.383 0.135 . . . . 0.0 111.22 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 4.9 t -98.03 -49.19 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.48 -34.79 8.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.77 26.6 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.616 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.39 79.0 1.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.969 0.414 . . . . 0.0 110.772 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 5' ' ' LEU . 8.0 ptt85 -88.24 -43.82 11.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.98 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 6.1 p -92.99 139.28 30.68 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.824 0.345 . . . . 0.0 110.97 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -129.71 107.67 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.79 152.53 20.77 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.681 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.0 t -102.08 120.28 51.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.929 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.39 -71.05 0.7 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -89.46 145.78 6.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.072 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.76 151.66 23.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.217 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.09 -102.97 0.18 Allowed Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.418 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.71 -27.35 11.36 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.603 0.224 . . . . 0.0 111.603 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 129.14 39.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.764 0.316 . . . . 0.0 111.336 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.78 174.72 6.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.04 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 68' ' ' LEU . 15.2 t -75.99 -39.59 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.126 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -76.41 -31.34 54.84 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.791 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -56.1 -48.38 76.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.716 0.293 . . . . 0.0 110.682 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.95 -26.84 39.89 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.125 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.402 ' HA ' ' CH2' ' A' ' 3' ' ' TRP . 7.1 tt -59.45 -58.76 7.19 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.84 -42.76 94.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.052 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -52.87 -56.15 17.99 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.24 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.421 HD23 ' CZ3' ' A' ' 3' ' ' TRP . 7.7 mp -62.14 -29.72 70.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.778 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.44 -53.4 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.005 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.26 15.52 0.06 OUTLIER Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.056 -1.068 . . . . 0.0 114.806 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -105.16 -1.25 25.69 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.704 0.752 . . . . 0.0 111.655 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.77 75.31 43.39 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-O 120.945 0.403 . . . . 0.0 110.282 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -53.59 -14.22 4.77 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.981 2.454 . . . . 0.0 113.252 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.37 -28.59 20.17 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.444 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 1.2 mp -100.67 -12.99 18.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.99 109.88 12.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.647 0.26 . . . . 0.0 111.604 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -90.18 -41.31 11.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.241 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 62.67 77.22 0.34 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.606 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.0 t -92.41 -66.61 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.315 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -136.14 76.67 1.62 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.933 0.397 . . . . 0.0 110.729 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.26 -86.1 0.5 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.377 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -147.05 164.05 34.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.739 0.304 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -115.51 31.67 6.56 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.962 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.18 83.62 0.06 OUTLIER Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.781 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.66 128.02 34.66 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.745 0.307 . . . . 0.0 111.357 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.53 161.42 7.75 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.023 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 112.72 25.52 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.961 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.51 154.48 43.67 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.195 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -135.35 102.86 5.29 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.302 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.85 -49.88 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.985 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.02 -167.06 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.212 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -90.61 151.58 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 111.131 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 tp -129.81 150.56 51.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 111.309 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HG3' ' HB3' ' A' ' 77' ' ' GLU . 3.5 mtt180 -143.14 146.34 33.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.962 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -52.44 -21.31 3.55 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.68 23.78 5.52 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.775 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -130.21 165.93 21.35 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.733 0.301 . . . . 0.0 110.739 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.52 121.65 10.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.252 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.08 144.56 56.04 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.387 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -92.52 -177.6 4.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 28' ' ' VAL . 5.2 tt -168.64 -50.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.652 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.51 25.39 21.1 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.869 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -171.59 96.78 0.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.839 0.32 . . . . 0.0 110.979 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.4 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -58.17 -26.82 63.2 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.694 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.11 34.03 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.721 0.296 . . . . 0.0 111.515 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.67 178.58 6.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.694 0.283 . . . . 0.0 111.478 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.41 72.0 9.47 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.937 0.398 . . . . 0.0 111.243 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.65 145.0 2.23 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.261 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -124.12 -79.07 0.61 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.792 0.33 . . . . 0.0 110.852 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.473 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 1.4 pt-20 -141.15 -177.69 5.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.47 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.74 -52.94 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.632 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -159.34 174.35 14.88 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 5' ' ' LEU . 3.1 tt -153.35 118.11 5.02 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.839 0.352 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -139.76 108.11 7.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.72 158.17 50.9 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.831 2.354 . . . . 0.0 112.593 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 C--N 1.35 0.612 0 C-N-CA 123.074 2.516 . . . . 0.0 113.192 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.964 0.412 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -144.29 169.18 18.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.529 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -155.51 142.4 19.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.215 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -138.77 145.89 40.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -149.32 164.63 34.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 111.907 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -85.79 179.79 6.98 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.496 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.04 -13.69 38.76 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.2 -34.69 23.57 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.716 0.293 . . . . 0.0 110.748 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' HB2' ' CD2' ' A' ' 5' ' ' LEU . 4.9 mp -105.07 -10.26 17.29 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.678 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.23 -2.24 55.34 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -35.83 73.66 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 56.1 t -97.65 -49.92 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.47 -34.38 9.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.99 25.79 28.27 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.313 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.17 98.33 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.874 0.369 . . . . 0.0 111.136 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -99.07 -45.3 5.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.075 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.8 p -93.47 147.7 22.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.144 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.24 113.74 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.168 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -105.7 141.83 36.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.836 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.56 120.5 56.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.085 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.28 -45.08 1.69 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.321 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.3 t -86.84 137.41 20.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -116.98 172.32 7.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.273 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.97 -91.13 0.13 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.24 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.91 -35.16 7.39 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.529 0.204 . . . . 0.0 111.115 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.59 135.81 55.54 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 111.14 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.07 -179.74 3.87 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 m -79.91 -35.2 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.785 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.29 -23.4 29.36 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.415 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.36 -40.27 96.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.704 0.288 . . . . 0.0 110.991 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.459 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -81.22 -39.67 25.02 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.707 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 tt -53.29 -57.13 11.64 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.74 0.305 . . . . 0.0 110.435 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.3 -34.75 75.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.47 -52.97 26.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.4 mt -63.37 -26.22 68.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.317 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.01 -42.6 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.58 0.229 . . . . 0.0 111.569 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.91 -34.54 90.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.102 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.95 -41.34 5.63 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.485 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 27.9 m170 63.16 49.17 1.07 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.345 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 39' ' ' HIS . 9.9 Cg_endo -53.57 -24.21 28.22 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.231 1.954 . . . . 0.0 112.109 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.17 74.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.532 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.54 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 1.4 pp -120.59 1.86 10.63 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.276 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -132.8 78.14 1.78 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.794 0.33 . . . . 0.0 110.952 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.2 p -81.46 -44.28 17.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.706 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.86 99.44 0.77 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.001 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.17 -72.03 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.377 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -167.01 -46.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.409 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.52 -51.34 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.715 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -175.06 149.92 1.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.0 110.575 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.99 -28.99 63.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.51 111.31 0.29 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.778 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -102.84 136.2 43.1 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.744 0.307 . . . . 0.0 111.0 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.07 -46.01 1.69 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -156.99 112.39 2.85 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.794 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -146.35 138.88 25.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -104.78 126.89 52.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.971 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 pp -151.24 132.09 4.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.334 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -90.83 143.29 26.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.795 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.83 150.43 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 111.771 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.37 128.93 56.41 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.826 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.78 145.92 28.49 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.059 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -20.98 59.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.713 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.48 23.66 5.62 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.891 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -95.84 162.19 13.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.082 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.66 102.5 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.974 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 49.91 75.88 0.15 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.983 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.32 133.99 33.62 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.805 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.27 -71.3 0.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.318 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.0 53.78 3.62 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.769 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -159.4 72.94 0.56 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.752 0.31 . . . . 0.0 111.279 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.66 68.35 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.339 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.31 36.38 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.345 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.77 -178.39 4.83 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.956 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.12 68.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.485 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.94 157.76 9.11 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.505 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -95.49 -67.52 0.85 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.561 0.22 . . . . 0.0 110.871 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.73 -179.88 6.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.231 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.67 -47.72 2.97 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.16 169.87 22.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.102 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tt -153.89 95.44 1.87 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.055 0.455 . . . . 0.0 110.645 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -131.12 144.96 55.66 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.254 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.2 154.7 56.84 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.519 2.146 . . . . 0.0 112.109 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo . . . . . 0 C--N 1.349 0.56 0 C-N-CA 122.872 2.381 . . . . 0.0 112.497 179.935 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -146.52 159.97 42.73 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.496 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 41.8 m95 -143.51 128.34 18.33 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.643 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 0.3 OUTLIER -129.4 149.83 51.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.482 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -126.66 144.95 50.75 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.644 0.259 . . . . 0.0 111.051 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -82.44 176.67 9.23 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.34 -31.97 35.98 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.564 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -49.45 -35.17 18.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 110.776 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.4 HD11 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -109.24 -32.85 7.04 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.393 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.37 -2.51 49.56 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.38 -34.89 76.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.775 0.322 . . . . 0.0 110.724 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.416 ' CG1' ' HB2' ' A' ' 44' ' ' SER . 20.5 t -94.87 -49.36 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.727 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 -38.25 63.0 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.27 -24.24 29.87 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.701 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.02 96.13 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.6 28.18 6.27 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.143 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.437 ' CG2' ' HG2' ' A' ' 4' ' ' LYS . 11.1 p -92.09 132.76 36.34 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.647 0.261 . . . . 0.0 110.924 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.31 159.82 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.245 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -124.89 138.05 54.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.591 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.13 123.45 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.948 0.404 . . . . 0.0 111.424 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.27 -47.11 1.76 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.219 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.17 152.72 3.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.463 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -112.12 160.29 17.69 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.209 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.15 -130.22 1.54 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.423 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.91 -33.22 63.91 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.735 0.267 . . . . 0.0 111.145 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.0 134.74 49.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.255 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.28 175.84 5.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.002 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.409 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 58.5 t -75.64 -42.32 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 120.956 0.407 . . . . 0.0 110.032 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -82.54 -32.95 26.39 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.893 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.56 -41.07 96.55 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.721 0.296 . . . . 0.0 110.791 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.95 -31.57 51.01 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.805 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.6 -58.78 6.75 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.33 -32.74 74.24 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.87 -51.97 34.72 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.106 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.9 -34.62 73.43 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.176 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.08 -43.69 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.334 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.62 6.88 75.81 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.423 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.473 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -62.97 -58.32 7.73 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.191 0.496 . . . . 0.0 110.712 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.66 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 13.9 m-70 103.79 -57.52 0.0 OUTLIER Pre-proline 0 C--N 1.345 0.403 0 C-N-CA 124.637 1.175 . . . . 0.0 112.073 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.66 ' HD3' ' HB2' ' A' ' 39' ' ' HIS . 61.2 Cg_exo -50.98 -22.93 11.14 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.028 1.818 . . . . 0.0 112.434 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.44 -32.55 68.8 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.622 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.4 ' CD2' HD11 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -136.75 25.11 3.1 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.146 179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.03 66.26 1.4 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.783 0.325 . . . . 0.0 110.985 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.416 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 3.3 m -82.41 -44.74 15.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.627 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -163.62 111.07 1.17 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.895 0.379 . . . . 0.0 111.227 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.08 -48.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.236 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.75 -165.65 0.45 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.72 43.86 3.29 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.897 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 67.87 133.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.092 0.472 . . . . 0.0 111.665 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -88.1 -28.15 21.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.373 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.27 -60.89 2.21 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.256 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.77 118.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.682 0.393 . . . . 0.0 111.936 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.9 mt -91.71 -32.28 15.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.684 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.11 122.52 34.46 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.71 0.29 . . . . 0.0 111.477 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.29 129.68 43.56 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.887 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.34 135.2 52.21 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.964 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -151.87 131.2 3.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.851 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -91.42 164.82 13.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.782 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 p -138.76 147.36 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.05 128.0 53.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.953 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.62 145.89 50.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.016 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -59.31 -21.0 59.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.675 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.91 23.72 5.47 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.747 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.2 166.29 12.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.746 0.308 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.33 112.57 11.76 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.81 123.79 42.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.47 165.57 18.01 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.681 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.424 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -108.16 -38.88 5.65 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.13 24.9 13.79 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.142 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -162.54 96.06 0.93 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.84 0.32 . . . . 0.0 110.953 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -70.33 -6.65 36.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.708 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 t -75.86 1.28 15.47 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.8 -178.48 1.54 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 111.398 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.6 86.91 6.84 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.477 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.67 159.17 28.05 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.116 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -109.58 -77.4 0.6 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -157.4 -175.16 5.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.793 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.7 mt -108.12 -37.69 5.98 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.99 172.0 10.6 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.087 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 tt -136.65 97.3 3.51 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.274 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.86 136.49 20.74 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.68 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.22 150.83 42.87 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.409 2.073 . . . . 0.0 112.451 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.351 0.677 0 C-N-CA 122.819 2.346 . . . . 0.0 112.106 179.892 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ttt . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.618 0.247 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -147.56 138.79 23.68 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.061 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -135.59 118.45 16.22 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.717 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.411 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 39.8 mtpt -116.91 139.78 50.23 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.423 ' CB ' ' HB3' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -123.45 142.45 50.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.634 0.254 . . . . 0.0 110.796 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 8' ' ' ASP . 20.7 p90 -81.11 -173.19 4.16 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.173 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -41.09 -26.18 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.45 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -39.95 -47.27 2.2 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.884 0.373 . . . . 0.0 111.292 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -113.23 -23.17 10.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.422 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.44 -3.01 38.18 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.15 -34.28 65.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.652 0.263 . . . . 0.0 111.073 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.82 -53.6 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.719 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.64 -40.48 49.02 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.78 -30.33 7.23 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.455 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.2 p -156.95 124.96 5.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.632 0.253 . . . . 0.0 111.23 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.69 34.51 5.19 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.951 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.411 ' CG2' ' HG2' ' A' ' 4' ' ' LYS . 21.5 p -104.34 126.67 51.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -139.37 151.66 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -120.07 158.34 27.06 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.885 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 t -102.26 120.38 51.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.886 0.374 . . . . 0.0 111.215 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.99 -46.02 0.65 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.065 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.0 p -86.76 147.7 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.422 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -99.17 136.41 39.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.936 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.56 175.65 35.6 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.635 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.9 -31.49 68.67 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.548 0.213 . . . . 0.0 111.35 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 117.97 6.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.824 0.345 . . . . 0.0 111.049 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.28 179.52 1.58 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.498 HG22 ' CB ' ' A' ' 67' ' ' ALA . 2.6 m -74.54 -42.53 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.252 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.418 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -88.38 -28.49 22.21 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.276 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.78 -34.74 73.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.785 0.326 . . . . 0.0 110.728 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.09 -30.57 15.93 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.503 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tt -62.21 -53.69 51.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.781 0.324 . . . . 0.0 110.612 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -65.96 -31.76 72.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.245 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.0 -44.86 53.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.111 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.98 -32.78 74.21 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.928 0.394 . . . . 0.0 110.655 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -87.97 -34.62 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.286 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.23 19.45 51.33 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.295 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -63.68 -52.2 61.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.053 0.426 . . . . 0.0 111.072 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.728 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 28.9 m170 104.63 -59.87 0.0 OUTLIER Pre-proline 0 C--N 1.345 0.391 0 C-N-CA 124.527 1.131 . . . . 0.0 112.071 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 39' ' ' HIS . 42.6 Cg_exo -55.69 -22.06 34.63 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.691 1.594 . . . . 0.0 111.992 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.31 -29.25 70.3 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.645 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 9' ' ' LEU . 2.3 pt? -135.69 26.81 3.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.838 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 70.95 136.02 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.5 m -58.45 -39.41 79.79 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.489 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 59.85 76.07 0.38 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.894 0.378 . . . . 0.0 111.244 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.3 68.56 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.508 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -141.18 -46.73 0.39 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.148 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.3 -63.34 1.51 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.049 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.92 155.53 1.64 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.792 0.33 . . . . 0.0 110.816 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -120.15 31.19 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.956 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.93 -99.63 2.63 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.512 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.14 93.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.832 0.348 . . . . 0.0 111.432 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 mp -94.82 18.66 11.37 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.527 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -133.24 128.85 36.76 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.618 0.247 . . . . 0.0 111.196 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.25 147.47 41.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -140.17 121.82 15.28 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.5 tt -173.6 145.39 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.47 168.4 10.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.612 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 p -139.33 141.98 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.552 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.49 118.32 31.48 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.609 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -126.51 145.76 50.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.715 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.34 -10.59 56.01 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.895 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.56 5.58 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.945 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -118.8 166.08 13.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.631 0.253 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.11 125.78 27.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.64 130.3 46.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.24 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' CB ' HG22 ' A' ' 28' ' ' VAL . . . -98.27 134.54 41.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.418 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -128.59 -63.96 0.96 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.897 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.06 43.84 2.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.835 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -165.37 94.25 0.62 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.703 0.287 . . . . 0.0 111.236 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.56 -10.13 59.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.809 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.1 35.88 1.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 111.413 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.94 165.69 11.8 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.865 0.364 . . . . 0.0 111.327 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.3 80.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.15 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.76 -177.47 48.15 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.538 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.77 -74.9 0.59 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.792 0.33 . . . . 0.0 110.701 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -148.68 -177.61 5.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.39 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.59 -32.74 7.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.343 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -167.48 169.77 11.86 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.41 97.74 3.44 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.555 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -140.14 153.65 69.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.253 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD3' ' CD1' ' A' ' 6' ' ' PHE . 24.6 Cg_endo -61.74 156.18 49.69 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.632 2.222 . . . . 0.0 112.31 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 C--N 1.347 0.463 0 C-N-CA 122.676 2.251 . . . . 0.0 112.421 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.444 ' HG3' ' CG1' ' A' ' 28' ' ' VAL . 2.8 ttp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.056 0.455 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -120.04 147.13 45.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.087 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.442 ' CD1' HD11 ' A' ' 5' ' ' LEU . 2.1 t90 -150.04 125.16 10.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.727 0.299 . . . . 0.0 111.168 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -122.23 148.47 44.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.297 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.48 HD23 ' CD2' ' A' ' 9' ' ' LEU . 7.6 mp -140.18 152.62 46.18 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.75 0.31 . . . . 0.0 111.334 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -98.27 179.15 4.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.67 -29.88 40.78 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.94 -37.73 33.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.004 0.431 . . . . 0.0 110.19 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.48 ' CD2' HD23 ' A' ' 5' ' ' LEU . 2.5 mp -110.73 -9.75 14.49 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.187 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.81 -4.9 49.34 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.99 -36.84 75.49 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 14.6 t -93.47 -33.51 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . . . -92.58 -45.03 8.3 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.38 -35.58 4.28 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.842 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.9 t -172.43 126.4 0.52 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.565 0.221 . . . . 0.0 110.824 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.402 ' HG3' ' CB ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -123.05 28.2 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.291 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.8 p -99.33 112.55 24.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.571 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.5 144.5 28.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.221 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -130.25 158.48 39.64 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.701 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 1' ' ' MET . 13.4 p -103.95 136.97 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.893 0.378 . . . . 0.0 111.632 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.04 -48.62 1.11 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.918 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -86.65 165.67 2.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.284 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.09 118.07 33.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.08 -139.33 3.89 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.491 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.48 30.95 6.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.62 0.248 . . . . 0.0 111.302 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.46 146.3 25.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.898 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.08 167.75 12.28 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.83 0.348 . . . . 0.0 111.213 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 76' ' ' ASP . 2.5 m -78.2 -36.88 21.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.435 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.554 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -79.21 -31.28 42.93 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.879 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -50.84 -42.17 58.31 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.885 0.374 . . . . 0.0 110.556 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.49 -30.89 17.02 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.126 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.34 -56.07 26.85 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.829 -0.168 . . . . 0.0 110.96 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -57.18 -36.26 70.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.628 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.15 -53.95 9.71 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 110.469 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 39' ' ' HIS . 7.8 mp -61.43 -25.3 67.12 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.244 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.4 t -91.92 -45.89 14.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.432 0.158 . . . . 0.0 111.336 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.28 -40.53 94.09 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.861 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.14 -56.35 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.652 0.263 . . . . 0.0 111.053 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.459 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER 72.52 55.5 0.34 Allowed Pre-proline 0 C--O 1.231 0.106 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.75 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 52.7 Cg_exo -53.12 -17.71 8.66 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.22 1.947 . . . . 0.0 112.06 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HA ' ' CB ' ' A' ' 13' ' ' ALA . . . -57.13 -40.49 77.23 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.189 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.482 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -134.5 13.17 3.78 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.642 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.14 118.64 26.55 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.842 0.354 . . . . 0.0 111.442 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.9 m -94.97 7.46 46.0 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.694 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 71.49 31.7 2.23 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.683 0.277 . . . . 0.0 111.063 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -168.47 87.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.172 0.511 . . . . 0.0 111.37 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -157.57 104.67 2.0 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.183 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.42 -80.2 0.64 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.383 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.76 -62.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.814 0.34 . . . . 0.0 110.499 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.71 -28.94 51.04 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.465 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.09 -63.42 0.55 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.383 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.54 156.07 40.69 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.771 0.319 . . . . 0.0 111.059 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.56 -67.89 0.96 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -151.67 134.27 15.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.005 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.15 164.31 29.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.2 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -108.62 126.4 52.92 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pp -148.87 120.09 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.553 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -77.27 151.31 35.12 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.868 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.0 p -136.92 146.7 27.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.678 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.34 124.3 49.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.732 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.71 145.61 51.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -61.09 -25.19 66.79 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.653 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.43 23.49 5.99 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.916 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.24 166.07 12.03 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.653 0.263 . . . . 0.0 110.772 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.03 114.29 2.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.982 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.03 111.54 10.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.075 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.54 -175.89 3.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.251 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.554 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -141.16 -42.35 0.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.562 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.73 35.94 3.88 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.855 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -167.94 91.28 0.33 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.88 -0.97 53.47 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.716 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 t -84.82 -26.56 27.38 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.436 0.16 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.26 139.45 53.37 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.747 0.308 . . . . 0.0 110.913 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.94 -74.68 0.06 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.88 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.99 -151.21 18.45 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.505 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.453 ' HB3' ' HB ' ' A' ' 28' ' ' VAL . 25.3 p-10 -111.63 -50.77 2.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.406 0.146 . . . . 0.0 110.74 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -171.35 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.741 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.1 mt -107.66 -36.79 6.34 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.215 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 4' ' ' LYS . . . -165.22 170.93 14.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.631 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.64 100.1 3.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.899 0.38 . . . . 0.0 110.545 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 12.5 m-85 -114.09 133.95 22.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.009 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 81' ' ' PHE . 37.1 Cg_exo -57.33 170.72 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.797 2.331 . . . . 0.0 112.403 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 C--N 1.349 0.573 0 C-N-CA 122.771 2.314 . . . . 0.0 112.362 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.579 0.228 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.44 160.14 40.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.882 0.372 . . . . 0.0 110.887 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -155.27 144.83 21.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.02 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -137.63 141.16 41.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.938 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 11.7 tp -133.08 158.24 43.26 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.991 0.425 . . . . 0.0 111.893 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -91.14 177.93 6.13 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.716 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.93 -10.24 59.58 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.417 ' HB3' HD23 ' A' ' 9' ' ' LEU . 6.2 t70 -56.65 -39.72 74.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -111.66 -39.6 4.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.417 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . . . -61.43 -14.23 26.62 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.37 -26.9 61.2 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.364 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.5 t -89.66 -41.63 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.12 -43.55 10.39 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.68 -20.31 22.69 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.828 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.9 m -111.64 130.68 55.69 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.882 0.341 . . . . 0.0 110.665 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.439 ' HD3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -113.81 -49.08 2.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 p -93.1 146.68 23.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.92 0.39 . . . . 0.0 111.435 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.0 t -145.36 119.33 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.24 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -102.42 138.59 39.14 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.358 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.75 123.21 65.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.438 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.08 -31.86 11.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.19 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 p -91.81 151.34 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -116.88 121.97 43.01 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.98 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.91 45.07 1.18 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.467 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.3 t0 55.48 33.57 21.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.868 0.365 . . . . 0.0 111.295 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.57 127.08 33.46 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.654 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.08 168.07 20.46 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.796 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.405 HG12 ' HG3' ' A' ' 61' ' ' ARG . 22.6 t -75.25 -34.43 30.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -85.07 -28.64 30.49 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.304 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.83 -41.44 74.25 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.559 0.218 . . . . 0.0 110.955 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.51 -32.29 19.5 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -61.86 2.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.645 0.259 . . . . 0.0 110.54 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -62.06 -33.17 73.9 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.672 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.08 -54.5 24.93 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.291 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.54 -19.22 64.61 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.459 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.2 t -91.99 -47.81 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.31 -34.22 2.55 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.789 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.61 -1.23 41.36 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -127.1 65.69 65.28 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.781 0.324 . . . . 0.0 110.675 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.01 -19.11 14.81 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.779 2.319 . . . . 0.0 112.469 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.72 -26.43 14.01 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.631 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -95.91 -23.76 16.73 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.679 0.275 . . . . 0.0 110.99 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 78.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.084 0.469 . . . . 0.0 111.022 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.8 t -80.42 -53.38 6.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.813 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -176.49 107.47 0.07 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.61 -55.71 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.655 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -172.25 48.05 0.02 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.609 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.34 -45.23 2.6 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.528 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.06 156.76 45.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.723 0.297 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.37 -28.84 9.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.242 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.4 158.87 22.63 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.623 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.57 97.31 3.71 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.677 0.275 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 mt 70.93 -63.72 0.41 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.26 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -113.45 138.49 50.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.77 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -103.6 126.45 50.75 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 141.12 46.04 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.193 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.464 HG23 HD12 ' A' ' 57' ' ' ILE . 13.4 mt -146.86 130.83 9.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.285 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -101.65 146.53 27.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.957 0.408 . . . . 0.0 111.143 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.78 154.08 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tp -124.61 120.92 33.29 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.017 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 77' ' ' GLU . 2.5 tmm_? -127.5 88.42 2.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.619 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 57.54 18.68 4.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.851 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.48 23.66 39.11 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.642 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -102.01 166.0 10.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.951 0.405 . . . . 0.0 111.199 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.52 102.9 14.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.533 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 63.2 105.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.066 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.419 ' CB ' ' HG3' ' A' ' 61' ' ' ARG . . . -109.95 162.57 14.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.225 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.427 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 2.6 tt -169.9 -65.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.602 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.45 63.39 1.97 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.137 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -123.82 30.48 6.16 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.32 -22.9 54.82 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -76.74 -25.0 53.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.243 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.84 154.52 41.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.69 0.281 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.4 66.74 3.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.825 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.53 -173.93 27.46 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.549 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -117.36 -72.74 0.67 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.582 0.229 . . . . 0.0 110.694 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.461 ' HA ' ' HG2' ' A' ' 61' ' ' ARG . 1.3 pt-20 -149.41 -169.21 3.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.716 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -113.52 -48.74 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.407 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -162.5 166.74 24.49 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.249 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 tt -146.55 111.88 5.49 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.83 0.348 . . . . 0.0 110.942 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -151.44 156.7 34.93 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.485 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.0 153.06 76.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.543 2.162 . . . . 0.0 112.383 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 C--N 1.347 0.469 0 C-N-CA 122.609 2.206 . . . . 0.0 112.703 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.621 0.248 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -116.71 159.22 22.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.815 0.34 . . . . 0.0 111.28 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -151.27 143.05 23.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -138.24 145.91 41.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.774 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.437 ' HB3' ' CB ' ' A' ' 16' ' ' ARG . 10.5 tp -138.48 159.76 41.26 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.044 0.449 . . . . 0.0 111.683 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.13 173.39 9.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.327 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' GLU . . . -65.52 -25.5 67.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.746 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.48 -39.52 23.31 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.865 0.364 . . . . 0.0 110.675 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 1.3 mp -101.1 -34.26 9.79 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.337 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.29 -12.01 61.29 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -71.1 -34.4 71.07 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 121.289 -0.164 . . . . 0.0 111.361 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.3 -37.79 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.15 -45.83 9.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.586 0.232 . . . . 0.0 111.437 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.34 -25.57 27.81 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.534 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 t -106.14 111.58 24.25 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.857 0.36 . . . . 0.0 110.814 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.437 ' CB ' ' HB3' ' A' ' 5' ' ' LEU . 1.7 ptt-85 -102.66 -45.77 4.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.709 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 p -99.73 140.64 33.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 111.436 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.09 129.59 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.927 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -110.52 136.0 50.32 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.519 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.51 137.43 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.861 0.362 . . . . 0.0 111.652 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.71 -21.25 11.77 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.584 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.87 152.21 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.875 0.369 . . . . 0.0 111.615 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.7 153.53 26.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.132 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.68 -155.08 9.02 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.784 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.56 30.36 5.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.725 0.298 . . . . 0.0 111.492 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.13 123.7 29.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.044 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.72 164.25 26.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.781 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.7 t -73.76 -30.08 27.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.536 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.656 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -87.21 -29.48 22.4 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.425 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.44 -41.84 77.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.589 0.233 . . . . 0.0 111.077 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.504 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -84.27 -32.31 24.48 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.373 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 tt -56.48 -61.22 2.56 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.346 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.68 -37.74 88.49 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.403 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -59.83 -53.58 56.26 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.618 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.1 mt -64.88 -20.62 66.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.007 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.34 -48.47 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.57 -39.47 1.21 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.804 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.461 ' C ' ' HD3' ' A' ' 40' ' ' PRO . . . -72.85 -0.49 13.6 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.79 68.73 16.18 Favored Pre-proline 0 N--CA 1.453 -0.301 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 85.9 Cg_exo -48.63 -19.11 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.123 2.549 . . . . 0.0 113.362 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.36 -38.72 54.67 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -83.79 -19.81 34.38 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 64.48 118.89 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.7 t -94.94 -26.64 16.04 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.046 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.48 174.16 10.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.016 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.22 39.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.885 0.374 . . . . 0.0 111.543 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -175.3 83.49 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.928 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.93 -97.67 0.11 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.36 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -156.75 141.73 17.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.718 0.294 . . . . 0.0 111.029 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -100.49 -28.92 12.65 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.365 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.99 -159.54 21.73 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.222 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -160.31 145.03 14.55 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.755 0.312 . . . . 0.0 111.465 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -172.4 -49.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.075 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -146.23 141.15 27.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -106.19 119.47 39.31 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.89 97.25 10.25 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -163.07 126.19 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.991 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -85.87 144.02 27.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.515 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.99 147.9 23.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.338 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tp -107.46 118.3 36.37 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.849 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.31 85.8 1.81 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.297 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 63.8 16.32 9.7 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.917 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.6 23.75 27.72 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.536 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.98 162.67 14.61 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.831 0.348 . . . . 0.0 110.858 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.31 102.48 13.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.42 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.75 109.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.305 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -104.75 148.66 26.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.028 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.656 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 6.2 tt -139.11 -67.37 0.45 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.045 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.02 52.75 3.69 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.844 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.49 24.77 7.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.63 0.252 . . . . 0.0 111.621 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.06 -29.65 65.57 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.308 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.68 1.38 56.88 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.97 175.28 6.77 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.833 0.349 . . . . 0.0 111.363 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.68 53.59 2.76 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.215 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.34 163.54 9.62 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.878 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.71 -67.9 0.76 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 110.531 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.57 -172.32 2.87 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.739 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.11 -52.47 2.76 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.69 0.281 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.16 170.13 22.97 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.949 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tt -147.99 112.23 5.23 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.837 0.351 . . . . 0.0 111.083 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -130.9 136.32 28.71 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.054 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.31 146.19 50.23 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.628 2.219 . . . . 0.0 112.531 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--N 1.35 0.636 0 C-N-CA 122.805 2.337 . . . . 0.0 112.603 -179.915 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.042 0.449 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 77' ' ' GLU . 19.9 mt-10 -141.04 175.44 9.63 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.438 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CH2' ' HA ' ' A' ' 32' ' ' LEU . 1.5 t90 -155.41 118.62 4.38 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.986 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 7.0 mtpp -102.55 145.79 29.09 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.559 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -136.5 137.21 40.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.722 0.296 . . . . 0.0 111.723 -179.111 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.58 163.39 14.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.632 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.08 -29.19 28.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.518 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -47.62 -38.5 14.79 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.958 0.409 . . . . 0.0 110.667 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mp -119.19 -3.18 10.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.481 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.99 -9.18 40.79 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.55 -44.37 76.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.578 0.228 . . . . 0.0 111.108 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 15.4 t -94.26 -29.96 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.074 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . . . -69.43 -41.67 76.02 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.582 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.62 -6.78 81.75 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.479 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.39 152.17 51.57 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 110.998 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.559 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -110.7 -76.81 0.6 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.474 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.7 p -95.93 136.65 36.08 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.854 0.359 . . . . 0.0 111.428 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.21 121.33 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.763 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.41 151.19 21.81 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.955 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p -118.16 120.74 65.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.84 0.353 . . . . 0.0 111.275 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -33.52 6.02 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.17 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 m -87.41 134.23 28.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.15 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -117.01 134.21 55.03 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.82 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.45 -109.17 0.29 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.649 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.15 25.8 6.47 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 111.454 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.32 141.97 49.55 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.753 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.5 177.38 4.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' A' ' 68' ' ' LEU . 42.2 t -78.1 -50.32 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.055 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -78.67 -25.63 60.27 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.146 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.69 -39.86 85.95 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.645 0.26 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.94 -33.1 18.58 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.815 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.527 ' HA ' ' CH2' ' A' ' 3' ' ' TRP . 0.3 OUTLIER -60.27 -57.47 12.66 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.457 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.29 -33.97 73.11 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.382 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.86 -52.35 15.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.096 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.8 -27.76 68.99 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.428 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.4 t -94.24 -41.07 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.54 0.21 . . . . 0.0 111.365 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.2 -37.0 91.15 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.045 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.08 -25.07 13.55 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.561 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 17.0 m80 63.19 44.78 0.59 Allowed Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 122.675 0.39 . . . . 0.0 111.324 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 53.6 Cg_exo -51.77 -31.31 41.3 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.942 1.761 . . . . 0.0 111.71 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 12' ' ' VAL . . . -56.46 -32.1 64.63 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.389 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.94 -3.12 9.15 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -79.47 87.47 5.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.832 0.348 . . . . 0.0 111.041 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.0 -53.6 3.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.26 103.87 0.07 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.526 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.6 t 56.59 70.12 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.994 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.17 -59.58 1.39 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.936 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.48 62.68 0.54 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.487 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.65 -70.23 0.25 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.485 0.183 . . . . 0.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -109.89 -29.48 8.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.295 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.02 123.77 0.22 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.909 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -127.37 33.75 4.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.682 0.277 . . . . 0.0 111.273 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.45 163.3 36.96 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.89 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -101.82 112.24 24.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.97 147.89 44.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.41 ' HB3' ' HG2' ' A' ' 83' ' ' PRO . 3.5 t60 -117.25 149.79 39.85 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 pt -136.8 104.45 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.29 151.4 33.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.8 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.98 151.81 33.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.714 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -114.35 130.07 56.67 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.663 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -123.18 145.6 48.49 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.741 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -52.09 -38.4 57.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.371 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.04 22.64 6.79 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.807 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.82 164.63 19.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.726 0.263 . . . . 0.0 110.715 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.27 105.76 0.97 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.23 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.31 153.46 46.98 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.375 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -113.7 179.85 3.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.293 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.453 ' HA ' ' HB ' ' A' ' 28' ' ' VAL . 3.2 pp -111.67 -33.16 6.43 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.989 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.5 32.22 3.69 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.854 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -153.28 90.96 1.46 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.813 0.306 . . . . 0.0 111.269 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.407 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -67.66 -12.7 61.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.97 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 t -88.2 34.14 0.74 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.953 0.406 . . . . 0.0 111.056 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.56 167.38 11.97 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.11 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.48 40.56 1.84 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.699 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.58 67.0 0.02 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.59 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' HB3' HG11 ' A' ' 28' ' ' VAL . 34.6 m-20 -69.17 -71.16 0.23 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.711 0.291 . . . . 0.0 110.57 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 2' ' ' GLU . 34.7 tt0 -140.45 156.36 46.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.554 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -100.62 -42.99 6.31 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.766 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.451 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -169.44 163.18 10.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.425 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.26 113.24 10.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.994 0.426 . . . . 0.0 110.439 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -146.22 140.57 15.57 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.303 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.46 151.46 37.53 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.36 2.04 . . . . 0.0 111.857 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.41 ' HG2' ' HB3' ' A' ' 56' ' ' HIS . 34.7 Cg_exo . . . . . 0 C--N 1.348 0.529 0 C-N-CA 122.673 2.248 . . . . 0.0 112.068 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.893 0.378 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -142.58 163.76 31.95 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.03 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -153.99 141.54 19.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.103 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -138.43 143.1 39.55 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 16' ' ' ARG . 13.2 tp -136.73 156.48 48.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 111.646 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.553 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -81.27 -177.73 6.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.359 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.38 -12.29 60.23 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -54.03 -38.12 64.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.781 0.324 . . . . 0.0 111.044 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 42' ' ' LEU . 2.2 mp -105.48 -38.22 6.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.326 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 16' ' ' ARG . . . -64.73 -17.83 64.48 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -67.13 -26.85 66.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.429 0.156 . . . . 0.0 111.166 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 t -98.19 -44.37 12.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.62 -42.55 10.13 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.48 -28.14 14.46 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.84 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 t -100.45 108.25 20.18 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.826 0.346 . . . . 0.0 111.043 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -98.62 -42.43 7.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.531 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -93.75 147.5 22.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.068 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -142.11 113.24 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.191 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.13 136.24 37.95 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.441 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.56 124.88 66.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 111.407 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.78 -34.41 7.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.054 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.62 145.3 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 120.813 0.339 . . . . 0.0 111.257 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -116.66 121.72 42.48 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.99 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.84 -107.93 1.62 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.395 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.33 -10.64 16.88 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.21 145.34 51.54 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.744 0.307 . . . . 0.0 111.39 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.03 170.92 7.92 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.084 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 24.6 t -75.01 -37.64 41.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.462 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' H ' ' HA ' ' A' ' 68' ' ' LEU . . . -88.78 -33.87 9.58 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.17 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -55.49 -45.22 77.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.665 0.269 . . . . 0.0 111.139 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.75 -24.68 52.98 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.934 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 tt -66.72 -58.17 5.63 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -62.63 -31.6 72.48 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.832 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.62 -48.3 48.83 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.938 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.31 -21.45 66.61 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.011 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.4 -49.26 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.82 -35.41 1.38 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.826 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.47 -1.21 20.18 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -126.11 65.63 57.22 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 110.471 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.28 -19.64 9.77 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.825 2.35 . . . . 0.0 112.576 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.03 -29.03 27.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.576 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -96.21 -16.25 21.56 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.597 0.237 . . . . 0.0 111.453 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -73.25 131.56 42.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.708 0.29 . . . . 0.0 111.394 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -89.67 -32.84 16.86 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.214 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -145.61 164.46 31.66 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.7 0.286 . . . . 0.0 111.129 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.56 59.28 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -151.79 93.53 1.87 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.848 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.09 32.32 83.74 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.825 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -90.41 -35.45 15.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.631 0.215 . . . . 0.0 111.101 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -28.74 66.98 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.588 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.57 105.45 0.22 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.526 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -84.36 75.36 10.24 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.802 0.334 . . . . 0.0 111.109 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 tt 68.19 -70.51 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.193 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -117.72 123.68 46.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.655 0.264 . . . . 0.0 110.569 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -149.61 143.65 25.68 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.241 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -97.84 144.46 27.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.2 pt -152.51 125.33 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.743 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -99.94 135.39 41.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 p -140.6 153.96 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.256 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mp -132.18 133.09 43.81 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.965 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.11 84.29 1.64 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.424 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 54.11 18.96 1.91 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.076 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.36 23.06 59.36 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.711 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -138.1 166.99 22.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.08 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.39 127.86 34.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.744 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.16 157.52 13.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.508 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.435 ' O ' ' HB ' ' A' ' 28' ' ' VAL . . . -110.25 174.54 5.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.403 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.46 ' HA ' ' H ' ' A' ' 29' ' ' GLY . 2.1 tt -149.58 20.23 0.92 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.445 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.31 19.38 1.35 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.588 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 178.27 85.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.139 0.469 . . . . 0.0 111.417 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB1' ' N ' ' A' ' 28' ' ' VAL . . . -82.71 6.97 16.22 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.779 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 t -83.91 -14.9 49.84 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.53 0.205 . . . . 0.0 111.254 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.08 131.26 54.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.707 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.82 23.73 11.59 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.975 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.71 -129.82 22.27 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.346 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.34 -72.85 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.52 0.2 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.53 -166.85 1.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mt -111.75 -55.47 2.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.708 0.289 . . . . 0.0 110.958 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.89 164.37 38.96 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.225 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.29 115.29 10.23 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.004 0.43 . . . . 0.0 110.741 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -107.77 108.26 61.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 6' ' ' PHE . 58.7 Cg_endo -71.67 171.48 16.31 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.777 2.318 . . . . 0.0 112.492 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo . . . . . 0 C--N 1.349 0.598 0 C-N-CA 122.651 2.234 . . . . 0.0 112.583 -179.936 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.609 0.242 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.94 154.14 44.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.046 0.45 . . . . 0.0 111.497 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -145.8 143.85 29.92 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.412 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 12.9 mttp -135.03 136.43 42.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.525 0.202 . . . . 0.0 110.654 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.538 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 3.9 tp -129.95 135.21 48.06 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.798 0.332 . . . . 0.0 111.07 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -81.8 176.35 9.67 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.414 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 11' ' ' GLU . . . -63.79 -16.16 60.52 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -55.51 -30.43 60.65 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.739 0.304 . . . . 0.0 110.906 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 3.3 mp -119.31 -36.26 3.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.335 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.47 -15.48 50.13 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -71.63 -26.79 62.71 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -95.7 -39.14 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.19 -42.4 9.38 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.18 23.19 10.72 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.736 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.71 136.96 49.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.538 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -113.5 -81.63 0.6 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.428 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 5.0 p -92.69 149.0 21.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.872 0.368 . . . . 0.0 111.464 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.16 118.29 6.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.976 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 148.17 28.18 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.467 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -103.14 120.2 52.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.97 -15.88 14.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.541 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.79 150.81 3.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.594 0.235 . . . . 0.0 110.968 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.86 172.48 0.95 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.433 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.15 85.13 0.91 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.937 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.59 -44.09 4.77 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.472 0.177 . . . . 0.0 111.402 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.55 165.82 12.15 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.751 0.31 . . . . 0.0 111.246 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.16 165.17 22.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.45 -24.3 14.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.731 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 68' ' ' LEU . . . -88.95 -27.52 23.52 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.051 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.18 -47.78 68.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.687 0.279 . . . . 0.0 110.912 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.499 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -79.61 -34.59 40.54 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.605 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.4 ' CD1' HG21 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -53.12 -60.06 3.77 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.393 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.2 -35.48 80.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.13 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -57.87 -55.38 35.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.646 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 17.9 mt -66.77 -23.16 66.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.875 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.21 -47.58 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -125.41 -37.8 0.51 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.201 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -71.48 -1.54 13.62 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -129.29 67.03 78.09 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 120.816 0.341 . . . . 0.0 110.667 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.33 -16.82 14.31 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.715 2.277 . . . . 0.0 112.588 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.45 -25.59 16.77 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -99.5 -22.43 15.49 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.634 0.254 . . . . 0.0 111.365 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -98.85 163.61 12.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.917 0.389 . . . . 0.0 111.363 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -97.81 -49.52 4.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.71 135.66 23.6 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.732 0.301 . . . . 0.0 111.176 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -154.71 31.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.132 0.491 . . . . 0.0 111.287 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.2 -75.21 0.6 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.864 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.26 74.59 0.38 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.263 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.52 167.67 5.37 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.782 0.325 . . . . 0.0 111.343 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -96.86 31.58 2.32 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.441 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.11 57.79 0.03 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.903 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -163.94 132.72 3.75 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.794 0.331 . . . . 0.0 111.317 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.37 -38.15 5.06 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 135.54 46.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.603 0.24 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.29 168.82 11.06 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.145 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -114.5 111.23 21.07 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.087 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 mt -149.74 126.42 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.074 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.24 163.4 16.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 32' ' ' LEU . 10.8 p -140.64 149.6 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.372 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.61 118.31 33.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.717 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.3 85.53 2.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.556 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 61.44 16.87 7.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.736 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.62 23.62 33.04 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.31 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -101.99 163.16 12.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.859 0.361 . . . . 0.0 110.82 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 102.91 14.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.424 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 54.7 96.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.884 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.73 143.69 32.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.438 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.462 ' HA ' ' N ' ' A' ' 29' ' ' GLY . 9.0 tt -143.79 -52.49 0.34 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.014 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.88 53.04 4.04 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.1 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.31 22.15 8.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.62 0.248 . . . . 0.0 111.533 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.89 -30.01 60.87 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.169 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.88 31.13 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.338 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.22 -175.39 2.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.75 0.31 . . . . 0.0 111.105 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.86 -32.42 67.47 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.514 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.14 -124.62 1.54 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.559 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.21 -79.05 0.39 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.684 0.278 . . . . 0.0 110.737 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -147.23 -165.38 2.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.606 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 tp -112.69 -51.95 2.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.628 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -153.95 167.22 30.48 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.171 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.04 97.69 3.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.699 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.463 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 34.9 p90 -149.58 149.64 29.03 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-O 120.638 0.256 . . . . 0.0 111.603 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.531 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 39.1 Cg_exo -55.39 -49.45 16.14 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.871 2.381 . . . . 0.0 112.915 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 82' ' ' PRO . 76.5 Cg_exo . . . . . 0 C--N 1.355 0.902 0 C-N-CA 122.689 2.259 . . . . 0.0 112.974 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttm . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -146.84 171.98 14.36 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.814 0.34 . . . . 0.0 111.193 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -145.82 131.84 19.27 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.091 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -136.8 158.41 44.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.504 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.455 ' CB ' ' HB3' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -150.1 163.0 39.32 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.879 0.371 . . . . 0.0 111.588 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.96 179.99 4.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.338 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.57 -11.84 47.71 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.236 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.412 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -52.81 -36.78 58.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.88 0.371 . . . . 0.0 110.357 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.598 ' HB3' HD13 ' A' ' 42' ' ' LEU . 7.8 mt -122.03 -39.44 2.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.469 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.73 -13.96 38.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -82.84 -28.12 30.36 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.844 0.354 . . . . 0.0 110.503 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 74.8 t -85.73 -30.88 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.355 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 42' ' ' LEU . . . -99.22 -39.52 8.41 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.891 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.61 -37.64 2.14 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.152 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.2 p -173.95 138.17 0.6 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.594 0.235 . . . . 0.0 110.766 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 3.2 tpm_? -131.02 17.65 5.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.75 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.8 p -96.95 122.29 39.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.652 0.263 . . . . 0.0 110.413 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.57 166.07 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.44 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.05 142.89 50.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.377 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -102.19 120.52 52.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.169 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.71 -54.44 0.77 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.23 154.52 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.274 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -117.15 122.04 42.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.33 -81.31 0.04 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.061 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.96 25.14 4.97 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.775 0.321 . . . . 0.0 111.211 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.19 116.93 25.85 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.803 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.4 174.57 5.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.984 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.42 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 54.9 t -73.3 -36.94 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.28 -33.39 44.52 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.86 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.8 -37.55 79.44 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.558 0.343 . . . . 0.0 110.988 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.54 -30.93 21.54 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.93 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -58.69 7.39 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.524 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.68 -36.67 83.64 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -59.6 -51.56 69.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.585 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.9 mp -67.39 -30.74 70.6 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.706 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.78 -52.13 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.835 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.24 30.34 0.05 OUTLIER Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.748 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -105.24 -0.58 26.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.799 0.3 . . . . 0.0 111.565 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -123.62 69.39 44.13 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -44.24 -21.85 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.29 2.66 . . . . 0.0 113.627 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.411 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -50.82 -28.0 8.49 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.598 HD13 ' HB3' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -113.87 5.81 16.4 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -94.09 120.73 34.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.535 0.207 . . . . 0.0 111.08 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 t -97.1 -53.31 3.54 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.658 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.44 146.68 36.81 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.837 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -112.89 18.47 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.549 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 38.6 t80 69.67 -67.95 0.21 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 122.649 0.38 . . . . 0.0 111.567 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.39 -2.15 85.44 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.304 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' HA ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER 67.65 -75.55 0.06 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.033 0.417 . . . . 0.0 111.1 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -120.52 31.8 6.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.956 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.14 112.45 0.53 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.516 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.14 107.81 7.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.859 0.361 . . . . 0.0 111.19 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -107.6 -35.03 6.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.207 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -101.5 134.2 44.98 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.675 0.274 . . . . 0.0 111.145 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.4 129.28 56.15 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.058 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -147.1 129.27 15.61 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.5 tt -170.17 146.71 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.61 141.61 35.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.17 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.2 153.82 24.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.211 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.94 127.3 54.09 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.725 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 142.8 49.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -63.0 -21.29 66.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.691 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.56 5.58 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.7 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.7 165.99 12.64 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.609 0.242 . . . . 0.0 110.776 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.29 121.68 10.72 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.27 127.69 33.37 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.509 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.74 179.22 5.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.634 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.7 tt -167.38 -54.31 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.904 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.86 19.75 43.59 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.096 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -174.47 101.17 0.09 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.987 0.394 . . . . 0.0 111.012 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -75.64 -5.15 44.09 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.785 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 t -91.29 33.89 0.96 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.044 0.449 . . . . 0.0 111.07 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.41 -173.7 3.67 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.74 -33.54 56.02 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.497 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.33 146.82 6.65 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.715 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.24 -80.11 0.31 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.33 -173.54 4.62 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.39 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.3 mt -108.41 -40.15 5.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.632 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -169.79 169.68 8.28 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.869 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.79 105.94 5.24 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 110.983 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -92.12 112.37 54.68 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.842 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HG2' ' HB2' ' A' ' 8' ' ' ASP . 51.0 Cg_exo -54.14 167.73 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.047 2.498 . . . . 0.0 113.082 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo . . . . . 0 C--N 1.35 0.646 0 C-N-CA 123.117 2.545 . . . . 0.0 112.836 -179.622 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptm . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 120.619 0.247 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -143.45 160.3 40.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -148.43 143.54 26.83 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.28 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . 0.6 OUTLIER -134.95 143.57 46.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.293 179.331 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.405 ' HB3' ' CA ' ' A' ' 16' ' ' ARG . 12.2 tp -133.08 157.8 44.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 111.308 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -89.14 162.6 15.86 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.76 62.11 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.762 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -55.2 -32.09 61.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.79 0.329 . . . . 0.0 110.525 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -110.9 -38.39 5.12 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.094 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.47 -13.25 60.57 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -72.16 -25.73 61.81 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 t -93.72 -44.18 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.21 -28.94 26.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.628 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.1 -21.53 44.69 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.726 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.26 130.23 55.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.405 ' CA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -109.5 -48.03 3.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.735 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.4 ' CG2' ' HG2' ' A' ' 4' ' ' LYS . 2.3 p -92.3 141.14 28.88 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.038 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.7 t -142.09 125.8 15.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -95.87 154.11 17.4 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.697 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 t -102.02 120.54 51.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.0 -73.99 0.66 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 p -98.53 146.22 8.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.001 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -88.12 137.71 32.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.52 -120.77 0.6 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.452 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -100.69 36.54 1.9 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 111.048 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.33 120.1 39.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.752 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.08 173.57 6.43 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -77.62 -39.59 27.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.973 0.416 . . . . 0.0 110.137 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.405 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -81.21 -32.04 32.78 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.75 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.98 -45.61 94.1 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.692 0.282 . . . . 0.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.43 -30.95 57.6 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.648 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.03 -58.29 8.82 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.928 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -60.51 -39.31 87.31 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.413 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.453 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -58.57 -55.19 38.29 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.34 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.28 -24.01 67.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.926 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.525 HG21 HG22 ' A' ' 57' ' ' ILE . 94.4 t -83.87 -50.1 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.391 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.63 -27.87 0.03 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.557 -0.83 . . . . 0.0 114.529 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -65.96 -5.79 10.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.72 70.9 80.95 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.44 ' HA ' ' CD ' ' A' ' 43' ' ' GLU . 84.4 Cg_exo -49.38 -17.35 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.176 2.584 . . . . 0.0 113.388 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.69 7.34 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -100.38 -19.33 16.34 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' CD ' ' HA ' ' A' ' 40' ' ' PRO . 2.1 pt-20 -107.57 126.94 53.16 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.121 -0.362 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -79.31 -52.35 8.22 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.971 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.69 144.95 9.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.86 0.362 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -158.34 -41.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.523 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 81.51 -59.08 0.24 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.657 0.383 . . . . 0.0 110.321 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.41 57.41 4.93 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.495 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.13 -48.69 73.32 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.669 0.271 . . . . 0.0 110.781 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -27.61 54.71 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.78 -41.38 2.16 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.812 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.21 27.53 16.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.626 0.25 . . . . 0.0 111.453 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mt -175.02 -66.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.852 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -130.26 132.95 46.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.165 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -131.97 115.21 15.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.99 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.61 145.88 50.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.701 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.525 HG22 HG21 ' A' ' 36' ' ' VAL . 1.6 pt -150.32 111.06 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.878 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -73.08 139.14 46.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -139.3 151.94 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.403 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -112.99 130.53 56.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.899 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -115.16 145.47 42.34 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.501 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -89.76 15.32 9.9 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.681 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.43 23.15 12.9 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.645 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -115.65 163.5 15.7 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.707 0.289 . . . . 0.0 110.981 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.16 127.73 32.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.454 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.77 95.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.245 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.1 174.64 7.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.942 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 5.7 tt -163.71 -59.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.913 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.63 23.57 34.64 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.887 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -172.51 88.79 0.09 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.83 0.348 . . . . 0.0 110.785 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.31 -7.02 54.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.547 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -91.74 11.32 24.98 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.548 0.213 . . . . 0.0 111.38 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.83 132.56 53.32 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.624 0.249 . . . . 0.0 111.283 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.06 -76.04 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.804 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.8 164.73 30.07 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.459 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.41 -83.37 0.13 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.601 0.238 . . . . 0.0 110.803 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 2.8 pt-20 -168.91 -169.24 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -110.28 -46.65 3.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.301 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -157.04 164.64 37.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 tp -144.62 97.93 3.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 111.047 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -115.56 127.69 26.59 Favored Pre-proline 0 N--CA 1.463 0.184 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.207 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.77 172.59 1.07 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.851 2.367 . . . . 0.0 112.632 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--N 1.348 0.516 0 C-N-CA 122.687 2.258 . . . . 0.0 112.282 179.801 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.421 ' SD ' HG12 ' A' ' 20' ' ' VAL . 14.2 mmt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.667 0.27 . . . . 0.0 111.514 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.416 ' HB3' ' HG3' ' A' ' 19' ' ' ARG . 1.7 mt-10 -156.08 174.79 14.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.961 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.96 139.42 23.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.588 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 0.7 OUTLIER -131.31 156.38 45.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.304 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.498 ' CD2' ' HB3' ' A' ' 16' ' ' ARG . 2.8 mm? -140.0 156.33 46.68 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.111 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.22 -178.67 3.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.761 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.32 -33.23 12.79 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -51.5 -36.8 46.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 110.232 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 4.8 mp -110.27 -8.88 14.68 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.089 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.48 -9.49 38.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -59.2 -39.34 82.31 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 25.8 t -97.85 -36.9 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . . . -88.6 -45.8 9.58 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.91 -32.01 7.06 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.916 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.3 107.03 0.07 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.698 0.285 . . . . 0.0 110.63 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.498 ' HB3' ' CD2' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.23 35.38 2.42 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.428 ' CG2' ' HG2' ' A' ' 4' ' ' LYS . 8.8 p -93.66 113.95 26.16 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.082 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.463 ' HB ' ' CD1' ' A' ' 3' ' ' TRP . 1.9 t -131.34 166.62 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.035 0.445 . . . . 0.0 111.934 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.416 ' HG3' ' HB3' ' A' ' 2' ' ' GLU . 3.2 mpp_? -131.4 158.8 39.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.421 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.421 HG12 ' SD ' ' A' ' 1' ' ' MET . 11.9 p -102.03 120.43 51.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.095 0.474 . . . . 0.0 111.103 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.16 -45.02 1.25 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.172 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.83 113.73 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.15 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -116.21 139.12 50.68 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.8 37.0 1.46 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.716 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.22 -60.33 0.17 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.701 0.286 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.31 176.37 5.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.779 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.35 171.67 7.34 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.025 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -77.29 -39.46 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 120.765 0.317 . . . . 0.0 110.989 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.458 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -88.13 -27.68 25.12 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.417 -0.896 . . . . 0.0 112.32 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.57 -35.89 73.09 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.62 0.247 . . . . 0.0 110.911 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -91.64 -37.07 13.28 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.484 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tt -51.31 -50.88 58.5 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 120.746 0.308 . . . . 0.0 110.369 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -58.91 -34.55 71.81 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.25 -52.89 11.01 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.773 0.321 . . . . 0.0 110.743 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -65.73 -22.84 66.63 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.451 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.1 t -95.23 -40.32 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.817 -0.174 . . . . 0.0 111.052 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.78 -37.38 90.11 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.608 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.04 -34.25 9.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.609 0.242 . . . . 0.0 111.299 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.477 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 12.8 m-70 60.14 54.81 4.08 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.327 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 51.1 Cg_exo -52.44 -22.08 15.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.242 1.961 . . . . 0.0 111.993 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.459 ' HA ' ' CB ' ' A' ' 13' ' ' ALA . . . -62.2 -35.14 77.97 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.497 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.4 1.5 10.16 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.507 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -84.46 103.65 13.79 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 m -75.55 -28.95 59.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.42 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 60.28 76.03 0.38 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 111.004 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.23 -59.76 3.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.824 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -173.23 -58.23 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.78 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -134.22 95.79 0.28 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.261 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -63.44 160.42 16.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.927 0.394 . . . . 0.0 111.343 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -76.73 -29.05 56.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.203 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.55 -139.61 14.62 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.774 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -158.79 139.55 12.72 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.662 0.267 . . . . 0.0 110.913 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.21 -57.1 3.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.873 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -125.87 161.4 27.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.825 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.72 113.59 25.9 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.234 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.25 116.79 14.8 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.383 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.1 tp -172.52 143.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -120.15 156.36 31.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.809 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.58 144.9 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.516 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.12 118.4 36.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.422 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.14 145.62 47.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.103 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -61.42 -15.86 41.04 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.764 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.95 23.91 5.39 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.856 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -104.13 166.06 10.65 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.731 0.301 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.94 121.44 13.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.89 113.32 2.01 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.232 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.75 166.31 15.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CD2' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -164.98 -50.68 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.399 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.36 28.96 13.61 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.125 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -164.04 102.44 0.87 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.788 0.294 . . . . 0.0 110.98 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.33 -26.82 68.65 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.241 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.3 t -95.99 37.18 1.24 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.07 0.462 . . . . 0.0 111.206 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.06 -173.68 4.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.09 -55.84 27.82 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.352 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.7 133.69 2.36 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.149 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -81.58 0.07 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.572 0.225 . . . . 0.0 110.535 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -160.14 179.89 8.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.489 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.6 mt -101.19 -41.13 6.84 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.777 0.323 . . . . 0.0 110.517 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.65 167.46 26.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.985 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.46 100.9 4.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.324 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -123.69 136.7 27.61 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.47 148.81 30.17 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.348 2.032 . . . . 0.0 112.042 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 122.839 2.359 . . . . 0.0 112.059 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.661 0.267 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -152.15 167.41 28.64 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.795 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.447 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -155.02 166.89 32.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.108 0.48 . . . . 0.0 111.372 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 35.0 mtpt -136.44 156.97 47.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.33 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 16' ' ' ARG . 6.8 tp -146.37 160.48 42.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.262 0.554 . . . . 0.0 112.229 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -97.66 172.96 7.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.332 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.19 -19.1 62.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.741 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.82 -42.33 25.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.807 0.337 . . . . 0.0 111.029 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.411 ' HG ' ' CD2' ' A' ' 42' ' ' LEU . 5.9 mp -108.66 -33.29 7.05 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.645 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.89 -10.76 41.52 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -56.43 -40.31 74.52 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.462 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 11.7 t -97.77 -53.07 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.77 -41.32 97.56 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.508 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.68 -15.15 62.25 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.416 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -116.77 128.68 55.53 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -109.58 -58.54 2.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.804 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 6.0 p -92.86 133.53 35.99 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.817 0.342 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 3' ' ' TRP . 9.6 t -140.34 163.37 23.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -130.52 149.87 51.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.58 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.9 t -101.97 120.22 51.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.939 0.4 . . . . 0.0 110.939 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.38 -50.84 0.75 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.73 154.56 3.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.23 133.06 56.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.067 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.5 -153.69 6.88 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.603 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -33.61 76.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.558 0.179 . . . . 0.0 111.288 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.08 116.15 4.31 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.137 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.82 178.08 8.2 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.781 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -77.98 -38.04 23.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.617 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.574 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -87.74 -27.51 26.56 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.23 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.31 -41.13 68.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.651 0.262 . . . . 0.0 110.768 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.14 -26.45 23.6 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.86 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.7 tp -62.24 -57.46 11.36 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.382 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -56.99 -40.4 76.5 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.982 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.95 -51.87 59.43 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.645 0.259 . . . . 0.0 110.36 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.9 mp -62.52 -35.88 80.81 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.86 -52.27 63.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.59 0.233 . . . . 0.0 110.69 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 158.02 52.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.638 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.35 -61.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.208 0.051 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.412 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 1.3 m-70 172.02 -62.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 123.442 0.464 . . . . 0.0 111.008 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 39' ' ' HIS . 8.0 Cg_endo -50.03 -27.76 17.43 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.626 2.217 . . . . 0.0 112.326 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.54 -31.67 70.76 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 1.6 pt? -136.65 29.76 2.9 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.28 155.77 0.12 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 111.251 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.1 p -78.35 -35.54 47.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.214 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -62.83 98.21 0.12 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.855 0.359 . . . . 0.0 110.994 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -58.03 -40.21 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.613 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.85 87.12 0.1 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 49' ' ' ASP . . . 100.32 -34.22 5.72 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.661 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 1.8 m-20 70.11 139.93 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.956 0.407 . . . . 0.0 111.383 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -111.03 -28.9 8.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.786 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.29 156.74 6.96 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.94 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.3 98.26 3.28 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.832 0.349 . . . . 0.0 111.362 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 54' ' ' TYR . 1.3 pt? -174.1 -42.8 0.01 OUTLIER 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.557 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.414 ' N ' ' HG ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -158.83 141.5 14.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.654 0.264 . . . . 0.0 111.234 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.06 142.05 29.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.176 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.437 ' CD2' ' HG2' ' A' ' 83' ' ' PRO . 2.0 t60 -110.68 135.06 51.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.636 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.5 pt -143.91 115.01 2.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -90.49 138.28 31.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.833 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.89 151.32 27.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.198 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.88 118.9 36.8 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.615 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -121.69 145.52 47.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.909 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -67.9 -13.4 62.12 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.724 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.58 23.57 5.63 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.736 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -103.19 165.49 10.99 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.782 0.325 . . . . 0.0 110.793 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.33 125.08 25.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.54 95.45 0.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.83 149.03 25.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.101 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.574 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 8.1 tt -126.2 -61.13 1.24 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.203 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.11 44.81 3.38 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.129 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -151.11 72.93 1.08 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.761 0.28 . . . . 0.0 111.104 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.05 -28.01 15.76 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.635 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.22 34.78 0.93 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.756 0.313 . . . . 0.0 111.442 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.77 176.72 6.05 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.894 0.378 . . . . 0.0 111.242 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.67 32.05 3.54 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.668 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.63 158.82 10.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.557 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -76.39 0.59 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.743 0.306 . . . . 0.0 111.275 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -145.53 -162.65 1.55 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.972 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.66 -45.12 2.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.487 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -156.61 169.14 25.35 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tt -153.32 122.15 6.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.859 0.361 . . . . 0.0 110.605 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -150.7 135.84 10.11 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.285 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 6' ' ' PHE . 84.4 Cg_endo -78.94 146.55 20.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.671 2.248 . . . . 0.0 112.614 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.437 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 45.6 Cg_exo -56.32 145.36 78.52 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.808 2.339 . . . . 0.0 112.489 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -165.74 119.99 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.977 0.418 . . . . 0.0 111.192 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m -142.66 135.86 28.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.853 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.14 -44.31 1.51 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.483 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.341 -1.255 . . . . 0.0 112.374 179.923 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.817 0.341 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -160.57 172.97 16.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.7 140.84 21.26 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.417 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' HG2' HG22 ' A' ' 17' ' ' THR . 35.9 mttt -137.62 151.9 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.388 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.45 151.11 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.095 0.474 . . . . 0.0 111.879 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.12 -175.61 5.92 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.049 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.48 -20.18 43.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.939 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.68 -43.14 12.38 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.979 0.418 . . . . 0.0 110.81 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.452 ' HG ' ' CD2' ' A' ' 42' ' ' LEU . 4.7 mp -105.17 -31.37 9.16 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.011 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.08 -4.3 28.11 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -36.67 84.7 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.668 0.27 . . . . 0.0 110.936 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 t -97.21 -46.11 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.813 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.25 -45.17 20.31 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.99 -29.55 7.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.114 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 t -167.49 117.14 0.82 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.669 0.271 . . . . 0.0 110.994 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.57 29.19 7.42 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.043 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.408 HG22 ' HG2' ' A' ' 4' ' ' LYS . 11.5 p -95.63 114.03 25.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.328 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.7 161.72 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.215 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.81 152.58 46.77 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.744 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.3 120.33 51.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 0.0 110.776 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.33 -50.09 2.13 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.869 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.55 134.23 52.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.158 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -115.95 152.52 33.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.951 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.91 -81.62 0.15 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.963 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -82.71 -46.65 12.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.665 0.269 . . . . 0.0 111.125 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.64 116.16 4.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.66 172.86 11.88 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.439 HG21 ' CB ' ' A' ' 70' ' ' GLU . 39.0 t -76.71 -35.5 25.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.509 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.25 -32.44 9.64 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.353 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.84 -42.8 80.3 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.741 0.305 . . . . 0.0 110.775 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.62 -27.75 26.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.046 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tp -62.45 -57.2 12.08 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.7 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.04 -40.42 76.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.237 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.02 -52.1 61.07 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.794 0.33 . . . . 0.0 110.949 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.88 -34.41 75.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.318 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.4 -48.89 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.603 0.239 . . . . 0.0 111.023 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.87 53.23 0.02 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.646 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.83 -61.78 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.448 0.166 . . . . 0.0 110.744 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.407 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 2.5 m-70 -179.74 -62.92 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 39' ' ' HIS . 9.8 Cg_endo -52.27 -26.68 27.84 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.301 2.001 . . . . 0.0 112.064 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.41 -27.89 69.4 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.452 ' CD2' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -135.4 28.89 3.34 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 71.16 150.34 0.09 Allowed 'General case' 0 C--N 1.342 0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 110.847 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.9 m -60.38 -43.09 96.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.523 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.62 148.33 29.19 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.805 0.335 . . . . 0.0 110.814 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 p -169.02 -43.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.417 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -172.9 106.79 0.16 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.673 0.273 . . . . 0.0 110.755 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.23 92.57 0.11 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.495 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -65.53 -52.15 54.73 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.572 0.225 . . . . 0.0 110.855 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.24 -28.9 69.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.079 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.25 -166.89 14.0 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.707 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.38 179.8 4.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.692 0.282 . . . . 0.0 110.927 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -35.84 59.86 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.134 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.15 128.97 48.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.72 0.295 . . . . 0.0 111.003 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.18 130.02 55.61 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -142.01 108.29 5.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.176 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.9 pp -150.29 127.72 2.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.51 162.56 12.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.063 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -135.62 152.64 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.649 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.86 131.04 54.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.4 145.46 40.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.202 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -3.63 25.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.895 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.77 23.57 5.57 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.902 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.27 157.71 16.01 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.817 0.342 . . . . 0.0 110.684 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.73 102.73 14.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.297 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.03 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.95 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.84 133.71 50.13 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.991 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.8 -69.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.107 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.03 64.26 1.73 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.479 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' CB ' HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -140.73 47.29 1.75 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.7 -28.15 13.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.782 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.31 33.48 2.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.668 0.27 . . . . 0.0 111.258 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -96.52 174.16 6.99 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.815 0.34 . . . . 0.0 111.461 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.54 -34.09 17.51 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.469 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.68 157.93 27.47 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.429 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -109.32 -72.96 0.7 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.761 0.281 . . . . 0.0 110.644 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.53 -173.16 3.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.308 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.58 -53.22 2.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.611 0.243 . . . . 0.0 110.987 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -164.9 173.71 11.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.1 95.27 3.17 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.214 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -130.32 148.97 72.0 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.245 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.05 148.68 51.21 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.552 2.168 . . . . 0.0 112.545 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.53 134.01 19.83 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.656 2.237 . . . . 0.0 112.479 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 m -65.45 141.16 18.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.41 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.8 p -133.33 -72.04 0.51 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.83 -168.52 38.4 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.735 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.495 -1.17 . . . . 0.0 112.684 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.838 0.352 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -160.3 173.33 15.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.469 ' CH2' HD13 ' A' ' 32' ' ' LEU . 3.1 t90 -155.85 146.17 21.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.44 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -138.07 144.81 41.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.015 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' HB3' ' CB ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -135.34 164.35 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.042 0.449 . . . . 0.0 111.375 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.402 ' HB2' ' CD ' ' A' ' 82' ' ' PRO . 6.4 t80 -89.5 170.08 10.81 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.816 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.57 -9.24 57.92 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.48 -44.06 65.37 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 111.224 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' A' ' 5' ' ' LEU . 5.0 mp -107.49 -32.84 7.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.177 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.68 -7.06 35.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -40.6 91.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.543 0.211 . . . . 0.0 111.005 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 21.1 t -95.08 -46.89 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.522 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.07 -46.51 80.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.752 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.52 11.81 70.87 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.901 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -139.08 92.96 2.64 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.452 ' CB ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -91.22 -42.79 10.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.181 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.8 p -96.64 145.42 25.78 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 120.718 0.294 . . . . 0.0 111.216 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -142.87 108.58 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.24 152.32 21.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.779 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.84 120.23 51.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.748 0.309 . . . . 0.0 111.032 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.34 -72.79 0.38 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.049 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.0 p -94.88 148.54 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.213 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.27 116.07 22.25 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.04 -139.31 3.89 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.635 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -107.01 36.12 2.78 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.845 0.355 . . . . 0.0 111.193 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.89 123.03 41.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.741 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.03 169.32 8.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.766 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 40.8 t -74.18 -33.55 35.28 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.132 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.72 -36.92 9.87 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.086 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.37 -38.68 74.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 110.666 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.39 -23.21 22.24 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.752 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.469 HD13 ' CH2' ' A' ' 3' ' ' TRP . 23.8 tp -63.53 -52.53 60.79 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.499 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -58.54 -41.87 86.54 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.447 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.68 -49.68 61.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.753 0.311 . . . . 0.0 111.206 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.19 -33.35 74.28 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.466 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.51 -48.89 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-O 120.705 0.288 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.91 54.84 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.612 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -62.49 -61.64 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.465 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . 1.1 m170 155.02 -66.47 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.646 0.778 . . . . 0.0 110.423 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 39' ' ' HIS . 11.0 Cg_endo -54.17 -24.74 34.76 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.511 2.141 . . . . 0.0 111.805 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 12' ' ' VAL . . . -61.45 -28.28 69.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.054 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.47 22.8 2.0 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.89 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 61.97 160.06 0.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.246 0.546 . . . . 0.0 111.875 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -14.15 22.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.515 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 150.74 32.49 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.5 p 45.38 34.33 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.169 0.509 . . . . 0.0 111.981 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.95 -60.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.088 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.3 69.27 1.99 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.565 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -69.77 165.19 21.94 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.574 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -82.15 -20.97 36.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.756 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.14 -152.51 1.99 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.596 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.82 91.49 2.71 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.845 0.355 . . . . 0.0 111.192 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tp -97.59 142.7 29.08 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.626 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.03 127.54 53.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.104 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.94 146.97 48.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.075 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -111.42 152.76 27.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.637 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.401 HG22 ' HB3' ' A' ' 82' ' ' PRO . 1.7 pt -156.55 124.99 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.761 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -90.56 137.42 32.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.02 157.99 30.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.31 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.84 122.21 44.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.075 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 145.45 50.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.743 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.94 -19.42 65.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.663 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.28 23.5 5.74 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.743 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.94 165.74 23.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.603 0.24 . . . . 0.0 111.006 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.15 124.64 29.42 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.289 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.22 146.79 23.43 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.368 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.1 -177.75 6.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.968 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.3 -45.02 0.62 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.225 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.53 31.97 6.38 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.787 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -164.7 91.46 0.57 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.787 0.327 . . . . 0.0 111.221 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.45 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -64.83 -17.63 64.41 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.835 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 t -88.83 33.92 0.78 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 111.246 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.68 168.84 12.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.213 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.65 80.36 8.01 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.64 149.87 3.21 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.985 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -133.3 -49.52 0.85 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.573 0.225 . . . . 0.0 111.335 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.461 ' HG3' ' CD1' ' A' ' 3' ' ' TRP . 0.5 OUTLIER -165.04 -172.43 2.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.56 179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.19 -45.18 2.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.516 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -170.35 174.02 5.43 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.343 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tt -152.93 117.72 5.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.324 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -141.46 138.28 17.34 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.568 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 6' ' ' PHE . 77.8 Cg_endo -77.71 169.55 20.61 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.712 2.274 . . . . 0.0 112.452 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.8 131.97 42.7 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.817 2.345 . . . . 0.0 112.038 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.6 t -62.87 133.67 28.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.177 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.07 170.27 7.97 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.958 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.75 -36.61 0.12 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.44 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.615 -1.103 . . . . 0.0 112.692 179.929 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.872 0.368 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' HG2' ' HG3' ' A' ' 19' ' ' ARG . 6.3 mt-10 -146.95 166.17 27.6 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.89 137.69 18.97 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.025 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -134.92 148.86 50.16 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.066 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 3.1 mm? -130.9 152.44 50.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.742 0.306 . . . . 0.0 111.257 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -174.95 3.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 11' ' ' GLU . . . -57.03 -23.04 43.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.854 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.72 -37.8 19.76 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.715 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 10.3 mt -120.57 -34.96 3.49 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.623 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.06 -2.8 22.71 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -91.14 -29.16 17.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.797 0.332 . . . . 0.0 110.36 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.549 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 97.3 t -93.11 -35.89 7.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.357 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 42' ' ' LEU . . . -94.42 -43.5 8.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.62 0.247 . . . . 0.0 111.1 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.98 -40.34 1.75 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.356 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.34 141.12 2.43 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.47 ' HG3' HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -137.57 27.04 2.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.45 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 p -96.45 112.01 23.91 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 110.401 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.97 157.99 41.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.408 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.419 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -129.61 148.91 51.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.584 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.3 120.22 56.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.907 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.35 -52.02 0.82 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.725 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -90.67 153.31 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.32 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.6 142.22 35.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.086 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.19 -111.54 0.27 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.689 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.98 38.25 4.18 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.054 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.03 133.13 56.35 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.981 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.29 167.94 10.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.22 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 t -74.99 -39.18 44.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.943 0.401 . . . . 0.0 110.213 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -83.19 -34.38 20.83 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.221 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.24 -45.83 83.58 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.832 0.349 . . . . 0.0 110.405 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.12 -26.74 53.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.563 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.37 -61.07 2.59 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.258 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.65 -34.25 72.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.114 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -69.05 -50.6 47.06 Favored 'General case' 0 C--N 1.335 -0.046 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.186 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.414 ' N ' HD11 ' A' ' 35' ' ' LEU . 11.1 mp -68.26 -19.5 64.73 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.703 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.78 -44.81 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -133.42 -34.37 0.32 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.273 -0.965 . . . . 0.0 114.476 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.573 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -69.67 -0.94 7.69 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -121.81 64.87 18.11 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 120.738 0.304 . . . . 0.0 110.821 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 86.4 Cg_exo -50.64 -18.9 4.4 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.887 2.392 . . . . 0.0 112.942 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.427 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -49.47 -31.63 10.39 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 4.1 pp -106.68 -6.84 17.62 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -158.95 70.97 0.51 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.868 0.365 . . . . 0.0 110.524 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -31.6 66.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.346 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -134.85 125.03 26.01 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.392 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.22 37.88 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.87 0.367 . . . . 0.0 111.313 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 60.65 99.21 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.394 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.13 -36.03 4.48 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.508 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 70.52 -66.32 0.29 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.622 0.369 . . . . 0.0 111.101 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.27 31.4 3.4 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 111.154 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.85 -75.55 1.22 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.335 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.45 144.56 21.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 0.0 111.034 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tp -92.13 95.68 9.89 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.487 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -124.72 123.75 40.67 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.048 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -111.75 114.71 27.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.72 103.51 5.44 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.027 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 pt -149.35 121.76 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.831 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -82.81 153.32 25.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 p -135.58 145.95 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.577 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.29 120.97 41.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.597 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -132.17 142.47 49.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.717 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -62.74 -20.56 65.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.482 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.72 23.75 5.52 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.76 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.18 163.8 12.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 110.633 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.15 124.55 36.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.26 159.81 36.75 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.78 169.26 9.03 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.231 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -103.68 -35.3 8.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.173 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.45 28.37 8.36 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.077 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -173.44 103.16 0.12 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.826 0.313 . . . . 0.0 110.862 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.2 6.32 17.01 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.93 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.72 1.36 26.81 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.8 -176.2 1.03 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.787 0.327 . . . . 0.0 111.34 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.97 83.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.448 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.34 172.61 43.72 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.663 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.0 -70.22 0.73 Allowed 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.67 -165.83 1.1 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.529 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tp -108.57 -50.83 2.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.782 0.325 . . . . 0.0 110.751 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -155.38 171.57 19.66 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.339 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.5 tp -135.54 110.56 8.85 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.594 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -129.13 124.56 22.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.34 133.61 13.38 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.647 2.231 . . . . 0.0 112.52 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.72 134.2 18.01 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.726 2.284 . . . . 0.0 112.53 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 p -91.61 112.72 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 110.98 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 m -92.15 -51.68 5.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.356 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.7 -135.39 1.58 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.331 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.231 179.826 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.738 0.304 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -148.03 167.05 25.93 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.07 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.43 ' O ' ' HA ' ' A' ' 17' ' ' THR . 54.4 m95 -145.96 138.59 25.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.942 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -138.51 136.19 35.86 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.436 ' HB3' ' CB ' ' A' ' 16' ' ' ARG . 4.4 tp -130.91 153.7 48.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 111.23 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.13 173.29 8.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.48 -15.06 62.28 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.925 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.52 -35.38 72.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.933 0.397 . . . . 0.0 110.524 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -112.11 -40.56 4.17 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.763 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 16' ' ' ARG . . . -64.74 -13.94 56.85 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -74.95 -27.12 60.06 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.505 -0.122 . . . . 0.0 111.232 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -90.79 -42.25 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.19 -42.85 9.66 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.76 -26.76 11.21 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.648 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.45 126.96 49.66 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.7 0.286 . . . . 0.0 111.244 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' CB ' ' HB3' ' A' ' 5' ' ' LEU . 1.7 ptt-85 -118.42 -58.4 1.98 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.53 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' TRP . 9.1 p -93.33 136.33 33.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -142.32 124.34 13.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.8 132.83 56.59 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 t -148.68 121.31 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.338 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.61 32.64 2.76 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.07 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.34 150.69 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.104 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -115.71 125.15 52.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.84 88.11 0.14 Allowed Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.397 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.41 26.02 13.64 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.692 0.282 . . . . 0.0 111.592 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.66 116.07 23.91 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.788 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.03 169.01 11.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.558 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.75 -33.53 16.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.642 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.06 -27.49 31.02 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.449 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.34 -42.69 82.44 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.672 0.272 . . . . 0.0 110.975 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -83.16 -38.16 22.74 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 tt -53.23 -54.98 28.15 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -59.32 -41.09 88.27 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.169 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.469 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -59.47 -56.5 21.17 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.58 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.6 mt -62.4 -20.56 64.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.167 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.5 t -88.59 -48.52 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 111.571 0.211 . . . . 0.0 111.571 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.56 -30.64 0.04 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.478 -0.867 . . . . 0.0 114.661 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -69.54 -1.38 8.56 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -133.04 72.8 76.15 Favored Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -51.44 -15.25 2.37 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.32 2.68 . . . . 0.0 113.967 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.63 -28.92 23.45 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -100.07 -13.22 19.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HB2' HD22 ' A' ' 9' ' ' LEU . 4.2 tp10 -140.0 114.71 9.44 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.246 -0.284 . . . . 0.0 111.425 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -8.56 53.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.085 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 60.63 58.64 2.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.998 0.428 . . . . 0.0 111.017 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 m -96.44 34.92 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.553 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -167.15 -56.05 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.74 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.15 60.32 4.81 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.661 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.2 -49.27 11.88 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.708 0.29 . . . . 0.0 110.683 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.76 31.91 2.78 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.7 -100.22 0.19 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.675 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 56.77 -167.74 0.11 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.092 0.157 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 66.22 -75.69 0.05 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.455 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -111.9 125.52 54.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.031 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.67 158.37 31.72 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.179 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -137.21 113.39 9.9 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.414 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -144.83 103.87 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.9 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -85.23 144.85 27.88 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.194 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 p -140.58 140.58 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.939 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -93.61 139.49 30.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.7 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.36 146.14 47.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.102 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.402 ' HB3' HD23 ' A' ' 78' ' ' LEU . 12.2 p-10 -84.96 19.28 2.17 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.181 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.32 23.72 5.65 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.885 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -108.42 155.8 20.16 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.737 0.303 . . . . 0.0 111.032 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 102.81 14.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.242 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.01 109.24 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.821 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.51 133.71 42.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.625 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.26 -68.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.4 49.19 1.14 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.573 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.66 31.35 5.7 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.59 -34.95 62.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.215 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.63 31.25 2.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.527 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.47 150.56 32.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.6 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.14 72.45 2.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 110.783 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.2 147.07 6.77 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.469 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.16 -73.25 0.69 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.689 0.28 . . . . 0.0 110.766 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 2.7 pt-20 -148.9 -169.58 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.543 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.402 HD23 ' HB3' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -112.11 -42.65 3.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.791 179.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.22 166.95 31.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.205 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tt -146.06 99.82 3.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.785 0.326 . . . . 0.0 110.842 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -151.47 143.23 15.91 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.413 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.56 153.47 23.36 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.855 2.37 . . . . 0.0 112.552 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.67 -45.25 2.44 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.576 2.184 . . . . 0.0 112.551 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.53 118.92 4.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.588 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.2 p -85.66 123.99 31.69 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.723 0.297 . . . . 0.0 110.879 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.91 55.19 0.52 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.61 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.242 -1.31 . . . . 0.0 112.894 -179.844 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -146.17 164.33 32.56 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.915 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -147.4 118.58 7.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.974 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 23.3 mttm -106.16 141.96 36.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.627 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 11.6 tp -132.49 144.42 50.43 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.889 0.376 . . . . 0.0 111.412 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.489 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -82.57 172.43 12.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.265 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.05 66.36 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.008 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -34.46 53.31 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.573 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 3.9 mp -113.24 -38.05 4.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.978 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 -13.05 45.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -79.28 -27.28 42.26 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HB ' ' C ' ' A' ' 42' ' ' LEU . 16.4 t -87.13 -39.44 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.43 -38.09 10.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.22 27.42 8.19 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.455 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.3 t -140.91 128.99 22.06 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.634 0.255 . . . . 0.0 110.758 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.627 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 3.2 ptm180 -113.79 -75.08 0.6 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.543 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 3.5 p -97.43 134.06 41.19 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.792 0.329 . . . . 0.0 111.409 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -145.27 129.83 12.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.843 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.0 mtm-85 -100.77 139.21 36.77 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.423 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.81 120.35 52.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.815 0.341 . . . . 0.0 111.261 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.57 -36.53 5.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.93 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.59 149.98 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.268 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -108.51 166.27 10.9 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.149 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.01 -124.29 0.87 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.633 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.51 34.52 2.19 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.939 0.399 . . . . 0.0 111.004 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.33 120.12 37.22 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.588 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.66 -176.94 3.89 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.009 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.3 t -75.2 -42.22 44.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.506 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -75.64 -26.7 64.64 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.923 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -50.93 -45.24 60.41 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.489 0.316 . . . . 0.0 110.876 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.91 -32.23 20.28 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tt -56.71 -60.73 3.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 110.098 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -60.87 -40.97 94.97 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.305 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.42 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -53.49 -56.02 20.51 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.228 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.57 -29.84 70.88 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.956 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.62 -53.02 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.585 0.231 . . . . 0.0 110.827 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.02 20.58 0.06 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.248 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -105.15 -1.17 25.81 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.44 0.62 . . . . 0.0 111.579 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.32 72.65 81.96 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.44 -20.6 1.65 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.371 2.714 . . . . 0.0 113.551 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.52 -32.26 17.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.8 OUTLIER -99.7 -15.92 18.34 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.467 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -165.07 95.73 0.69 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.705 0.288 . . . . 0.0 111.161 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.78 -48.92 22.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.282 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -155.46 133.63 11.56 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.718 0.294 . . . . 0.0 110.839 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.49 -44.3 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.733 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -171.95 -67.41 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.964 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.42 99.57 1.01 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.595 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.36 -62.81 1.5 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.618 0.247 . . . . 0.0 111.146 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.87 -26.41 13.76 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.527 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.73 82.07 0.31 Allowed Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.767 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 59.85 80.0 0.21 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.985 0.421 . . . . 0.0 111.253 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.1 tp -96.0 97.5 9.65 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.692 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -147.9 116.99 6.83 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.277 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -147.17 149.7 33.49 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -87.49 157.64 19.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.594 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.5 124.23 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.67 0.272 . . . . 0.0 110.787 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -97.58 136.9 37.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 110.862 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 p -140.4 141.09 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.358 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.8 tp -97.81 134.51 40.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.803 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 145.84 47.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -55.43 -21.26 15.12 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.7 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.81 23.76 5.49 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.41 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.85 165.93 13.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.369 0.267 . . . . 0.0 110.468 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.38 123.62 16.09 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.771 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.37 102.19 0.08 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.338 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.25 160.48 28.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.073 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.506 ' CD2' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -158.15 22.53 0.25 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.499 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.19 14.45 2.33 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.133 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 178.54 96.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.717 0.294 . . . . 0.0 110.41 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.41 -6.66 41.94 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.894 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 t -75.23 1.52 13.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.89 -177.73 0.86 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.357 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 77.91 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.47 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.8 160.94 9.72 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.667 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.43 -78.79 0.59 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.674 0.273 . . . . 0.0 110.27 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -131.76 -177.01 4.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 110.823 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.76 -37.86 6.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.842 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -174.25 166.39 4.09 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.972 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.47 110.36 7.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.895 0.379 . . . . 0.0 110.602 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.44 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 23.3 m-85 -112.73 161.47 26.29 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.101 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 6' ' ' PHE . 96.6 Cg_endo -81.96 169.48 14.69 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.671 2.247 . . . . 0.0 112.584 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.9 -42.54 6.24 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.819 2.346 . . . . 0.0 112.547 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.2 t -82.54 114.52 23.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.156 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 p -103.47 -34.62 8.64 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.158 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.47 173.55 54.95 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.856 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.29 -1.283 . . . . 0.0 112.606 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.788 0.328 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -160.68 163.64 32.32 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.166 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -155.36 174.68 14.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.997 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 27.0 mttm -137.13 152.98 50.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.132 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -141.51 132.38 25.91 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.811 0.338 . . . . 0.0 111.528 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.401 ' O ' HD12 ' A' ' 5' ' ' LEU . 1.1 t80 -81.35 175.77 10.3 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.112 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.82 -10.97 60.4 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.41 -46.31 62.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.901 0.381 . . . . 0.0 110.911 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -112.44 -36.03 5.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.121 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.95 -10.46 13.71 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -40.7 74.4 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.485 0.183 . . . . 0.0 111.067 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 4.2 t -94.51 -45.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.532 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.34 -46.75 79.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.09 11.24 61.61 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.546 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.3 m -116.83 129.73 56.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.773 0.32 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.521 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -111.73 -85.91 0.56 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.728 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.7 p -102.66 134.37 46.14 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.571 0.224 . . . . 0.0 111.405 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 t -147.75 154.39 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.031 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 1.3 mtt85 -108.45 152.27 24.93 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.617 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.0 120.32 51.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.072 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.81 -46.43 0.95 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.388 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 m -87.37 122.15 38.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.444 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -116.45 129.36 56.17 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.096 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.21 -125.63 0.77 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.651 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.54 -45.67 91.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.581 0.229 . . . . 0.0 111.173 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.44 122.0 22.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.19 171.05 15.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.289 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG23 ' CB ' ' A' ' 67' ' ' ALA . 8.7 m -74.75 -37.08 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 68' ' ' LEU . . . -80.27 -33.23 32.73 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.937 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -50.98 -47.5 61.38 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.78 0.324 . . . . 0.0 110.831 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.21 -25.8 33.89 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.886 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.1 -60.25 3.69 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.8 -36.57 72.38 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.091 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.61 -52.28 63.99 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.758 0.313 . . . . 0.0 110.267 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 5.6 mp -68.9 -33.26 73.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.984 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.6 t -55.66 -51.15 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.681 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.66 49.73 0.02 OUTLIER Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.959 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.19 -61.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.426 0.155 . . . . 0.0 110.588 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.423 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER 170.87 -58.78 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.78 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 39' ' ' HIS . 54.4 Cg_exo -50.67 -29.25 24.9 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.206 1.937 . . . . 0.0 111.914 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 35' ' ' LEU . . . -61.98 -26.09 68.01 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.492 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.428 ' HB3' ' HA ' ' A' ' 9' ' ' LEU . 1.9 pt? -139.99 27.59 2.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.714 0.292 . . . . 0.0 110.765 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 64.78 165.61 0.16 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.201 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.1 p -69.68 -41.83 74.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.582 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.09 129.1 6.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.731 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.87 -37.87 11.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.995 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -154.05 35.64 0.43 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.204 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.91 97.6 0.38 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.221 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -61.37 142.94 56.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.827 0.346 . . . . 0.0 111.401 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.41 -28.87 65.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.631 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.62 62.76 0.63 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.784 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -123.98 118.23 26.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.564 0.221 . . . . 0.0 110.704 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.5 79.28 5.54 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.596 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.1 134.07 19.17 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.324 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.98 119.27 12.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -143.19 133.14 24.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.187 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.8 tt -169.88 146.9 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.46 155.33 16.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.871 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -140.54 149.02 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.365 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.59 123.11 49.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.814 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -114.16 144.41 43.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.818 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -74.12 -16.35 61.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.521 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.7 23.26 6.0 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.83 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.48 165.92 11.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.717 0.294 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.25 124.91 19.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.971 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.89 87.79 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.964 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.45 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -70.24 142.76 52.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.265 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.432 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -141.61 -59.24 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.005 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.36 36.69 3.66 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.67 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.79 90.81 1.49 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.698 0.285 . . . . 0.0 111.285 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.12 -24.51 63.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.516 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.92 33.56 0.78 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.686 0.279 . . . . 0.0 111.571 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.33 171.18 12.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.859 0.362 . . . . 0.0 111.674 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.1 92.97 3.93 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.023 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.07 122.41 3.81 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.892 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -107.18 -65.27 1.11 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.709 0.29 . . . . 0.0 111.003 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -162.95 -159.37 0.54 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.584 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.8 tp -123.29 -53.11 1.83 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.558 0.218 . . . . 0.0 110.951 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -152.8 153.54 33.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.196 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.93 101.37 5.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.752 0.31 . . . . 0.0 110.73 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -146.81 145.13 21.66 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.469 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.16 150.42 65.9 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.668 2.245 . . . . 0.0 112.103 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.78 60.75 6.81 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.589 2.193 . . . . 0.0 112.074 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.33 135.7 61.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.02 -57.8 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.094 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.97 125.02 7.42 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.289 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 CA-C-O 118.654 -1.081 . . . . 0.0 112.854 179.889 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -135.48 153.22 51.82 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 111.635 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.424 ' CD1' ' HG3' ' A' ' 77' ' ' GLU . 1.9 t90 -155.48 148.28 24.29 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.112 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 2.9 mttp -137.98 146.61 43.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.351 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 1.1 tt -135.54 165.1 26.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.974 0.416 . . . . 0.0 111.028 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.79 -178.61 6.89 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.205 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.62 -8.73 50.0 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.29 -40.22 61.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.681 0.276 . . . . 0.0 111.431 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 4.7 mp -100.24 -33.23 10.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.596 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.52 -7.52 48.12 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -79.9 -29.57 39.89 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.383 0.135 . . . . 0.0 111.22 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 4.9 t -98.03 -49.19 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.48 -34.79 8.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.77 26.6 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.616 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.39 79.0 1.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.969 0.414 . . . . 0.0 110.772 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 5' ' ' LEU . 8.0 ptt85 -88.24 -43.82 11.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.98 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 6.1 p -92.99 139.28 30.68 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.824 0.345 . . . . 0.0 110.97 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -129.71 107.67 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.79 152.53 20.77 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.681 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.0 t -102.08 120.28 51.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.929 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.39 -71.05 0.7 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -89.46 145.78 6.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.072 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.76 151.66 23.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.217 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.09 -102.97 0.18 Allowed Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.418 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.71 -27.35 11.36 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.603 0.224 . . . . 0.0 111.603 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 129.14 39.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.764 0.316 . . . . 0.0 111.336 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.78 174.72 6.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.04 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 68' ' ' LEU . 15.2 t -75.99 -39.59 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.126 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -76.41 -31.34 54.84 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.791 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -56.1 -48.38 76.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.716 0.293 . . . . 0.0 110.682 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.95 -26.84 39.89 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.125 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.402 ' HA ' ' CH2' ' A' ' 3' ' ' TRP . 7.1 tt -59.45 -58.76 7.19 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.84 -42.76 94.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.052 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -52.87 -56.15 17.99 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.24 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.421 HD23 ' CZ3' ' A' ' 3' ' ' TRP . 7.7 mp -62.14 -29.72 70.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.778 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.44 -53.4 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.005 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.26 15.52 0.06 OUTLIER Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.056 -1.068 . . . . 0.0 114.806 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -105.16 -1.25 25.69 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.704 0.752 . . . . 0.0 111.655 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.77 75.31 43.39 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-O 120.945 0.403 . . . . 0.0 110.282 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -53.59 -14.22 4.77 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.981 2.454 . . . . 0.0 113.252 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.37 -28.59 20.17 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.444 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 1.2 mp -100.67 -12.99 18.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.99 109.88 12.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.647 0.26 . . . . 0.0 111.604 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -90.18 -41.31 11.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.241 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 62.67 77.22 0.34 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.606 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.0 t -92.41 -66.61 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.315 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -136.14 76.67 1.62 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.933 0.397 . . . . 0.0 110.729 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.26 -86.1 0.5 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.377 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -147.05 164.05 34.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.739 0.304 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -115.51 31.67 6.56 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.962 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.18 83.62 0.06 OUTLIER Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.781 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.66 128.02 34.66 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.745 0.307 . . . . 0.0 111.357 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.53 161.42 7.75 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.023 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 112.72 25.52 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.961 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.51 154.48 43.67 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.195 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -135.35 102.86 5.29 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.302 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.85 -49.88 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.985 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.02 -167.06 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.212 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -90.61 151.58 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 111.131 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 tp -129.81 150.56 51.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 111.309 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HG3' ' HB3' ' A' ' 77' ' ' GLU . 3.5 mtt180 -143.14 146.34 33.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.962 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -52.44 -21.31 3.55 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.68 23.78 5.52 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.775 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -130.21 165.93 21.35 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.733 0.301 . . . . 0.0 110.739 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.52 121.65 10.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.252 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.08 144.56 56.04 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.387 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -92.52 -177.6 4.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 28' ' ' VAL . 5.2 tt -168.64 -50.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.652 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.51 25.39 21.1 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.869 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -171.59 96.78 0.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.839 0.32 . . . . 0.0 110.979 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.4 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -58.17 -26.82 63.2 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.694 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.11 34.03 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.721 0.296 . . . . 0.0 111.515 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.67 178.58 6.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.694 0.283 . . . . 0.0 111.478 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.41 72.0 9.47 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.937 0.398 . . . . 0.0 111.243 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.65 145.0 2.23 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.261 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -124.12 -79.07 0.61 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.792 0.33 . . . . 0.0 110.852 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.473 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 1.4 pt-20 -141.15 -177.69 5.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.47 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.74 -52.94 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.632 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -159.34 174.35 14.88 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 5' ' ' LEU . 3.1 tt -153.35 118.11 5.02 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.839 0.352 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -139.76 108.11 7.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.72 158.17 50.9 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.831 2.354 . . . . 0.0 112.593 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -87.42 32.27 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.074 2.516 . . . . 0.0 113.192 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p 38.43 84.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.239 0.616 . . . . 0.0 112.295 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 t -85.42 128.73 34.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.32 -162.83 54.32 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.719 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.068 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.964 0.412 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -144.29 169.18 18.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.529 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -155.51 142.4 19.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.215 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -138.77 145.89 40.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -149.32 164.63 34.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 111.907 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -85.79 179.79 6.98 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.496 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.04 -13.69 38.76 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.2 -34.69 23.57 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.716 0.293 . . . . 0.0 110.748 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' HB2' ' CD2' ' A' ' 5' ' ' LEU . 4.9 mp -105.07 -10.26 17.29 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.678 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.23 -2.24 55.34 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -35.83 73.66 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 56.1 t -97.65 -49.92 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.47 -34.38 9.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.99 25.79 28.27 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.313 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.17 98.33 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.874 0.369 . . . . 0.0 111.136 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -99.07 -45.3 5.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.075 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.8 p -93.47 147.7 22.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.144 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.24 113.74 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.168 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -105.7 141.83 36.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.836 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.56 120.5 56.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.085 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.28 -45.08 1.69 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.321 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.3 t -86.84 137.41 20.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -116.98 172.32 7.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.273 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.97 -91.13 0.13 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.24 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.91 -35.16 7.39 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.529 0.204 . . . . 0.0 111.115 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.59 135.81 55.54 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 111.14 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.07 -179.74 3.87 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 m -79.91 -35.2 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.785 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.29 -23.4 29.36 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.415 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.36 -40.27 96.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.704 0.288 . . . . 0.0 110.991 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.459 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -81.22 -39.67 25.02 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.707 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 tt -53.29 -57.13 11.64 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.74 0.305 . . . . 0.0 110.435 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.3 -34.75 75.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.47 -52.97 26.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.4 mt -63.37 -26.22 68.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.317 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.01 -42.6 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.58 0.229 . . . . 0.0 111.569 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.91 -34.54 90.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.102 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.95 -41.34 5.63 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.485 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 27.9 m170 63.16 49.17 1.07 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.345 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 39' ' ' HIS . 9.9 Cg_endo -53.57 -24.21 28.22 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.231 1.954 . . . . 0.0 112.109 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.17 74.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.532 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.54 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 1.4 pp -120.59 1.86 10.63 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.276 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -132.8 78.14 1.78 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.794 0.33 . . . . 0.0 110.952 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.2 p -81.46 -44.28 17.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.706 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.86 99.44 0.77 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.001 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.17 -72.03 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.377 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -167.01 -46.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.409 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.52 -51.34 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.715 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -175.06 149.92 1.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.0 110.575 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.99 -28.99 63.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.51 111.31 0.29 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.778 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -102.84 136.2 43.1 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.744 0.307 . . . . 0.0 111.0 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.07 -46.01 1.69 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -156.99 112.39 2.85 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.794 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -146.35 138.88 25.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -104.78 126.89 52.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.971 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 pp -151.24 132.09 4.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.334 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -90.83 143.29 26.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.795 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.83 150.43 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 111.771 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.37 128.93 56.41 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.826 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.78 145.92 28.49 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.059 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -20.98 59.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.713 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.48 23.66 5.62 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.891 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -95.84 162.19 13.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.082 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.66 102.5 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.974 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 49.91 75.88 0.15 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.983 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.32 133.99 33.62 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.805 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.27 -71.3 0.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.318 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.0 53.78 3.62 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.769 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -159.4 72.94 0.56 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.752 0.31 . . . . 0.0 111.279 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.66 68.35 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.339 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.31 36.38 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.345 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.77 -178.39 4.83 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.956 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.12 68.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.485 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.94 157.76 9.11 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.505 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -95.49 -67.52 0.85 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.561 0.22 . . . . 0.0 110.871 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.73 -179.88 6.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.231 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.67 -47.72 2.97 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.16 169.87 22.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.102 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tt -153.89 95.44 1.87 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.055 0.455 . . . . 0.0 110.645 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -131.12 144.96 55.66 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.254 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.2 154.7 56.84 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.519 2.146 . . . . 0.0 112.109 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.85 -172.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.872 2.381 . . . . 0.0 112.497 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.88 112.06 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.973 0.415 . . . . 0.0 111.579 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.58 -174.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.418 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.72 32.66 26.6 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.834 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.639 -1.09 . . . . 0.0 112.852 179.866 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -146.52 159.97 42.73 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.496 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 41.8 m95 -143.51 128.34 18.33 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.643 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 0.3 OUTLIER -129.4 149.83 51.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.482 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -126.66 144.95 50.75 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.644 0.259 . . . . 0.0 111.051 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -82.44 176.67 9.23 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.34 -31.97 35.98 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.564 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -49.45 -35.17 18.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 110.776 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.4 HD11 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -109.24 -32.85 7.04 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.393 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.37 -2.51 49.56 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.38 -34.89 76.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.775 0.322 . . . . 0.0 110.724 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.416 ' CG1' ' HB2' ' A' ' 44' ' ' SER . 20.5 t -94.87 -49.36 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.727 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 -38.25 63.0 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.27 -24.24 29.87 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.701 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.02 96.13 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.6 28.18 6.27 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.143 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.437 ' CG2' ' HG2' ' A' ' 4' ' ' LYS . 11.1 p -92.09 132.76 36.34 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.647 0.261 . . . . 0.0 110.924 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.31 159.82 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.245 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -124.89 138.05 54.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.591 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.13 123.45 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.948 0.404 . . . . 0.0 111.424 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.27 -47.11 1.76 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.219 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.17 152.72 3.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.463 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -112.12 160.29 17.69 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.209 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.15 -130.22 1.54 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.423 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.91 -33.22 63.91 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.735 0.267 . . . . 0.0 111.145 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.0 134.74 49.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.255 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.28 175.84 5.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.002 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.409 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 58.5 t -75.64 -42.32 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 120.956 0.407 . . . . 0.0 110.032 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -82.54 -32.95 26.39 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.893 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.56 -41.07 96.55 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.721 0.296 . . . . 0.0 110.791 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.95 -31.57 51.01 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.805 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.6 -58.78 6.75 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.33 -32.74 74.24 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.87 -51.97 34.72 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.106 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.9 -34.62 73.43 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.176 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.08 -43.69 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.334 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.62 6.88 75.81 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.423 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.473 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -62.97 -58.32 7.73 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.191 0.496 . . . . 0.0 110.712 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.66 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 13.9 m-70 103.79 -57.52 0.0 OUTLIER Pre-proline 0 C--N 1.345 0.403 0 C-N-CA 124.637 1.175 . . . . 0.0 112.073 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.66 ' HD3' ' HB2' ' A' ' 39' ' ' HIS . 61.2 Cg_exo -50.98 -22.93 11.14 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.028 1.818 . . . . 0.0 112.434 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.44 -32.55 68.8 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.622 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.4 ' CD2' HD11 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -136.75 25.11 3.1 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.146 179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.03 66.26 1.4 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.783 0.325 . . . . 0.0 110.985 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.416 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 3.3 m -82.41 -44.74 15.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.627 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -163.62 111.07 1.17 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.895 0.379 . . . . 0.0 111.227 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.08 -48.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.236 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.75 -165.65 0.45 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.72 43.86 3.29 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.897 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 67.87 133.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.092 0.472 . . . . 0.0 111.665 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -88.1 -28.15 21.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.373 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.27 -60.89 2.21 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.256 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.77 118.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.682 0.393 . . . . 0.0 111.936 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.9 mt -91.71 -32.28 15.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.684 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.11 122.52 34.46 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.71 0.29 . . . . 0.0 111.477 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.29 129.68 43.56 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.887 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.34 135.2 52.21 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.964 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -151.87 131.2 3.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.851 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -91.42 164.82 13.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.782 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 p -138.76 147.36 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.05 128.0 53.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.953 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.62 145.89 50.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.016 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -59.31 -21.0 59.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.675 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.91 23.72 5.47 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.747 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.2 166.29 12.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.746 0.308 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.33 112.57 11.76 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.81 123.79 42.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.47 165.57 18.01 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.681 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.424 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -108.16 -38.88 5.65 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.13 24.9 13.79 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.142 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -162.54 96.06 0.93 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.84 0.32 . . . . 0.0 110.953 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -70.33 -6.65 36.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.708 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 t -75.86 1.28 15.47 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.8 -178.48 1.54 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 111.398 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.6 86.91 6.84 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.477 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.67 159.17 28.05 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.116 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -109.58 -77.4 0.6 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -157.4 -175.16 5.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.793 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.7 mt -108.12 -37.69 5.98 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.99 172.0 10.6 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.087 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 tt -136.65 97.3 3.51 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.274 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.86 136.49 20.74 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.68 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.22 150.83 42.87 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.409 2.073 . . . . 0.0 112.451 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.73 159.25 9.26 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.819 2.346 . . . . 0.0 112.106 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 m -65.97 82.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.991 0.424 . . . . 0.0 111.427 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 t -92.48 161.4 14.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.214 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.42 85.99 0.11 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.55 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.202 -1.332 . . . . 0.0 112.904 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ttt . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.618 0.247 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -147.56 138.79 23.68 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.061 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -135.59 118.45 16.22 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.717 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.411 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 39.8 mtpt -116.91 139.78 50.23 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.423 ' CB ' ' HB3' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -123.45 142.45 50.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.634 0.254 . . . . 0.0 110.796 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 8' ' ' ASP . 20.7 p90 -81.11 -173.19 4.16 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.173 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -41.09 -26.18 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.45 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -39.95 -47.27 2.2 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.884 0.373 . . . . 0.0 111.292 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -113.23 -23.17 10.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.422 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.44 -3.01 38.18 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.15 -34.28 65.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.652 0.263 . . . . 0.0 111.073 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.82 -53.6 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.719 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.64 -40.48 49.02 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.78 -30.33 7.23 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.455 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.2 p -156.95 124.96 5.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.632 0.253 . . . . 0.0 111.23 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.69 34.51 5.19 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.951 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.411 ' CG2' ' HG2' ' A' ' 4' ' ' LYS . 21.5 p -104.34 126.67 51.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -139.37 151.66 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -120.07 158.34 27.06 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.885 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 t -102.26 120.38 51.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.886 0.374 . . . . 0.0 111.215 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.99 -46.02 0.65 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.065 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.0 p -86.76 147.7 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.422 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -99.17 136.41 39.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.936 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.56 175.65 35.6 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.635 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.9 -31.49 68.67 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.548 0.213 . . . . 0.0 111.35 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 117.97 6.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.824 0.345 . . . . 0.0 111.049 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.28 179.52 1.58 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.498 HG22 ' CB ' ' A' ' 67' ' ' ALA . 2.6 m -74.54 -42.53 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.252 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -88.38 -28.49 22.21 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.276 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.78 -34.74 73.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.785 0.326 . . . . 0.0 110.728 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.09 -30.57 15.93 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.503 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tt -62.21 -53.69 51.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.781 0.324 . . . . 0.0 110.612 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -65.96 -31.76 72.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.245 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.0 -44.86 53.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.111 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.98 -32.78 74.21 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.928 0.394 . . . . 0.0 110.655 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -87.97 -34.62 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.286 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.23 19.45 51.33 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.295 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -63.68 -52.2 61.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.053 0.426 . . . . 0.0 111.072 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.728 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 28.9 m170 104.63 -59.87 0.0 OUTLIER Pre-proline 0 C--N 1.345 0.391 0 C-N-CA 124.527 1.131 . . . . 0.0 112.071 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 39' ' ' HIS . 42.6 Cg_exo -55.69 -22.06 34.63 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.691 1.594 . . . . 0.0 111.992 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.31 -29.25 70.3 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.645 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 9' ' ' LEU . 2.3 pt? -135.69 26.81 3.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.838 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 70.95 136.02 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.5 m -58.45 -39.41 79.79 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.489 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 59.85 76.07 0.38 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.894 0.378 . . . . 0.0 111.244 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.3 68.56 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.508 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -141.18 -46.73 0.39 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.148 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.3 -63.34 1.51 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.049 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.92 155.53 1.64 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.792 0.33 . . . . 0.0 110.816 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -120.15 31.19 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.956 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.93 -99.63 2.63 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.512 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.14 93.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.832 0.348 . . . . 0.0 111.432 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 mp -94.82 18.66 11.37 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.527 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -133.24 128.85 36.76 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.618 0.247 . . . . 0.0 111.196 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.25 147.47 41.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -140.17 121.82 15.28 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.5 tt -173.6 145.39 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -97.47 168.4 10.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.612 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 p -139.33 141.98 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.552 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.49 118.32 31.48 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.609 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -126.51 145.76 50.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.715 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.34 -10.59 56.01 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.895 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.56 5.58 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.945 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -118.8 166.08 13.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.631 0.253 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.11 125.78 27.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.64 130.3 46.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.24 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' CB ' HG22 ' A' ' 28' ' ' VAL . . . -98.27 134.54 41.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.418 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -128.59 -63.96 0.96 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.897 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.06 43.84 2.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.835 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -165.37 94.25 0.62 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.703 0.287 . . . . 0.0 111.236 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.56 -10.13 59.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.809 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.1 35.88 1.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 111.413 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.94 165.69 11.8 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.865 0.364 . . . . 0.0 111.327 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.3 80.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.15 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.76 -177.47 48.15 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.538 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.77 -74.9 0.59 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.792 0.33 . . . . 0.0 110.701 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -148.68 -177.61 5.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.39 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.59 -32.74 7.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.343 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -167.48 169.77 11.86 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.41 97.74 3.44 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.555 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -140.14 153.65 69.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.253 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD3' ' CD1' ' A' ' 6' ' ' PHE . 24.6 Cg_endo -61.74 156.18 49.69 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.632 2.222 . . . . 0.0 112.31 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.42 -41.29 6.78 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.676 2.251 . . . . 0.0 112.421 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.38 122.66 53.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.734 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.29 155.27 40.88 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.84 70.83 0.34 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.749 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.64 -1.089 . . . . 0.0 112.643 179.807 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HG3' ' CG1' ' A' ' 28' ' ' VAL . 2.8 ttp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.056 0.455 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -120.04 147.13 45.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.087 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.442 ' CD1' HD11 ' A' ' 5' ' ' LEU . 2.1 t90 -150.04 125.16 10.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.727 0.299 . . . . 0.0 111.168 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -122.23 148.47 44.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.297 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.48 HD23 ' CD2' ' A' ' 9' ' ' LEU . 7.6 mp -140.18 152.62 46.18 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.75 0.31 . . . . 0.0 111.334 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -98.27 179.15 4.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.67 -29.88 40.78 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.94 -37.73 33.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.004 0.431 . . . . 0.0 110.19 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.48 ' CD2' HD23 ' A' ' 5' ' ' LEU . 2.5 mp -110.73 -9.75 14.49 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.187 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.81 -4.9 49.34 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.99 -36.84 75.49 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 14.6 t -93.47 -33.51 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . . . -92.58 -45.03 8.3 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.38 -35.58 4.28 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.842 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.9 t -172.43 126.4 0.52 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.565 0.221 . . . . 0.0 110.824 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.402 ' HG3' ' CB ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -123.05 28.2 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.291 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.8 p -99.33 112.55 24.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.571 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.5 144.5 28.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.221 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -130.25 158.48 39.64 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.701 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 1' ' ' MET . 13.4 p -103.95 136.97 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.893 0.378 . . . . 0.0 111.632 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.04 -48.62 1.11 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.918 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -86.65 165.67 2.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.284 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.09 118.07 33.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.08 -139.33 3.89 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.491 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.48 30.95 6.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.62 0.248 . . . . 0.0 111.302 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.46 146.3 25.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.898 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.08 167.75 12.28 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.83 0.348 . . . . 0.0 111.213 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 76' ' ' ASP . 2.5 m -78.2 -36.88 21.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.435 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.554 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -79.21 -31.28 42.93 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.879 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -50.84 -42.17 58.31 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.885 0.374 . . . . 0.0 110.556 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.49 -30.89 17.02 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.126 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.34 -56.07 26.85 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.829 -0.168 . . . . 0.0 110.96 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -57.18 -36.26 70.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.628 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.15 -53.95 9.71 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 110.469 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 39' ' ' HIS . 7.8 mp -61.43 -25.3 67.12 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.244 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.4 t -91.92 -45.89 14.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.432 0.158 . . . . 0.0 111.336 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.28 -40.53 94.09 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.861 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.14 -56.35 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.652 0.263 . . . . 0.0 111.053 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.459 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER 72.52 55.5 0.34 Allowed Pre-proline 0 C--O 1.231 0.106 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.75 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 52.7 Cg_exo -53.12 -17.71 8.66 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.22 1.947 . . . . 0.0 112.06 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HA ' ' CB ' ' A' ' 13' ' ' ALA . . . -57.13 -40.49 77.23 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.189 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.482 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -134.5 13.17 3.78 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.642 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.14 118.64 26.55 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.842 0.354 . . . . 0.0 111.442 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.9 m -94.97 7.46 46.0 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.694 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 71.49 31.7 2.23 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.683 0.277 . . . . 0.0 111.063 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -168.47 87.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.172 0.511 . . . . 0.0 111.37 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -157.57 104.67 2.0 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.183 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.42 -80.2 0.64 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.383 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.76 -62.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.814 0.34 . . . . 0.0 110.499 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.71 -28.94 51.04 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.465 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.09 -63.42 0.55 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.383 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.54 156.07 40.69 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.771 0.319 . . . . 0.0 111.059 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.56 -67.89 0.96 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -151.67 134.27 15.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.005 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.15 164.31 29.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.2 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -108.62 126.4 52.92 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pp -148.87 120.09 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.553 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -77.27 151.31 35.12 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.868 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.0 p -136.92 146.7 27.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.678 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.34 124.3 49.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.732 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.71 145.61 51.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -61.09 -25.19 66.79 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.653 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.43 23.49 5.99 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.916 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.24 166.07 12.03 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.653 0.263 . . . . 0.0 110.772 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.03 114.29 2.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.982 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.03 111.54 10.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.075 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.54 -175.89 3.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.251 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.554 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -141.16 -42.35 0.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.562 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.73 35.94 3.88 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.855 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -167.94 91.28 0.33 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.88 -0.97 53.47 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.716 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 t -84.82 -26.56 27.38 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.436 0.16 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.26 139.45 53.37 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.747 0.308 . . . . 0.0 110.913 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.94 -74.68 0.06 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.88 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.99 -151.21 18.45 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.505 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.453 ' HB3' ' HB ' ' A' ' 28' ' ' VAL . 25.3 p-10 -111.63 -50.77 2.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.406 0.146 . . . . 0.0 110.74 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -171.35 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.741 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.1 mt -107.66 -36.79 6.34 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.215 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 4' ' ' LYS . . . -165.22 170.93 14.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.631 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.64 100.1 3.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.899 0.38 . . . . 0.0 110.545 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 12.5 m-85 -114.09 133.95 22.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.009 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 81' ' ' PHE . 37.1 Cg_exo -57.33 170.72 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.797 2.331 . . . . 0.0 112.403 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.19 74.23 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.771 2.314 . . . . 0.0 112.362 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -95.71 144.02 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.34 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.5 m -104.91 153.05 21.9 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.47 -166.51 26.91 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.769 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.688 -1.062 . . . . 0.0 112.851 179.845 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.579 0.228 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.44 160.14 40.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.882 0.372 . . . . 0.0 110.887 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -155.27 144.83 21.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.02 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -137.63 141.16 41.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.938 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 11.7 tp -133.08 158.24 43.26 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.991 0.425 . . . . 0.0 111.893 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -91.14 177.93 6.13 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.716 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.93 -10.24 59.58 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.417 ' HB3' HD23 ' A' ' 9' ' ' LEU . 6.2 t70 -56.65 -39.72 74.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -111.66 -39.6 4.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.417 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . . . -61.43 -14.23 26.62 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.37 -26.9 61.2 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.364 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.5 t -89.66 -41.63 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.12 -43.55 10.39 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.68 -20.31 22.69 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.828 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.9 m -111.64 130.68 55.69 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.882 0.341 . . . . 0.0 110.665 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.439 ' HD3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -113.81 -49.08 2.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 p -93.1 146.68 23.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.92 0.39 . . . . 0.0 111.435 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.0 t -145.36 119.33 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.24 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -102.42 138.59 39.14 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.358 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.75 123.21 65.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.438 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.08 -31.86 11.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.19 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 p -91.81 151.34 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -116.88 121.97 43.01 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.98 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.91 45.07 1.18 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.467 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.3 t0 55.48 33.57 21.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.868 0.365 . . . . 0.0 111.295 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.57 127.08 33.46 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.654 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.08 168.07 20.46 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.796 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.405 HG12 ' HG3' ' A' ' 61' ' ' ARG . 22.6 t -75.25 -34.43 30.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -85.07 -28.64 30.49 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.304 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.83 -41.44 74.25 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.559 0.218 . . . . 0.0 110.955 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.51 -32.29 19.5 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -61.86 2.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.645 0.259 . . . . 0.0 110.54 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -62.06 -33.17 73.9 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.672 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.08 -54.5 24.93 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.291 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.54 -19.22 64.61 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.459 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.2 t -91.99 -47.81 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.31 -34.22 2.55 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.789 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.61 -1.23 41.36 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -127.1 65.69 65.28 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.781 0.324 . . . . 0.0 110.675 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.01 -19.11 14.81 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.779 2.319 . . . . 0.0 112.469 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.72 -26.43 14.01 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.631 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -95.91 -23.76 16.73 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.679 0.275 . . . . 0.0 110.99 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 78.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.084 0.469 . . . . 0.0 111.022 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.8 t -80.42 -53.38 6.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.813 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -176.49 107.47 0.07 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.61 -55.71 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.655 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -172.25 48.05 0.02 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.609 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.34 -45.23 2.6 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.528 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.06 156.76 45.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.723 0.297 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.37 -28.84 9.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.242 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.4 158.87 22.63 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.623 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.57 97.31 3.71 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.677 0.275 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 mt 70.93 -63.72 0.41 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.26 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -113.45 138.49 50.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.77 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -103.6 126.45 50.75 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 141.12 46.04 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.193 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.464 HG23 HD12 ' A' ' 57' ' ' ILE . 13.4 mt -146.86 130.83 9.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.285 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -101.65 146.53 27.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.957 0.408 . . . . 0.0 111.143 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.78 154.08 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tp -124.61 120.92 33.29 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.017 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 77' ' ' GLU . 2.5 tmm_? -127.5 88.42 2.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.619 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 57.54 18.68 4.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.851 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.48 23.66 39.11 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.642 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -102.01 166.0 10.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.951 0.405 . . . . 0.0 111.199 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.52 102.9 14.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.533 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 63.2 105.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.066 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.419 ' CB ' ' HG3' ' A' ' 61' ' ' ARG . . . -109.95 162.57 14.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.225 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.427 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 2.6 tt -169.9 -65.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.602 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.45 63.39 1.97 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.137 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -123.82 30.48 6.16 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.32 -22.9 54.82 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -76.74 -25.0 53.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.243 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.84 154.52 41.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.69 0.281 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.4 66.74 3.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.825 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.53 -173.93 27.46 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.549 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -117.36 -72.74 0.67 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.582 0.229 . . . . 0.0 110.694 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.461 ' HA ' ' HG2' ' A' ' 61' ' ' ARG . 1.3 pt-20 -149.41 -169.21 3.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.716 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -113.52 -48.74 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.407 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -162.5 166.74 24.49 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.249 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 tt -146.55 111.88 5.49 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.83 0.348 . . . . 0.0 110.942 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -151.44 156.7 34.93 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.485 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.0 153.06 76.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.543 2.162 . . . . 0.0 112.383 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.37 -42.66 3.59 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.609 2.206 . . . . 0.0 112.703 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.2 149.36 32.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.933 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.5 t -103.71 102.41 12.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.727 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.48 170.48 36.47 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.673 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.236 -1.313 . . . . 0.0 112.868 179.893 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.621 0.248 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -116.71 159.22 22.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.815 0.34 . . . . 0.0 111.28 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -151.27 143.05 23.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -138.24 145.91 41.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.774 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.437 ' HB3' ' CB ' ' A' ' 16' ' ' ARG . 10.5 tp -138.48 159.76 41.26 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.044 0.449 . . . . 0.0 111.683 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.13 173.39 9.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.327 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' GLU . . . -65.52 -25.5 67.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.746 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.48 -39.52 23.31 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.865 0.364 . . . . 0.0 110.675 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 1.3 mp -101.1 -34.26 9.79 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.337 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.29 -12.01 61.29 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -71.1 -34.4 71.07 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 121.289 -0.164 . . . . 0.0 111.361 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.3 -37.79 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.15 -45.83 9.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.586 0.232 . . . . 0.0 111.437 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.34 -25.57 27.81 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.534 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 t -106.14 111.58 24.25 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.857 0.36 . . . . 0.0 110.814 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' CB ' ' HB3' ' A' ' 5' ' ' LEU . 1.7 ptt-85 -102.66 -45.77 4.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.709 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 p -99.73 140.64 33.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 111.436 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.09 129.59 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.927 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -110.52 136.0 50.32 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.519 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.51 137.43 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.861 0.362 . . . . 0.0 111.652 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.71 -21.25 11.77 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.584 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.87 152.21 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.875 0.369 . . . . 0.0 111.615 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.7 153.53 26.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.132 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.68 -155.08 9.02 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.784 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.56 30.36 5.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.725 0.298 . . . . 0.0 111.492 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.13 123.7 29.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.044 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.72 164.25 26.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.781 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.7 t -73.76 -30.08 27.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.536 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.656 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -87.21 -29.48 22.4 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.425 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.44 -41.84 77.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.589 0.233 . . . . 0.0 111.077 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.504 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -84.27 -32.31 24.48 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.373 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 tt -56.48 -61.22 2.56 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.346 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.68 -37.74 88.49 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.403 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -59.83 -53.58 56.26 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.618 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.1 mt -64.88 -20.62 66.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.007 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.34 -48.47 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.57 -39.47 1.21 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.804 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.461 ' C ' ' HD3' ' A' ' 40' ' ' PRO . . . -72.85 -0.49 13.6 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.79 68.73 16.18 Favored Pre-proline 0 N--CA 1.453 -0.301 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 85.9 Cg_exo -48.63 -19.11 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.123 2.549 . . . . 0.0 113.362 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.36 -38.72 54.67 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -83.79 -19.81 34.38 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 64.48 118.89 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.7 t -94.94 -26.64 16.04 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.046 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.48 174.16 10.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.016 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.22 39.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.885 0.374 . . . . 0.0 111.543 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -175.3 83.49 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.928 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.93 -97.67 0.11 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.36 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -156.75 141.73 17.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.718 0.294 . . . . 0.0 111.029 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -100.49 -28.92 12.65 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.365 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.99 -159.54 21.73 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.222 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -160.31 145.03 14.55 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.755 0.312 . . . . 0.0 111.465 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -172.4 -49.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.075 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -146.23 141.15 27.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -106.19 119.47 39.31 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.89 97.25 10.25 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -163.07 126.19 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.991 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -85.87 144.02 27.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.515 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.99 147.9 23.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.338 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tp -107.46 118.3 36.37 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.849 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.31 85.8 1.81 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.297 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 63.8 16.32 9.7 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.917 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.6 23.75 27.72 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.536 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.98 162.67 14.61 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.831 0.348 . . . . 0.0 110.858 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.31 102.48 13.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.42 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.75 109.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.305 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -104.75 148.66 26.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.028 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.656 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 6.2 tt -139.11 -67.37 0.45 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.045 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.02 52.75 3.69 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.844 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.49 24.77 7.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.63 0.252 . . . . 0.0 111.621 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.06 -29.65 65.57 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.308 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.68 1.38 56.88 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.97 175.28 6.77 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.833 0.349 . . . . 0.0 111.363 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.68 53.59 2.76 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.215 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.34 163.54 9.62 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.878 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.71 -67.9 0.76 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 110.531 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.57 -172.32 2.87 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.739 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.11 -52.47 2.76 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.69 0.281 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.16 170.13 22.97 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.949 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tt -147.99 112.23 5.23 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.837 0.351 . . . . 0.0 111.083 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -130.9 136.32 28.71 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.054 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.31 146.19 50.23 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.628 2.219 . . . . 0.0 112.531 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.55 137.22 27.4 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.805 2.337 . . . . 0.0 112.603 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 m -95.69 37.81 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.404 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 t -121.71 95.8 4.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.396 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.98 -53.01 0.38 Allowed Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.548 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.361 -1.244 . . . . 0.0 112.815 -179.869 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.042 0.449 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 77' ' ' GLU . 19.9 mt-10 -141.04 175.44 9.63 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.438 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CH2' ' HA ' ' A' ' 32' ' ' LEU . 1.5 t90 -155.41 118.62 4.38 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.986 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 7.0 mtpp -102.55 145.79 29.09 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.559 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -136.5 137.21 40.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.722 0.296 . . . . 0.0 111.723 -179.111 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.58 163.39 14.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.632 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.08 -29.19 28.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.518 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -47.62 -38.5 14.79 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.958 0.409 . . . . 0.0 110.667 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mp -119.19 -3.18 10.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.481 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.99 -9.18 40.79 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.55 -44.37 76.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.578 0.228 . . . . 0.0 111.108 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 15.4 t -94.26 -29.96 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.074 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . . . -69.43 -41.67 76.02 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.582 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.62 -6.78 81.75 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.479 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.39 152.17 51.57 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 110.998 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.559 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -110.7 -76.81 0.6 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.474 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.7 p -95.93 136.65 36.08 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.854 0.359 . . . . 0.0 111.428 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.21 121.33 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.763 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.41 151.19 21.81 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.955 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p -118.16 120.74 65.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.84 0.353 . . . . 0.0 111.275 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -33.52 6.02 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.17 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 m -87.41 134.23 28.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.15 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -117.01 134.21 55.03 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.82 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.45 -109.17 0.29 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.649 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.15 25.8 6.47 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 111.454 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.32 141.97 49.55 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.753 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.5 177.38 4.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' A' ' 68' ' ' LEU . 42.2 t -78.1 -50.32 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.055 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -78.67 -25.63 60.27 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.146 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.69 -39.86 85.95 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.645 0.26 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.94 -33.1 18.58 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.815 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.527 ' HA ' ' CH2' ' A' ' 3' ' ' TRP . 0.3 OUTLIER -60.27 -57.47 12.66 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.457 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.29 -33.97 73.11 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.382 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.86 -52.35 15.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.096 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.8 -27.76 68.99 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.428 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.4 t -94.24 -41.07 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.54 0.21 . . . . 0.0 111.365 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.2 -37.0 91.15 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.045 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.08 -25.07 13.55 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.561 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 17.0 m80 63.19 44.78 0.59 Allowed Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 122.675 0.39 . . . . 0.0 111.324 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 53.6 Cg_exo -51.77 -31.31 41.3 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.942 1.761 . . . . 0.0 111.71 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 12' ' ' VAL . . . -56.46 -32.1 64.63 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.389 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.94 -3.12 9.15 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -79.47 87.47 5.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.832 0.348 . . . . 0.0 111.041 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.0 -53.6 3.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.26 103.87 0.07 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.526 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.6 t 56.59 70.12 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.994 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.17 -59.58 1.39 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.936 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.48 62.68 0.54 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.487 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.65 -70.23 0.25 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.485 0.183 . . . . 0.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -109.89 -29.48 8.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.295 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.02 123.77 0.22 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.909 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -127.37 33.75 4.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.682 0.277 . . . . 0.0 111.273 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.45 163.3 36.96 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.89 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -101.82 112.24 24.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.97 147.89 44.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.41 ' HB3' ' HG2' ' A' ' 83' ' ' PRO . 3.5 t60 -117.25 149.79 39.85 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 pt -136.8 104.45 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.29 151.4 33.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.8 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.98 151.81 33.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.714 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -114.35 130.07 56.67 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.663 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -123.18 145.6 48.49 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.741 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -52.09 -38.4 57.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.371 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.04 22.64 6.79 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.807 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.82 164.63 19.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.726 0.263 . . . . 0.0 110.715 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.27 105.76 0.97 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.23 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.31 153.46 46.98 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.375 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -113.7 179.85 3.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.293 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.453 ' HA ' ' HB ' ' A' ' 28' ' ' VAL . 3.2 pp -111.67 -33.16 6.43 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.989 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.5 32.22 3.69 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.854 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -153.28 90.96 1.46 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.813 0.306 . . . . 0.0 111.269 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.407 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -67.66 -12.7 61.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.97 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 t -88.2 34.14 0.74 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.953 0.406 . . . . 0.0 111.056 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.56 167.38 11.97 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.11 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.48 40.56 1.84 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.699 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.58 67.0 0.02 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.59 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' HB3' HG11 ' A' ' 28' ' ' VAL . 34.6 m-20 -69.17 -71.16 0.23 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.711 0.291 . . . . 0.0 110.57 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 2' ' ' GLU . 34.7 tt0 -140.45 156.36 46.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.554 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -100.62 -42.99 6.31 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.766 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.451 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -169.44 163.18 10.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.425 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.26 113.24 10.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.994 0.426 . . . . 0.0 110.439 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -146.22 140.57 15.57 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.303 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.46 151.46 37.53 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.36 2.04 . . . . 0.0 111.857 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.41 ' HG2' ' HB3' ' A' ' 56' ' ' HIS . 34.7 Cg_exo -60.83 90.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.673 2.248 . . . . 0.0 112.068 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 m -60.78 134.99 26.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.516 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.67 156.29 23.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.327 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.23 -161.47 8.74 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.868 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.328 -179.891 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.893 0.378 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -142.58 163.76 31.95 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.03 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -153.99 141.54 19.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.103 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -138.43 143.1 39.55 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 16' ' ' ARG . 13.2 tp -136.73 156.48 48.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 111.646 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.553 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -81.27 -177.73 6.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.359 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.38 -12.29 60.23 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -54.03 -38.12 64.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.781 0.324 . . . . 0.0 111.044 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 42' ' ' LEU . 2.2 mp -105.48 -38.22 6.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.326 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 16' ' ' ARG . . . -64.73 -17.83 64.48 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -67.13 -26.85 66.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.429 0.156 . . . . 0.0 111.166 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 t -98.19 -44.37 12.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.62 -42.55 10.13 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.48 -28.14 14.46 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.84 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 t -100.45 108.25 20.18 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.826 0.346 . . . . 0.0 111.043 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -98.62 -42.43 7.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.531 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -93.75 147.5 22.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.068 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -142.11 113.24 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.191 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.13 136.24 37.95 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.441 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.56 124.88 66.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 111.407 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.78 -34.41 7.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.054 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.62 145.3 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 120.813 0.339 . . . . 0.0 111.257 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -116.66 121.72 42.48 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.99 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.84 -107.93 1.62 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.395 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.33 -10.64 16.88 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.21 145.34 51.54 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.744 0.307 . . . . 0.0 111.39 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.03 170.92 7.92 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.084 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 24.6 t -75.01 -37.64 41.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.462 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' H ' ' HA ' ' A' ' 68' ' ' LEU . . . -88.78 -33.87 9.58 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.17 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -55.49 -45.22 77.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.665 0.269 . . . . 0.0 111.139 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.75 -24.68 52.98 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.934 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 tt -66.72 -58.17 5.63 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -62.63 -31.6 72.48 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.832 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.62 -48.3 48.83 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.938 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.31 -21.45 66.61 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.011 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.4 -49.26 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.82 -35.41 1.38 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.826 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.47 -1.21 20.18 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -126.11 65.63 57.22 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 110.471 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.28 -19.64 9.77 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.825 2.35 . . . . 0.0 112.576 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.03 -29.03 27.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.576 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -96.21 -16.25 21.56 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.597 0.237 . . . . 0.0 111.453 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -73.25 131.56 42.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.708 0.29 . . . . 0.0 111.394 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -89.67 -32.84 16.86 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.214 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -145.61 164.46 31.66 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.7 0.286 . . . . 0.0 111.129 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.56 59.28 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -151.79 93.53 1.87 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.848 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.09 32.32 83.74 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.825 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -90.41 -35.45 15.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.631 0.215 . . . . 0.0 111.101 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -28.74 66.98 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.588 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.57 105.45 0.22 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.526 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -84.36 75.36 10.24 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.802 0.334 . . . . 0.0 111.109 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 tt 68.19 -70.51 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.193 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -117.72 123.68 46.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.655 0.264 . . . . 0.0 110.569 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -149.61 143.65 25.68 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.241 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -97.84 144.46 27.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.2 pt -152.51 125.33 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.743 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -99.94 135.39 41.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 p -140.6 153.96 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.256 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mp -132.18 133.09 43.81 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.965 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.11 84.29 1.64 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.424 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 54.11 18.96 1.91 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.076 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.36 23.06 59.36 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.711 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -138.1 166.99 22.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.08 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.39 127.86 34.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.744 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.16 157.52 13.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.508 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.435 ' O ' ' HB ' ' A' ' 28' ' ' VAL . . . -110.25 174.54 5.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.403 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' HA ' ' H ' ' A' ' 29' ' ' GLY . 2.1 tt -149.58 20.23 0.92 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.445 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.31 19.38 1.35 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.588 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 178.27 85.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.139 0.469 . . . . 0.0 111.417 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB1' ' N ' ' A' ' 28' ' ' VAL . . . -82.71 6.97 16.22 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.779 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 t -83.91 -14.9 49.84 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.53 0.205 . . . . 0.0 111.254 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.08 131.26 54.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.707 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.82 23.73 11.59 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.975 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.71 -129.82 22.27 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.346 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.34 -72.85 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.52 0.2 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.53 -166.85 1.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mt -111.75 -55.47 2.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.708 0.289 . . . . 0.0 110.958 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.89 164.37 38.96 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.225 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.29 115.29 10.23 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.004 0.43 . . . . 0.0 110.741 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -107.77 108.26 61.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 6' ' ' PHE . 58.7 Cg_endo -71.67 171.48 16.31 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.777 2.318 . . . . 0.0 112.492 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.96 -177.1 3.23 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.651 2.234 . . . . 0.0 112.583 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.48 139.17 17.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.989 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.4 t -146.89 151.59 37.3 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.77 0.319 . . . . 0.0 111.498 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.39 -158.28 11.71 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.438 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.709 -1.05 . . . . 0.0 112.434 -179.5 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.609 0.242 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.94 154.14 44.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.046 0.45 . . . . 0.0 111.497 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -145.8 143.85 29.92 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.412 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 12.9 mttp -135.03 136.43 42.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.525 0.202 . . . . 0.0 110.654 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.538 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 3.9 tp -129.95 135.21 48.06 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.798 0.332 . . . . 0.0 111.07 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -81.8 176.35 9.67 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.414 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 11' ' ' GLU . . . -63.79 -16.16 60.52 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -55.51 -30.43 60.65 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.739 0.304 . . . . 0.0 110.906 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 3.3 mp -119.31 -36.26 3.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.335 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.47 -15.48 50.13 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -71.63 -26.79 62.71 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -95.7 -39.14 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.19 -42.4 9.38 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.18 23.19 10.72 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.736 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.71 136.96 49.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.538 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -113.5 -81.63 0.6 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.428 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 5.0 p -92.69 149.0 21.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.872 0.368 . . . . 0.0 111.464 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.16 118.29 6.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.976 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 148.17 28.18 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.467 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -103.14 120.2 52.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.97 -15.88 14.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.541 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.79 150.81 3.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.594 0.235 . . . . 0.0 110.968 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.86 172.48 0.95 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.433 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.15 85.13 0.91 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.937 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.59 -44.09 4.77 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.472 0.177 . . . . 0.0 111.402 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.55 165.82 12.15 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.751 0.31 . . . . 0.0 111.246 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.16 165.17 22.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.45 -24.3 14.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.731 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 68' ' ' LEU . . . -88.95 -27.52 23.52 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.051 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.18 -47.78 68.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.687 0.279 . . . . 0.0 110.912 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.499 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -79.61 -34.59 40.54 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.605 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.4 ' CD1' HG21 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -53.12 -60.06 3.77 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.393 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.2 -35.48 80.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.13 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -57.87 -55.38 35.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.646 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 17.9 mt -66.77 -23.16 66.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.875 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.21 -47.58 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -125.41 -37.8 0.51 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.201 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -71.48 -1.54 13.62 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -129.29 67.03 78.09 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 120.816 0.341 . . . . 0.0 110.667 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.33 -16.82 14.31 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.715 2.277 . . . . 0.0 112.588 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.45 -25.59 16.77 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -99.5 -22.43 15.49 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.634 0.254 . . . . 0.0 111.365 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -98.85 163.61 12.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.917 0.389 . . . . 0.0 111.363 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -97.81 -49.52 4.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.71 135.66 23.6 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.732 0.301 . . . . 0.0 111.176 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -154.71 31.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.132 0.491 . . . . 0.0 111.287 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.2 -75.21 0.6 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.864 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.26 74.59 0.38 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.263 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.52 167.67 5.37 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.782 0.325 . . . . 0.0 111.343 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -96.86 31.58 2.32 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.441 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.11 57.79 0.03 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.903 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -163.94 132.72 3.75 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.794 0.331 . . . . 0.0 111.317 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.37 -38.15 5.06 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 135.54 46.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.603 0.24 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.29 168.82 11.06 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.145 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -114.5 111.23 21.07 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.087 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.6 mt -149.74 126.42 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.074 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.24 163.4 16.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 32' ' ' LEU . 10.8 p -140.64 149.6 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.372 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.61 118.31 33.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.717 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.3 85.53 2.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.556 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 61.44 16.87 7.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.736 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.62 23.62 33.04 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.31 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -101.99 163.16 12.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.859 0.361 . . . . 0.0 110.82 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 102.91 14.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.424 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 54.7 96.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.884 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.73 143.69 32.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.438 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.462 ' HA ' ' N ' ' A' ' 29' ' ' GLY . 9.0 tt -143.79 -52.49 0.34 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.014 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.88 53.04 4.04 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.1 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.31 22.15 8.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.62 0.248 . . . . 0.0 111.533 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.89 -30.01 60.87 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.169 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.88 31.13 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.338 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.22 -175.39 2.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.75 0.31 . . . . 0.0 111.105 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.86 -32.42 67.47 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.514 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.14 -124.62 1.54 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.559 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.21 -79.05 0.39 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.684 0.278 . . . . 0.0 110.737 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -147.23 -165.38 2.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.606 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 tp -112.69 -51.95 2.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.628 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -153.95 167.22 30.48 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.171 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.04 97.69 3.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.699 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.463 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 34.9 p90 -149.58 149.64 29.03 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-O 120.638 0.256 . . . . 0.0 111.603 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.531 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 39.1 Cg_exo -55.39 -49.45 16.14 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.871 2.381 . . . . 0.0 112.915 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 82' ' ' PRO . 76.5 Cg_exo -50.4 160.08 1.74 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.689 2.259 . . . . 0.0 112.974 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.67 116.95 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.385 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m 64.21 110.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.454 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.74 -74.73 0.05 OUTLIER Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.584 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.506 -1.163 . . . . 0.0 112.664 -179.891 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttm . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -146.84 171.98 14.36 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.814 0.34 . . . . 0.0 111.193 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -145.82 131.84 19.27 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.091 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -136.8 158.41 44.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.504 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.455 ' CB ' ' HB3' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -150.1 163.0 39.32 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.879 0.371 . . . . 0.0 111.588 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.96 179.99 4.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.338 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.57 -11.84 47.71 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.236 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.412 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -52.81 -36.78 58.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.88 0.371 . . . . 0.0 110.357 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.598 ' HB3' HD13 ' A' ' 42' ' ' LEU . 7.8 mt -122.03 -39.44 2.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.469 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.73 -13.96 38.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -82.84 -28.12 30.36 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.844 0.354 . . . . 0.0 110.503 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 74.8 t -85.73 -30.88 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.355 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 42' ' ' LEU . . . -99.22 -39.52 8.41 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.891 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.61 -37.64 2.14 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.152 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.2 p -173.95 138.17 0.6 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.594 0.235 . . . . 0.0 110.766 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 3.2 tpm_? -131.02 17.65 5.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.75 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.8 p -96.95 122.29 39.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.652 0.263 . . . . 0.0 110.413 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.57 166.07 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.44 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.05 142.89 50.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.377 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -102.19 120.52 52.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.169 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.71 -54.44 0.77 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.23 154.52 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.274 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -117.15 122.04 42.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.33 -81.31 0.04 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.061 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.96 25.14 4.97 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.775 0.321 . . . . 0.0 111.211 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.19 116.93 25.85 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.803 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.4 174.57 5.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.984 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.42 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 54.9 t -73.3 -36.94 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.28 -33.39 44.52 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.86 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.8 -37.55 79.44 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.558 0.343 . . . . 0.0 110.988 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.54 -30.93 21.54 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.93 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -58.69 7.39 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.524 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.68 -36.67 83.64 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -59.6 -51.56 69.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.585 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.9 mp -67.39 -30.74 70.6 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.706 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.78 -52.13 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.835 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.24 30.34 0.05 OUTLIER Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.748 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -105.24 -0.58 26.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.799 0.3 . . . . 0.0 111.565 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -123.62 69.39 44.13 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -44.24 -21.85 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.29 2.66 . . . . 0.0 113.627 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.411 ' O ' HG11 ' A' ' 12' ' ' VAL . . . -50.82 -28.0 8.49 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.598 HD13 ' HB3' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -113.87 5.81 16.4 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -94.09 120.73 34.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.535 0.207 . . . . 0.0 111.08 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 t -97.1 -53.31 3.54 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.658 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.44 146.68 36.81 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.837 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -112.89 18.47 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.549 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 38.6 t80 69.67 -67.95 0.21 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 122.649 0.38 . . . . 0.0 111.567 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.39 -2.15 85.44 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.304 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' HA ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER 67.65 -75.55 0.06 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.033 0.417 . . . . 0.0 111.1 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -120.52 31.8 6.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.956 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.14 112.45 0.53 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.516 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.14 107.81 7.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.859 0.361 . . . . 0.0 111.19 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -107.6 -35.03 6.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.207 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -101.5 134.2 44.98 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.675 0.274 . . . . 0.0 111.145 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.4 129.28 56.15 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.058 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -147.1 129.27 15.61 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.5 tt -170.17 146.71 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.61 141.61 35.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.17 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.2 153.82 24.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.211 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.94 127.3 54.09 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.725 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 142.8 49.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -63.0 -21.29 66.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.691 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.56 5.58 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.7 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.7 165.99 12.64 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.609 0.242 . . . . 0.0 110.776 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.29 121.68 10.72 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.27 127.69 33.37 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.509 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.74 179.22 5.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.634 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.7 tt -167.38 -54.31 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.904 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.86 19.75 43.59 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.096 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -174.47 101.17 0.09 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.987 0.394 . . . . 0.0 111.012 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -75.64 -5.15 44.09 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.785 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 t -91.29 33.89 0.96 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.044 0.449 . . . . 0.0 111.07 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.41 -173.7 3.67 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.74 -33.54 56.02 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.497 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.33 146.82 6.65 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.715 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.24 -80.11 0.31 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.33 -173.54 4.62 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.39 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.3 mt -108.41 -40.15 5.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.632 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -169.79 169.68 8.28 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.869 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.79 105.94 5.24 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 110.983 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -92.12 112.37 54.68 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.842 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HG2' ' HB2' ' A' ' 8' ' ' ASP . 51.0 Cg_exo -54.14 167.73 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.047 2.498 . . . . 0.0 113.082 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.22 136.41 68.39 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.117 2.545 . . . . 0.0 112.836 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.4 t -144.81 118.08 2.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.146 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.9 p -175.1 -64.81 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -106.05 -31.67 4.05 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.802 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.578 -1.124 . . . . 0.0 112.471 179.659 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptm . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 120.619 0.247 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -143.45 160.3 40.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -148.43 143.54 26.83 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.28 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . 0.6 OUTLIER -134.95 143.57 46.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.293 179.331 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.405 ' HB3' ' CA ' ' A' ' 16' ' ' ARG . 12.2 tp -133.08 157.8 44.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 111.308 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -89.14 162.6 15.86 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.76 62.11 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.762 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -55.2 -32.09 61.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.79 0.329 . . . . 0.0 110.525 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -110.9 -38.39 5.12 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.094 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.47 -13.25 60.57 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -72.16 -25.73 61.81 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 t -93.72 -44.18 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.21 -28.94 26.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.628 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.1 -21.53 44.69 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.726 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.26 130.23 55.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.405 ' CA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -109.5 -48.03 3.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.735 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.4 ' CG2' ' HG2' ' A' ' 4' ' ' LYS . 2.3 p -92.3 141.14 28.88 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.038 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.7 t -142.09 125.8 15.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -95.87 154.11 17.4 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.697 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 t -102.02 120.54 51.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.0 -73.99 0.66 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 p -98.53 146.22 8.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.001 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -88.12 137.71 32.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.52 -120.77 0.6 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.452 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -100.69 36.54 1.9 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 111.048 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.33 120.1 39.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.752 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.08 173.57 6.43 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -77.62 -39.59 27.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.973 0.416 . . . . 0.0 110.137 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -81.21 -32.04 32.78 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.75 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.98 -45.61 94.1 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.692 0.282 . . . . 0.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.43 -30.95 57.6 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.648 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.03 -58.29 8.82 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.928 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -60.51 -39.31 87.31 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.413 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.453 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . . . -58.57 -55.19 38.29 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.34 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.28 -24.01 67.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.926 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.525 HG21 HG22 ' A' ' 57' ' ' ILE . 94.4 t -83.87 -50.1 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.391 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.63 -27.87 0.03 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.557 -0.83 . . . . 0.0 114.529 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 34' ' ' ALA . . . -65.96 -5.79 10.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.72 70.9 80.95 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.44 ' HA ' ' CD ' ' A' ' 43' ' ' GLU . 84.4 Cg_exo -49.38 -17.35 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.176 2.584 . . . . 0.0 113.388 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.69 7.34 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -100.38 -19.33 16.34 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' CD ' ' HA ' ' A' ' 40' ' ' PRO . 2.1 pt-20 -107.57 126.94 53.16 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.121 -0.362 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -79.31 -52.35 8.22 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.971 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.69 144.95 9.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.86 0.362 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -158.34 -41.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.523 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 81.51 -59.08 0.24 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.657 0.383 . . . . 0.0 110.321 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.41 57.41 4.93 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.495 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.13 -48.69 73.32 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.669 0.271 . . . . 0.0 110.781 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -27.61 54.71 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.78 -41.38 2.16 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.812 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.21 27.53 16.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.626 0.25 . . . . 0.0 111.453 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mt -175.02 -66.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.852 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -130.26 132.95 46.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.165 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -131.97 115.21 15.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.99 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.61 145.88 50.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.701 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.525 HG22 HG21 ' A' ' 36' ' ' VAL . 1.6 pt -150.32 111.06 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.878 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -73.08 139.14 46.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -139.3 151.94 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.403 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -112.99 130.53 56.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.899 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -115.16 145.47 42.34 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.501 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -89.76 15.32 9.9 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.681 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.43 23.15 12.9 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.645 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -115.65 163.5 15.7 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.707 0.289 . . . . 0.0 110.981 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.16 127.73 32.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.454 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.77 95.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.245 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.1 174.64 7.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.942 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 5.7 tt -163.71 -59.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.913 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.63 23.57 34.64 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.887 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -172.51 88.79 0.09 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.83 0.348 . . . . 0.0 110.785 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.31 -7.02 54.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.547 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -91.74 11.32 24.98 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.548 0.213 . . . . 0.0 111.38 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.83 132.56 53.32 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.624 0.249 . . . . 0.0 111.283 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.06 -76.04 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.804 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.8 164.73 30.07 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.459 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.41 -83.37 0.13 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.601 0.238 . . . . 0.0 110.803 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 2.8 pt-20 -168.91 -169.24 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -110.28 -46.65 3.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.301 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -157.04 164.64 37.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 tp -144.62 97.93 3.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 111.047 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -115.56 127.69 26.59 Favored Pre-proline 0 N--CA 1.463 0.184 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.207 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.77 172.59 1.07 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.851 2.367 . . . . 0.0 112.632 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.9 -173.0 1.09 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.687 2.258 . . . . 0.0 112.282 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.8 100.23 10.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.3 96.49 3.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.921 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.23 57.79 0.27 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.493 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.274 -1.292 . . . . 0.0 112.935 -179.922 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' SD ' HG12 ' A' ' 20' ' ' VAL . 14.2 mmt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.667 0.27 . . . . 0.0 111.514 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.416 ' HB3' ' HG3' ' A' ' 19' ' ' ARG . 1.7 mt-10 -156.08 174.79 14.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.961 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.96 139.42 23.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.588 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 0.7 OUTLIER -131.31 156.38 45.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.304 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.498 ' CD2' ' HB3' ' A' ' 16' ' ' ARG . 2.8 mm? -140.0 156.33 46.68 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.111 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.22 -178.67 3.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.761 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.32 -33.23 12.79 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -51.5 -36.8 46.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 110.232 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 4.8 mp -110.27 -8.88 14.68 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.089 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.48 -9.49 38.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -59.2 -39.34 82.31 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 25.8 t -97.85 -36.9 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . . . -88.6 -45.8 9.58 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.91 -32.01 7.06 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.916 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.3 107.03 0.07 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.698 0.285 . . . . 0.0 110.63 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.498 ' HB3' ' CD2' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.23 35.38 2.42 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.428 ' CG2' ' HG2' ' A' ' 4' ' ' LYS . 8.8 p -93.66 113.95 26.16 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.082 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.463 ' HB ' ' CD1' ' A' ' 3' ' ' TRP . 1.9 t -131.34 166.62 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.035 0.445 . . . . 0.0 111.934 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.416 ' HG3' ' HB3' ' A' ' 2' ' ' GLU . 3.2 mpp_? -131.4 158.8 39.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.421 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.421 HG12 ' SD ' ' A' ' 1' ' ' MET . 11.9 p -102.03 120.43 51.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.095 0.474 . . . . 0.0 111.103 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.16 -45.02 1.25 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.172 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.83 113.73 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.15 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -116.21 139.12 50.68 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.8 37.0 1.46 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.716 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.22 -60.33 0.17 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.701 0.286 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.31 176.37 5.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.779 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.35 171.67 7.34 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.025 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -77.29 -39.46 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 120.765 0.317 . . . . 0.0 110.989 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.458 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -88.13 -27.68 25.12 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.417 -0.896 . . . . 0.0 112.32 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.57 -35.89 73.09 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.62 0.247 . . . . 0.0 110.911 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -91.64 -37.07 13.28 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.484 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tt -51.31 -50.88 58.5 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 120.746 0.308 . . . . 0.0 110.369 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -58.91 -34.55 71.81 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.25 -52.89 11.01 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.773 0.321 . . . . 0.0 110.743 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -65.73 -22.84 66.63 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.451 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.1 t -95.23 -40.32 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.817 -0.174 . . . . 0.0 111.052 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.78 -37.38 90.11 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.608 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.04 -34.25 9.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.609 0.242 . . . . 0.0 111.299 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.477 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 12.8 m-70 60.14 54.81 4.08 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.327 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 51.1 Cg_exo -52.44 -22.08 15.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.242 1.961 . . . . 0.0 111.993 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.459 ' HA ' ' CB ' ' A' ' 13' ' ' ALA . . . -62.2 -35.14 77.97 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.497 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.4 1.5 10.16 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.507 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -84.46 103.65 13.79 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 m -75.55 -28.95 59.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.42 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 60.28 76.03 0.38 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 111.004 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.23 -59.76 3.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.824 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -173.23 -58.23 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.78 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -134.22 95.79 0.28 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.261 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -63.44 160.42 16.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.927 0.394 . . . . 0.0 111.343 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -76.73 -29.05 56.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.203 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.55 -139.61 14.62 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.774 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -158.79 139.55 12.72 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.662 0.267 . . . . 0.0 110.913 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.21 -57.1 3.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.873 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -125.87 161.4 27.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.825 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.72 113.59 25.9 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.234 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.25 116.79 14.8 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.383 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.1 tp -172.52 143.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -120.15 156.36 31.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.809 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.58 144.9 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.516 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.12 118.4 36.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.422 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.14 145.62 47.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.103 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -61.42 -15.86 41.04 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.764 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.95 23.91 5.39 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.856 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -104.13 166.06 10.65 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.731 0.301 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.94 121.44 13.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.89 113.32 2.01 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.232 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.75 166.31 15.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CD2' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -164.98 -50.68 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.399 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.36 28.96 13.61 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.125 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -164.04 102.44 0.87 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.788 0.294 . . . . 0.0 110.98 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.33 -26.82 68.65 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.241 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.3 t -95.99 37.18 1.24 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.07 0.462 . . . . 0.0 111.206 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.06 -173.68 4.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.09 -55.84 27.82 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.352 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.7 133.69 2.36 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.149 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -81.58 0.07 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.572 0.225 . . . . 0.0 110.535 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -160.14 179.89 8.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.489 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.6 mt -101.19 -41.13 6.84 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.777 0.323 . . . . 0.0 110.517 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.65 167.46 26.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.985 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.46 100.9 4.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.324 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -123.69 136.7 27.61 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.47 148.81 30.17 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.348 2.032 . . . . 0.0 112.042 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -57.35 92.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.839 2.359 . . . . 0.0 112.059 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.69 134.02 10.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.417 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.33 35.55 0.65 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.95 -56.6 0.69 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.366 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.754 -1.026 . . . . 0.0 112.893 179.998 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.661 0.267 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -152.15 167.41 28.64 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.795 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.462 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -155.02 166.89 32.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.108 0.48 . . . . 0.0 111.372 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 35.0 mtpt -136.44 156.97 47.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.33 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.499 HD11 ' O ' ' A' ' 35' ' ' LEU . 6.8 tp -146.37 160.48 42.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.262 0.554 . . . . 0.0 112.229 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -97.66 172.96 7.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.332 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.19 -19.1 62.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.741 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.82 -42.33 25.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.807 0.337 . . . . 0.0 111.029 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.898 HD21 ' HA2' ' A' ' 37' ' ' GLY . 5.9 mp -108.66 -33.29 7.05 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.645 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.89 -10.76 41.52 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -56.43 -40.31 74.52 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 11.7 t -97.77 -53.07 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.77 -41.32 97.56 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.508 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.68 -15.15 62.25 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.416 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -116.77 128.68 55.53 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -109.58 -58.54 2.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.804 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 6.0 p -92.86 133.53 35.99 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.817 0.342 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.462 ' HB ' ' CD1' ' A' ' 3' ' ' TRP . 9.6 t -140.34 163.37 23.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.457 ' N ' HG12 ' A' ' 18' ' ' VAL . 15.6 ptt85 -130.52 149.87 51.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.58 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.9 t -101.97 120.22 51.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.939 0.4 . . . . 0.0 110.939 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.38 -50.84 0.75 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.73 154.56 3.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.23 133.06 56.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.067 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.5 -153.69 6.88 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.603 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -33.61 76.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.558 0.179 . . . . 0.0 111.288 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.08 116.15 4.31 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.137 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.696 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -78.82 178.08 8.2 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.781 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.638 HG13 ' HA ' ' A' ' 71' ' ' ALA . 2.8 m -77.98 -38.04 23.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.617 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.591 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -87.74 -27.51 26.56 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.23 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.31 -41.13 68.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.651 0.262 . . . . 0.0 110.768 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.14 -26.45 23.6 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.86 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.782 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.7 tp -62.24 -57.46 11.36 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.382 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -56.99 -40.4 76.5 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.982 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -64.95 -51.87 59.43 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.645 0.259 . . . . 0.0 110.36 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.654 ' O ' HD22 ' A' ' 9' ' ' LEU . 6.9 mp -62.52 -35.88 80.81 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 32' ' ' LEU . 57.6 t -60.86 -52.27 63.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.59 0.233 . . . . 0.0 110.69 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.898 ' HA2' HD21 ' A' ' 9' ' ' LEU . . . 158.02 52.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.638 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -77.35 -61.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.208 0.051 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.415 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 1.3 m-70 172.02 -62.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 123.442 0.464 . . . . 0.0 111.008 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 39' ' ' HIS . 8.0 Cg_endo -50.03 -27.76 17.43 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.626 2.217 . . . . 0.0 112.326 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.685 ' CB ' HD23 ' A' ' 9' ' ' LEU . . . -60.54 -31.67 70.76 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.772 HD22 ' HG ' ' A' ' 9' ' ' LEU . 1.6 pt? -136.65 29.76 2.9 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.28 155.77 0.12 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 111.251 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.1 p -78.35 -35.54 47.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.214 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -62.83 98.21 0.12 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.855 0.359 . . . . 0.0 110.994 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.434 HG21 ' CG ' ' A' ' 49' ' ' ASP . 17.3 m -58.03 -40.21 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.613 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.85 87.12 0.1 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 49' ' ' ASP . . . 100.32 -34.22 5.72 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.661 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 1.8 m-20 70.11 139.93 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.956 0.407 . . . . 0.0 111.383 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -111.03 -28.9 8.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.786 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.29 156.74 6.96 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.94 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.3 98.26 3.28 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.832 0.349 . . . . 0.0 111.362 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 54' ' ' TYR . 1.3 pt? -174.1 -42.8 0.01 OUTLIER 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.557 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.43 ' N ' ' HG ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -158.83 141.5 14.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.654 0.264 . . . . 0.0 111.234 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.06 142.05 29.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.176 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -110.68 135.06 51.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.636 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.499 HD13 ' CG1' ' A' ' 36' ' ' VAL . 1.5 pt -143.91 115.01 2.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -90.49 138.28 31.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.833 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.89 151.32 27.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.198 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -111.88 118.9 36.8 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.615 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HG2' ' CB ' ' A' ' 77' ' ' GLU . 2.0 mtt85 -121.69 145.52 47.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.909 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -67.9 -13.4 62.12 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.724 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.58 23.57 5.63 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.736 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -103.19 165.49 10.99 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.782 0.325 . . . . 0.0 110.793 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.33 125.08 25.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.54 95.45 0.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.83 149.03 25.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.101 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.591 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 8.1 tt -126.2 -61.13 1.24 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.203 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.659 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -86.11 44.81 3.38 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.129 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -151.11 72.93 1.08 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.761 0.28 . . . . 0.0 111.104 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.696 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -52.05 -28.01 15.76 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.635 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.22 34.78 0.93 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.756 0.313 . . . . 0.0 111.442 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.77 176.72 6.05 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.894 0.378 . . . . 0.0 111.242 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.67 32.05 3.54 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.668 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.63 158.82 10.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.557 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -76.39 0.59 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.743 0.306 . . . . 0.0 111.275 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.41 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 20.0 pt-20 -145.53 -162.65 1.55 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.972 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 78' ' ' LEU . 2.8 mm? -120.66 -45.12 2.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.487 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -156.61 169.14 25.35 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.61 HD11 HG22 ' A' ' 36' ' ' VAL . 2.5 tt -153.32 122.15 6.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.859 0.361 . . . . 0.0 110.605 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -150.7 135.84 10.11 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.285 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 6' ' ' PHE . 84.4 Cg_endo -78.94 146.55 20.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.671 2.248 . . . . 0.0 112.614 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 45.6 Cg_exo . . . . . 0 C--N 1.349 0.598 0 C-N-CA 122.808 2.339 . . . . 0.0 112.489 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.817 0.341 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -160.57 172.97 16.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.4 ' CE3' ' HG2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -151.7 140.84 21.26 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.417 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -137.62 151.9 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.388 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.733 ' CD1' HD22 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -147.45 151.11 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.095 0.474 . . . . 0.0 111.879 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.12 -175.61 5.92 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.049 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -58.48 -20.18 43.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.939 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.68 -43.14 12.38 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.979 0.418 . . . . 0.0 110.81 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.858 HD23 ' HB1' ' A' ' 41' ' ' ALA . 4.7 mp -105.17 -31.37 9.16 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.011 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -72.08 -4.3 28.11 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -36.67 84.7 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.668 0.27 . . . . 0.0 110.936 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.807 HG11 ' HB2' ' A' ' 43' ' ' GLU . 15.8 t -97.21 -46.11 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.813 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.25 -45.17 20.31 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.99 -29.55 7.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.114 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 t -167.49 117.14 0.82 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.669 0.271 . . . . 0.0 110.994 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.57 29.19 7.42 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.043 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.5 p -95.63 114.03 25.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.328 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 19' ' ' ARG . 3.6 t -122.7 161.72 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.215 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.409 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -126.81 152.58 46.77 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.744 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.574 HG21 ' OD2' ' A' ' 76' ' ' ASP . 19.2 t -102.3 120.33 51.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 0.0 110.776 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.33 -50.09 2.13 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.869 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.55 134.23 52.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.158 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -115.95 152.52 33.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.951 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.91 -81.62 0.15 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.963 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -82.71 -46.65 12.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.665 0.269 . . . . 0.0 111.125 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.64 116.16 4.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.443 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -83.66 172.86 11.88 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.085 HG11 ' HB1' ' A' ' 67' ' ' ALA . 39.0 t -76.71 -35.5 25.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.509 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.25 -32.44 9.64 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.353 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.84 -42.8 80.3 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.741 0.305 . . . . 0.0 110.775 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.62 -27.75 26.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.046 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.5 tp -62.45 -57.2 12.08 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.7 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.04 -40.42 76.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.237 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . . . -64.02 -52.1 61.07 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.794 0.33 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 3' ' ' TRP . 8.8 mp -68.88 -34.41 75.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.318 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 32' ' ' LEU . 21.2 t -57.4 -48.89 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.603 0.239 . . . . 0.0 111.023 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 9' ' ' LEU . . . 161.87 53.23 0.02 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.646 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 34' ' ' ALA . . . -65.83 -61.78 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.448 0.166 . . . . 0.0 110.744 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.413 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 2.5 m-70 -179.74 -62.92 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 39' ' ' HIS . 9.8 Cg_endo -52.27 -26.68 27.84 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.301 2.001 . . . . 0.0 112.064 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.858 ' HB1' HD23 ' A' ' 9' ' ' LEU . . . -62.41 -27.89 69.4 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -135.4 28.89 3.34 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.807 ' HB2' HG11 ' A' ' 12' ' ' VAL . 0.5 OUTLIER 71.16 150.34 0.09 Allowed 'General case' 0 C--N 1.342 0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 110.847 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.9 m -60.38 -43.09 96.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.523 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.62 148.33 29.19 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.805 0.335 . . . . 0.0 110.814 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 p -169.02 -43.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.417 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -172.9 106.79 0.16 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.673 0.273 . . . . 0.0 110.755 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.23 92.57 0.11 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.495 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -65.53 -52.15 54.73 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.572 0.225 . . . . 0.0 110.855 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.24 -28.9 69.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.079 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.25 -166.89 14.0 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.707 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.38 179.8 4.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.692 0.282 . . . . 0.0 110.927 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -35.84 59.86 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.134 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.15 128.97 48.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.72 0.295 . . . . 0.0 111.003 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.18 130.02 55.61 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -142.01 108.29 5.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.176 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.9 pp -150.29 127.72 2.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.49 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -100.51 162.56 12.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.063 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -135.62 152.64 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.649 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -107.86 131.04 54.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.427 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -112.4 145.46 40.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.202 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -3.63 25.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.895 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.77 23.57 5.57 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.902 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.27 157.71 16.01 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.817 0.342 . . . . 0.0 110.684 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.73 102.73 14.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.297 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.03 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.95 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 1.085 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -105.84 133.71 50.13 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.991 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.8 -69.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.107 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.03 64.26 1.73 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.479 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -140.73 47.29 1.75 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -51.7 -28.15 13.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.782 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.31 33.48 2.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.668 0.27 . . . . 0.0 111.258 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . . . -96.52 174.16 6.99 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.815 0.34 . . . . 0.0 111.461 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.54 -34.09 17.51 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.469 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.68 157.93 27.47 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.429 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.574 ' OD2' HG21 ' A' ' 20' ' ' VAL . 6.6 m-20 -109.32 -72.96 0.7 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.761 0.281 . . . . 0.0 110.644 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HG2' ' CE3' ' A' ' 3' ' ' TRP . 0.4 OUTLIER -139.53 -173.16 3.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.308 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -108.58 -53.22 2.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.611 0.243 . . . . 0.0 110.987 -179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -164.9 173.71 11.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 58' ' ' ASN . 1.0 OUTLIER -136.1 95.27 3.17 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.214 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -130.32 148.97 72.0 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.245 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.05 148.68 51.21 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.552 2.168 . . . . 0.0 112.545 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.348 0.508 0 C-N-CA 122.656 2.237 . . . . 0.0 112.479 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.838 0.352 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -160.3 173.33 15.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.667 ' CE3' HD22 ' A' ' 35' ' ' LEU . 3.1 t90 -155.85 146.17 21.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.44 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.433 ' HG2' HG22 ' A' ' 17' ' ' THR . 24.7 mttt -138.07 144.81 41.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.015 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.612 HD21 HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -135.34 164.35 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.042 0.449 . . . . 0.0 111.375 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 5' ' ' LEU . 6.4 t80 -89.5 170.08 10.81 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.816 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.57 -9.24 57.92 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.529 ' HB3' HD12 ' A' ' 9' ' ' LEU . 1.2 t0 -52.48 -44.06 65.37 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 111.224 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.651 HD23 HD22 ' A' ' 42' ' ' LEU . 5.0 mp -107.49 -32.84 7.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.177 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -69.68 -7.06 35.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -40.6 91.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.543 0.211 . . . . 0.0 111.005 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 21.1 t -95.08 -46.89 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.522 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.07 -46.51 80.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.752 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.52 11.81 70.87 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.901 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -139.08 92.96 2.64 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -91.22 -42.79 10.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.181 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.433 HG22 ' HG2' ' A' ' 4' ' ' LYS . 5.8 p -96.64 145.42 25.78 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 120.718 0.294 . . . . 0.0 111.216 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -142.87 108.58 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.24 152.32 21.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.779 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.84 120.23 51.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.748 0.309 . . . . 0.0 111.032 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.34 -72.79 0.38 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.049 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.0 p -94.88 148.54 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.213 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.27 116.07 22.25 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.04 -139.31 3.89 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.635 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -107.01 36.12 2.78 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.845 0.355 . . . . 0.0 111.193 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.89 123.03 41.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.741 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -109.03 169.32 8.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.766 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 71' ' ' ALA . 40.8 t -74.18 -33.55 35.28 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.132 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.72 -36.92 9.87 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.086 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.37 -38.68 74.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 110.666 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.39 -23.21 22.24 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.752 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 36' ' ' VAL . 23.8 tp -63.53 -52.53 60.79 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.499 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -58.54 -41.87 86.54 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.447 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.68 -49.68 61.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.753 0.311 . . . . 0.0 111.206 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.667 HD22 ' CE3' ' A' ' 3' ' ' TRP . 8.6 mp -68.19 -33.35 74.28 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.466 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 32' ' ' LEU . 12.4 t -62.51 -48.89 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-O 120.705 0.288 . . . . 0.0 110.418 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.91 54.84 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.612 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -62.49 -61.64 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.465 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . 1.1 m170 155.02 -66.47 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.646 0.778 . . . . 0.0 110.423 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 39' ' ' HIS . 11.0 Cg_endo -54.17 -24.74 34.76 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.511 2.141 . . . . 0.0 111.805 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.531 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -61.45 -28.28 69.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.054 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.651 HD22 HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -142.47 22.8 2.0 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.89 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 61.97 160.06 0.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.246 0.546 . . . . 0.0 111.875 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -14.15 22.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.515 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.466 ' O ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -78.69 150.74 32.49 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 45' ' ' ARG . 8.5 p 45.38 34.33 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.169 0.509 . . . . 0.0 111.981 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.95 -60.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.088 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.3 69.27 1.99 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.565 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -69.77 165.19 21.94 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.574 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -82.15 -20.97 36.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.756 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.14 -152.51 1.99 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.596 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.82 91.49 2.71 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.845 0.355 . . . . 0.0 111.192 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tp -97.59 142.7 29.08 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.626 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.03 127.54 53.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.104 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.94 146.97 48.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.075 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 57' ' ' ILE . 66.3 m-70 -111.42 152.76 27.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.637 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.561 HG22 ' HB3' ' A' ' 82' ' ' PRO . 1.7 pt -156.55 124.99 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.761 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -90.56 137.42 32.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -124.02 157.99 30.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.31 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.84 122.21 44.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.075 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 145.45 50.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.743 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.94 -19.42 65.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.663 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.28 23.5 5.74 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.743 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.94 165.74 23.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.603 0.24 . . . . 0.0 111.006 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.15 124.64 29.42 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.289 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 76' ' ' ASP . . . -92.22 146.79 23.43 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.368 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.1 -177.75 6.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.968 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -136.3 -45.02 0.62 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.225 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.409 ' N ' ' HG ' ' A' ' 68' ' ' LEU . . . -94.53 31.97 6.38 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.787 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -164.7 91.46 0.57 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.787 0.327 . . . . 0.0 111.221 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.66 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -64.83 -17.63 64.41 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.835 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 t -88.83 33.92 0.78 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 111.246 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.68 168.84 12.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.213 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.65 80.36 8.01 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.64 149.87 3.21 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.985 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 20.0 p-10 -133.3 -49.52 0.85 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.573 0.225 . . . . 0.0 111.335 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.459 ' HG3' ' CD1' ' A' ' 3' ' ' TRP . 0.5 OUTLIER -165.04 -172.43 2.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.56 179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.19 -45.18 2.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.516 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -170.35 174.02 5.43 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.343 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.641 ' HB2' HG12 ' A' ' 59' ' ' VAL . 6.0 tt -152.93 117.72 5.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.324 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -141.46 138.28 17.34 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.568 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.561 ' HB3' HG22 ' A' ' 57' ' ' ILE . 77.8 Cg_endo -77.71 169.55 20.61 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.712 2.274 . . . . 0.0 112.452 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 C--N 1.349 0.59 0 C-N-CA 122.817 2.345 . . . . 0.0 112.038 179.784 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.872 0.368 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.436 ' HG2' ' HG3' ' A' ' 19' ' ' ARG . 6.3 mt-10 -146.95 166.17 27.6 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.497 ' HE1' HD13 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -150.89 137.69 18.97 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.025 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.511 ' O ' HD22 ' A' ' 5' ' ' LEU . 34.7 mttt -134.92 148.86 50.16 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.839 HD11 HD23 ' A' ' 80' ' ' LEU . 3.1 mm? -130.9 152.44 50.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.742 0.306 . . . . 0.0 111.257 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -174.95 3.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 11' ' ' GLU . . . -57.03 -23.04 43.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.854 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.502 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -48.72 -37.8 19.76 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.715 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.74 HD22 HD13 ' A' ' 42' ' ' LEU . 10.3 mt -120.57 -34.96 3.49 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.623 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.06 -2.8 22.71 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -91.14 -29.16 17.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.797 0.332 . . . . 0.0 110.36 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 41' ' ' ALA . 97.3 t -93.11 -35.89 7.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.357 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -94.42 -43.5 8.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.62 0.247 . . . . 0.0 111.1 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.98 -40.34 1.75 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.356 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.34 141.12 2.43 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -137.57 27.04 2.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.45 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 p -96.45 112.01 23.91 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 110.401 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.97 157.99 41.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.408 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.436 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -129.61 148.91 51.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.584 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.3 120.22 56.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.907 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.35 -52.02 0.82 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.725 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -90.67 153.31 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.32 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.6 142.22 35.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.086 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.19 -111.54 0.27 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.689 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.98 38.25 4.18 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.054 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.03 133.13 56.35 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.981 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -113.29 167.94 10.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.22 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 71' ' ' ALA . 27.3 t -74.99 -39.18 44.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.943 0.401 . . . . 0.0 110.213 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -83.19 -34.38 20.83 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.221 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.24 -45.83 83.58 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.832 0.349 . . . . 0.0 110.405 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -77.12 -26.74 53.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.563 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.719 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.1 tp -63.37 -61.07 2.59 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.258 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.65 -34.25 72.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.114 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.943 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -69.05 -50.6 47.06 Favored 'General case' 0 C--N 1.335 -0.046 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.186 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 31' ' ' ALA . 11.1 mp -68.26 -19.5 64.73 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.703 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 32' ' ' LEU . 70.1 t -83.78 -44.81 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -133.42 -34.37 0.32 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.273 -0.965 . . . . 0.0 114.476 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.943 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -69.67 -0.94 7.69 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -121.81 64.87 18.11 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 120.738 0.304 . . . . 0.0 110.821 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 86.4 Cg_exo -50.64 -18.9 4.4 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.887 2.392 . . . . 0.0 112.942 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.767 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -49.47 -31.63 10.39 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.74 HD13 HD22 ' A' ' 9' ' ' LEU . 4.1 pp -106.68 -6.84 17.62 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -158.95 70.97 0.51 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.868 0.365 . . . . 0.0 110.524 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -31.6 66.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.346 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -134.85 125.03 26.01 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.392 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.22 37.88 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.87 0.367 . . . . 0.0 111.313 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 60.65 99.21 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.394 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.13 -36.03 4.48 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.508 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 70.52 -66.32 0.29 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.622 0.369 . . . . 0.0 111.101 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.27 31.4 3.4 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 111.154 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.85 -75.55 1.22 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.335 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.45 144.56 21.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 0.0 111.034 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tp -92.13 95.68 9.89 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.487 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -124.72 123.75 40.67 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.048 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -111.75 114.71 27.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.72 103.51 5.44 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.027 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 pt -149.35 121.76 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.831 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -82.81 153.32 25.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 80' ' ' LEU . 13.7 p -135.58 145.95 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.577 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.418 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -103.29 120.97 41.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.597 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.418 ' N ' HD13 ' A' ' 60' ' ' LEU . 62.1 mtt180 -132.17 142.47 49.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.717 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -62.74 -20.56 65.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.482 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.72 23.75 5.52 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.76 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.18 163.8 12.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 110.633 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.15 124.55 36.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.26 159.81 36.75 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.78 169.26 9.03 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.231 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.433 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -103.68 -35.3 8.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.173 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.45 28.37 8.36 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.077 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 27' ' ' THR . 2.1 mt-10 -173.44 103.16 0.12 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.826 0.313 . . . . 0.0 110.862 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -82.2 6.32 17.01 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.93 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.72 1.36 26.81 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.8 -176.2 1.03 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.787 0.327 . . . . 0.0 111.34 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.97 83.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.448 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.34 172.61 43.72 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.663 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.0 -70.22 0.73 Allowed 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.67 -165.83 1.1 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.529 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tp -108.57 -50.83 2.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.782 0.325 . . . . 0.0 110.751 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -155.38 171.57 19.66 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.339 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.839 HD23 HD11 ' A' ' 5' ' ' LEU . 11.5 tp -135.54 110.56 8.85 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.594 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -129.13 124.56 22.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.34 133.61 13.38 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.647 2.231 . . . . 0.0 112.52 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 122.726 2.284 . . . . 0.0 112.53 -179.785 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.738 0.304 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -148.03 167.05 25.93 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.07 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' THR . 54.4 m95 -145.96 138.59 25.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.942 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -138.51 136.19 35.86 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 80' ' ' LEU . 4.4 tp -130.91 153.7 48.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 111.23 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.13 173.29 8.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.48 -15.06 62.28 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.925 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.52 -35.38 72.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.933 0.397 . . . . 0.0 110.524 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -112.11 -40.56 4.17 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.763 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.75 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -64.74 -13.94 56.85 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -74.95 -27.12 60.06 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.505 -0.122 . . . . 0.0 111.232 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -90.79 -42.25 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.483 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -92.19 -42.85 9.66 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.76 -26.76 11.21 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.648 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.45 126.96 49.66 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.7 0.286 . . . . 0.0 111.244 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.75 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 1.7 ptt-85 -118.42 -58.4 1.98 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.53 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 3' ' ' TRP . 9.1 p -93.33 136.33 33.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -142.32 124.34 13.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.8 132.83 56.59 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 22' ' ' VAL . 19.0 t -148.68 121.31 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.338 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.61 32.64 2.76 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.07 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.516 ' H ' HG12 ' A' ' 20' ' ' VAL . 11.1 p -147.34 150.69 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.104 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -115.71 125.15 52.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.84 88.11 0.14 Allowed Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.397 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.41 26.02 13.64 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.692 0.282 . . . . 0.0 111.592 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.66 116.07 23.91 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.788 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -91.03 169.01 11.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.558 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.885 HG11 ' HB1' ' A' ' 67' ' ' ALA . 22.3 t -78.75 -33.53 16.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.642 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.615 ' HA3' HD13 ' A' ' 68' ' ' LEU . . . -86.06 -27.49 31.02 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.449 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.34 -42.69 82.44 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.672 0.272 . . . . 0.0 110.975 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -83.16 -38.16 22.74 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.635 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.3 tt -53.23 -54.98 28.15 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -59.32 -41.09 88.27 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.169 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -59.47 -56.5 21.17 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.58 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.6 mt -62.4 -20.56 64.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.167 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.801 HG13 HG21 ' A' ' 57' ' ' ILE . 65.5 t -88.59 -48.52 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 111.571 0.211 . . . . 0.0 111.571 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.56 -30.64 0.04 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.478 -0.867 . . . . 0.0 114.661 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.768 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -69.54 -1.38 8.56 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.591 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 8.7 t-80 -133.04 72.8 76.15 Favored Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -51.44 -15.25 2.37 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.32 2.68 . . . . 0.0 113.967 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.63 -28.92 23.45 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.581 ' HB2' HD23 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -100.07 -13.22 19.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -140.0 114.71 9.44 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.246 -0.284 . . . . 0.0 111.425 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -8.56 53.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.085 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 60.63 58.64 2.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.998 0.428 . . . . 0.0 111.017 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 m -96.44 34.92 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.553 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -167.15 -56.05 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.74 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.15 60.32 4.81 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.661 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.2 -49.27 11.88 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.708 0.29 . . . . 0.0 110.683 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.76 31.91 2.78 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.7 -100.22 0.19 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.675 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 56.77 -167.74 0.11 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.092 0.157 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 66.22 -75.69 0.05 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.455 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -111.9 125.52 54.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.031 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.67 158.37 31.72 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.179 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -137.21 113.39 9.9 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.414 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.801 HG21 HG13 ' A' ' 36' ' ' VAL . 1.6 pt -144.83 103.87 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.9 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -85.23 144.85 27.88 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.194 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 p -140.58 140.58 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.939 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -93.61 139.49 30.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.7 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.422 ' H ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -121.36 146.14 47.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.102 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.541 ' HB3' HD23 ' A' ' 78' ' ' LEU . 12.2 p-10 -84.96 19.28 2.17 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.181 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.32 23.72 5.65 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.885 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -108.42 155.8 20.16 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.737 0.303 . . . . 0.0 111.032 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 102.81 14.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.242 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.01 109.24 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.821 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.885 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -98.51 133.71 42.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.625 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.615 HD13 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -171.26 -68.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 27' ' ' THR . . . -100.4 49.19 1.14 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.573 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' HB2' HG21 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -108.66 31.35 5.7 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -54.59 -34.95 62.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.215 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.63 31.25 2.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.527 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.47 150.56 32.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.6 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.14 72.45 2.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 110.783 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.2 147.07 6.77 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.469 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.16 -73.25 0.69 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.689 0.28 . . . . 0.0 110.766 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 2.7 pt-20 -148.9 -169.58 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.543 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -112.11 -42.65 3.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.791 179.593 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.22 166.95 31.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.205 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 5' ' ' LEU . 6.1 tt -146.06 99.82 3.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.785 0.326 . . . . 0.0 110.842 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -151.47 143.23 15.91 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.413 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.56 153.47 23.36 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.855 2.37 . . . . 0.0 112.552 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.576 2.184 . . . . 0.0 112.551 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.403 ' HB3' ' HG2' ' A' ' 19' ' ' ARG . 3.7 pt-20 -146.17 164.33 32.56 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.915 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -147.4 118.58 7.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.974 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.474 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 23.3 mttm -106.16 141.96 36.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.642 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 11.6 tp -132.49 144.42 50.43 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.889 0.376 . . . . 0.0 111.412 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.48 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -82.57 172.43 12.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.265 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.05 66.36 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.008 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -34.46 53.31 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.573 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 3.9 mp -113.24 -38.05 4.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.978 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 -13.05 45.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -79.28 -27.28 42.26 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.439 ' HB ' ' C ' ' A' ' 42' ' ' LEU . 16.4 t -87.13 -39.44 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -96.43 -38.09 10.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.22 27.42 8.19 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.455 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.3 t -140.91 128.99 22.06 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.634 0.255 . . . . 0.0 110.758 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.642 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 3.2 ptm180 -113.79 -75.08 0.6 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.543 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 3.5 p -97.43 134.06 41.19 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.792 0.329 . . . . 0.0 111.409 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -145.27 129.83 12.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.843 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.403 ' HG2' ' HB3' ' A' ' 2' ' ' GLU . 67.0 mtm-85 -100.77 139.21 36.77 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.423 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.81 120.35 52.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.815 0.341 . . . . 0.0 111.261 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.57 -36.53 5.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.93 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.59 149.98 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.268 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -108.51 166.27 10.9 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.149 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.01 -124.29 0.87 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.633 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.51 34.52 2.19 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.939 0.399 . . . . 0.0 111.004 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.33 120.12 37.22 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.588 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.472 ' C ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -95.66 -176.94 3.89 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.009 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 67' ' ' ALA . 21.3 t -75.2 -42.22 44.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.518 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -75.64 -26.7 64.64 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.923 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -50.93 -45.24 60.41 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.489 0.316 . . . . 0.0 110.876 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.91 -32.23 20.28 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.6 tt -56.71 -60.73 3.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 110.098 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -60.87 -40.97 94.97 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.305 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -53.49 -56.02 20.51 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.228 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.57 -29.84 70.88 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.956 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 32' ' ' LEU . 92.0 t -73.62 -53.02 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.585 0.231 . . . . 0.0 110.827 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.02 20.58 0.06 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.248 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.742 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -105.15 -1.17 25.81 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.44 0.62 . . . . 0.0 111.579 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.489 ' HB3' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -129.32 72.65 81.96 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.44 -20.6 1.65 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.371 2.714 . . . . 0.0 113.551 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.52 -32.26 17.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.8 OUTLIER -99.7 -15.92 18.34 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.467 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -165.07 95.73 0.69 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.705 0.288 . . . . 0.0 111.161 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.78 -48.92 22.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.282 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -155.46 133.63 11.56 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.718 0.294 . . . . 0.0 110.839 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.49 -44.3 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.733 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -171.95 -67.41 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.964 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.42 99.57 1.01 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.595 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.36 -62.81 1.5 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.618 0.247 . . . . 0.0 111.146 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.87 -26.41 13.76 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.527 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.73 82.07 0.31 Allowed Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.767 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 59.85 80.0 0.21 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.985 0.421 . . . . 0.0 111.253 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.1 tp -96.0 97.5 9.65 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.692 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -147.9 116.99 6.83 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.277 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -147.17 149.7 33.49 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -87.49 157.64 19.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.594 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.637 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -153.5 124.23 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.67 0.272 . . . . 0.0 110.787 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -97.58 136.9 37.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 110.862 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 p -140.4 141.09 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.358 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 60' ' ' LEU . 9.8 tp -97.81 134.51 40.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 145.84 47.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -55.43 -21.26 15.12 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.7 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.81 23.76 5.49 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.41 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.85 165.93 13.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.369 0.267 . . . . 0.0 110.468 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.38 123.62 16.09 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.771 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.37 102.19 0.08 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.338 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.65 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -77.25 160.48 28.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.073 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.518 ' CD2' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -158.15 22.53 0.25 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.499 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.19 14.45 2.33 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.133 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.643 ' HG2' HG22 ' A' ' 72' ' ' THR . 2.0 tt0 178.54 96.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.717 0.294 . . . . 0.0 110.41 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.472 ' HB2' ' C ' ' A' ' 27' ' ' THR . . . -71.41 -6.66 41.94 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.894 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.643 HG22 ' HG2' ' A' ' 70' ' ' GLU . 13.4 t -75.23 1.52 13.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.89 -177.73 0.86 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.357 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 77.91 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.47 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.8 160.94 9.72 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.667 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.43 -78.79 0.59 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.674 0.273 . . . . 0.0 110.27 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -131.76 -177.01 4.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 110.823 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.76 -37.86 6.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.842 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -174.25 166.39 4.09 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.972 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.47 110.36 7.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.895 0.379 . . . . 0.0 110.602 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.459 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 23.3 m-85 -112.73 161.47 26.29 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.101 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 6' ' ' PHE . 96.6 Cg_endo -81.96 169.48 14.69 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.671 2.247 . . . . 0.0 112.584 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 C--N 1.348 0.516 0 C-N-CA 122.819 2.346 . . . . 0.0 112.547 179.887 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.788 0.328 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -160.68 163.64 32.32 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.166 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.516 ' CZ2' HD22 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -155.36 174.68 14.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.997 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 27.0 mttm -137.13 152.98 50.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.132 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.717 HD11 HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -141.51 132.38 25.91 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.811 0.338 . . . . 0.0 111.528 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.418 ' N ' HD13 ' A' ' 5' ' ' LEU . 1.1 t80 -81.35 175.77 10.3 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.112 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.82 -10.97 60.4 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.41 -46.31 62.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.901 0.381 . . . . 0.0 110.911 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -112.44 -36.03 5.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.121 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.95 -10.46 13.71 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -40.7 74.4 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.485 0.183 . . . . 0.0 111.067 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.834 HG11 ' HB2' ' A' ' 43' ' ' GLU . 4.2 t -94.51 -45.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.532 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 41' ' ' ALA . . . -65.34 -46.75 79.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.09 11.24 61.61 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.546 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.3 m -116.83 129.73 56.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.773 0.32 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -111.73 -85.91 0.56 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.728 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.7 p -102.66 134.37 46.14 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.571 0.224 . . . . 0.0 111.405 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 t -147.75 154.39 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.031 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 1.3 mtt85 -108.45 152.27 24.93 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.617 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.0 120.32 51.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.072 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.81 -46.43 0.95 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.388 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 m -87.37 122.15 38.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.444 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -116.45 129.36 56.17 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.096 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.21 -125.63 0.77 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.651 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.54 -45.67 91.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.581 0.229 . . . . 0.0 111.173 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.44 122.0 22.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.676 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -79.19 171.05 15.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.289 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.874 HG13 ' HA ' ' A' ' 71' ' ' ALA . 8.7 m -74.75 -37.08 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.502 ' HA3' HD23 ' A' ' 68' ' ' LEU . . . -80.27 -33.23 32.73 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.937 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -50.98 -47.5 61.38 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.78 0.324 . . . . 0.0 110.831 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.21 -25.8 33.89 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.886 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.797 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -63.1 -60.25 3.69 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.8 -36.57 72.38 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.091 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -62.61 -52.28 63.99 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.758 0.313 . . . . 0.0 110.267 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.516 HD22 ' CZ2' ' A' ' 3' ' ' TRP . 5.6 mp -68.9 -33.26 73.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.984 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 32' ' ' LEU . 41.6 t -55.66 -51.15 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.681 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' HD22 ' A' ' 9' ' ' LEU . . . 163.66 49.73 0.02 OUTLIER Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.959 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -82.19 -61.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.426 0.155 . . . . 0.0 110.588 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.432 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER 170.87 -58.78 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.78 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 39' ' ' HIS . 54.4 Cg_exo -50.67 -29.25 24.9 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.206 1.937 . . . . 0.0 111.914 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.62 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -61.98 -26.09 68.01 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.492 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.675 HD22 HD23 ' A' ' 9' ' ' LEU . 1.9 pt? -139.99 27.59 2.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.714 0.292 . . . . 0.0 110.765 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.834 ' HB2' HG11 ' A' ' 12' ' ' VAL . 3.3 tt0 64.78 165.61 0.16 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.201 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.1 p -69.68 -41.83 74.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.582 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.09 129.1 6.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.731 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.87 -37.87 11.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.995 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -154.05 35.64 0.43 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.204 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.91 97.6 0.38 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.221 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -61.37 142.94 56.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.827 0.346 . . . . 0.0 111.401 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.41 -28.87 65.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.631 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.62 62.76 0.63 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.784 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -123.98 118.23 26.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.564 0.221 . . . . 0.0 110.704 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.5 79.28 5.54 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.596 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.1 134.07 19.17 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.324 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.98 119.27 12.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -143.19 133.14 24.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.187 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.8 tt -169.88 146.9 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.46 155.33 16.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.871 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.556 HG23 ' HG ' ' A' ' 80' ' ' LEU . 11.6 p -140.54 149.02 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.365 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.59 123.11 49.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.814 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.546 ' NH1' ' HB2' ' A' ' 66' ' ' ALA . 3.6 tpp85 -114.16 144.41 43.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.818 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -74.12 -16.35 61.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.521 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.7 23.26 6.0 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.83 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.48 165.92 11.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.717 0.294 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.25 124.91 19.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.971 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.546 ' HB2' ' NH1' ' A' ' 61' ' ' ARG . . . -67.89 87.79 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.964 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.46 ' HB1' HG21 ' A' ' 28' ' ' VAL . . . -70.24 142.76 52.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.265 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.502 HD23 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -141.61 -59.24 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.005 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.594 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -94.36 36.69 3.66 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.67 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 73' ' ' ALA . 4.7 pt-20 -152.79 90.81 1.49 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.698 0.285 . . . . 0.0 111.285 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.874 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -59.12 -24.51 63.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.516 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.92 33.56 0.78 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.686 0.279 . . . . 0.0 111.571 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . . . -85.33 171.18 12.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.859 0.362 . . . . 0.0 111.674 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.1 92.97 3.93 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.023 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.07 122.41 3.81 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.892 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -107.18 -65.27 1.11 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.709 0.29 . . . . 0.0 111.003 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -162.95 -159.37 0.54 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.584 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.8 tp -123.29 -53.11 1.83 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.558 0.218 . . . . 0.0 110.951 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -152.8 153.54 33.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.196 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.597 HD11 HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -132.93 101.37 5.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.752 0.31 . . . . 0.0 110.73 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -146.81 145.13 21.66 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.469 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.16 150.42 65.9 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.668 2.245 . . . . 0.0 112.103 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--N 1.347 0.491 0 C-N-CA 122.589 2.193 . . . . 0.0 112.074 179.789 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -135.48 153.22 51.82 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 111.635 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.441 ' CZ2' HD13 ' A' ' 80' ' ' LEU . 1.9 t90 -155.48 148.28 24.29 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.112 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.452 ' HG2' HG22 ' A' ' 17' ' ' THR . 2.9 mttp -137.98 146.61 43.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.351 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.843 HD22 ' HB2' ' A' ' 9' ' ' LEU . 1.1 tt -135.54 165.1 26.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.974 0.416 . . . . 0.0 111.028 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.536 ' N ' HD23 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -80.79 -178.61 6.89 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.205 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.62 -8.73 50.0 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.29 -40.22 61.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.681 0.276 . . . . 0.0 111.431 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.843 ' HB2' HD22 ' A' ' 5' ' ' LEU . 4.7 mp -100.24 -33.23 10.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.596 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -71.52 -7.52 48.12 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -79.9 -29.57 39.89 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.383 0.135 . . . . 0.0 111.22 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 4.9 t -98.03 -49.19 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -104.48 -34.79 8.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.77 26.6 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.616 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.465 ' HB2' HD21 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -125.39 79.0 1.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.969 0.414 . . . . 0.0 110.772 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 5' ' ' LEU . 8.0 ptt85 -88.24 -43.82 11.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.98 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.452 HG22 ' HG2' ' A' ' 4' ' ' LYS . 6.1 p -92.99 139.28 30.68 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.824 0.345 . . . . 0.0 110.97 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -129.71 107.67 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.79 152.53 20.77 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.681 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.482 HG11 ' O ' ' A' ' 71' ' ' ALA . 29.0 t -102.08 120.28 51.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.39 -71.05 0.7 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -89.46 145.78 6.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.072 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HB2' HG21 ' A' ' 72' ' ' THR . 25.9 t0 -104.76 151.66 23.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.217 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.09 -102.97 0.18 Allowed Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.418 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.71 -27.35 11.36 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.603 0.224 . . . . 0.0 111.603 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 129.14 39.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.764 0.316 . . . . 0.0 111.336 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.468 HG22 ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -120.78 174.72 6.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.04 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.595 HG11 ' OD1' ' A' ' 76' ' ' ASP . 15.2 t -75.99 -39.59 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.126 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -76.41 -31.34 54.84 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.791 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -56.1 -48.38 76.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.716 0.293 . . . . 0.0 110.682 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.95 -26.84 39.89 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.125 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.1 tt -59.45 -58.76 7.19 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.84 -42.76 94.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.052 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.78 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -52.87 -56.15 17.99 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.24 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.546 ' O ' HD21 ' A' ' 9' ' ' LEU . 7.7 mp -62.14 -29.72 70.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.778 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 32' ' ' LEU . 84.0 t -74.44 -53.4 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.005 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.26 15.52 0.06 OUTLIER Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.056 -1.068 . . . . 0.0 114.806 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.78 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -105.16 -1.25 25.69 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.704 0.752 . . . . 0.0 111.655 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.516 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -137.77 75.31 43.39 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-O 120.945 0.403 . . . . 0.0 110.282 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -53.59 -14.22 4.77 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.981 2.454 . . . . 0.0 113.252 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.37 -28.59 20.17 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.503 HD13 HD23 ' A' ' 9' ' ' LEU . 1.2 mp -100.67 -12.99 18.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.99 109.88 12.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.647 0.26 . . . . 0.0 111.604 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -90.18 -41.31 11.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.241 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 62.67 77.22 0.34 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.606 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' HD1' ' A' ' 47' ' ' PHE . 20.0 t -92.41 -66.61 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.315 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.564 ' HD1' HG12 ' A' ' 46' ' ' VAL . 5.5 m-85 -136.14 76.67 1.62 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.933 0.397 . . . . 0.0 110.729 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.26 -86.1 0.5 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.377 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -147.05 164.05 34.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.739 0.304 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -115.51 31.67 6.56 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.962 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.18 83.62 0.06 OUTLIER Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.781 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.66 128.02 34.66 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.745 0.307 . . . . 0.0 111.357 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.53 161.42 7.75 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.023 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 112.72 25.52 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.961 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.51 154.48 43.67 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.195 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -135.35 102.86 5.29 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.302 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.85 -49.88 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.985 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.02 -167.06 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.212 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.638 ' CG1' HD12 ' A' ' 80' ' ' LEU . 3.7 m -90.61 151.58 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 111.131 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 60' ' ' LEU . 7.5 tp -129.81 150.56 51.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 111.309 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.516 ' HG3' ' HB3' ' A' ' 77' ' ' GLU . 3.5 mtt180 -143.14 146.34 33.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.962 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -52.44 -21.31 3.55 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.68 23.78 5.52 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.775 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -130.21 165.93 21.35 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.733 0.301 . . . . 0.0 110.739 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.52 121.65 10.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.252 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.08 144.56 56.04 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.387 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -92.52 -177.6 4.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HA ' ' HB ' ' A' ' 28' ' ' VAL . 5.2 tt -168.64 -50.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.652 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.51 25.39 21.1 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.869 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.468 ' N ' HG22 ' A' ' 27' ' ' THR . 1.2 tt0 -171.59 96.78 0.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.839 0.32 . . . . 0.0 110.979 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.482 ' O ' HG11 ' A' ' 20' ' ' VAL . . . -58.17 -26.82 63.2 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.694 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 23' ' ' ASP . 1.0 OUTLIER -91.11 34.03 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.721 0.296 . . . . 0.0 111.515 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.67 178.58 6.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.694 0.283 . . . . 0.0 111.478 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.41 72.0 9.47 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.937 0.398 . . . . 0.0 111.243 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.65 145.0 2.23 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.261 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.595 ' OD1' HG11 ' A' ' 28' ' ' VAL . 3.2 m-20 -124.12 -79.07 0.61 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.792 0.33 . . . . 0.0 110.852 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 1.4 pt-20 -141.15 -177.69 5.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.47 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.74 -52.94 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.632 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB1' ' CE2' ' A' ' 81' ' ' PHE . . . -159.34 174.35 14.88 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.638 HD12 ' CG1' ' A' ' 59' ' ' VAL . 3.1 tt -153.35 118.11 5.02 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.839 0.352 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.442 ' CE2' ' HB1' ' A' ' 79' ' ' ALA . 21.0 m-85 -139.76 108.11 7.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.886 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.72 158.17 50.9 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.831 2.354 . . . . 0.0 112.593 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 C--N 1.35 0.612 0 C-N-CA 123.074 2.516 . . . . 0.0 113.192 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.964 0.412 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -144.29 169.18 18.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.529 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.482 ' CZ3' HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -155.51 142.4 19.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.215 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.582 ' HG2' HG22 ' A' ' 17' ' ' THR . 8.2 mtmm -138.77 145.89 40.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.945 HD22 ' HB2' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -149.32 164.63 34.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 111.907 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.604 ' N ' HD23 ' A' ' 5' ' ' LEU . 2.1 t80 -85.79 179.79 6.98 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.496 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -63.04 -13.69 38.76 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.2 -34.69 23.57 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.716 0.293 . . . . 0.0 110.748 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.945 ' HB2' HD22 ' A' ' 5' ' ' LEU . 4.9 mp -105.07 -10.26 17.29 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.678 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.692 ' HB2' ' HG2' ' A' ' 16' ' ' ARG . . . -93.23 -2.24 55.34 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -35.83 73.66 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 56.1 t -97.65 -49.92 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.725 ' HB3' ' HA ' ' A' ' 41' ' ' ALA . . . -102.47 -34.38 9.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.99 25.79 28.27 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.313 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.17 98.33 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.874 0.369 . . . . 0.0 111.136 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.692 ' HG2' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -99.07 -45.3 5.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.075 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.582 HG22 ' HG2' ' A' ' 4' ' ' LYS . 11.8 p -93.47 147.7 22.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.144 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.24 113.74 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.168 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -105.7 141.83 36.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.836 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.56 120.5 56.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.085 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.28 -45.08 1.69 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.321 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.3 t -86.84 137.41 20.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -116.98 172.32 7.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.273 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.97 -91.13 0.13 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.24 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.91 -35.16 7.39 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.529 0.204 . . . . 0.0 111.115 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.59 135.81 55.54 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 111.14 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.874 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -110.07 -179.74 3.87 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.891 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.903 HG13 ' HA ' ' A' ' 71' ' ' ALA . 12.4 m -79.91 -35.2 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.785 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' HA3' HD23 ' A' ' 68' ' ' LEU . . . -91.29 -23.4 29.36 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.415 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.36 -40.27 96.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.704 0.288 . . . . 0.0 110.991 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -81.22 -39.67 25.02 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.707 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.616 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.6 tt -53.29 -57.13 11.64 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.74 0.305 . . . . 0.0 110.435 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.3 -34.75 75.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.47 -52.97 26.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.482 HD12 ' CZ3' ' A' ' 3' ' ' TRP . 12.4 mt -63.37 -26.22 68.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.317 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 32' ' ' LEU . 62.1 t -91.01 -42.6 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.58 0.229 . . . . 0.0 111.569 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.91 -34.54 90.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.102 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB3' ' HD3' ' A' ' 40' ' ' PRO . . . -104.95 -41.34 5.63 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.567 ' HB3' HD11 ' A' ' 42' ' ' LEU . 27.9 m170 63.16 49.17 1.07 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.345 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 39' ' ' HIS . 9.9 Cg_endo -53.57 -24.21 28.22 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.231 1.954 . . . . 0.0 112.109 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.725 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . . . -58.85 -36.17 74.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.532 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 39' ' ' HIS . 1.4 pp -120.59 1.86 10.63 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.276 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -132.8 78.14 1.78 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.794 0.33 . . . . 0.0 110.952 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.2 p -81.46 -44.28 17.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.706 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.86 99.44 0.77 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.001 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.17 -72.03 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.377 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -167.01 -46.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.409 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.52 -51.34 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.715 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -175.06 149.92 1.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.0 110.575 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.99 -28.99 63.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.51 111.31 0.29 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.778 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -102.84 136.2 43.1 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.744 0.307 . . . . 0.0 111.0 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -126.07 -46.01 1.69 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.462 ' HB2' HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -156.99 112.39 2.85 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.794 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -146.35 138.88 25.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -104.78 126.89 52.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.971 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 2.0 pp -151.24 132.09 4.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.334 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -90.83 143.29 26.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.795 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.491 ' CG2' HD12 ' A' ' 80' ' ' LEU . 14.7 p -140.83 150.43 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 111.771 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -115.37 128.93 56.41 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.826 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.49 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -101.78 145.92 28.49 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.059 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -20.98 59.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.713 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.48 23.66 5.62 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.891 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -95.84 162.19 13.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.082 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.66 102.5 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.974 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 49.91 75.88 0.15 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.983 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.32 133.99 33.62 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.805 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.43 HD23 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -161.27 -71.3 0.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.318 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.67 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -90.0 53.78 3.62 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.769 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 10.9 tt0 -159.4 72.94 0.56 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.752 0.31 . . . . 0.0 111.279 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.903 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -60.35 -28.66 68.35 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.339 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.31 36.38 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.345 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . . . -92.77 -178.39 4.83 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.956 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.12 68.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.485 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.94 157.76 9.11 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.505 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.518 ' OD2' HD12 ' A' ' 32' ' ' LEU . 15.4 t70 -95.49 -67.52 0.85 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.561 0.22 . . . . 0.0 110.871 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.73 -179.88 6.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.231 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 60' ' ' LEU . 11.0 mt -113.67 -47.72 2.97 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.602 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.16 169.87 22.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.102 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD12 ' CG2' ' A' ' 59' ' ' VAL . 7.6 tt -153.89 95.44 1.87 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.055 0.455 . . . . 0.0 110.645 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -131.12 144.96 55.66 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.254 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 59.8 Cg_endo -72.2 154.7 56.84 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.519 2.146 . . . . 0.0 112.109 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 39.7 Cg_exo . . . . . 0 C--N 1.349 0.56 0 C-N-CA 122.872 2.381 . . . . 0.0 112.497 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -146.52 159.97 42.73 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.496 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 41.8 m95 -143.51 128.34 18.33 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.643 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.517 ' C ' HD22 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -129.4 149.83 51.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.482 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 16' ' ' ARG . 4.0 mm? -126.66 144.95 50.75 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.644 0.259 . . . . 0.0 111.051 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -82.44 176.67 9.23 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 11' ' ' GLU . . . -52.34 -31.97 35.98 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.564 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.441 ' C ' HD13 ' A' ' 9' ' ' LEU . 1.1 t0 -49.45 -35.17 18.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 110.776 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.764 HD12 HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -109.24 -32.85 7.04 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.393 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.37 -2.51 49.56 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 28.1 tt0 -68.38 -34.89 76.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.775 0.322 . . . . 0.0 110.724 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' CG1' ' HB2' ' A' ' 44' ' ' SER . 20.5 t -94.87 -49.36 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.727 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 -38.25 63.0 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.27 -24.24 29.87 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.701 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.02 96.13 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.767 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.6 28.18 6.27 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.143 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 4' ' ' LYS . 11.1 p -92.09 132.76 36.34 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.647 0.261 . . . . 0.0 110.924 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.31 159.82 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.245 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -124.89 138.05 54.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.591 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.13 123.45 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.948 0.404 . . . . 0.0 111.424 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.27 -47.11 1.76 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.219 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.17 152.72 3.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.463 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.455 ' OD1' ' HB3' ' A' ' 71' ' ' ALA . 35.3 t0 -112.12 160.29 17.69 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.209 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.15 -130.22 1.54 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.423 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.91 -33.22 63.91 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.735 0.267 . . . . 0.0 111.145 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.0 134.74 49.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.255 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -111.28 175.84 5.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.002 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.698 HG23 ' HA ' ' A' ' 71' ' ' ALA . 58.5 t -75.64 -42.32 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 120.956 0.407 . . . . 0.0 110.032 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -82.54 -32.95 26.39 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.893 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.56 -41.07 96.55 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.721 0.296 . . . . 0.0 110.791 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.95 -31.57 51.01 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.805 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.6 tt -61.6 -58.78 6.75 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.33 -32.74 74.24 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.87 -51.97 34.72 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.106 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.9 -34.62 73.43 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.176 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 32' ' ' LEU . 40.9 t -85.08 -43.69 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.334 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.62 6.88 75.81 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.423 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.473 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -62.97 -58.32 7.73 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.191 0.496 . . . . 0.0 110.712 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.691 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 13.9 m-70 103.79 -57.52 0.0 OUTLIER Pre-proline 0 C--N 1.345 0.403 0 C-N-CA 124.637 1.175 . . . . 0.0 112.073 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 39' ' ' HIS . 61.2 Cg_exo -50.98 -22.93 11.14 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.028 1.818 . . . . 0.0 112.434 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -58.44 -32.55 68.8 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.622 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.764 HD22 HD12 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -136.75 25.11 3.1 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.146 179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.03 66.26 1.4 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.783 0.325 . . . . 0.0 110.985 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.406 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 3.3 m -82.41 -44.74 15.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.627 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -163.62 111.07 1.17 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.895 0.379 . . . . 0.0 111.227 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 47' ' ' PHE . 8.9 p -157.08 -48.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.236 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.437 ' N ' HG13 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -170.75 -165.65 0.45 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.72 43.86 3.29 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.897 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 67.87 133.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.092 0.472 . . . . 0.0 111.665 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -88.1 -28.15 21.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.373 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.27 -60.89 2.21 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.256 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.77 118.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.682 0.393 . . . . 0.0 111.936 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.9 mt -91.71 -32.28 15.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.684 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.11 122.52 34.46 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.71 0.29 . . . . 0.0 111.477 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.29 129.68 43.56 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.887 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.34 135.2 52.21 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.964 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HB ' HD21 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -151.87 131.2 3.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.851 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -91.42 164.82 13.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.782 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 p -138.76 147.36 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.435 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -106.05 128.0 53.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.953 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.435 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -126.62 145.89 50.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.016 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -59.31 -21.0 59.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.675 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.91 23.72 5.47 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.747 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.2 166.29 12.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.746 0.308 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.33 112.57 11.76 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.81 123.79 42.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.47 165.57 18.01 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.681 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.436 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -108.16 -38.88 5.65 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.13 24.9 13.79 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.142 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -162.54 96.06 0.93 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.84 0.32 . . . . 0.0 110.953 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.698 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -70.33 -6.65 36.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.708 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 t -75.86 1.28 15.47 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.8 -178.48 1.54 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 111.398 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.6 86.91 6.84 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.477 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.67 159.17 28.05 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.116 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -109.58 -77.4 0.6 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -157.4 -175.16 5.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.793 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.7 mt -108.12 -37.69 5.98 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.99 172.0 10.6 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.087 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.427 HD21 ' HB ' ' A' ' 57' ' ' ILE . 7.4 tt -136.65 97.3 3.51 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.274 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.86 136.49 20.74 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.68 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 66.2 Cg_endo -74.22 150.83 42.87 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.409 2.073 . . . . 0.0 112.451 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 52.7 Cg_exo . . . . . 0 C--N 1.351 0.677 0 C-N-CA 122.819 2.346 . . . . 0.0 112.106 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ttt . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.618 0.247 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -147.56 138.79 23.68 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.061 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.48 ' CE2' HD12 ' A' ' 32' ' ' LEU . 2.8 m0 -135.59 118.45 16.22 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.717 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 39.8 mtpt -116.91 139.78 50.23 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.589 ' HG ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -123.45 142.45 50.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.634 0.254 . . . . 0.0 110.796 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.484 ' H ' HD13 ' A' ' 5' ' ' LEU . 20.7 p90 -81.11 -173.19 4.16 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.173 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -41.09 -26.18 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.456 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -39.95 -47.27 2.2 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.884 0.373 . . . . 0.0 111.292 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.589 HD13 ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -113.23 -23.17 10.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.422 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.44 -3.01 38.18 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.15 -34.28 65.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.652 0.263 . . . . 0.0 111.073 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.425 HG21 ' C ' ' A' ' 42' ' ' LEU . 12.6 t -95.82 -53.6 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.719 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.64 -40.48 49.02 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.78 -30.33 7.23 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.455 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.2 p -156.95 124.96 5.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.632 0.253 . . . . 0.0 111.23 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.437 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.69 34.51 5.19 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.951 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.423 ' CG2' ' HG2' ' A' ' 4' ' ' LYS . 21.5 p -104.34 126.67 51.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -139.37 151.66 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -120.07 158.34 27.06 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.885 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 t -102.26 120.38 51.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.886 0.374 . . . . 0.0 111.215 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.99 -46.02 0.65 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.065 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.0 p -86.76 147.7 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.422 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -99.17 136.41 39.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.936 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.56 175.65 35.6 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.635 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.9 -31.49 68.67 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.548 0.213 . . . . 0.0 111.35 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 117.97 6.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.824 0.345 . . . . 0.0 111.049 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.855 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -68.28 179.52 1.58 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.876 HG13 ' HA ' ' A' ' 71' ' ' ALA . 2.6 m -74.54 -42.53 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.252 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -88.38 -28.49 22.21 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.276 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.78 -34.74 73.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.785 0.326 . . . . 0.0 110.728 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.601 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -92.09 -30.57 15.93 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.503 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 36' ' ' VAL . 4.0 tt -62.21 -53.69 51.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.781 0.324 . . . . 0.0 110.612 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -65.96 -31.76 72.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.245 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.0 -44.86 53.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.111 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 31' ' ' ALA . 8.1 mp -62.98 -32.78 74.21 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.928 0.394 . . . . 0.0 110.655 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 32' ' ' LEU . 47.0 t -87.97 -34.62 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.286 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.23 19.45 51.33 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.295 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -63.68 -52.2 61.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.053 0.426 . . . . 0.0 111.072 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.768 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 28.9 m170 104.63 -59.87 0.0 OUTLIER Pre-proline 0 C--N 1.345 0.391 0 C-N-CA 124.527 1.131 . . . . 0.0 112.071 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.768 ' HD3' ' HB2' ' A' ' 39' ' ' HIS . 42.6 Cg_exo -55.69 -22.06 34.63 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.691 1.594 . . . . 0.0 111.992 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.425 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -62.31 -29.25 70.3 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.645 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.528 HD22 ' CD2' ' A' ' 9' ' ' LEU . 2.3 pt? -135.69 26.81 3.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.838 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 70.95 136.02 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.5 m -58.45 -39.41 79.79 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.489 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 59.85 76.07 0.38 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.894 0.378 . . . . 0.0 111.244 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.3 68.56 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.508 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -141.18 -46.73 0.39 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.148 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.3 -63.34 1.51 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.049 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.92 155.53 1.64 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.792 0.33 . . . . 0.0 110.816 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -120.15 31.19 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.956 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.93 -99.63 2.63 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.512 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.14 93.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.832 0.348 . . . . 0.0 111.432 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 mp -94.82 18.66 11.37 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.527 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -133.24 128.85 36.76 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.618 0.247 . . . . 0.0 111.196 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.25 147.47 41.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -140.17 121.82 15.28 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.5 tt -173.6 145.39 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.404 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.6 m-80 -97.47 168.4 10.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.612 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' A' ' 80' ' ' LEU . 10.9 p -139.33 141.98 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.552 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.49 118.32 31.48 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.609 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -126.51 145.76 50.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.715 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.34 -10.59 56.01 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.895 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.56 5.58 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.945 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -118.8 166.08 13.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.631 0.253 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.11 125.78 27.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.64 130.3 46.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.24 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.476 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -98.27 134.54 41.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -128.59 -63.96 0.96 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.897 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.06 43.84 2.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.835 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -165.37 94.25 0.62 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.703 0.287 . . . . 0.0 111.236 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.876 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -71.56 -10.13 59.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.809 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.1 35.88 1.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 111.413 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.94 165.69 11.8 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.865 0.364 . . . . 0.0 111.327 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.3 80.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.15 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.76 -177.47 48.15 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.538 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.77 -74.9 0.59 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.792 0.33 . . . . 0.0 110.701 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -148.68 -177.61 5.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.39 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.59 -32.74 7.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.343 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB2' ' HD3' ' A' ' 4' ' ' LYS . . . -167.48 169.77 11.86 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.439 ' HG ' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -138.41 97.74 3.44 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.555 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -140.14 153.65 69.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.253 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HD3' ' CD1' ' A' ' 6' ' ' PHE . 24.6 Cg_endo -61.74 156.18 49.69 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.632 2.222 . . . . 0.0 112.31 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 C--N 1.347 0.463 0 C-N-CA 122.676 2.251 . . . . 0.0 112.421 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.759 ' HG3' HG12 ' A' ' 28' ' ' VAL . 2.8 ttp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.056 0.455 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -120.04 147.13 45.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.087 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.617 ' CH2' HD12 ' A' ' 32' ' ' LEU . 2.1 t90 -150.04 125.16 10.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.727 0.299 . . . . 0.0 111.168 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.652 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -122.23 148.47 44.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.297 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.668 HD13 ' HB3' ' A' ' 16' ' ' ARG . 7.6 mp -140.18 152.62 46.18 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.75 0.31 . . . . 0.0 111.334 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -98.27 179.15 4.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.62 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -53.67 -29.88 40.78 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.94 -37.73 33.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.004 0.431 . . . . 0.0 110.19 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.654 ' CB ' HD23 ' A' ' 5' ' ' LEU . 2.5 mp -110.73 -9.75 14.49 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.187 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.62 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -93.81 -4.9 49.34 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.99 -36.84 75.49 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 14.6 t -93.47 -33.51 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.797 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . . . -92.58 -45.03 8.3 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.38 -35.58 4.28 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.842 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.9 t -172.43 126.4 0.52 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.565 0.221 . . . . 0.0 110.824 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.668 ' HB3' HD13 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -123.05 28.2 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.291 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 5' ' ' LEU . 19.8 p -99.33 112.55 24.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.571 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.5 144.5 28.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.221 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -130.25 158.48 39.64 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.701 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.447 HG11 ' HB3' ' A' ' 1' ' ' MET . 13.4 p -103.95 136.97 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.893 0.378 . . . . 0.0 111.632 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.04 -48.62 1.11 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.918 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -86.65 165.67 2.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.284 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.09 118.07 33.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.08 -139.33 3.89 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.491 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.48 30.95 6.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.62 0.248 . . . . 0.0 111.302 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.46 146.3 25.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.898 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.533 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -121.08 167.75 12.28 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.83 0.348 . . . . 0.0 111.213 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.889 HG23 ' HA ' ' A' ' 68' ' ' LEU . 2.5 m -78.2 -36.88 21.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.435 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -79.21 -31.28 42.93 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.879 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -50.84 -42.17 58.31 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.885 0.374 . . . . 0.0 110.556 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.49 -30.89 17.02 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.126 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.617 HD12 ' CH2' ' A' ' 3' ' ' TRP . 0.7 OUTLIER -58.34 -56.07 26.85 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.829 -0.168 . . . . 0.0 110.96 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -57.18 -36.26 70.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.628 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.15 -53.95 9.71 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 110.469 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 39' ' ' HIS . 7.8 mp -61.43 -25.3 67.12 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.244 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 32' ' ' LEU . 90.4 t -91.92 -45.89 14.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.432 0.158 . . . . 0.0 111.336 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.28 -40.53 94.09 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.861 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.14 -56.35 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.652 0.263 . . . . 0.0 111.053 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.474 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER 72.52 55.5 0.34 Allowed Pre-proline 0 C--O 1.231 0.106 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.75 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 52.7 Cg_exo -53.12 -17.71 8.66 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.22 1.947 . . . . 0.0 112.06 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . . . -57.13 -40.49 77.23 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.189 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -134.5 13.17 3.78 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.642 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.14 118.64 26.55 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.842 0.354 . . . . 0.0 111.442 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.9 m -94.97 7.46 46.0 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.694 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 71.49 31.7 2.23 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.683 0.277 . . . . 0.0 111.063 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 46' ' ' VAL . 7.5 p -168.47 87.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.172 0.511 . . . . 0.0 111.37 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -157.57 104.67 2.0 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.183 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.42 -80.2 0.64 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.383 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.76 -62.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.814 0.34 . . . . 0.0 110.499 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.71 -28.94 51.04 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.465 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.09 -63.42 0.55 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.383 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.54 156.07 40.69 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.771 0.319 . . . . 0.0 111.059 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.56 -67.89 0.96 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -151.67 134.27 15.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.005 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.15 164.31 29.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.2 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -108.62 126.4 52.92 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.061 HD13 HD21 ' A' ' 80' ' ' LEU . 1.7 pp -148.87 120.09 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.553 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -77.27 151.31 35.12 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.868 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.684 HG23 HD12 ' A' ' 80' ' ' LEU . 11.0 p -136.92 146.7 27.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.678 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.34 124.3 49.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.732 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.71 145.61 51.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -61.09 -25.19 66.79 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.653 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.43 23.49 5.99 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.916 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.24 166.07 12.03 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.653 0.263 . . . . 0.0 110.772 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.03 114.29 2.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.982 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.03 111.54 10.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.075 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.54 -175.89 3.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.251 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.889 ' HA ' HG23 ' A' ' 28' ' ' VAL . 0.7 OUTLIER -141.16 -42.35 0.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.562 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.73 35.94 3.88 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.855 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HG2' HG22 ' A' ' 72' ' ' THR . 4.8 tt0 -167.94 91.28 0.33 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -83.88 -0.97 53.47 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.716 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.524 HG22 ' HG2' ' A' ' 70' ' ' GLU . 12.8 t -84.82 -26.56 27.38 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.436 0.16 . . . . 0.0 111.092 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.26 139.45 53.37 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.747 0.308 . . . . 0.0 110.913 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.94 -74.68 0.06 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.88 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.624 ' C ' HG11 ' A' ' 28' ' ' VAL . . . 113.99 -151.21 18.45 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.505 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 28' ' ' VAL . 25.3 p-10 -111.63 -50.77 2.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.406 0.146 . . . . 0.0 110.74 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -171.35 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.741 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.1 mt -107.66 -36.79 6.34 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.215 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 4' ' ' LYS . . . -165.22 170.93 14.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.631 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.061 HD21 HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -145.64 100.1 3.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.899 0.38 . . . . 0.0 110.545 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 12.5 m-85 -114.09 133.95 22.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.009 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 81' ' ' PHE . 37.1 Cg_exo -57.33 170.72 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.797 2.331 . . . . 0.0 112.403 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 C--N 1.349 0.573 0 C-N-CA 122.771 2.314 . . . . 0.0 112.362 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.579 0.228 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.44 160.14 40.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.882 0.372 . . . . 0.0 110.887 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.69 ' CH2' HD13 ' A' ' 80' ' ' LEU . 6.1 t-105 -155.27 144.83 21.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.02 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -137.63 141.16 41.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.938 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.617 HD21 ' HB2' ' A' ' 9' ' ' LEU . 11.7 tp -133.08 158.24 43.26 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.991 0.425 . . . . 0.0 111.893 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -91.14 177.93 6.13 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.716 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.495 ' HB1' ' HG3' ' A' ' 11' ' ' GLU . . . -72.93 -10.24 59.58 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.588 ' C ' HD13 ' A' ' 9' ' ' LEU . 6.2 t70 -56.65 -39.72 74.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.617 ' HB2' HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -111.66 -39.6 4.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.417 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -61.43 -14.23 26.62 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.495 ' HG3' ' HB1' ' A' ' 7' ' ' ALA . 35.1 mt-10 -73.37 -26.9 61.2 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.364 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 41' ' ' ALA . 16.5 t -89.66 -41.63 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.77 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -90.12 -43.55 10.39 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.68 -20.31 22.69 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.828 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.9 m -111.64 130.68 55.69 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.882 0.341 . . . . 0.0 110.665 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.623 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -113.81 -49.08 2.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 p -93.1 146.68 23.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.92 0.39 . . . . 0.0 111.435 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.0 t -145.36 119.33 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.24 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -102.42 138.59 39.14 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.358 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.75 123.21 65.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.438 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.08 -31.86 11.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.19 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 p -91.81 151.34 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -116.88 121.97 43.01 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.98 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.91 45.07 1.18 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.467 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.3 t0 55.48 33.57 21.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.868 0.365 . . . . 0.0 111.295 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.57 127.08 33.46 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.654 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.628 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -78.08 168.07 20.46 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.796 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.49 HG11 ' HG3' ' A' ' 61' ' ' ARG . 22.6 t -75.25 -34.43 30.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.451 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -85.07 -28.64 30.49 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.304 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.83 -41.44 74.25 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.559 0.218 . . . . 0.0 110.955 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.51 -32.29 19.5 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -61.43 -61.86 2.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.645 0.259 . . . . 0.0 110.54 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -62.06 -33.17 73.9 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.672 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -66.08 -54.5 24.93 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.291 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.54 -19.22 64.61 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.459 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 32' ' ' LEU . 88.2 t -91.99 -47.81 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.31 -34.22 2.55 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.789 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -80.61 -1.23 41.36 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.424 ' O ' HD12 ' A' ' 42' ' ' LEU . 7.8 m170 -127.1 65.69 65.28 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.781 0.324 . . . . 0.0 110.675 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 53.3 Cg_exo -54.01 -19.11 14.81 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.779 2.319 . . . . 0.0 112.469 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -52.72 -26.43 14.01 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.631 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.77 HD23 ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -95.91 -23.76 16.73 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.679 0.275 . . . . 0.0 110.99 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 78.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.084 0.469 . . . . 0.0 111.022 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.8 t -80.42 -53.38 6.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.813 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -176.49 107.47 0.07 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.61 -55.71 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.655 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -172.25 48.05 0.02 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.609 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.34 -45.23 2.6 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.528 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.06 156.76 45.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.723 0.297 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.37 -28.84 9.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.242 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.4 158.87 22.63 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.623 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.57 97.31 3.71 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.677 0.275 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 mt 70.93 -63.72 0.41 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.26 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -113.45 138.49 50.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.77 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -103.6 126.45 50.75 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 141.12 46.04 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.193 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.4 mt -146.86 130.83 9.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.285 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -101.65 146.53 27.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.957 0.408 . . . . 0.0 111.143 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.78 154.08 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tp -124.61 120.92 33.29 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.017 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HG3' HG11 ' A' ' 28' ' ' VAL . 2.5 tmm_? -127.5 88.42 2.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.619 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 57.54 18.68 4.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.851 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.48 23.66 39.11 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.642 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -102.01 166.0 10.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.951 0.405 . . . . 0.0 111.199 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.52 102.9 14.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.533 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 63.2 105.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.066 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.416 ' CB ' ' HG3' ' A' ' 61' ' ' ARG . . . -109.95 162.57 14.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.225 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.451 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 2.6 tt -169.9 -65.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.602 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.483 ' HA2' HG22 ' A' ' 27' ' ' THR . . . -93.45 63.39 1.97 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.137 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -123.82 30.48 6.16 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -58.32 -22.9 54.82 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -76.74 -25.0 53.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.243 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.84 154.52 41.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.69 0.281 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.4 66.74 3.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.825 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.53 -173.93 27.46 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.549 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -117.36 -72.74 0.67 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.582 0.229 . . . . 0.0 110.694 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.455 ' HA ' ' HG2' ' A' ' 61' ' ' ARG . 1.3 pt-20 -149.41 -169.21 3.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.716 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -113.52 -48.74 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.407 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -162.5 166.74 24.49 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.249 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.69 HD13 ' CH2' ' A' ' 3' ' ' TRP . 4.8 tt -146.55 111.88 5.49 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.83 0.348 . . . . 0.0 110.942 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -151.44 156.7 34.93 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.485 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.0 153.06 76.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.543 2.162 . . . . 0.0 112.383 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 C--N 1.347 0.469 0 C-N-CA 122.609 2.206 . . . . 0.0 112.703 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG3' ' HA2' ' A' ' 75' ' ' GLY . 6.4 mtm . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.621 0.248 . . . . 0.0 111.434 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -116.71 159.22 22.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.815 0.34 . . . . 0.0 111.28 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.709 ' CH2' HD13 ' A' ' 80' ' ' LEU . 7.2 t-105 -151.27 143.05 23.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.627 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.541 ' HG2' HG22 ' A' ' 17' ' ' THR . 2.1 mtmm -138.24 145.91 41.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.774 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.478 HD11 HD13 ' A' ' 9' ' ' LEU . 10.5 tp -138.48 159.76 41.26 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.044 0.449 . . . . 0.0 111.683 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -87.13 173.39 9.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.327 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 11' ' ' GLU . . . -65.52 -25.5 67.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.746 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.48 -39.52 23.31 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.865 0.364 . . . . 0.0 110.675 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.729 ' HB3' HD22 ' A' ' 42' ' ' LEU . 1.3 mp -101.1 -34.26 9.79 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.337 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -70.29 -12.01 61.29 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -71.1 -34.4 71.07 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 121.289 -0.164 . . . . 0.0 111.361 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.698 HG21 ' HB2' ' A' ' 43' ' ' GLU . 5.1 t -98.3 -37.79 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.655 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -88.15 -45.83 9.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.586 0.232 . . . . 0.0 111.437 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.34 -25.57 27.81 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.534 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 t -106.14 111.58 24.25 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.857 0.36 . . . . 0.0 110.814 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.597 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 1.7 ptt-85 -102.66 -45.77 4.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.709 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.541 HG22 ' HG2' ' A' ' 4' ' ' LYS . 4.8 p -99.73 140.64 33.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 111.436 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.09 129.59 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.927 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -110.52 136.0 50.32 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.519 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.51 137.43 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.861 0.362 . . . . 0.0 111.652 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.71 -21.25 11.77 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.584 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.87 152.21 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.875 0.369 . . . . 0.0 111.615 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.7 153.53 26.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.132 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.68 -155.08 9.02 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.784 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.56 30.36 5.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.725 0.298 . . . . 0.0 111.492 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.13 123.7 29.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.044 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.711 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -76.72 164.25 26.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.781 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.878 HG11 ' HB3' ' A' ' 67' ' ' ALA . 38.7 t -73.76 -30.08 27.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.536 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.676 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -87.21 -29.48 22.4 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.425 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.44 -41.84 77.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.589 0.233 . . . . 0.0 111.077 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -84.27 -32.31 24.48 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.373 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.4 tt -56.48 -61.22 2.56 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.346 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.68 -37.74 88.49 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.403 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -59.83 -53.58 56.26 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.618 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.1 mt -64.88 -20.62 66.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.007 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 32' ' ' LEU . 57.3 t -86.34 -48.47 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.57 -39.47 1.21 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.804 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -72.85 -0.49 13.6 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.401 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 1.4 t-80 -120.79 68.73 16.18 Favored Pre-proline 0 N--CA 1.453 -0.301 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.487 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 85.9 Cg_exo -48.63 -19.11 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.123 2.549 . . . . 0.0 113.362 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.443 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -51.36 -38.72 54.67 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -83.79 -19.81 34.38 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.698 ' HB2' HG21 ' A' ' 12' ' ' VAL . 1.8 mm-40 64.48 118.89 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.7 t -94.94 -26.64 16.04 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.046 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.48 174.16 10.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.016 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.22 39.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.885 0.374 . . . . 0.0 111.543 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -175.3 83.49 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.928 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.93 -97.67 0.11 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.36 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -156.75 141.73 17.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.718 0.294 . . . . 0.0 111.029 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -100.49 -28.92 12.65 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.365 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.99 -159.54 21.73 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.222 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -160.31 145.03 14.55 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.755 0.312 . . . . 0.0 111.465 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -172.4 -49.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.075 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -146.23 141.15 27.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -106.19 119.47 39.31 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.586 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -93.89 97.25 10.25 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 56' ' ' HIS . 0.8 OUTLIER -163.07 126.19 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.991 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -85.87 144.02 27.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.515 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.51 ' CG2' HD12 ' A' ' 80' ' ' LEU . 14.4 p -139.99 147.9 23.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.338 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tp -107.46 118.3 36.37 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.849 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.31 85.8 1.81 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.297 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 63.8 16.32 9.7 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.917 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.6 23.75 27.72 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.536 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.98 162.67 14.61 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.831 0.348 . . . . 0.0 110.858 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.31 102.48 13.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.42 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.75 109.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.305 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.878 ' HB3' HG11 ' A' ' 28' ' ' VAL . . . -104.75 148.66 26.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.028 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.676 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 6.2 tt -139.11 -67.37 0.45 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.045 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.02 52.75 3.69 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.844 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.49 24.77 7.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.63 0.252 . . . . 0.0 111.621 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -58.06 -29.65 65.57 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.308 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.68 1.38 56.88 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.97 175.28 6.77 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.833 0.349 . . . . 0.0 111.363 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.68 53.59 2.76 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.215 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA2' ' HG3' ' A' ' 1' ' ' MET . . . 138.34 163.54 9.62 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.878 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.71 -67.9 0.76 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 110.531 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.57 -172.32 2.87 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.739 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.11 -52.47 2.76 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.69 0.281 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.16 170.13 22.97 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.949 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.709 HD13 ' CH2' ' A' ' 3' ' ' TRP . 1.1 tt -147.99 112.23 5.23 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.837 0.351 . . . . 0.0 111.083 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -130.9 136.32 28.71 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.054 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 6' ' ' PHE . 57.7 Cg_endo -71.31 146.19 50.23 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.628 2.219 . . . . 0.0 112.531 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--N 1.35 0.636 0 C-N-CA 122.805 2.337 . . . . 0.0 112.603 -179.915 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.042 0.449 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 77' ' ' GLU . 19.9 mt-10 -141.04 175.44 9.63 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.438 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.765 ' CZ3' HD22 ' A' ' 35' ' ' LEU . 1.5 t90 -155.41 118.62 4.38 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.986 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 7.0 mtpp -102.55 145.79 29.09 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -136.5 137.21 40.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.722 0.296 . . . . 0.0 111.723 -179.111 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.58 163.39 14.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.632 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -53.08 -29.19 28.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.518 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.705 ' HB3' HD12 ' A' ' 9' ' ' LEU . 4.3 t70 -47.62 -38.5 14.79 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.958 0.409 . . . . 0.0 110.667 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.707 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 4.2 mp -119.19 -3.18 10.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.481 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -92.99 -9.18 40.79 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.55 -44.37 76.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.578 0.228 . . . . 0.0 111.108 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 15.4 t -94.26 -29.96 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.074 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.926 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . . . -69.43 -41.67 76.02 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.582 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.62 -6.78 81.75 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.479 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.39 152.17 51.57 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 110.998 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -110.7 -76.81 0.6 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.474 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.7 p -95.93 136.65 36.08 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.854 0.359 . . . . 0.0 111.428 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.21 121.33 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.763 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.41 151.19 21.81 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.955 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 20' ' ' VAL . 11.5 p -118.16 120.74 65.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.84 0.353 . . . . 0.0 111.275 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -33.52 6.02 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.17 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 m -87.41 134.23 28.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.15 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -117.01 134.21 55.03 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.82 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.45 -109.17 0.29 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.649 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.15 25.8 6.47 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 111.454 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.32 141.97 49.55 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.753 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.65 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -117.5 177.38 4.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 68' ' ' LEU . 42.2 t -78.1 -50.32 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.055 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.495 ' HA3' HD13 ' A' ' 68' ' ' LEU . . . -78.67 -25.63 60.27 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.146 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.69 -39.86 85.95 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.645 0.26 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.94 -33.1 18.58 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.815 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.565 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -60.27 -57.47 12.66 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.457 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.29 -33.97 73.11 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.382 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.86 -52.35 15.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.096 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.765 HD22 ' CZ3' ' A' ' 3' ' ' TRP . 8.8 mp -61.8 -27.76 68.99 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.428 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 32' ' ' LEU . 42.4 t -94.24 -41.07 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.54 0.21 . . . . 0.0 111.365 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.2 -37.0 91.15 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.045 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.08 -25.07 13.55 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.582 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 17.0 m80 63.19 44.78 0.59 Allowed Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 122.675 0.39 . . . . 0.0 111.324 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 53.6 Cg_exo -51.77 -31.31 41.3 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.942 1.761 . . . . 0.0 111.71 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.926 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . . . -56.46 -32.1 64.63 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.389 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.59 HD21 HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -121.94 -3.12 9.15 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -79.47 87.47 5.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.832 0.348 . . . . 0.0 111.041 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.0 -53.6 3.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.26 103.87 0.07 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.526 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 46' ' ' VAL . 63.6 t 56.59 70.12 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.994 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.17 -59.58 1.39 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.936 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.48 62.68 0.54 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.487 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.65 -70.23 0.25 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.485 0.183 . . . . 0.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -109.89 -29.48 8.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.295 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.02 123.77 0.22 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.909 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -127.37 33.75 4.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.682 0.277 . . . . 0.0 111.273 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.45 163.3 36.96 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.89 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -101.82 112.24 24.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.97 147.89 44.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.413 ' HB3' ' HG2' ' A' ' 83' ' ' PRO . 3.5 t60 -117.25 149.79 39.85 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 pt -136.8 104.45 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.29 151.4 33.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.8 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.502 HG23 ' OE2' ' A' ' 77' ' ' GLU . 9.1 p -133.98 151.81 33.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.714 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.533 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -114.35 130.07 56.67 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.663 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.533 ' N ' HD13 ' A' ' 60' ' ' LEU . 18.8 mtt180 -123.18 145.6 48.49 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.741 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -52.09 -38.4 57.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.371 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.04 22.64 6.79 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.807 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.82 164.63 19.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.726 0.263 . . . . 0.0 110.715 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.27 105.76 0.97 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.23 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.31 153.46 46.98 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.375 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -113.7 179.85 3.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.293 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD13 ' HA3' ' A' ' 29' ' ' GLY . 3.2 pp -111.67 -33.16 6.43 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.989 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.477 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -85.5 32.22 3.69 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.854 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -153.28 90.96 1.46 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.813 0.306 . . . . 0.0 111.269 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.65 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -67.66 -12.7 61.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.97 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 t -88.2 34.14 0.74 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.953 0.406 . . . . 0.0 111.056 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.56 167.38 11.97 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.11 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.48 40.56 1.84 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.699 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.58 67.0 0.02 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.59 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -69.17 -71.16 0.23 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.711 0.291 . . . . 0.0 110.57 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.502 ' OE2' HG23 ' A' ' 59' ' ' VAL . 34.7 tt0 -140.45 156.36 46.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.554 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -100.62 -42.99 6.31 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.766 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -169.44 163.18 10.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.425 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -136.26 113.24 10.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.994 0.426 . . . . 0.0 110.439 179.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -146.22 140.57 15.57 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.303 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 73.2 Cg_endo -75.46 151.46 37.53 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.36 2.04 . . . . 0.0 111.857 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' A' ' 56' ' ' HIS . 34.7 Cg_exo . . . . . 0 C--N 1.348 0.529 0 C-N-CA 122.673 2.248 . . . . 0.0 112.068 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.893 0.378 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 17.3 mt-10 -142.58 163.76 31.95 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.03 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.736 ' CZ2' HD22 ' A' ' 80' ' ' LEU . 5.3 t-105 -153.99 141.54 19.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.103 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -138.43 143.1 39.55 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.644 HD21 HD22 ' A' ' 9' ' ' LEU . 13.2 tp -136.73 156.48 48.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 111.646 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.563 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -81.27 -177.73 6.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.359 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.38 -12.29 60.23 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -54.03 -38.12 64.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.781 0.324 . . . . 0.0 111.044 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.796 HD23 HD13 ' A' ' 42' ' ' LEU . 2.2 mp -105.48 -38.22 6.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.326 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -64.73 -17.83 64.48 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -67.13 -26.85 66.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.429 0.156 . . . . 0.0 111.166 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 41' ' ' ALA . 8.9 t -98.19 -44.37 12.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.9 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -91.62 -42.55 10.13 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.48 -28.14 14.46 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.84 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 t -100.45 108.25 20.18 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.826 0.346 . . . . 0.0 111.043 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.816 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -98.62 -42.43 7.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.531 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -93.75 147.5 22.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.068 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -142.11 113.24 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.191 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.13 136.24 37.95 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.441 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.56 124.88 66.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 111.407 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.78 -34.41 7.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.054 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.62 145.3 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 120.813 0.339 . . . . 0.0 111.257 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -116.66 121.72 42.48 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.99 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.84 -107.93 1.62 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.395 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.33 -10.64 16.88 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.21 145.34 51.54 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.744 0.307 . . . . 0.0 111.39 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.03 170.92 7.92 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.084 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.571 HG22 ' HA ' ' A' ' 76' ' ' ASP . 24.6 t -75.01 -37.64 41.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.462 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.68 ' HA3' HD12 ' A' ' 68' ' ' LEU . . . -88.78 -33.87 9.58 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.17 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -55.49 -45.22 77.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.665 0.269 . . . . 0.0 111.139 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -76.75 -24.68 52.98 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.934 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.744 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.4 tt -66.72 -58.17 5.63 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -62.63 -31.6 72.48 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.832 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' CA ' ' HB3' ' A' ' 38' ' ' ALA . . . -71.62 -48.3 48.83 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.938 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 31' ' ' ALA . 8.9 mp -64.31 -21.45 66.61 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.011 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 32' ' ' LEU . 97.9 t -84.4 -49.26 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.82 -35.41 1.38 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.826 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HB3' ' CA ' ' A' ' 34' ' ' ALA . . . -74.47 -1.21 20.18 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 5.7 m80 -126.11 65.63 57.22 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 110.471 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 77.6 Cg_exo -52.28 -19.64 9.77 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.825 2.35 . . . . 0.0 112.576 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -53.03 -29.03 27.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.576 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.9 HD23 ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -96.21 -16.25 21.56 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.597 0.237 . . . . 0.0 111.453 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' C ' HG21 ' A' ' 12' ' ' VAL . 4.4 mt-10 -73.25 131.56 42.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.708 0.29 . . . . 0.0 111.394 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -89.67 -32.84 16.86 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.214 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -145.61 164.46 31.66 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.7 0.286 . . . . 0.0 111.129 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.56 59.28 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -151.79 93.53 1.87 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.848 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.09 32.32 83.74 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.825 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -90.41 -35.45 15.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.631 0.215 . . . . 0.0 111.101 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -28.74 66.98 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.588 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.57 105.45 0.22 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.526 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -84.36 75.36 10.24 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.802 0.334 . . . . 0.0 111.109 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' A' ' 54' ' ' TYR . 9.8 tt 68.19 -70.51 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.193 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HB2' HD23 ' A' ' 53' ' ' LEU . 1.5 t80 -117.72 123.68 46.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.655 0.264 . . . . 0.0 110.569 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -149.61 143.65 25.68 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.241 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -97.84 144.46 27.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.52 HG22 ' HD3' ' A' ' 83' ' ' PRO . 8.2 pt -152.51 125.33 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.743 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -99.94 135.39 41.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.437 HG23 HD12 ' A' ' 80' ' ' LEU . 13.8 p -140.6 153.96 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.256 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mp -132.18 133.09 43.81 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.965 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -146.11 84.29 1.64 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.424 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 54.11 18.96 1.91 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.076 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.36 23.06 59.36 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.711 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -138.1 166.99 22.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.08 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.39 127.86 34.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.744 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.16 157.52 13.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.508 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 28' ' ' VAL . . . -110.25 174.54 5.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.403 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.68 HD12 ' HA3' ' A' ' 29' ' ' GLY . 2.1 tt -149.58 20.23 0.92 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.445 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.31 19.38 1.35 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.588 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 178.27 85.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.139 0.469 . . . . 0.0 111.417 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB2' ' N ' ' A' ' 28' ' ' VAL . . . -82.71 6.97 16.22 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.779 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 t -83.91 -14.9 49.84 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.53 0.205 . . . . 0.0 111.254 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.08 131.26 54.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.707 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.82 23.73 11.59 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.975 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.71 -129.82 22.27 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.346 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.571 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -121.34 -72.85 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.52 0.2 . . . . 0.0 110.859 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -162.53 -166.85 1.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 78' ' ' LEU . 11.2 mt -111.75 -55.47 2.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.708 0.289 . . . . 0.0 110.958 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.89 164.37 38.96 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.225 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.736 HD22 ' CZ2' ' A' ' 3' ' ' TRP . 0.5 OUTLIER -139.29 115.29 10.23 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.004 0.43 . . . . 0.0 110.741 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -107.77 108.26 61.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 6' ' ' PHE . 58.7 Cg_endo -71.67 171.48 16.31 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.777 2.318 . . . . 0.0 112.492 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.52 ' HD3' HG22 ' A' ' 57' ' ' ILE . 70.6 Cg_endo . . . . . 0 C--N 1.349 0.598 0 C-N-CA 122.651 2.234 . . . . 0.0 112.583 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.609 0.242 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.94 154.14 44.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.046 0.45 . . . . 0.0 111.497 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -145.8 143.85 29.92 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.412 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.47 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 12.9 mttp -135.03 136.43 42.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.525 0.202 . . . . 0.0 110.654 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.742 HD21 ' CB ' ' A' ' 9' ' ' LEU . 3.9 tp -129.95 135.21 48.06 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.798 0.332 . . . . 0.0 111.07 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -81.8 176.35 9.67 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.414 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.545 ' HB1' ' CD ' ' A' ' 11' ' ' GLU . . . -63.79 -16.16 60.52 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -55.51 -30.43 60.65 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.739 0.304 . . . . 0.0 110.906 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.742 ' CB ' HD21 ' A' ' 5' ' ' LEU . 3.3 mp -119.31 -36.26 3.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.335 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.47 -15.48 50.13 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.545 ' CD ' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -71.63 -26.79 62.71 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -95.7 -39.14 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.888 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -93.19 -42.4 9.38 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.18 23.19 10.72 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.736 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.71 136.96 49.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.553 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -113.5 -81.63 0.6 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.428 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 5.0 p -92.69 149.0 21.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.872 0.368 . . . . 0.0 111.464 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.16 118.29 6.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.976 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 148.17 28.18 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.467 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -103.14 120.2 52.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.97 -15.88 14.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.541 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.79 150.81 3.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.594 0.235 . . . . 0.0 110.968 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.86 172.48 0.95 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.433 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.15 85.13 0.91 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.937 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.59 -44.09 4.77 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.472 0.177 . . . . 0.0 111.402 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.55 165.82 12.15 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.751 0.31 . . . . 0.0 111.246 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.672 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -80.16 165.17 22.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 179.809 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.45 -24.3 14.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.731 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.474 ' N ' ' HA ' ' A' ' 68' ' ' LEU . . . -88.95 -27.52 23.52 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.051 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.18 -47.78 68.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.687 0.279 . . . . 0.0 110.912 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -79.61 -34.59 40.54 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.605 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -53.12 -60.06 3.77 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.393 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.2 -35.48 80.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.13 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.887 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -57.87 -55.38 35.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.646 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.52 HD23 ' ND1' ' A' ' 39' ' ' HIS . 17.9 mt -66.77 -23.16 66.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.875 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 32' ' ' LEU . 56.1 t -80.21 -47.58 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -125.41 -37.8 0.51 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.201 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.887 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -71.48 -1.54 13.62 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.52 ' ND1' HD23 ' A' ' 35' ' ' LEU . 15.7 m80 -129.29 67.03 78.09 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 120.816 0.341 . . . . 0.0 110.667 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.33 -16.82 14.31 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.715 2.277 . . . . 0.0 112.588 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.45 -25.59 16.77 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.888 HD23 ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -99.5 -22.43 15.49 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.634 0.254 . . . . 0.0 111.365 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -98.85 163.61 12.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.917 0.389 . . . . 0.0 111.363 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -97.81 -49.52 4.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.71 135.66 23.6 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.732 0.301 . . . . 0.0 111.176 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 46' ' ' VAL . 9.5 p -154.71 31.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.132 0.491 . . . . 0.0 111.287 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.2 -75.21 0.6 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.864 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.26 74.59 0.38 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.263 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.52 167.67 5.37 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.782 0.325 . . . . 0.0 111.343 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -96.86 31.58 2.32 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.441 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.11 57.79 0.03 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.903 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -163.94 132.72 3.75 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.794 0.331 . . . . 0.0 111.317 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.37 -38.15 5.06 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 135.54 46.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.603 0.24 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.29 168.82 11.06 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.145 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -114.5 111.23 21.07 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.087 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.546 HD12 HG13 ' A' ' 36' ' ' VAL . 7.6 mt -149.74 126.42 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.074 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.24 163.4 16.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 32' ' ' LEU . 10.8 p -140.64 149.6 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.372 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.61 118.31 33.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.717 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.3 85.53 2.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.556 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 61.44 16.87 7.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.736 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.62 23.62 33.04 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.31 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -101.99 163.16 12.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.859 0.361 . . . . 0.0 110.82 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 102.91 14.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.424 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 54.7 96.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.884 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.73 143.69 32.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.438 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.474 ' HA ' ' N ' ' A' ' 29' ' ' GLY . 9.0 tt -143.79 -52.49 0.34 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.014 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.88 53.04 4.04 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.1 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.31 22.15 8.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.62 0.248 . . . . 0.0 111.533 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -55.89 -30.01 60.87 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.169 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.88 31.13 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.338 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.22 -175.39 2.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.75 0.31 . . . . 0.0 111.105 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.86 -32.42 67.47 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.514 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.14 -124.62 1.54 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.559 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.21 -79.05 0.39 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.684 0.278 . . . . 0.0 110.737 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -147.23 -165.38 2.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.606 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 78' ' ' LEU . 3.3 tp -112.69 -51.95 2.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.628 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -153.95 167.22 30.48 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.171 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.04 97.69 3.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.699 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.467 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 34.9 p90 -149.58 149.64 29.03 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-O 120.638 0.256 . . . . 0.0 111.603 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.509 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 39.1 Cg_exo -55.39 -49.45 16.14 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.871 2.381 . . . . 0.0 112.915 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 82' ' ' PRO . 76.5 Cg_exo . . . . . 0 C--N 1.355 0.902 0 C-N-CA 122.689 2.259 . . . . 0.0 112.974 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttm . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -146.84 171.98 14.36 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.814 0.34 . . . . 0.0 111.193 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.415 ' HE1' HG21 ' A' ' 20' ' ' VAL . 59.1 m95 -145.82 131.84 19.27 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.091 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -136.8 158.41 44.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.504 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HD12 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -150.1 163.0 39.32 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.879 0.371 . . . . 0.0 111.588 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.96 179.99 4.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.338 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.57 -11.84 47.71 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.236 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.471 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -52.81 -36.78 58.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.88 0.371 . . . . 0.0 110.357 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.056 HD12 HD21 ' A' ' 5' ' ' LEU . 7.8 mt -122.03 -39.44 2.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.469 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.73 -13.96 38.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -82.84 -28.12 30.36 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.844 0.354 . . . . 0.0 110.503 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 74.8 t -85.73 -30.88 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.355 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -99.22 -39.52 8.41 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.891 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.61 -37.64 2.14 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.152 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.2 p -173.95 138.17 0.6 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.594 0.235 . . . . 0.0 110.766 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.618 ' HG2' HD22 ' A' ' 5' ' ' LEU . 3.2 tpm_? -131.02 17.65 5.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.75 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.8 p -96.95 122.29 39.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.652 0.263 . . . . 0.0 110.413 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.57 166.07 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.44 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.05 142.89 50.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.377 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.415 HG21 ' HE1' ' A' ' 3' ' ' TRP . 21.1 t -102.19 120.52 52.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.169 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.71 -54.44 0.77 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.23 154.52 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.274 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -117.15 122.04 42.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.33 -81.31 0.04 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.061 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.96 25.14 4.97 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.775 0.321 . . . . 0.0 111.211 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.19 116.93 25.85 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.803 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -108.4 174.57 5.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.042 HG21 ' HB3' ' A' ' 67' ' ' ALA . 54.9 t -73.3 -36.94 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.413 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -77.28 -33.39 44.52 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.86 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.8 -37.55 79.44 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.558 0.343 . . . . 0.0 110.988 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -86.54 -30.93 21.54 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.93 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -60.62 -58.69 7.39 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.524 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.68 -36.67 83.64 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 1.035 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -59.6 -51.56 69.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.585 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 31' ' ' ALA . 7.9 mp -67.39 -30.74 70.6 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.706 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 32' ' ' LEU . 58.2 t -62.78 -52.13 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.835 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.24 30.34 0.05 OUTLIER Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.748 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -105.24 -0.58 26.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.799 0.3 . . . . 0.0 111.565 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -123.62 69.39 44.13 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -44.24 -21.85 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.29 2.66 . . . . 0.0 113.627 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -50.82 -28.0 8.49 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -113.87 5.81 16.4 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -94.09 120.73 34.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.535 0.207 . . . . 0.0 111.08 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 t -97.1 -53.31 3.54 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.658 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.44 146.68 36.81 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.837 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -112.89 18.47 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.549 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 38.6 t80 69.67 -67.95 0.21 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 122.649 0.38 . . . . 0.0 111.567 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.39 -2.15 85.44 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.304 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.508 ' HA ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER 67.65 -75.55 0.06 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.033 0.417 . . . . 0.0 111.1 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -120.52 31.8 6.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.956 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.14 112.45 0.53 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.516 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.14 107.81 7.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.859 0.361 . . . . 0.0 111.19 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -107.6 -35.03 6.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.207 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -101.5 134.2 44.98 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.675 0.274 . . . . 0.0 111.145 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.4 129.28 56.15 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.058 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -147.1 129.27 15.61 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.5 tt -170.17 146.71 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.61 141.61 35.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.17 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.43 HG23 ' HG ' ' A' ' 80' ' ' LEU . 12.0 p -139.2 153.82 24.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.211 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.685 HD12 HD12 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -116.94 127.3 54.09 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.725 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 142.8 49.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -63.0 -21.29 66.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.691 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.56 5.58 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.7 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.7 165.99 12.64 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.609 0.242 . . . . 0.0 110.776 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.29 121.68 10.72 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.27 127.69 33.37 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.509 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 1.042 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -94.74 179.22 5.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.634 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 68' ' ' LEU . 4.7 tt -167.38 -54.31 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.904 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.86 19.75 43.59 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.096 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 27' ' ' THR . 9.3 pt-20 -174.47 101.17 0.09 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.987 0.394 . . . . 0.0 111.012 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.578 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -75.64 -5.15 44.09 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.785 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 t -91.29 33.89 0.96 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.044 0.449 . . . . 0.0 111.07 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.41 -173.7 3.67 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.74 -33.54 56.02 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.497 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.33 146.82 6.65 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.715 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' CG ' HG22 ' A' ' 28' ' ' VAL . 15.1 m-20 -89.24 -80.11 0.31 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.33 -173.54 4.62 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.39 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.685 HD12 HD12 ' A' ' 60' ' ' LEU . 11.3 mt -108.41 -40.15 5.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.632 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -169.79 169.68 8.28 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.869 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.543 ' HB3' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -139.79 105.94 5.24 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 110.983 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -92.12 112.37 54.68 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.842 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.417 ' HG2' ' HB2' ' A' ' 8' ' ' ASP . 51.0 Cg_exo -54.14 167.73 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.047 2.498 . . . . 0.0 113.082 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo . . . . . 0 C--N 1.35 0.646 0 C-N-CA 123.117 2.545 . . . . 0.0 112.836 -179.622 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptm . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 120.619 0.247 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -143.45 160.3 40.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -148.43 143.54 26.83 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.28 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.523 ' HG2' HG22 ' A' ' 17' ' ' THR . 0.6 OUTLIER -134.95 143.57 46.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.293 179.331 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.572 HD21 ' CB ' ' A' ' 9' ' ' LEU . 12.2 tp -133.08 157.8 44.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 111.308 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -89.14 162.6 15.86 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.76 62.11 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.762 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -55.2 -32.09 61.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.79 0.329 . . . . 0.0 110.525 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -110.9 -38.39 5.12 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.094 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -66.47 -13.25 60.57 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -72.16 -25.73 61.81 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG21 ' N ' ' A' ' 44' ' ' SER . 11.8 t -93.72 -44.18 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.509 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -84.21 -28.94 26.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.628 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.1 -21.53 44.69 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.726 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.26 130.23 55.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.755 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -109.5 -48.03 3.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.735 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.523 HG22 ' HG2' ' A' ' 4' ' ' LYS . 2.3 p -92.3 141.14 28.88 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.038 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.7 t -142.09 125.8 15.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -95.87 154.11 17.4 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.697 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 t -102.02 120.54 51.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.0 -73.99 0.66 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 p -98.53 146.22 8.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.001 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -88.12 137.71 32.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.52 -120.77 0.6 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.452 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -100.69 36.54 1.9 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 111.048 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.33 120.1 39.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.752 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -115.08 173.57 6.43 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.103 HG21 ' HB3' ' A' ' 67' ' ' ALA . 38.5 t -77.62 -39.59 27.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.973 0.416 . . . . 0.0 110.137 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -81.21 -32.04 32.78 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.75 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.98 -45.61 94.1 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.692 0.282 . . . . 0.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.43 -30.95 57.6 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.648 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.755 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -57.03 -58.29 8.82 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.928 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 38' ' ' ALA . 22.5 t0 -60.51 -39.31 87.31 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.413 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.788 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -58.57 -55.19 38.29 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.34 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.431 HD23 HD23 ' A' ' 80' ' ' LEU . 8.1 mp -62.28 -24.01 67.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.926 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 32' ' ' LEU . 94.4 t -83.87 -50.1 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.391 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.63 -27.87 0.03 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.557 -0.83 . . . . 0.0 114.529 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.788 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -65.96 -5.79 10.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -128.72 70.9 80.95 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.458 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 84.4 Cg_exo -49.38 -17.35 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.176 2.584 . . . . 0.0 113.388 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.69 7.34 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.673 ' HB2' HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -100.38 -19.33 16.34 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 2.1 pt-20 -107.57 126.94 53.16 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.121 -0.362 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.432 ' N ' HG21 ' A' ' 12' ' ' VAL . 15.7 m -79.31 -52.35 8.22 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.971 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.69 144.95 9.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.86 0.362 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -158.34 -41.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.523 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 81.51 -59.08 0.24 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.657 0.383 . . . . 0.0 110.321 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.41 57.41 4.93 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.495 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.13 -48.69 73.32 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.669 0.271 . . . . 0.0 110.781 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -27.61 54.71 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.78 -41.38 2.16 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.812 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.21 27.53 16.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.626 0.25 . . . . 0.0 111.453 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mt -175.02 -66.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.852 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -130.26 132.95 46.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.165 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -131.97 115.21 15.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.99 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.61 145.88 50.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.701 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -150.32 111.06 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -73.08 139.14 46.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -139.3 151.94 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.403 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.556 HD12 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -112.99 130.53 56.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.899 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.484 ' N ' HD13 ' A' ' 60' ' ' LEU . 2.9 mtm180 -115.16 145.47 42.34 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.501 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -89.76 15.32 9.9 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.681 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.43 23.15 12.9 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.645 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HG3' ' HB1' ' A' ' 74' ' ' ALA . 2.1 tp10 -115.65 163.5 15.7 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.707 0.289 . . . . 0.0 110.981 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.16 127.73 32.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.454 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.77 95.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.245 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 1.103 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -73.1 174.64 7.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.942 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 68' ' ' LEU . 5.7 tt -163.71 -59.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.913 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.63 23.57 34.64 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.887 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -172.51 88.79 0.09 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.83 0.348 . . . . 0.0 110.785 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -76.31 -7.02 54.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.547 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -91.74 11.32 24.98 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.548 0.213 . . . . 0.0 111.38 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.83 132.56 53.32 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.624 0.249 . . . . 0.0 111.283 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.542 ' HB1' ' HG3' ' A' ' 64' ' ' GLU . . . 65.06 -76.04 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.804 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.8 164.73 30.07 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.459 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.41 -83.37 0.13 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.601 0.238 . . . . 0.0 110.803 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 2.8 pt-20 -168.91 -169.24 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.556 HD13 HD12 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -110.28 -46.65 3.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.301 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.479 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -157.04 164.64 37.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 5' ' ' LEU . 47.4 tp -144.62 97.93 3.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 111.047 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -115.56 127.69 26.59 Favored Pre-proline 0 N--CA 1.463 0.184 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.207 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.77 172.59 1.07 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.851 2.367 . . . . 0.0 112.632 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--N 1.348 0.516 0 C-N-CA 122.687 2.258 . . . . 0.0 112.282 179.801 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.777 ' SD ' HG11 ' A' ' 20' ' ' VAL . 14.2 mmt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.667 0.27 . . . . 0.0 111.514 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.41 ' HB3' ' HG3' ' A' ' 19' ' ' ARG . 1.7 mt-10 -156.08 174.79 14.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.961 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.478 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.96 139.42 23.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.588 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.653 ' C ' HD22 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -131.31 156.38 45.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.304 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.017 HD12 HD13 ' A' ' 9' ' ' LEU . 2.8 mm? -140.0 156.33 46.68 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.111 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.22 -178.67 3.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.761 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -49.32 -33.23 12.79 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -51.5 -36.8 46.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 110.232 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.017 HD13 HD12 ' A' ' 5' ' ' LEU . 4.8 mp -110.27 -8.88 14.68 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.089 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -93.48 -9.49 38.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -59.2 -39.34 82.31 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 25.8 t -97.85 -36.9 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.845 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . . . -88.6 -45.8 9.58 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.91 -32.01 7.06 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.916 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.3 107.03 0.07 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.698 0.285 . . . . 0.0 110.63 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.792 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.23 35.38 2.42 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.639 HG22 ' HG2' ' A' ' 4' ' ' LYS . 8.8 p -93.66 113.95 26.16 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.082 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.478 ' HB ' ' CD1' ' A' ' 3' ' ' TRP . 1.9 t -131.34 166.62 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.035 0.445 . . . . 0.0 111.934 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.43 ' H ' HG12 ' A' ' 18' ' ' VAL . 3.2 mpp_? -131.4 158.8 39.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.421 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.777 HG11 ' SD ' ' A' ' 1' ' ' MET . 11.9 p -102.03 120.43 51.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.095 0.474 . . . . 0.0 111.103 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.16 -45.02 1.25 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.172 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.83 113.73 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.15 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -116.21 139.12 50.68 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.8 37.0 1.46 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.716 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.22 -60.33 0.17 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.701 0.286 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.31 176.37 5.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.779 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.516 HG21 ' HA2' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -111.35 171.67 7.34 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.025 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.92 HG13 ' HA ' ' A' ' 71' ' ' ALA . 3.1 m -77.29 -39.46 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 120.765 0.317 . . . . 0.0 110.989 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -88.13 -27.68 25.12 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.417 -0.896 . . . . 0.0 112.32 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.57 -35.89 73.09 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.62 0.247 . . . . 0.0 110.911 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -91.64 -37.07 13.28 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.484 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.3 tt -51.31 -50.88 58.5 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 120.746 0.308 . . . . 0.0 110.369 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -58.91 -34.55 71.81 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.25 -52.89 11.01 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.773 0.321 . . . . 0.0 110.743 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -65.73 -22.84 66.63 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.451 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 32' ' ' LEU . 94.1 t -95.23 -40.32 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.817 -0.174 . . . . 0.0 111.052 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.78 -37.38 90.11 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.608 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.04 -34.25 9.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.609 0.242 . . . . 0.0 111.299 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.491 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 12.8 m-70 60.14 54.81 4.08 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.327 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 51.1 Cg_exo -52.44 -22.08 15.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.242 1.961 . . . . 0.0 111.993 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.845 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . . . -62.2 -35.14 77.97 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.497 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.547 HD22 ' HG ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -121.4 1.5 10.16 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.507 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -84.46 103.65 13.79 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 m -75.55 -28.95 59.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.42 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 60.28 76.03 0.38 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 111.004 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.23 -59.76 3.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.824 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -173.23 -58.23 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.78 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -134.22 95.79 0.28 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.261 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -63.44 160.42 16.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.927 0.394 . . . . 0.0 111.343 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -76.73 -29.05 56.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.203 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.55 -139.61 14.62 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.774 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -158.79 139.55 12.72 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.662 0.267 . . . . 0.0 110.913 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.21 -57.1 3.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.873 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -125.87 161.4 27.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.825 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.72 113.59 25.9 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.234 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.25 116.79 14.8 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.383 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.1 tp -172.52 143.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -120.15 156.36 31.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.809 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.7 HG23 ' HG ' ' A' ' 80' ' ' LEU . 8.3 p -139.58 144.9 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.516 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.12 118.4 36.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.422 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.14 145.62 47.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.103 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -61.42 -15.86 41.04 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.764 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.95 23.91 5.39 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.856 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' OE1' ' HB3' ' A' ' 74' ' ' ALA . 4.0 tm-20 -104.13 166.06 10.65 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.731 0.301 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.94 121.44 13.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.89 113.32 2.01 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.232 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.62 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -67.75 166.31 15.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.481 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -164.98 -50.68 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.399 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.516 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -101.36 28.96 13.61 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.125 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -164.04 102.44 0.87 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.788 0.294 . . . . 0.0 110.98 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.92 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -64.33 -26.82 68.65 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.241 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.3 t -95.99 37.18 1.24 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.07 0.462 . . . . 0.0 111.206 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.06 -173.68 4.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.473 ' HB3' ' OE1' ' A' ' 64' ' ' GLU . . . -61.09 -55.84 27.82 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.352 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.7 133.69 2.36 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.149 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -81.58 0.07 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.572 0.225 . . . . 0.0 110.535 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -160.14 179.89 8.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.489 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.6 mt -101.19 -41.13 6.84 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.777 0.323 . . . . 0.0 110.517 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.65 167.46 26.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.985 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.7 ' HG ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -138.46 100.9 4.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.324 179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -123.69 136.7 27.61 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.47 148.81 30.17 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.348 2.032 . . . . 0.0 112.042 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 122.839 2.359 . . . . 0.0 112.059 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.661 0.267 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -152.15 167.41 28.64 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.795 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.462 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -155.02 166.89 32.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.108 0.48 . . . . 0.0 111.372 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 35.0 mtpt -136.44 156.97 47.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.33 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.499 HD11 ' O ' ' A' ' 35' ' ' LEU . 6.8 tp -146.37 160.48 42.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.262 0.554 . . . . 0.0 112.229 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -97.66 172.96 7.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.332 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.19 -19.1 62.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.741 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.82 -42.33 25.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.807 0.337 . . . . 0.0 111.029 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.898 HD21 ' HA2' ' A' ' 37' ' ' GLY . 5.9 mp -108.66 -33.29 7.05 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.645 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.89 -10.76 41.52 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -56.43 -40.31 74.52 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 11.7 t -97.77 -53.07 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.77 -41.32 97.56 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.508 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.68 -15.15 62.25 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.416 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -116.77 128.68 55.53 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -109.58 -58.54 2.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.804 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 6.0 p -92.86 133.53 35.99 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.817 0.342 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.462 ' HB ' ' CD1' ' A' ' 3' ' ' TRP . 9.6 t -140.34 163.37 23.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.457 ' N ' HG12 ' A' ' 18' ' ' VAL . 15.6 ptt85 -130.52 149.87 51.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.58 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.9 t -101.97 120.22 51.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.939 0.4 . . . . 0.0 110.939 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.38 -50.84 0.75 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.73 154.56 3.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.23 133.06 56.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.067 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.5 -153.69 6.88 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.603 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -33.61 76.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.558 0.179 . . . . 0.0 111.288 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.08 116.15 4.31 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.137 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.696 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -78.82 178.08 8.2 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.781 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.638 HG13 ' HA ' ' A' ' 71' ' ' ALA . 2.8 m -77.98 -38.04 23.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.617 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.591 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -87.74 -27.51 26.56 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.23 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.31 -41.13 68.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.651 0.262 . . . . 0.0 110.768 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.14 -26.45 23.6 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.86 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.782 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.7 tp -62.24 -57.46 11.36 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.382 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -56.99 -40.4 76.5 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.982 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -64.95 -51.87 59.43 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.645 0.259 . . . . 0.0 110.36 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.654 ' O ' HD22 ' A' ' 9' ' ' LEU . 6.9 mp -62.52 -35.88 80.81 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 32' ' ' LEU . 57.6 t -60.86 -52.27 63.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.59 0.233 . . . . 0.0 110.69 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.898 ' HA2' HD21 ' A' ' 9' ' ' LEU . . . 158.02 52.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.638 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -77.35 -61.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.208 0.051 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.415 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 1.3 m-70 172.02 -62.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 123.442 0.464 . . . . 0.0 111.008 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 39' ' ' HIS . 8.0 Cg_endo -50.03 -27.76 17.43 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.626 2.217 . . . . 0.0 112.326 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.685 ' CB ' HD23 ' A' ' 9' ' ' LEU . . . -60.54 -31.67 70.76 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.772 HD22 ' HG ' ' A' ' 9' ' ' LEU . 1.6 pt? -136.65 29.76 2.9 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.28 155.77 0.12 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 111.251 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.1 p -78.35 -35.54 47.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.214 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -62.83 98.21 0.12 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.855 0.359 . . . . 0.0 110.994 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.434 HG21 ' CG ' ' A' ' 49' ' ' ASP . 17.3 m -58.03 -40.21 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.613 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.85 87.12 0.1 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 49' ' ' ASP . . . 100.32 -34.22 5.72 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.661 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 1.8 m-20 70.11 139.93 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.956 0.407 . . . . 0.0 111.383 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -111.03 -28.9 8.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.786 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.29 156.74 6.96 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.94 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.3 98.26 3.28 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.832 0.349 . . . . 0.0 111.362 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 54' ' ' TYR . 1.3 pt? -174.1 -42.8 0.01 OUTLIER 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.557 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.43 ' N ' ' HG ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -158.83 141.5 14.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.654 0.264 . . . . 0.0 111.234 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.06 142.05 29.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.176 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -110.68 135.06 51.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.636 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.499 HD13 ' CG1' ' A' ' 36' ' ' VAL . 1.5 pt -143.91 115.01 2.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -90.49 138.28 31.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.833 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.89 151.32 27.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.198 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -111.88 118.9 36.8 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.615 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HG2' ' CB ' ' A' ' 77' ' ' GLU . 2.0 mtt85 -121.69 145.52 47.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.909 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -67.9 -13.4 62.12 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.724 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.58 23.57 5.63 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.736 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -103.19 165.49 10.99 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.782 0.325 . . . . 0.0 110.793 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.33 125.08 25.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.54 95.45 0.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.83 149.03 25.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.101 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.591 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 8.1 tt -126.2 -61.13 1.24 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.203 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.659 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -86.11 44.81 3.38 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.129 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -151.11 72.93 1.08 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.761 0.28 . . . . 0.0 111.104 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.696 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -52.05 -28.01 15.76 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.635 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.22 34.78 0.93 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.756 0.313 . . . . 0.0 111.442 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.77 176.72 6.05 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.894 0.378 . . . . 0.0 111.242 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.67 32.05 3.54 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.668 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.63 158.82 10.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.557 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -76.39 0.59 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.743 0.306 . . . . 0.0 111.275 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.41 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 20.0 pt-20 -145.53 -162.65 1.55 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.972 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 78' ' ' LEU . 2.8 mm? -120.66 -45.12 2.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.487 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -156.61 169.14 25.35 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.61 HD11 HG22 ' A' ' 36' ' ' VAL . 2.5 tt -153.32 122.15 6.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.859 0.361 . . . . 0.0 110.605 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -150.7 135.84 10.11 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.285 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 6' ' ' PHE . 84.4 Cg_endo -78.94 146.55 20.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.671 2.248 . . . . 0.0 112.614 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 45.6 Cg_exo -56.32 145.36 78.52 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.808 2.339 . . . . 0.0 112.489 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 84' ' ' VAL . 12.5 p -165.74 119.99 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.977 0.418 . . . . 0.0 111.192 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m -142.66 135.86 28.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.853 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.14 -44.31 1.51 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.483 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.341 -1.255 . . . . 0.0 112.374 179.923 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.817 0.341 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -160.57 172.97 16.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.4 ' CE3' ' HG2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -151.7 140.84 21.26 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.417 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -137.62 151.9 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.388 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.733 ' CD1' HD22 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -147.45 151.11 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.095 0.474 . . . . 0.0 111.879 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.12 -175.61 5.92 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.049 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -58.48 -20.18 43.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.939 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.68 -43.14 12.38 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.979 0.418 . . . . 0.0 110.81 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.858 HD23 ' HB1' ' A' ' 41' ' ' ALA . 4.7 mp -105.17 -31.37 9.16 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.011 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -72.08 -4.3 28.11 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -36.67 84.7 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.668 0.27 . . . . 0.0 110.936 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.807 HG11 ' HB2' ' A' ' 43' ' ' GLU . 15.8 t -97.21 -46.11 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.813 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.25 -45.17 20.31 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.99 -29.55 7.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.114 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 t -167.49 117.14 0.82 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.669 0.271 . . . . 0.0 110.994 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.57 29.19 7.42 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.043 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.5 p -95.63 114.03 25.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.328 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 19' ' ' ARG . 3.6 t -122.7 161.72 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.215 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.409 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -126.81 152.58 46.77 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.744 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.574 HG21 ' OD2' ' A' ' 76' ' ' ASP . 19.2 t -102.3 120.33 51.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 0.0 110.776 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.33 -50.09 2.13 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.869 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.55 134.23 52.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.158 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -115.95 152.52 33.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.951 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.91 -81.62 0.15 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.963 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -82.71 -46.65 12.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.665 0.269 . . . . 0.0 111.125 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.64 116.16 4.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.443 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -83.66 172.86 11.88 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.085 HG11 ' HB1' ' A' ' 67' ' ' ALA . 39.0 t -76.71 -35.5 25.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.509 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.25 -32.44 9.64 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.353 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.84 -42.8 80.3 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.741 0.305 . . . . 0.0 110.775 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.62 -27.75 26.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.046 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.5 tp -62.45 -57.2 12.08 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.7 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.04 -40.42 76.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.237 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . . . -64.02 -52.1 61.07 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.794 0.33 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 3' ' ' TRP . 8.8 mp -68.88 -34.41 75.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.318 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 32' ' ' LEU . 21.2 t -57.4 -48.89 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.603 0.239 . . . . 0.0 111.023 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 9' ' ' LEU . . . 161.87 53.23 0.02 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.646 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 34' ' ' ALA . . . -65.83 -61.78 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.448 0.166 . . . . 0.0 110.744 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.413 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 2.5 m-70 -179.74 -62.92 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 39' ' ' HIS . 9.8 Cg_endo -52.27 -26.68 27.84 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.301 2.001 . . . . 0.0 112.064 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.858 ' HB1' HD23 ' A' ' 9' ' ' LEU . . . -62.41 -27.89 69.4 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -135.4 28.89 3.34 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.807 ' HB2' HG11 ' A' ' 12' ' ' VAL . 0.5 OUTLIER 71.16 150.34 0.09 Allowed 'General case' 0 C--N 1.342 0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 110.847 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.9 m -60.38 -43.09 96.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.523 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.62 148.33 29.19 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.805 0.335 . . . . 0.0 110.814 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 p -169.02 -43.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.417 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -172.9 106.79 0.16 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.673 0.273 . . . . 0.0 110.755 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.23 92.57 0.11 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.495 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -65.53 -52.15 54.73 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.572 0.225 . . . . 0.0 110.855 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.24 -28.9 69.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.079 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.25 -166.89 14.0 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.707 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.38 179.8 4.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.692 0.282 . . . . 0.0 110.927 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -35.84 59.86 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.134 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.15 128.97 48.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.72 0.295 . . . . 0.0 111.003 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.18 130.02 55.61 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -142.01 108.29 5.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.176 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.9 pp -150.29 127.72 2.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.49 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -100.51 162.56 12.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.063 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -135.62 152.64 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.649 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -107.86 131.04 54.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.427 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -112.4 145.46 40.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.202 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -3.63 25.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.895 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.77 23.57 5.57 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.902 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.27 157.71 16.01 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.817 0.342 . . . . 0.0 110.684 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.73 102.73 14.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.297 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.03 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.95 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 1.085 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -105.84 133.71 50.13 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.991 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.8 -69.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.107 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.03 64.26 1.73 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.479 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -140.73 47.29 1.75 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -51.7 -28.15 13.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.782 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.31 33.48 2.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.668 0.27 . . . . 0.0 111.258 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . . . -96.52 174.16 6.99 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.815 0.34 . . . . 0.0 111.461 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.54 -34.09 17.51 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.469 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.68 157.93 27.47 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.429 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.574 ' OD2' HG21 ' A' ' 20' ' ' VAL . 6.6 m-20 -109.32 -72.96 0.7 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.761 0.281 . . . . 0.0 110.644 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HG2' ' CE3' ' A' ' 3' ' ' TRP . 0.4 OUTLIER -139.53 -173.16 3.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.308 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -108.58 -53.22 2.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.611 0.243 . . . . 0.0 110.987 -179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -164.9 173.71 11.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 58' ' ' ASN . 1.0 OUTLIER -136.1 95.27 3.17 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.214 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -130.32 148.97 72.0 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.245 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.05 148.68 51.21 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.552 2.168 . . . . 0.0 112.545 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.53 134.01 19.83 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.656 2.237 . . . . 0.0 112.479 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 m -65.45 141.16 18.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.41 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.8 p -133.33 -72.04 0.51 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.83 -168.52 38.4 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.735 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.495 -1.17 . . . . 0.0 112.684 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.838 0.352 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -160.3 173.33 15.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.667 ' CE3' HD22 ' A' ' 35' ' ' LEU . 3.1 t90 -155.85 146.17 21.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.44 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.433 ' HG2' HG22 ' A' ' 17' ' ' THR . 24.7 mttt -138.07 144.81 41.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.015 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.612 HD21 HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -135.34 164.35 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.042 0.449 . . . . 0.0 111.375 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 5' ' ' LEU . 6.4 t80 -89.5 170.08 10.81 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.816 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.57 -9.24 57.92 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.529 ' HB3' HD12 ' A' ' 9' ' ' LEU . 1.2 t0 -52.48 -44.06 65.37 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 111.224 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.651 HD23 HD22 ' A' ' 42' ' ' LEU . 5.0 mp -107.49 -32.84 7.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.177 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -69.68 -7.06 35.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -40.6 91.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.543 0.211 . . . . 0.0 111.005 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 21.1 t -95.08 -46.89 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.522 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.07 -46.51 80.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.752 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.52 11.81 70.87 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.901 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -139.08 92.96 2.64 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -91.22 -42.79 10.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.181 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.433 HG22 ' HG2' ' A' ' 4' ' ' LYS . 5.8 p -96.64 145.42 25.78 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 120.718 0.294 . . . . 0.0 111.216 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -142.87 108.58 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.24 152.32 21.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.779 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.84 120.23 51.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.748 0.309 . . . . 0.0 111.032 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.34 -72.79 0.38 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.049 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.0 p -94.88 148.54 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.213 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.27 116.07 22.25 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.04 -139.31 3.89 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.635 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -107.01 36.12 2.78 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.845 0.355 . . . . 0.0 111.193 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.89 123.03 41.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.741 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -109.03 169.32 8.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.766 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 71' ' ' ALA . 40.8 t -74.18 -33.55 35.28 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.132 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.72 -36.92 9.87 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.086 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.37 -38.68 74.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 110.666 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.39 -23.21 22.24 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.752 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 36' ' ' VAL . 23.8 tp -63.53 -52.53 60.79 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.499 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -58.54 -41.87 86.54 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.447 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.68 -49.68 61.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.753 0.311 . . . . 0.0 111.206 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.667 HD22 ' CE3' ' A' ' 3' ' ' TRP . 8.6 mp -68.19 -33.35 74.28 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.466 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 32' ' ' LEU . 12.4 t -62.51 -48.89 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-O 120.705 0.288 . . . . 0.0 110.418 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.91 54.84 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.612 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -62.49 -61.64 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.465 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . 1.1 m170 155.02 -66.47 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.646 0.778 . . . . 0.0 110.423 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 39' ' ' HIS . 11.0 Cg_endo -54.17 -24.74 34.76 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.511 2.141 . . . . 0.0 111.805 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.531 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -61.45 -28.28 69.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.054 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.651 HD22 HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -142.47 22.8 2.0 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.89 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 61.97 160.06 0.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.246 0.546 . . . . 0.0 111.875 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -14.15 22.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.515 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.466 ' O ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -78.69 150.74 32.49 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 45' ' ' ARG . 8.5 p 45.38 34.33 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.169 0.509 . . . . 0.0 111.981 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.95 -60.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.088 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.3 69.27 1.99 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.565 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -69.77 165.19 21.94 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.574 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -82.15 -20.97 36.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.756 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.14 -152.51 1.99 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.596 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.82 91.49 2.71 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.845 0.355 . . . . 0.0 111.192 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tp -97.59 142.7 29.08 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.626 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.03 127.54 53.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.104 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.94 146.97 48.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.075 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 57' ' ' ILE . 66.3 m-70 -111.42 152.76 27.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.637 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.561 HG22 ' HB3' ' A' ' 82' ' ' PRO . 1.7 pt -156.55 124.99 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.761 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -90.56 137.42 32.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -124.02 157.99 30.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.31 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.84 122.21 44.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.075 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 145.45 50.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.743 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.94 -19.42 65.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.663 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.28 23.5 5.74 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.743 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.94 165.74 23.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.603 0.24 . . . . 0.0 111.006 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.15 124.64 29.42 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.289 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 76' ' ' ASP . . . -92.22 146.79 23.43 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.368 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.1 -177.75 6.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.968 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -136.3 -45.02 0.62 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.225 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.409 ' N ' ' HG ' ' A' ' 68' ' ' LEU . . . -94.53 31.97 6.38 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.787 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -164.7 91.46 0.57 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.787 0.327 . . . . 0.0 111.221 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.66 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -64.83 -17.63 64.41 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.835 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 t -88.83 33.92 0.78 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 111.246 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.68 168.84 12.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.213 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.65 80.36 8.01 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.64 149.87 3.21 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.985 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 20.0 p-10 -133.3 -49.52 0.85 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.573 0.225 . . . . 0.0 111.335 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.459 ' HG3' ' CD1' ' A' ' 3' ' ' TRP . 0.5 OUTLIER -165.04 -172.43 2.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.56 179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.19 -45.18 2.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.516 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -170.35 174.02 5.43 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.343 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.641 ' HB2' HG12 ' A' ' 59' ' ' VAL . 6.0 tt -152.93 117.72 5.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.324 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -141.46 138.28 17.34 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.568 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.561 ' HB3' HG22 ' A' ' 57' ' ' ILE . 77.8 Cg_endo -77.71 169.55 20.61 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.712 2.274 . . . . 0.0 112.452 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.8 131.97 42.7 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.817 2.345 . . . . 0.0 112.038 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.6 t -62.87 133.67 28.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.177 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.07 170.27 7.97 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.958 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.75 -36.61 0.12 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.44 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.615 -1.103 . . . . 0.0 112.692 179.929 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.872 0.368 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.436 ' HG2' ' HG3' ' A' ' 19' ' ' ARG . 6.3 mt-10 -146.95 166.17 27.6 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.497 ' HE1' HD13 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -150.89 137.69 18.97 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.025 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.511 ' O ' HD22 ' A' ' 5' ' ' LEU . 34.7 mttt -134.92 148.86 50.16 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.839 HD11 HD23 ' A' ' 80' ' ' LEU . 3.1 mm? -130.9 152.44 50.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.742 0.306 . . . . 0.0 111.257 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -174.95 3.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 11' ' ' GLU . . . -57.03 -23.04 43.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.854 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.502 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -48.72 -37.8 19.76 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.715 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.74 HD22 HD13 ' A' ' 42' ' ' LEU . 10.3 mt -120.57 -34.96 3.49 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.623 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.06 -2.8 22.71 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -91.14 -29.16 17.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.797 0.332 . . . . 0.0 110.36 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 41' ' ' ALA . 97.3 t -93.11 -35.89 7.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.357 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -94.42 -43.5 8.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.62 0.247 . . . . 0.0 111.1 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.98 -40.34 1.75 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.356 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.34 141.12 2.43 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -137.57 27.04 2.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.45 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 p -96.45 112.01 23.91 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 110.401 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.97 157.99 41.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.408 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.436 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -129.61 148.91 51.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.584 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.3 120.22 56.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.907 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.35 -52.02 0.82 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.725 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -90.67 153.31 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.32 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.6 142.22 35.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.086 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.19 -111.54 0.27 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.689 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.98 38.25 4.18 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.054 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.03 133.13 56.35 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.981 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -113.29 167.94 10.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.22 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 71' ' ' ALA . 27.3 t -74.99 -39.18 44.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.943 0.401 . . . . 0.0 110.213 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -83.19 -34.38 20.83 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.221 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.24 -45.83 83.58 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.832 0.349 . . . . 0.0 110.405 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -77.12 -26.74 53.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.563 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.719 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.1 tp -63.37 -61.07 2.59 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.258 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.65 -34.25 72.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.114 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.943 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -69.05 -50.6 47.06 Favored 'General case' 0 C--N 1.335 -0.046 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.186 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 31' ' ' ALA . 11.1 mp -68.26 -19.5 64.73 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.703 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 32' ' ' LEU . 70.1 t -83.78 -44.81 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -133.42 -34.37 0.32 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.273 -0.965 . . . . 0.0 114.476 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.943 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -69.67 -0.94 7.69 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -121.81 64.87 18.11 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 120.738 0.304 . . . . 0.0 110.821 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 86.4 Cg_exo -50.64 -18.9 4.4 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.887 2.392 . . . . 0.0 112.942 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.767 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -49.47 -31.63 10.39 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.74 HD13 HD22 ' A' ' 9' ' ' LEU . 4.1 pp -106.68 -6.84 17.62 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -158.95 70.97 0.51 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.868 0.365 . . . . 0.0 110.524 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -31.6 66.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.346 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -134.85 125.03 26.01 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.392 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.22 37.88 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.87 0.367 . . . . 0.0 111.313 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 60.65 99.21 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.394 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.13 -36.03 4.48 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.508 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 70.52 -66.32 0.29 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.622 0.369 . . . . 0.0 111.101 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.27 31.4 3.4 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 111.154 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.85 -75.55 1.22 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.335 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.45 144.56 21.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 0.0 111.034 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tp -92.13 95.68 9.89 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.487 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -124.72 123.75 40.67 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.048 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -111.75 114.71 27.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.72 103.51 5.44 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.027 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 pt -149.35 121.76 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.831 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -82.81 153.32 25.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 80' ' ' LEU . 13.7 p -135.58 145.95 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.577 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.418 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -103.29 120.97 41.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.597 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.418 ' N ' HD13 ' A' ' 60' ' ' LEU . 62.1 mtt180 -132.17 142.47 49.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.717 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -62.74 -20.56 65.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.482 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.72 23.75 5.52 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.76 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.18 163.8 12.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 110.633 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.15 124.55 36.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.26 159.81 36.75 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.78 169.26 9.03 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.231 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.433 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -103.68 -35.3 8.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.173 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.45 28.37 8.36 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.077 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 27' ' ' THR . 2.1 mt-10 -173.44 103.16 0.12 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.826 0.313 . . . . 0.0 110.862 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -82.2 6.32 17.01 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.93 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.72 1.36 26.81 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.8 -176.2 1.03 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.787 0.327 . . . . 0.0 111.34 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.97 83.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.448 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.34 172.61 43.72 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.663 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.0 -70.22 0.73 Allowed 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.67 -165.83 1.1 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.529 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tp -108.57 -50.83 2.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.782 0.325 . . . . 0.0 110.751 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -155.38 171.57 19.66 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.339 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.839 HD23 HD11 ' A' ' 5' ' ' LEU . 11.5 tp -135.54 110.56 8.85 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.594 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -129.13 124.56 22.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.34 133.61 13.38 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.647 2.231 . . . . 0.0 112.52 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.72 134.2 18.01 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.726 2.284 . . . . 0.0 112.53 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 84' ' ' VAL . 11.9 p -91.61 112.72 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 110.98 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 m -92.15 -51.68 5.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.356 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.7 -135.39 1.58 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.331 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.231 179.826 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.738 0.304 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -148.03 167.05 25.93 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.07 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' THR . 54.4 m95 -145.96 138.59 25.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.942 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -138.51 136.19 35.86 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 80' ' ' LEU . 4.4 tp -130.91 153.7 48.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 111.23 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.13 173.29 8.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.48 -15.06 62.28 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.925 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.52 -35.38 72.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.933 0.397 . . . . 0.0 110.524 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -112.11 -40.56 4.17 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.763 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.75 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -64.74 -13.94 56.85 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -74.95 -27.12 60.06 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.505 -0.122 . . . . 0.0 111.232 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -90.79 -42.25 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.483 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -92.19 -42.85 9.66 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.76 -26.76 11.21 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.648 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.45 126.96 49.66 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.7 0.286 . . . . 0.0 111.244 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.75 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 1.7 ptt-85 -118.42 -58.4 1.98 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.53 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 3' ' ' TRP . 9.1 p -93.33 136.33 33.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -142.32 124.34 13.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.8 132.83 56.59 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 22' ' ' VAL . 19.0 t -148.68 121.31 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.338 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.61 32.64 2.76 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.07 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.516 ' H ' HG12 ' A' ' 20' ' ' VAL . 11.1 p -147.34 150.69 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.104 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -115.71 125.15 52.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.84 88.11 0.14 Allowed Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.397 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.41 26.02 13.64 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.692 0.282 . . . . 0.0 111.592 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.66 116.07 23.91 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.788 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -91.03 169.01 11.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.558 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.885 HG11 ' HB1' ' A' ' 67' ' ' ALA . 22.3 t -78.75 -33.53 16.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.642 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.615 ' HA3' HD13 ' A' ' 68' ' ' LEU . . . -86.06 -27.49 31.02 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.449 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.34 -42.69 82.44 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.672 0.272 . . . . 0.0 110.975 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -83.16 -38.16 22.74 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.635 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.3 tt -53.23 -54.98 28.15 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -59.32 -41.09 88.27 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.169 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -59.47 -56.5 21.17 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.58 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.6 mt -62.4 -20.56 64.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.167 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.801 HG13 HG21 ' A' ' 57' ' ' ILE . 65.5 t -88.59 -48.52 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 111.571 0.211 . . . . 0.0 111.571 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.56 -30.64 0.04 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.478 -0.867 . . . . 0.0 114.661 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.768 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -69.54 -1.38 8.56 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.591 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 8.7 t-80 -133.04 72.8 76.15 Favored Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -51.44 -15.25 2.37 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.32 2.68 . . . . 0.0 113.967 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.63 -28.92 23.45 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.581 ' HB2' HD23 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -100.07 -13.22 19.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -140.0 114.71 9.44 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.246 -0.284 . . . . 0.0 111.425 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -8.56 53.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.085 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 60.63 58.64 2.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.998 0.428 . . . . 0.0 111.017 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 m -96.44 34.92 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.553 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -167.15 -56.05 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.74 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.15 60.32 4.81 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.661 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.2 -49.27 11.88 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.708 0.29 . . . . 0.0 110.683 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.76 31.91 2.78 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.7 -100.22 0.19 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.675 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 56.77 -167.74 0.11 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.092 0.157 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 66.22 -75.69 0.05 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.455 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -111.9 125.52 54.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.031 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.67 158.37 31.72 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.179 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -137.21 113.39 9.9 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.414 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.801 HG21 HG13 ' A' ' 36' ' ' VAL . 1.6 pt -144.83 103.87 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.9 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -85.23 144.85 27.88 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.194 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 p -140.58 140.58 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.939 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -93.61 139.49 30.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.7 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.422 ' H ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -121.36 146.14 47.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.102 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.541 ' HB3' HD23 ' A' ' 78' ' ' LEU . 12.2 p-10 -84.96 19.28 2.17 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.181 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.32 23.72 5.65 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.885 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -108.42 155.8 20.16 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.737 0.303 . . . . 0.0 111.032 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 102.81 14.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.242 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.01 109.24 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.821 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.885 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -98.51 133.71 42.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.625 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.615 HD13 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -171.26 -68.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 27' ' ' THR . . . -100.4 49.19 1.14 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.573 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' HB2' HG21 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -108.66 31.35 5.7 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -54.59 -34.95 62.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.215 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.63 31.25 2.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.527 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.47 150.56 32.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.6 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.14 72.45 2.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 110.783 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.2 147.07 6.77 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.469 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.16 -73.25 0.69 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.689 0.28 . . . . 0.0 110.766 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 2.7 pt-20 -148.9 -169.58 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.543 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -112.11 -42.65 3.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.791 179.593 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.22 166.95 31.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.205 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 5' ' ' LEU . 6.1 tt -146.06 99.82 3.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.785 0.326 . . . . 0.0 110.842 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -151.47 143.23 15.91 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.413 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.56 153.47 23.36 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.855 2.37 . . . . 0.0 112.552 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.67 -45.25 2.44 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.576 2.184 . . . . 0.0 112.551 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.53 118.92 4.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.588 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.2 p -85.66 123.99 31.69 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.723 0.297 . . . . 0.0 110.879 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.91 55.19 0.52 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.61 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.242 -1.31 . . . . 0.0 112.894 -179.844 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.403 ' HB3' ' HG2' ' A' ' 19' ' ' ARG . 3.7 pt-20 -146.17 164.33 32.56 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.915 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -147.4 118.58 7.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.974 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.474 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 23.3 mttm -106.16 141.96 36.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.642 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 11.6 tp -132.49 144.42 50.43 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.889 0.376 . . . . 0.0 111.412 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.48 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -82.57 172.43 12.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.265 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.05 66.36 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.008 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -34.46 53.31 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.573 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 3.9 mp -113.24 -38.05 4.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.978 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 -13.05 45.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -79.28 -27.28 42.26 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.439 ' HB ' ' C ' ' A' ' 42' ' ' LEU . 16.4 t -87.13 -39.44 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -96.43 -38.09 10.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.22 27.42 8.19 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.455 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.3 t -140.91 128.99 22.06 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.634 0.255 . . . . 0.0 110.758 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.642 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 3.2 ptm180 -113.79 -75.08 0.6 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.543 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 3.5 p -97.43 134.06 41.19 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.792 0.329 . . . . 0.0 111.409 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -145.27 129.83 12.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.843 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.403 ' HG2' ' HB3' ' A' ' 2' ' ' GLU . 67.0 mtm-85 -100.77 139.21 36.77 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.423 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.81 120.35 52.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.815 0.341 . . . . 0.0 111.261 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.57 -36.53 5.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.93 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.59 149.98 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.268 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -108.51 166.27 10.9 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.149 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.01 -124.29 0.87 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.633 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.51 34.52 2.19 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.939 0.399 . . . . 0.0 111.004 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.33 120.12 37.22 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.588 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.472 ' C ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -95.66 -176.94 3.89 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.009 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 67' ' ' ALA . 21.3 t -75.2 -42.22 44.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.518 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -75.64 -26.7 64.64 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.923 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -50.93 -45.24 60.41 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.489 0.316 . . . . 0.0 110.876 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.91 -32.23 20.28 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.6 tt -56.71 -60.73 3.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 110.098 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -60.87 -40.97 94.97 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.305 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -53.49 -56.02 20.51 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.228 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.57 -29.84 70.88 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.956 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 32' ' ' LEU . 92.0 t -73.62 -53.02 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.585 0.231 . . . . 0.0 110.827 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.02 20.58 0.06 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.248 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.742 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -105.15 -1.17 25.81 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.44 0.62 . . . . 0.0 111.579 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.489 ' HB3' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -129.32 72.65 81.96 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.44 -20.6 1.65 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.371 2.714 . . . . 0.0 113.551 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.52 -32.26 17.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.8 OUTLIER -99.7 -15.92 18.34 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.467 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -165.07 95.73 0.69 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.705 0.288 . . . . 0.0 111.161 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.78 -48.92 22.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.282 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -155.46 133.63 11.56 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.718 0.294 . . . . 0.0 110.839 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.49 -44.3 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.733 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -171.95 -67.41 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.964 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.42 99.57 1.01 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.595 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.36 -62.81 1.5 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.618 0.247 . . . . 0.0 111.146 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.87 -26.41 13.76 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.527 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.73 82.07 0.31 Allowed Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.767 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 59.85 80.0 0.21 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.985 0.421 . . . . 0.0 111.253 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.1 tp -96.0 97.5 9.65 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.692 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -147.9 116.99 6.83 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.277 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -147.17 149.7 33.49 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -87.49 157.64 19.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.594 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.637 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -153.5 124.23 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.67 0.272 . . . . 0.0 110.787 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -97.58 136.9 37.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 110.862 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 p -140.4 141.09 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.358 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 60' ' ' LEU . 9.8 tp -97.81 134.51 40.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 145.84 47.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -55.43 -21.26 15.12 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.7 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.81 23.76 5.49 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.41 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.85 165.93 13.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.369 0.267 . . . . 0.0 110.468 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.38 123.62 16.09 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.771 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.37 102.19 0.08 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.338 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.65 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -77.25 160.48 28.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.073 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.518 ' CD2' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -158.15 22.53 0.25 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.499 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.19 14.45 2.33 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.133 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.643 ' HG2' HG22 ' A' ' 72' ' ' THR . 2.0 tt0 178.54 96.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.717 0.294 . . . . 0.0 110.41 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.472 ' HB2' ' C ' ' A' ' 27' ' ' THR . . . -71.41 -6.66 41.94 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.894 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.643 HG22 ' HG2' ' A' ' 70' ' ' GLU . 13.4 t -75.23 1.52 13.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.89 -177.73 0.86 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.357 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 77.91 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.47 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.8 160.94 9.72 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.667 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.43 -78.79 0.59 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.674 0.273 . . . . 0.0 110.27 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -131.76 -177.01 4.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 110.823 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.76 -37.86 6.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.842 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -174.25 166.39 4.09 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.972 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.47 110.36 7.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.895 0.379 . . . . 0.0 110.602 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.459 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 23.3 m-85 -112.73 161.47 26.29 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.101 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 6' ' ' PHE . 96.6 Cg_endo -81.96 169.48 14.69 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.671 2.247 . . . . 0.0 112.584 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.9 -42.54 6.24 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.819 2.346 . . . . 0.0 112.547 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.2 t -82.54 114.52 23.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.156 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 p -103.47 -34.62 8.64 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.158 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.47 173.55 54.95 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.856 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.29 -1.283 . . . . 0.0 112.606 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.788 0.328 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -160.68 163.64 32.32 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.166 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.516 ' CZ2' HD22 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -155.36 174.68 14.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.997 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 27.0 mttm -137.13 152.98 50.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.132 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.717 HD11 HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -141.51 132.38 25.91 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.811 0.338 . . . . 0.0 111.528 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.418 ' N ' HD13 ' A' ' 5' ' ' LEU . 1.1 t80 -81.35 175.77 10.3 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.112 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.82 -10.97 60.4 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.41 -46.31 62.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.901 0.381 . . . . 0.0 110.911 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -112.44 -36.03 5.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.121 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.95 -10.46 13.71 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -40.7 74.4 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.485 0.183 . . . . 0.0 111.067 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.834 HG11 ' HB2' ' A' ' 43' ' ' GLU . 4.2 t -94.51 -45.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.532 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 41' ' ' ALA . . . -65.34 -46.75 79.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.09 11.24 61.61 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.546 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.3 m -116.83 129.73 56.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.773 0.32 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -111.73 -85.91 0.56 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.728 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.7 p -102.66 134.37 46.14 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.571 0.224 . . . . 0.0 111.405 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 t -147.75 154.39 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.031 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 1.3 mtt85 -108.45 152.27 24.93 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.617 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.0 120.32 51.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.072 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.81 -46.43 0.95 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.388 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 m -87.37 122.15 38.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.444 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -116.45 129.36 56.17 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.096 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.21 -125.63 0.77 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.651 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.54 -45.67 91.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.581 0.229 . . . . 0.0 111.173 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.44 122.0 22.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.676 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -79.19 171.05 15.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.289 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.874 HG13 ' HA ' ' A' ' 71' ' ' ALA . 8.7 m -74.75 -37.08 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.502 ' HA3' HD23 ' A' ' 68' ' ' LEU . . . -80.27 -33.23 32.73 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.937 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -50.98 -47.5 61.38 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.78 0.324 . . . . 0.0 110.831 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.21 -25.8 33.89 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.886 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.797 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -63.1 -60.25 3.69 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.8 -36.57 72.38 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.091 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -62.61 -52.28 63.99 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.758 0.313 . . . . 0.0 110.267 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.516 HD22 ' CZ2' ' A' ' 3' ' ' TRP . 5.6 mp -68.9 -33.26 73.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.984 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 32' ' ' LEU . 41.6 t -55.66 -51.15 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.681 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' HD22 ' A' ' 9' ' ' LEU . . . 163.66 49.73 0.02 OUTLIER Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.959 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -82.19 -61.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.426 0.155 . . . . 0.0 110.588 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.432 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER 170.87 -58.78 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.78 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 39' ' ' HIS . 54.4 Cg_exo -50.67 -29.25 24.9 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.206 1.937 . . . . 0.0 111.914 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.62 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -61.98 -26.09 68.01 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.492 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.675 HD22 HD23 ' A' ' 9' ' ' LEU . 1.9 pt? -139.99 27.59 2.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.714 0.292 . . . . 0.0 110.765 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.834 ' HB2' HG11 ' A' ' 12' ' ' VAL . 3.3 tt0 64.78 165.61 0.16 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.201 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.1 p -69.68 -41.83 74.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.582 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.09 129.1 6.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.731 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.87 -37.87 11.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.995 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -154.05 35.64 0.43 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.204 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.91 97.6 0.38 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.221 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -61.37 142.94 56.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.827 0.346 . . . . 0.0 111.401 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.41 -28.87 65.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.631 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.62 62.76 0.63 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.784 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -123.98 118.23 26.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.564 0.221 . . . . 0.0 110.704 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.5 79.28 5.54 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.596 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.1 134.07 19.17 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.324 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.98 119.27 12.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -143.19 133.14 24.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.187 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.8 tt -169.88 146.9 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.46 155.33 16.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.871 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.556 HG23 ' HG ' ' A' ' 80' ' ' LEU . 11.6 p -140.54 149.02 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.365 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.59 123.11 49.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.814 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.546 ' NH1' ' HB2' ' A' ' 66' ' ' ALA . 3.6 tpp85 -114.16 144.41 43.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.818 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -74.12 -16.35 61.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.521 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.7 23.26 6.0 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.83 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.48 165.92 11.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.717 0.294 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.25 124.91 19.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.971 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.546 ' HB2' ' NH1' ' A' ' 61' ' ' ARG . . . -67.89 87.79 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.964 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.46 ' HB1' HG21 ' A' ' 28' ' ' VAL . . . -70.24 142.76 52.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.265 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.502 HD23 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -141.61 -59.24 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.005 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.594 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -94.36 36.69 3.66 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.67 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 73' ' ' ALA . 4.7 pt-20 -152.79 90.81 1.49 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.698 0.285 . . . . 0.0 111.285 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.874 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -59.12 -24.51 63.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.516 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.92 33.56 0.78 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.686 0.279 . . . . 0.0 111.571 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . . . -85.33 171.18 12.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.859 0.362 . . . . 0.0 111.674 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.1 92.97 3.93 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.023 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.07 122.41 3.81 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.892 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -107.18 -65.27 1.11 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.709 0.29 . . . . 0.0 111.003 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -162.95 -159.37 0.54 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.584 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.8 tp -123.29 -53.11 1.83 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.558 0.218 . . . . 0.0 110.951 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -152.8 153.54 33.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.196 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.597 HD11 HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -132.93 101.37 5.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.752 0.31 . . . . 0.0 110.73 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -146.81 145.13 21.66 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.469 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.16 150.42 65.9 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.668 2.245 . . . . 0.0 112.103 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.78 60.75 6.81 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.589 2.193 . . . . 0.0 112.074 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.33 135.7 61.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.02 -57.8 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.094 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.97 125.02 7.42 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.289 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 CA-C-O 118.654 -1.081 . . . . 0.0 112.854 179.889 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -135.48 153.22 51.82 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 111.635 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.441 ' CZ2' HD13 ' A' ' 80' ' ' LEU . 1.9 t90 -155.48 148.28 24.29 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.112 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.452 ' HG2' HG22 ' A' ' 17' ' ' THR . 2.9 mttp -137.98 146.61 43.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.351 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.843 HD22 ' HB2' ' A' ' 9' ' ' LEU . 1.1 tt -135.54 165.1 26.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.974 0.416 . . . . 0.0 111.028 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.536 ' N ' HD23 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -80.79 -178.61 6.89 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.205 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.62 -8.73 50.0 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.29 -40.22 61.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.681 0.276 . . . . 0.0 111.431 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.843 ' HB2' HD22 ' A' ' 5' ' ' LEU . 4.7 mp -100.24 -33.23 10.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.596 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -71.52 -7.52 48.12 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -79.9 -29.57 39.89 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.383 0.135 . . . . 0.0 111.22 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 4.9 t -98.03 -49.19 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -104.48 -34.79 8.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.77 26.6 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.616 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.465 ' HB2' HD21 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -125.39 79.0 1.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.969 0.414 . . . . 0.0 110.772 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 5' ' ' LEU . 8.0 ptt85 -88.24 -43.82 11.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.98 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.452 HG22 ' HG2' ' A' ' 4' ' ' LYS . 6.1 p -92.99 139.28 30.68 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.824 0.345 . . . . 0.0 110.97 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -129.71 107.67 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.79 152.53 20.77 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.681 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.482 HG11 ' O ' ' A' ' 71' ' ' ALA . 29.0 t -102.08 120.28 51.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.39 -71.05 0.7 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -89.46 145.78 6.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.072 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HB2' HG21 ' A' ' 72' ' ' THR . 25.9 t0 -104.76 151.66 23.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.217 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.09 -102.97 0.18 Allowed Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.418 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.71 -27.35 11.36 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.603 0.224 . . . . 0.0 111.603 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 129.14 39.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.764 0.316 . . . . 0.0 111.336 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.468 HG22 ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -120.78 174.72 6.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.04 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.595 HG11 ' OD1' ' A' ' 76' ' ' ASP . 15.2 t -75.99 -39.59 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.126 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -76.41 -31.34 54.84 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.791 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -56.1 -48.38 76.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.716 0.293 . . . . 0.0 110.682 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.95 -26.84 39.89 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.125 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.1 tt -59.45 -58.76 7.19 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.84 -42.76 94.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.052 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.78 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -52.87 -56.15 17.99 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.24 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.546 ' O ' HD21 ' A' ' 9' ' ' LEU . 7.7 mp -62.14 -29.72 70.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.778 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 32' ' ' LEU . 84.0 t -74.44 -53.4 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.005 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.26 15.52 0.06 OUTLIER Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.056 -1.068 . . . . 0.0 114.806 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.78 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -105.16 -1.25 25.69 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.704 0.752 . . . . 0.0 111.655 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.516 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -137.77 75.31 43.39 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-O 120.945 0.403 . . . . 0.0 110.282 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -53.59 -14.22 4.77 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.981 2.454 . . . . 0.0 113.252 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.37 -28.59 20.17 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.503 HD13 HD23 ' A' ' 9' ' ' LEU . 1.2 mp -100.67 -12.99 18.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.99 109.88 12.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.647 0.26 . . . . 0.0 111.604 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -90.18 -41.31 11.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.241 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 62.67 77.22 0.34 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.606 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' HD1' ' A' ' 47' ' ' PHE . 20.0 t -92.41 -66.61 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.315 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.564 ' HD1' HG12 ' A' ' 46' ' ' VAL . 5.5 m-85 -136.14 76.67 1.62 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.933 0.397 . . . . 0.0 110.729 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.26 -86.1 0.5 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.377 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -147.05 164.05 34.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.739 0.304 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -115.51 31.67 6.56 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.962 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.18 83.62 0.06 OUTLIER Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.781 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.66 128.02 34.66 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.745 0.307 . . . . 0.0 111.357 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.53 161.42 7.75 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.023 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 112.72 25.52 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.961 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.51 154.48 43.67 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.195 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -135.35 102.86 5.29 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.302 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.85 -49.88 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.985 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.02 -167.06 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.212 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.638 ' CG1' HD12 ' A' ' 80' ' ' LEU . 3.7 m -90.61 151.58 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 111.131 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 60' ' ' LEU . 7.5 tp -129.81 150.56 51.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 111.309 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.516 ' HG3' ' HB3' ' A' ' 77' ' ' GLU . 3.5 mtt180 -143.14 146.34 33.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.962 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -52.44 -21.31 3.55 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.68 23.78 5.52 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.775 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -130.21 165.93 21.35 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.733 0.301 . . . . 0.0 110.739 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.52 121.65 10.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.252 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.08 144.56 56.04 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.387 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -92.52 -177.6 4.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HA ' ' HB ' ' A' ' 28' ' ' VAL . 5.2 tt -168.64 -50.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.652 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.51 25.39 21.1 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.869 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.468 ' N ' HG22 ' A' ' 27' ' ' THR . 1.2 tt0 -171.59 96.78 0.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.839 0.32 . . . . 0.0 110.979 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.482 ' O ' HG11 ' A' ' 20' ' ' VAL . . . -58.17 -26.82 63.2 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.694 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 23' ' ' ASP . 1.0 OUTLIER -91.11 34.03 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.721 0.296 . . . . 0.0 111.515 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.67 178.58 6.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.694 0.283 . . . . 0.0 111.478 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.41 72.0 9.47 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.937 0.398 . . . . 0.0 111.243 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.65 145.0 2.23 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.261 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.595 ' OD1' HG11 ' A' ' 28' ' ' VAL . 3.2 m-20 -124.12 -79.07 0.61 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.792 0.33 . . . . 0.0 110.852 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 1.4 pt-20 -141.15 -177.69 5.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.47 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.74 -52.94 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.632 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB1' ' CE2' ' A' ' 81' ' ' PHE . . . -159.34 174.35 14.88 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.638 HD12 ' CG1' ' A' ' 59' ' ' VAL . 3.1 tt -153.35 118.11 5.02 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.839 0.352 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.442 ' CE2' ' HB1' ' A' ' 79' ' ' ALA . 21.0 m-85 -139.76 108.11 7.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.886 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.72 158.17 50.9 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.831 2.354 . . . . 0.0 112.593 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -87.42 32.27 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.074 2.516 . . . . 0.0 113.192 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p 38.43 84.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.239 0.616 . . . . 0.0 112.295 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 t -85.42 128.73 34.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.32 -162.83 54.32 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.719 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.068 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.964 0.412 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -144.29 169.18 18.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.529 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.482 ' CZ3' HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -155.51 142.4 19.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.215 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.582 ' HG2' HG22 ' A' ' 17' ' ' THR . 8.2 mtmm -138.77 145.89 40.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.945 HD22 ' HB2' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -149.32 164.63 34.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 111.907 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.604 ' N ' HD23 ' A' ' 5' ' ' LEU . 2.1 t80 -85.79 179.79 6.98 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.496 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -63.04 -13.69 38.76 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.2 -34.69 23.57 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.716 0.293 . . . . 0.0 110.748 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.945 ' HB2' HD22 ' A' ' 5' ' ' LEU . 4.9 mp -105.07 -10.26 17.29 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.678 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.692 ' HB2' ' HG2' ' A' ' 16' ' ' ARG . . . -93.23 -2.24 55.34 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -35.83 73.66 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 56.1 t -97.65 -49.92 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.725 ' HB3' ' HA ' ' A' ' 41' ' ' ALA . . . -102.47 -34.38 9.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.99 25.79 28.27 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.313 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.17 98.33 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.874 0.369 . . . . 0.0 111.136 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.692 ' HG2' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -99.07 -45.3 5.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.075 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.582 HG22 ' HG2' ' A' ' 4' ' ' LYS . 11.8 p -93.47 147.7 22.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.144 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.24 113.74 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.168 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -105.7 141.83 36.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.836 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.56 120.5 56.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.085 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.28 -45.08 1.69 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.321 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.3 t -86.84 137.41 20.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -116.98 172.32 7.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.273 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.97 -91.13 0.13 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.24 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.91 -35.16 7.39 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.529 0.204 . . . . 0.0 111.115 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.59 135.81 55.54 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 111.14 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.874 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -110.07 -179.74 3.87 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.891 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.903 HG13 ' HA ' ' A' ' 71' ' ' ALA . 12.4 m -79.91 -35.2 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.785 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' HA3' HD23 ' A' ' 68' ' ' LEU . . . -91.29 -23.4 29.36 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.415 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.36 -40.27 96.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.704 0.288 . . . . 0.0 110.991 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -81.22 -39.67 25.02 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.707 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.616 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.6 tt -53.29 -57.13 11.64 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.74 0.305 . . . . 0.0 110.435 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.3 -34.75 75.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.47 -52.97 26.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.482 HD12 ' CZ3' ' A' ' 3' ' ' TRP . 12.4 mt -63.37 -26.22 68.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.317 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 32' ' ' LEU . 62.1 t -91.01 -42.6 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.58 0.229 . . . . 0.0 111.569 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.91 -34.54 90.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.102 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB3' ' HD3' ' A' ' 40' ' ' PRO . . . -104.95 -41.34 5.63 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.567 ' HB3' HD11 ' A' ' 42' ' ' LEU . 27.9 m170 63.16 49.17 1.07 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.345 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 39' ' ' HIS . 9.9 Cg_endo -53.57 -24.21 28.22 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.231 1.954 . . . . 0.0 112.109 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.725 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . . . -58.85 -36.17 74.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.532 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 39' ' ' HIS . 1.4 pp -120.59 1.86 10.63 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.276 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -132.8 78.14 1.78 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.794 0.33 . . . . 0.0 110.952 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.2 p -81.46 -44.28 17.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.706 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.86 99.44 0.77 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.001 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.17 -72.03 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.377 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -167.01 -46.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.409 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.52 -51.34 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.715 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -175.06 149.92 1.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.0 110.575 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.99 -28.99 63.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.51 111.31 0.29 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.778 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -102.84 136.2 43.1 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.744 0.307 . . . . 0.0 111.0 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -126.07 -46.01 1.69 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.462 ' HB2' HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -156.99 112.39 2.85 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.794 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -146.35 138.88 25.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -104.78 126.89 52.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.971 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 2.0 pp -151.24 132.09 4.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.334 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -90.83 143.29 26.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.795 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.491 ' CG2' HD12 ' A' ' 80' ' ' LEU . 14.7 p -140.83 150.43 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 111.771 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -115.37 128.93 56.41 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.826 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.49 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -101.78 145.92 28.49 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.059 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -20.98 59.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.713 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.48 23.66 5.62 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.891 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -95.84 162.19 13.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.082 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.66 102.5 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.974 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 49.91 75.88 0.15 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.983 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.32 133.99 33.62 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.805 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.43 HD23 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -161.27 -71.3 0.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.318 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.67 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -90.0 53.78 3.62 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.769 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 10.9 tt0 -159.4 72.94 0.56 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.752 0.31 . . . . 0.0 111.279 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.903 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -60.35 -28.66 68.35 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.339 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.31 36.38 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.345 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . . . -92.77 -178.39 4.83 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.956 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.12 68.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.485 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.94 157.76 9.11 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.505 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.518 ' OD2' HD12 ' A' ' 32' ' ' LEU . 15.4 t70 -95.49 -67.52 0.85 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.561 0.22 . . . . 0.0 110.871 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.73 -179.88 6.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.231 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 60' ' ' LEU . 11.0 mt -113.67 -47.72 2.97 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.602 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.16 169.87 22.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.102 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD12 ' CG2' ' A' ' 59' ' ' VAL . 7.6 tt -153.89 95.44 1.87 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.055 0.455 . . . . 0.0 110.645 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -131.12 144.96 55.66 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.254 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 59.8 Cg_endo -72.2 154.7 56.84 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.519 2.146 . . . . 0.0 112.109 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 39.7 Cg_exo -60.85 -172.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.872 2.381 . . . . 0.0 112.497 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 84' ' ' VAL . 9.9 p -141.88 112.06 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.973 0.415 . . . . 0.0 111.579 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.58 -174.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.418 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.72 32.66 26.6 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.834 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.639 -1.09 . . . . 0.0 112.852 179.866 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -146.52 159.97 42.73 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.496 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 41.8 m95 -143.51 128.34 18.33 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.643 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.517 ' C ' HD22 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -129.4 149.83 51.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.482 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 16' ' ' ARG . 4.0 mm? -126.66 144.95 50.75 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.644 0.259 . . . . 0.0 111.051 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -82.44 176.67 9.23 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 11' ' ' GLU . . . -52.34 -31.97 35.98 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.564 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.441 ' C ' HD13 ' A' ' 9' ' ' LEU . 1.1 t0 -49.45 -35.17 18.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 110.776 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.764 HD12 HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -109.24 -32.85 7.04 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.393 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.37 -2.51 49.56 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 28.1 tt0 -68.38 -34.89 76.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.775 0.322 . . . . 0.0 110.724 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' CG1' ' HB2' ' A' ' 44' ' ' SER . 20.5 t -94.87 -49.36 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.727 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 -38.25 63.0 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.27 -24.24 29.87 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.701 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.02 96.13 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.767 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.6 28.18 6.27 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.143 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 4' ' ' LYS . 11.1 p -92.09 132.76 36.34 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.647 0.261 . . . . 0.0 110.924 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.31 159.82 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.245 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -124.89 138.05 54.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.591 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.13 123.45 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.948 0.404 . . . . 0.0 111.424 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.27 -47.11 1.76 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.219 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.17 152.72 3.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.463 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.455 ' OD1' ' HB3' ' A' ' 71' ' ' ALA . 35.3 t0 -112.12 160.29 17.69 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.209 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.15 -130.22 1.54 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.423 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.91 -33.22 63.91 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.735 0.267 . . . . 0.0 111.145 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.0 134.74 49.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.255 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -111.28 175.84 5.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.002 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.698 HG23 ' HA ' ' A' ' 71' ' ' ALA . 58.5 t -75.64 -42.32 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 120.956 0.407 . . . . 0.0 110.032 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -82.54 -32.95 26.39 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.893 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.56 -41.07 96.55 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.721 0.296 . . . . 0.0 110.791 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.95 -31.57 51.01 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.805 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.6 tt -61.6 -58.78 6.75 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.33 -32.74 74.24 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.87 -51.97 34.72 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.106 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.9 -34.62 73.43 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.176 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 32' ' ' LEU . 40.9 t -85.08 -43.69 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.334 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.62 6.88 75.81 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.423 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.473 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -62.97 -58.32 7.73 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.191 0.496 . . . . 0.0 110.712 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.691 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 13.9 m-70 103.79 -57.52 0.0 OUTLIER Pre-proline 0 C--N 1.345 0.403 0 C-N-CA 124.637 1.175 . . . . 0.0 112.073 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 39' ' ' HIS . 61.2 Cg_exo -50.98 -22.93 11.14 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.028 1.818 . . . . 0.0 112.434 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -58.44 -32.55 68.8 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.622 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.764 HD22 HD12 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -136.75 25.11 3.1 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.146 179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.03 66.26 1.4 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.783 0.325 . . . . 0.0 110.985 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.406 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 3.3 m -82.41 -44.74 15.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.627 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -163.62 111.07 1.17 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.895 0.379 . . . . 0.0 111.227 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 47' ' ' PHE . 8.9 p -157.08 -48.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.236 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.437 ' N ' HG13 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -170.75 -165.65 0.45 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.72 43.86 3.29 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.897 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 67.87 133.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.092 0.472 . . . . 0.0 111.665 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -88.1 -28.15 21.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.373 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.27 -60.89 2.21 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.256 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.77 118.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.682 0.393 . . . . 0.0 111.936 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.9 mt -91.71 -32.28 15.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.684 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.11 122.52 34.46 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.71 0.29 . . . . 0.0 111.477 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.29 129.68 43.56 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.887 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.34 135.2 52.21 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.964 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HB ' HD21 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -151.87 131.2 3.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.851 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -91.42 164.82 13.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.782 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 p -138.76 147.36 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.435 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -106.05 128.0 53.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.953 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.435 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -126.62 145.89 50.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.016 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -59.31 -21.0 59.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.675 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.91 23.72 5.47 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.747 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.2 166.29 12.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.746 0.308 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.33 112.57 11.76 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.81 123.79 42.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.47 165.57 18.01 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.681 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.436 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -108.16 -38.88 5.65 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.13 24.9 13.79 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.142 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -162.54 96.06 0.93 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.84 0.32 . . . . 0.0 110.953 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.698 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -70.33 -6.65 36.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.708 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 t -75.86 1.28 15.47 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.8 -178.48 1.54 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 111.398 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.6 86.91 6.84 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.477 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.67 159.17 28.05 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.116 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -109.58 -77.4 0.6 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -157.4 -175.16 5.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.793 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.7 mt -108.12 -37.69 5.98 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.99 172.0 10.6 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.087 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.427 HD21 ' HB ' ' A' ' 57' ' ' ILE . 7.4 tt -136.65 97.3 3.51 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.274 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.86 136.49 20.74 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.68 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 66.2 Cg_endo -74.22 150.83 42.87 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.409 2.073 . . . . 0.0 112.451 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 52.7 Cg_exo -54.73 159.25 9.26 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.819 2.346 . . . . 0.0 112.106 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 m -65.97 82.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.991 0.424 . . . . 0.0 111.427 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 t -92.48 161.4 14.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.214 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.42 85.99 0.11 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.55 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.202 -1.332 . . . . 0.0 112.904 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ttt . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.618 0.247 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -147.56 138.79 23.68 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.061 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.48 ' CE2' HD12 ' A' ' 32' ' ' LEU . 2.8 m0 -135.59 118.45 16.22 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.717 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 39.8 mtpt -116.91 139.78 50.23 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.589 ' HG ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -123.45 142.45 50.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.634 0.254 . . . . 0.0 110.796 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.484 ' H ' HD13 ' A' ' 5' ' ' LEU . 20.7 p90 -81.11 -173.19 4.16 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.173 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -41.09 -26.18 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.456 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -39.95 -47.27 2.2 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.884 0.373 . . . . 0.0 111.292 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.589 HD13 ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -113.23 -23.17 10.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.422 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.44 -3.01 38.18 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.15 -34.28 65.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.652 0.263 . . . . 0.0 111.073 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.425 HG21 ' C ' ' A' ' 42' ' ' LEU . 12.6 t -95.82 -53.6 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.719 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.64 -40.48 49.02 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.78 -30.33 7.23 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.455 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.2 p -156.95 124.96 5.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.632 0.253 . . . . 0.0 111.23 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.69 34.51 5.19 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.951 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.423 ' CG2' ' HG2' ' A' ' 4' ' ' LYS . 21.5 p -104.34 126.67 51.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -139.37 151.66 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -120.07 158.34 27.06 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.885 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 t -102.26 120.38 51.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.886 0.374 . . . . 0.0 111.215 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.99 -46.02 0.65 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.065 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.0 p -86.76 147.7 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.422 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -99.17 136.41 39.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.936 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.56 175.65 35.6 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.635 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.9 -31.49 68.67 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.548 0.213 . . . . 0.0 111.35 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 117.97 6.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.824 0.345 . . . . 0.0 111.049 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.855 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -68.28 179.52 1.58 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.876 HG13 ' HA ' ' A' ' 71' ' ' ALA . 2.6 m -74.54 -42.53 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.252 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -88.38 -28.49 22.21 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.276 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.78 -34.74 73.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.785 0.326 . . . . 0.0 110.728 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.601 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -92.09 -30.57 15.93 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.503 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 36' ' ' VAL . 4.0 tt -62.21 -53.69 51.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.781 0.324 . . . . 0.0 110.612 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -65.96 -31.76 72.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.245 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.0 -44.86 53.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.111 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 31' ' ' ALA . 8.1 mp -62.98 -32.78 74.21 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.928 0.394 . . . . 0.0 110.655 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 32' ' ' LEU . 47.0 t -87.97 -34.62 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.286 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.23 19.45 51.33 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.295 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -63.68 -52.2 61.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.053 0.426 . . . . 0.0 111.072 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.768 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 28.9 m170 104.63 -59.87 0.0 OUTLIER Pre-proline 0 C--N 1.345 0.391 0 C-N-CA 124.527 1.131 . . . . 0.0 112.071 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.768 ' HD3' ' HB2' ' A' ' 39' ' ' HIS . 42.6 Cg_exo -55.69 -22.06 34.63 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.691 1.594 . . . . 0.0 111.992 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.425 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -62.31 -29.25 70.3 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.645 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.528 HD22 ' CD2' ' A' ' 9' ' ' LEU . 2.3 pt? -135.69 26.81 3.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.838 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 70.95 136.02 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.5 m -58.45 -39.41 79.79 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.489 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 59.85 76.07 0.38 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.894 0.378 . . . . 0.0 111.244 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.3 68.56 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.508 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -141.18 -46.73 0.39 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.148 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.3 -63.34 1.51 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.049 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.92 155.53 1.64 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.792 0.33 . . . . 0.0 110.816 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -120.15 31.19 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.956 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.93 -99.63 2.63 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.512 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.14 93.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.832 0.348 . . . . 0.0 111.432 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 mp -94.82 18.66 11.37 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.527 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -133.24 128.85 36.76 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.618 0.247 . . . . 0.0 111.196 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.25 147.47 41.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -140.17 121.82 15.28 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.5 tt -173.6 145.39 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.404 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.6 m-80 -97.47 168.4 10.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.612 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' A' ' 80' ' ' LEU . 10.9 p -139.33 141.98 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.552 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.49 118.32 31.48 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.609 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -126.51 145.76 50.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.715 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.34 -10.59 56.01 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.895 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.56 5.58 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.945 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -118.8 166.08 13.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.631 0.253 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.11 125.78 27.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.64 130.3 46.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.24 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.476 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -98.27 134.54 41.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -128.59 -63.96 0.96 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.897 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.06 43.84 2.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.835 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -165.37 94.25 0.62 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.703 0.287 . . . . 0.0 111.236 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.876 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -71.56 -10.13 59.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.809 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.1 35.88 1.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 111.413 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.94 165.69 11.8 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.865 0.364 . . . . 0.0 111.327 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.3 80.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.15 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.76 -177.47 48.15 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.538 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.77 -74.9 0.59 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.792 0.33 . . . . 0.0 110.701 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -148.68 -177.61 5.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.39 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.59 -32.74 7.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.343 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB2' ' HD3' ' A' ' 4' ' ' LYS . . . -167.48 169.77 11.86 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.439 ' HG ' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -138.41 97.74 3.44 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.555 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -140.14 153.65 69.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.253 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HD3' ' CD1' ' A' ' 6' ' ' PHE . 24.6 Cg_endo -61.74 156.18 49.69 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.632 2.222 . . . . 0.0 112.31 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.42 -41.29 6.78 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.676 2.251 . . . . 0.0 112.421 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.38 122.66 53.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.734 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.29 155.27 40.88 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.84 70.83 0.34 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.749 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.64 -1.089 . . . . 0.0 112.643 179.807 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.759 ' HG3' HG12 ' A' ' 28' ' ' VAL . 2.8 ttp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.056 0.455 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -120.04 147.13 45.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.087 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.617 ' CH2' HD12 ' A' ' 32' ' ' LEU . 2.1 t90 -150.04 125.16 10.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.727 0.299 . . . . 0.0 111.168 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.652 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -122.23 148.47 44.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.297 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.668 HD13 ' HB3' ' A' ' 16' ' ' ARG . 7.6 mp -140.18 152.62 46.18 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.75 0.31 . . . . 0.0 111.334 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -98.27 179.15 4.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.62 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -53.67 -29.88 40.78 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.94 -37.73 33.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.004 0.431 . . . . 0.0 110.19 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.654 ' CB ' HD23 ' A' ' 5' ' ' LEU . 2.5 mp -110.73 -9.75 14.49 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.187 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.62 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -93.81 -4.9 49.34 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.99 -36.84 75.49 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 14.6 t -93.47 -33.51 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.797 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . . . -92.58 -45.03 8.3 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.38 -35.58 4.28 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.842 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.9 t -172.43 126.4 0.52 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.565 0.221 . . . . 0.0 110.824 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.668 ' HB3' HD13 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -123.05 28.2 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.291 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 5' ' ' LEU . 19.8 p -99.33 112.55 24.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.571 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.5 144.5 28.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.221 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -130.25 158.48 39.64 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.701 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.447 HG11 ' HB3' ' A' ' 1' ' ' MET . 13.4 p -103.95 136.97 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.893 0.378 . . . . 0.0 111.632 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.04 -48.62 1.11 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.918 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -86.65 165.67 2.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.284 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.09 118.07 33.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.08 -139.33 3.89 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.491 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.48 30.95 6.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.62 0.248 . . . . 0.0 111.302 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.46 146.3 25.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.898 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.533 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -121.08 167.75 12.28 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.83 0.348 . . . . 0.0 111.213 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.889 HG23 ' HA ' ' A' ' 68' ' ' LEU . 2.5 m -78.2 -36.88 21.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.435 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -79.21 -31.28 42.93 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.879 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -50.84 -42.17 58.31 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.885 0.374 . . . . 0.0 110.556 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.49 -30.89 17.02 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.126 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.617 HD12 ' CH2' ' A' ' 3' ' ' TRP . 0.7 OUTLIER -58.34 -56.07 26.85 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.829 -0.168 . . . . 0.0 110.96 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -57.18 -36.26 70.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.628 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.15 -53.95 9.71 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 110.469 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 39' ' ' HIS . 7.8 mp -61.43 -25.3 67.12 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.244 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 32' ' ' LEU . 90.4 t -91.92 -45.89 14.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.432 0.158 . . . . 0.0 111.336 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.28 -40.53 94.09 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.861 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.14 -56.35 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.652 0.263 . . . . 0.0 111.053 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.474 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER 72.52 55.5 0.34 Allowed Pre-proline 0 C--O 1.231 0.106 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.75 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 52.7 Cg_exo -53.12 -17.71 8.66 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.22 1.947 . . . . 0.0 112.06 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . . . -57.13 -40.49 77.23 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.189 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -134.5 13.17 3.78 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.642 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.14 118.64 26.55 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.842 0.354 . . . . 0.0 111.442 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.9 m -94.97 7.46 46.0 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.694 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 71.49 31.7 2.23 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.683 0.277 . . . . 0.0 111.063 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 46' ' ' VAL . 7.5 p -168.47 87.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.172 0.511 . . . . 0.0 111.37 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -157.57 104.67 2.0 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.183 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.42 -80.2 0.64 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.383 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.76 -62.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.814 0.34 . . . . 0.0 110.499 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.71 -28.94 51.04 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.465 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.09 -63.42 0.55 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.383 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.54 156.07 40.69 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.771 0.319 . . . . 0.0 111.059 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.56 -67.89 0.96 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -151.67 134.27 15.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.005 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.15 164.31 29.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.2 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -108.62 126.4 52.92 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.061 HD13 HD21 ' A' ' 80' ' ' LEU . 1.7 pp -148.87 120.09 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.553 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -77.27 151.31 35.12 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.868 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.684 HG23 HD12 ' A' ' 80' ' ' LEU . 11.0 p -136.92 146.7 27.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.678 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.34 124.3 49.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.732 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.71 145.61 51.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -61.09 -25.19 66.79 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.653 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.43 23.49 5.99 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.916 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.24 166.07 12.03 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.653 0.263 . . . . 0.0 110.772 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.03 114.29 2.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.982 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.03 111.54 10.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.075 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.54 -175.89 3.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.251 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.889 ' HA ' HG23 ' A' ' 28' ' ' VAL . 0.7 OUTLIER -141.16 -42.35 0.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.562 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.73 35.94 3.88 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.855 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HG2' HG22 ' A' ' 72' ' ' THR . 4.8 tt0 -167.94 91.28 0.33 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -83.88 -0.97 53.47 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.716 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.524 HG22 ' HG2' ' A' ' 70' ' ' GLU . 12.8 t -84.82 -26.56 27.38 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.436 0.16 . . . . 0.0 111.092 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.26 139.45 53.37 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.747 0.308 . . . . 0.0 110.913 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.94 -74.68 0.06 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.88 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.624 ' C ' HG11 ' A' ' 28' ' ' VAL . . . 113.99 -151.21 18.45 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.505 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 28' ' ' VAL . 25.3 p-10 -111.63 -50.77 2.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.406 0.146 . . . . 0.0 110.74 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -171.35 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.741 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.1 mt -107.66 -36.79 6.34 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.215 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 4' ' ' LYS . . . -165.22 170.93 14.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.631 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.061 HD21 HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -145.64 100.1 3.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.899 0.38 . . . . 0.0 110.545 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 12.5 m-85 -114.09 133.95 22.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.009 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 81' ' ' PHE . 37.1 Cg_exo -57.33 170.72 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.797 2.331 . . . . 0.0 112.403 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.19 74.23 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.771 2.314 . . . . 0.0 112.362 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -95.71 144.02 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.34 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.5 m -104.91 153.05 21.9 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.47 -166.51 26.91 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.769 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.688 -1.062 . . . . 0.0 112.851 179.845 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.579 0.228 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.44 160.14 40.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.882 0.372 . . . . 0.0 110.887 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.69 ' CH2' HD13 ' A' ' 80' ' ' LEU . 6.1 t-105 -155.27 144.83 21.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.02 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -137.63 141.16 41.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.938 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.617 HD21 ' HB2' ' A' ' 9' ' ' LEU . 11.7 tp -133.08 158.24 43.26 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.991 0.425 . . . . 0.0 111.893 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -91.14 177.93 6.13 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.716 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.495 ' HB1' ' HG3' ' A' ' 11' ' ' GLU . . . -72.93 -10.24 59.58 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.588 ' C ' HD13 ' A' ' 9' ' ' LEU . 6.2 t70 -56.65 -39.72 74.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.617 ' HB2' HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -111.66 -39.6 4.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.417 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -61.43 -14.23 26.62 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.495 ' HG3' ' HB1' ' A' ' 7' ' ' ALA . 35.1 mt-10 -73.37 -26.9 61.2 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.364 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 41' ' ' ALA . 16.5 t -89.66 -41.63 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.77 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -90.12 -43.55 10.39 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.68 -20.31 22.69 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.828 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.9 m -111.64 130.68 55.69 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.882 0.341 . . . . 0.0 110.665 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.623 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -113.81 -49.08 2.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 p -93.1 146.68 23.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.92 0.39 . . . . 0.0 111.435 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.0 t -145.36 119.33 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.24 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -102.42 138.59 39.14 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.358 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.75 123.21 65.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.438 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.08 -31.86 11.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.19 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 p -91.81 151.34 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -116.88 121.97 43.01 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.98 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.91 45.07 1.18 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.467 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.3 t0 55.48 33.57 21.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.868 0.365 . . . . 0.0 111.295 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.57 127.08 33.46 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.654 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.628 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -78.08 168.07 20.46 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.796 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.49 HG11 ' HG3' ' A' ' 61' ' ' ARG . 22.6 t -75.25 -34.43 30.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.451 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -85.07 -28.64 30.49 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.304 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.83 -41.44 74.25 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.559 0.218 . . . . 0.0 110.955 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.51 -32.29 19.5 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -61.43 -61.86 2.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.645 0.259 . . . . 0.0 110.54 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -62.06 -33.17 73.9 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.672 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -66.08 -54.5 24.93 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.291 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.54 -19.22 64.61 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.459 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 32' ' ' LEU . 88.2 t -91.99 -47.81 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.31 -34.22 2.55 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.789 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -80.61 -1.23 41.36 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.424 ' O ' HD12 ' A' ' 42' ' ' LEU . 7.8 m170 -127.1 65.69 65.28 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.781 0.324 . . . . 0.0 110.675 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 53.3 Cg_exo -54.01 -19.11 14.81 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.779 2.319 . . . . 0.0 112.469 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -52.72 -26.43 14.01 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.631 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.77 HD23 ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -95.91 -23.76 16.73 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.679 0.275 . . . . 0.0 110.99 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 78.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.084 0.469 . . . . 0.0 111.022 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.8 t -80.42 -53.38 6.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.813 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -176.49 107.47 0.07 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.61 -55.71 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.655 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -172.25 48.05 0.02 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.609 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.34 -45.23 2.6 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.528 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.06 156.76 45.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.723 0.297 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.37 -28.84 9.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.242 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.4 158.87 22.63 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.623 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.57 97.31 3.71 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.677 0.275 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 mt 70.93 -63.72 0.41 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.26 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -113.45 138.49 50.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.77 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -103.6 126.45 50.75 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 141.12 46.04 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.193 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.4 mt -146.86 130.83 9.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.285 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -101.65 146.53 27.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.957 0.408 . . . . 0.0 111.143 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.78 154.08 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tp -124.61 120.92 33.29 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.017 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HG3' HG11 ' A' ' 28' ' ' VAL . 2.5 tmm_? -127.5 88.42 2.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.619 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 57.54 18.68 4.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.851 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.48 23.66 39.11 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.642 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -102.01 166.0 10.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.951 0.405 . . . . 0.0 111.199 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.52 102.9 14.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.533 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 63.2 105.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.066 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.416 ' CB ' ' HG3' ' A' ' 61' ' ' ARG . . . -109.95 162.57 14.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.225 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.451 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 2.6 tt -169.9 -65.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.602 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.483 ' HA2' HG22 ' A' ' 27' ' ' THR . . . -93.45 63.39 1.97 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.137 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -123.82 30.48 6.16 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -58.32 -22.9 54.82 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -76.74 -25.0 53.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.243 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.84 154.52 41.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.69 0.281 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.4 66.74 3.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.825 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.53 -173.93 27.46 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.549 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -117.36 -72.74 0.67 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.582 0.229 . . . . 0.0 110.694 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.455 ' HA ' ' HG2' ' A' ' 61' ' ' ARG . 1.3 pt-20 -149.41 -169.21 3.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.716 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -113.52 -48.74 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.407 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -162.5 166.74 24.49 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.249 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.69 HD13 ' CH2' ' A' ' 3' ' ' TRP . 4.8 tt -146.55 111.88 5.49 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.83 0.348 . . . . 0.0 110.942 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -151.44 156.7 34.93 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.485 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.0 153.06 76.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.543 2.162 . . . . 0.0 112.383 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.37 -42.66 3.59 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.609 2.206 . . . . 0.0 112.703 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.2 149.36 32.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.933 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.5 t -103.71 102.41 12.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.727 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.48 170.48 36.47 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.673 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.236 -1.313 . . . . 0.0 112.868 179.893 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG3' ' HA2' ' A' ' 75' ' ' GLY . 6.4 mtm . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.621 0.248 . . . . 0.0 111.434 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -116.71 159.22 22.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.815 0.34 . . . . 0.0 111.28 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.709 ' CH2' HD13 ' A' ' 80' ' ' LEU . 7.2 t-105 -151.27 143.05 23.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.627 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.541 ' HG2' HG22 ' A' ' 17' ' ' THR . 2.1 mtmm -138.24 145.91 41.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.774 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.478 HD11 HD13 ' A' ' 9' ' ' LEU . 10.5 tp -138.48 159.76 41.26 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.044 0.449 . . . . 0.0 111.683 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -87.13 173.39 9.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.327 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 11' ' ' GLU . . . -65.52 -25.5 67.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.746 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.48 -39.52 23.31 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.865 0.364 . . . . 0.0 110.675 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.729 ' HB3' HD22 ' A' ' 42' ' ' LEU . 1.3 mp -101.1 -34.26 9.79 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.337 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -70.29 -12.01 61.29 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -71.1 -34.4 71.07 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 121.289 -0.164 . . . . 0.0 111.361 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.698 HG21 ' HB2' ' A' ' 43' ' ' GLU . 5.1 t -98.3 -37.79 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.655 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -88.15 -45.83 9.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.586 0.232 . . . . 0.0 111.437 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.34 -25.57 27.81 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.534 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 t -106.14 111.58 24.25 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.857 0.36 . . . . 0.0 110.814 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.597 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 1.7 ptt-85 -102.66 -45.77 4.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.709 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.541 HG22 ' HG2' ' A' ' 4' ' ' LYS . 4.8 p -99.73 140.64 33.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 111.436 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.09 129.59 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.927 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -110.52 136.0 50.32 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.519 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.51 137.43 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.861 0.362 . . . . 0.0 111.652 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.71 -21.25 11.77 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.584 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.87 152.21 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.875 0.369 . . . . 0.0 111.615 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.7 153.53 26.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.132 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.68 -155.08 9.02 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.784 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.56 30.36 5.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.725 0.298 . . . . 0.0 111.492 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.13 123.7 29.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.044 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.711 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -76.72 164.25 26.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.781 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.878 HG11 ' HB3' ' A' ' 67' ' ' ALA . 38.7 t -73.76 -30.08 27.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.536 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.676 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -87.21 -29.48 22.4 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.425 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.44 -41.84 77.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.589 0.233 . . . . 0.0 111.077 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -84.27 -32.31 24.48 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.373 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.4 tt -56.48 -61.22 2.56 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.346 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.68 -37.74 88.49 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.403 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -59.83 -53.58 56.26 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.618 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.1 mt -64.88 -20.62 66.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.007 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 32' ' ' LEU . 57.3 t -86.34 -48.47 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.57 -39.47 1.21 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.804 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -72.85 -0.49 13.6 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.401 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 1.4 t-80 -120.79 68.73 16.18 Favored Pre-proline 0 N--CA 1.453 -0.301 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.487 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 85.9 Cg_exo -48.63 -19.11 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.123 2.549 . . . . 0.0 113.362 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -51.36 -38.72 54.67 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -83.79 -19.81 34.38 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.698 ' HB2' HG21 ' A' ' 12' ' ' VAL . 1.8 mm-40 64.48 118.89 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.7 t -94.94 -26.64 16.04 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.046 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.48 174.16 10.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.016 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.22 39.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.885 0.374 . . . . 0.0 111.543 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -175.3 83.49 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.928 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.93 -97.67 0.11 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.36 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -156.75 141.73 17.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.718 0.294 . . . . 0.0 111.029 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -100.49 -28.92 12.65 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.365 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.99 -159.54 21.73 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.222 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -160.31 145.03 14.55 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.755 0.312 . . . . 0.0 111.465 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -172.4 -49.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.075 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -146.23 141.15 27.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -106.19 119.47 39.31 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.586 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -93.89 97.25 10.25 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 56' ' ' HIS . 0.8 OUTLIER -163.07 126.19 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.991 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -85.87 144.02 27.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.515 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.51 ' CG2' HD12 ' A' ' 80' ' ' LEU . 14.4 p -139.99 147.9 23.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.338 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tp -107.46 118.3 36.37 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.849 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.31 85.8 1.81 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.297 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 63.8 16.32 9.7 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.917 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.6 23.75 27.72 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.536 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.98 162.67 14.61 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.831 0.348 . . . . 0.0 110.858 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.31 102.48 13.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.42 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.75 109.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.305 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.878 ' HB3' HG11 ' A' ' 28' ' ' VAL . . . -104.75 148.66 26.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.028 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.676 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 6.2 tt -139.11 -67.37 0.45 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.045 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.02 52.75 3.69 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.844 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.49 24.77 7.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.63 0.252 . . . . 0.0 111.621 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -58.06 -29.65 65.57 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.308 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.68 1.38 56.88 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.97 175.28 6.77 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.833 0.349 . . . . 0.0 111.363 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.68 53.59 2.76 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.215 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA2' ' HG3' ' A' ' 1' ' ' MET . . . 138.34 163.54 9.62 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.878 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.71 -67.9 0.76 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 110.531 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.57 -172.32 2.87 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.739 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.11 -52.47 2.76 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.69 0.281 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.16 170.13 22.97 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.949 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.709 HD13 ' CH2' ' A' ' 3' ' ' TRP . 1.1 tt -147.99 112.23 5.23 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.837 0.351 . . . . 0.0 111.083 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -130.9 136.32 28.71 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.054 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 6' ' ' PHE . 57.7 Cg_endo -71.31 146.19 50.23 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.628 2.219 . . . . 0.0 112.531 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.55 137.22 27.4 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.805 2.337 . . . . 0.0 112.603 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 m -95.69 37.81 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.404 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 t -121.71 95.8 4.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.396 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.98 -53.01 0.38 Allowed Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.548 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.361 -1.244 . . . . 0.0 112.815 -179.869 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.042 0.449 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 77' ' ' GLU . 19.9 mt-10 -141.04 175.44 9.63 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.438 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.765 ' CZ3' HD22 ' A' ' 35' ' ' LEU . 1.5 t90 -155.41 118.62 4.38 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.986 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 7.0 mtpp -102.55 145.79 29.09 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -136.5 137.21 40.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.722 0.296 . . . . 0.0 111.723 -179.111 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.58 163.39 14.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.632 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -53.08 -29.19 28.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.518 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.705 ' HB3' HD12 ' A' ' 9' ' ' LEU . 4.3 t70 -47.62 -38.5 14.79 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.958 0.409 . . . . 0.0 110.667 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.707 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 4.2 mp -119.19 -3.18 10.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.481 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -92.99 -9.18 40.79 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.55 -44.37 76.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.578 0.228 . . . . 0.0 111.108 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 15.4 t -94.26 -29.96 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.074 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.926 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . . . -69.43 -41.67 76.02 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.582 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.62 -6.78 81.75 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.479 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.39 152.17 51.57 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 110.998 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -110.7 -76.81 0.6 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.474 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.7 p -95.93 136.65 36.08 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.854 0.359 . . . . 0.0 111.428 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.21 121.33 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.763 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.41 151.19 21.81 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.955 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 20' ' ' VAL . 11.5 p -118.16 120.74 65.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.84 0.353 . . . . 0.0 111.275 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -33.52 6.02 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.17 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 m -87.41 134.23 28.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.15 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -117.01 134.21 55.03 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.82 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.45 -109.17 0.29 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.649 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.15 25.8 6.47 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 111.454 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.32 141.97 49.55 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.753 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.65 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -117.5 177.38 4.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 68' ' ' LEU . 42.2 t -78.1 -50.32 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.055 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.495 ' HA3' HD13 ' A' ' 68' ' ' LEU . . . -78.67 -25.63 60.27 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.146 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.69 -39.86 85.95 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.645 0.26 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.94 -33.1 18.58 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.815 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.565 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -60.27 -57.47 12.66 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.457 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.29 -33.97 73.11 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.382 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.86 -52.35 15.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.096 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.765 HD22 ' CZ3' ' A' ' 3' ' ' TRP . 8.8 mp -61.8 -27.76 68.99 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.428 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 32' ' ' LEU . 42.4 t -94.24 -41.07 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.54 0.21 . . . . 0.0 111.365 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.2 -37.0 91.15 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.045 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.08 -25.07 13.55 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.582 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 17.0 m80 63.19 44.78 0.59 Allowed Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 122.675 0.39 . . . . 0.0 111.324 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 53.6 Cg_exo -51.77 -31.31 41.3 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.942 1.761 . . . . 0.0 111.71 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.926 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . . . -56.46 -32.1 64.63 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.389 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.59 HD21 HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -121.94 -3.12 9.15 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -79.47 87.47 5.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.832 0.348 . . . . 0.0 111.041 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.0 -53.6 3.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.26 103.87 0.07 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.526 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 46' ' ' VAL . 63.6 t 56.59 70.12 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.994 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.17 -59.58 1.39 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.936 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.48 62.68 0.54 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.487 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.65 -70.23 0.25 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.485 0.183 . . . . 0.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -109.89 -29.48 8.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.295 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.02 123.77 0.22 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.909 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -127.37 33.75 4.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.682 0.277 . . . . 0.0 111.273 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.45 163.3 36.96 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.89 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -101.82 112.24 24.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.97 147.89 44.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.413 ' HB3' ' HG2' ' A' ' 83' ' ' PRO . 3.5 t60 -117.25 149.79 39.85 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 pt -136.8 104.45 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.29 151.4 33.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.8 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.502 HG23 ' OE2' ' A' ' 77' ' ' GLU . 9.1 p -133.98 151.81 33.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.714 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.533 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -114.35 130.07 56.67 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.663 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.533 ' N ' HD13 ' A' ' 60' ' ' LEU . 18.8 mtt180 -123.18 145.6 48.49 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.741 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -52.09 -38.4 57.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.371 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.04 22.64 6.79 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.807 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.82 164.63 19.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.726 0.263 . . . . 0.0 110.715 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.27 105.76 0.97 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.23 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.31 153.46 46.98 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.375 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -113.7 179.85 3.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.293 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD13 ' HA3' ' A' ' 29' ' ' GLY . 3.2 pp -111.67 -33.16 6.43 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.989 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.477 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -85.5 32.22 3.69 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.854 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -153.28 90.96 1.46 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.813 0.306 . . . . 0.0 111.269 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.65 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -67.66 -12.7 61.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.97 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 t -88.2 34.14 0.74 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.953 0.406 . . . . 0.0 111.056 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.56 167.38 11.97 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.11 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.48 40.56 1.84 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.699 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.58 67.0 0.02 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.59 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -69.17 -71.16 0.23 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.711 0.291 . . . . 0.0 110.57 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.502 ' OE2' HG23 ' A' ' 59' ' ' VAL . 34.7 tt0 -140.45 156.36 46.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.554 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -100.62 -42.99 6.31 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.766 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -169.44 163.18 10.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.425 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -136.26 113.24 10.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.994 0.426 . . . . 0.0 110.439 179.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -146.22 140.57 15.57 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.303 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 73.2 Cg_endo -75.46 151.46 37.53 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.36 2.04 . . . . 0.0 111.857 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' A' ' 56' ' ' HIS . 34.7 Cg_exo -60.83 90.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.673 2.248 . . . . 0.0 112.068 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 m -60.78 134.99 26.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.516 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.67 156.29 23.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.327 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.23 -161.47 8.74 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.868 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.328 -179.891 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.893 0.378 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 17.3 mt-10 -142.58 163.76 31.95 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.03 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.736 ' CZ2' HD22 ' A' ' 80' ' ' LEU . 5.3 t-105 -153.99 141.54 19.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.103 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -138.43 143.1 39.55 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.644 HD21 HD22 ' A' ' 9' ' ' LEU . 13.2 tp -136.73 156.48 48.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 111.646 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.563 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -81.27 -177.73 6.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.359 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.38 -12.29 60.23 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -54.03 -38.12 64.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.781 0.324 . . . . 0.0 111.044 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.796 HD23 HD13 ' A' ' 42' ' ' LEU . 2.2 mp -105.48 -38.22 6.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.326 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -64.73 -17.83 64.48 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -67.13 -26.85 66.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.429 0.156 . . . . 0.0 111.166 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 41' ' ' ALA . 8.9 t -98.19 -44.37 12.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.9 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -91.62 -42.55 10.13 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.48 -28.14 14.46 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.84 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 t -100.45 108.25 20.18 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.826 0.346 . . . . 0.0 111.043 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.816 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -98.62 -42.43 7.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.531 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -93.75 147.5 22.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.068 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -142.11 113.24 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.191 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.13 136.24 37.95 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.441 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.56 124.88 66.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 111.407 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.78 -34.41 7.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.054 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.62 145.3 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 120.813 0.339 . . . . 0.0 111.257 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -116.66 121.72 42.48 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.99 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.84 -107.93 1.62 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.395 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.33 -10.64 16.88 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.21 145.34 51.54 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.744 0.307 . . . . 0.0 111.39 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.03 170.92 7.92 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.084 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.571 HG22 ' HA ' ' A' ' 76' ' ' ASP . 24.6 t -75.01 -37.64 41.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.462 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.68 ' HA3' HD12 ' A' ' 68' ' ' LEU . . . -88.78 -33.87 9.58 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.17 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -55.49 -45.22 77.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.665 0.269 . . . . 0.0 111.139 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -76.75 -24.68 52.98 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.934 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.744 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.4 tt -66.72 -58.17 5.63 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -62.63 -31.6 72.48 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.832 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.528 ' CA ' ' HB3' ' A' ' 38' ' ' ALA . . . -71.62 -48.3 48.83 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.938 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 31' ' ' ALA . 8.9 mp -64.31 -21.45 66.61 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.011 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 32' ' ' LEU . 97.9 t -84.4 -49.26 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.82 -35.41 1.38 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.826 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HB3' ' CA ' ' A' ' 34' ' ' ALA . . . -74.47 -1.21 20.18 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 5.7 m80 -126.11 65.63 57.22 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 110.471 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 77.6 Cg_exo -52.28 -19.64 9.77 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.825 2.35 . . . . 0.0 112.576 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -53.03 -29.03 27.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.576 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.9 HD23 ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -96.21 -16.25 21.56 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.597 0.237 . . . . 0.0 111.453 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' C ' HG21 ' A' ' 12' ' ' VAL . 4.4 mt-10 -73.25 131.56 42.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.708 0.29 . . . . 0.0 111.394 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -89.67 -32.84 16.86 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.214 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -145.61 164.46 31.66 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.7 0.286 . . . . 0.0 111.129 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.56 59.28 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -151.79 93.53 1.87 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.848 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.09 32.32 83.74 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.825 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -90.41 -35.45 15.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.631 0.215 . . . . 0.0 111.101 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -28.74 66.98 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.588 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.57 105.45 0.22 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.526 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -84.36 75.36 10.24 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.802 0.334 . . . . 0.0 111.109 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' A' ' 54' ' ' TYR . 9.8 tt 68.19 -70.51 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.193 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HB2' HD23 ' A' ' 53' ' ' LEU . 1.5 t80 -117.72 123.68 46.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.655 0.264 . . . . 0.0 110.569 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -149.61 143.65 25.68 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.241 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -97.84 144.46 27.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.52 HG22 ' HD3' ' A' ' 83' ' ' PRO . 8.2 pt -152.51 125.33 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.743 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -99.94 135.39 41.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.437 HG23 HD12 ' A' ' 80' ' ' LEU . 13.8 p -140.6 153.96 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.256 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mp -132.18 133.09 43.81 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.965 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -146.11 84.29 1.64 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.424 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 54.11 18.96 1.91 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.076 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.36 23.06 59.36 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.711 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -138.1 166.99 22.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.08 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.39 127.86 34.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.744 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.16 157.52 13.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.508 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 28' ' ' VAL . . . -110.25 174.54 5.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.403 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.68 HD12 ' HA3' ' A' ' 29' ' ' GLY . 2.1 tt -149.58 20.23 0.92 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.445 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.31 19.38 1.35 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.588 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 178.27 85.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.139 0.469 . . . . 0.0 111.417 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB2' ' N ' ' A' ' 28' ' ' VAL . . . -82.71 6.97 16.22 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.779 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 t -83.91 -14.9 49.84 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.53 0.205 . . . . 0.0 111.254 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.08 131.26 54.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.707 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.82 23.73 11.59 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.975 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.71 -129.82 22.27 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.346 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.571 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -121.34 -72.85 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.52 0.2 . . . . 0.0 110.859 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -162.53 -166.85 1.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 78' ' ' LEU . 11.2 mt -111.75 -55.47 2.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.708 0.289 . . . . 0.0 110.958 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.89 164.37 38.96 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.225 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.736 HD22 ' CZ2' ' A' ' 3' ' ' TRP . 0.5 OUTLIER -139.29 115.29 10.23 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.004 0.43 . . . . 0.0 110.741 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -107.77 108.26 61.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 6' ' ' PHE . 58.7 Cg_endo -71.67 171.48 16.31 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.777 2.318 . . . . 0.0 112.492 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.52 ' HD3' HG22 ' A' ' 57' ' ' ILE . 70.6 Cg_endo -74.96 -177.1 3.23 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.651 2.234 . . . . 0.0 112.583 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.48 139.17 17.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.989 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.4 t -146.89 151.59 37.3 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.77 0.319 . . . . 0.0 111.498 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.39 -158.28 11.71 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.438 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.709 -1.05 . . . . 0.0 112.434 -179.5 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.609 0.242 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.94 154.14 44.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.046 0.45 . . . . 0.0 111.497 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -145.8 143.85 29.92 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.412 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.47 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 12.9 mttp -135.03 136.43 42.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.525 0.202 . . . . 0.0 110.654 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.742 HD21 ' CB ' ' A' ' 9' ' ' LEU . 3.9 tp -129.95 135.21 48.06 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.798 0.332 . . . . 0.0 111.07 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -81.8 176.35 9.67 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.414 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.545 ' HB1' ' CD ' ' A' ' 11' ' ' GLU . . . -63.79 -16.16 60.52 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -55.51 -30.43 60.65 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.739 0.304 . . . . 0.0 110.906 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.742 ' CB ' HD21 ' A' ' 5' ' ' LEU . 3.3 mp -119.31 -36.26 3.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.335 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.47 -15.48 50.13 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.545 ' CD ' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -71.63 -26.79 62.71 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -95.7 -39.14 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.888 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -93.19 -42.4 9.38 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.18 23.19 10.72 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.736 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.71 136.96 49.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.553 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -113.5 -81.63 0.6 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.428 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 5.0 p -92.69 149.0 21.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.872 0.368 . . . . 0.0 111.464 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.16 118.29 6.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.976 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 148.17 28.18 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.467 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -103.14 120.2 52.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.97 -15.88 14.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.541 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.79 150.81 3.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.594 0.235 . . . . 0.0 110.968 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.86 172.48 0.95 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.433 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.15 85.13 0.91 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.937 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.59 -44.09 4.77 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.472 0.177 . . . . 0.0 111.402 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.55 165.82 12.15 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.751 0.31 . . . . 0.0 111.246 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.672 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -80.16 165.17 22.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 179.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.45 -24.3 14.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.731 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.474 ' N ' ' HA ' ' A' ' 68' ' ' LEU . . . -88.95 -27.52 23.52 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.051 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.18 -47.78 68.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.687 0.279 . . . . 0.0 110.912 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -79.61 -34.59 40.54 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.605 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -53.12 -60.06 3.77 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.393 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.2 -35.48 80.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.13 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.887 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -57.87 -55.38 35.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.646 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.52 HD23 ' ND1' ' A' ' 39' ' ' HIS . 17.9 mt -66.77 -23.16 66.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.875 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 32' ' ' LEU . 56.1 t -80.21 -47.58 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -125.41 -37.8 0.51 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.201 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.887 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -71.48 -1.54 13.62 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.52 ' ND1' HD23 ' A' ' 35' ' ' LEU . 15.7 m80 -129.29 67.03 78.09 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 120.816 0.341 . . . . 0.0 110.667 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.33 -16.82 14.31 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.715 2.277 . . . . 0.0 112.588 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.45 -25.59 16.77 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.888 HD23 ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -99.5 -22.43 15.49 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.634 0.254 . . . . 0.0 111.365 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -98.85 163.61 12.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.917 0.389 . . . . 0.0 111.363 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -97.81 -49.52 4.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.71 135.66 23.6 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.732 0.301 . . . . 0.0 111.176 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 46' ' ' VAL . 9.5 p -154.71 31.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.132 0.491 . . . . 0.0 111.287 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.2 -75.21 0.6 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.864 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.26 74.59 0.38 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.263 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.52 167.67 5.37 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.782 0.325 . . . . 0.0 111.343 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -96.86 31.58 2.32 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.441 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.11 57.79 0.03 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.903 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -163.94 132.72 3.75 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.794 0.331 . . . . 0.0 111.317 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.37 -38.15 5.06 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 135.54 46.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.603 0.24 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.29 168.82 11.06 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.145 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -114.5 111.23 21.07 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.087 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.546 HD12 HG13 ' A' ' 36' ' ' VAL . 7.6 mt -149.74 126.42 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.074 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.24 163.4 16.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 32' ' ' LEU . 10.8 p -140.64 149.6 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.372 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.61 118.31 33.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.717 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.3 85.53 2.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.556 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 61.44 16.87 7.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.736 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.62 23.62 33.04 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.31 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -101.99 163.16 12.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.859 0.361 . . . . 0.0 110.82 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 102.91 14.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.424 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 54.7 96.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.884 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.73 143.69 32.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.438 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.474 ' HA ' ' N ' ' A' ' 29' ' ' GLY . 9.0 tt -143.79 -52.49 0.34 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.014 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.88 53.04 4.04 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.1 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.31 22.15 8.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.62 0.248 . . . . 0.0 111.533 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -55.89 -30.01 60.87 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.169 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.88 31.13 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.338 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.22 -175.39 2.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.75 0.31 . . . . 0.0 111.105 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.86 -32.42 67.47 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.514 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.14 -124.62 1.54 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.559 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.21 -79.05 0.39 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.684 0.278 . . . . 0.0 110.737 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -147.23 -165.38 2.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.606 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 78' ' ' LEU . 3.3 tp -112.69 -51.95 2.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.628 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -153.95 167.22 30.48 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.171 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.04 97.69 3.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.699 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.467 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 34.9 p90 -149.58 149.64 29.03 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-O 120.638 0.256 . . . . 0.0 111.603 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.509 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 39.1 Cg_exo -55.39 -49.45 16.14 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.871 2.381 . . . . 0.0 112.915 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 82' ' ' PRO . 76.5 Cg_exo -50.4 160.08 1.74 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.689 2.259 . . . . 0.0 112.974 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 84' ' ' VAL . 11.0 p -151.67 116.95 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.385 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m 64.21 110.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.454 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.74 -74.73 0.05 OUTLIER Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.584 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.506 -1.163 . . . . 0.0 112.664 -179.891 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttm . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -146.84 171.98 14.36 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.814 0.34 . . . . 0.0 111.193 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.415 ' HE1' HG21 ' A' ' 20' ' ' VAL . 59.1 m95 -145.82 131.84 19.27 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.091 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -136.8 158.41 44.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.504 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HD12 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -150.1 163.0 39.32 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.879 0.371 . . . . 0.0 111.588 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.96 179.99 4.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.338 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.57 -11.84 47.71 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.236 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.471 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -52.81 -36.78 58.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.88 0.371 . . . . 0.0 110.357 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.056 HD12 HD21 ' A' ' 5' ' ' LEU . 7.8 mt -122.03 -39.44 2.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.469 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.73 -13.96 38.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -82.84 -28.12 30.36 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.844 0.354 . . . . 0.0 110.503 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 74.8 t -85.73 -30.88 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.355 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -99.22 -39.52 8.41 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.891 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.61 -37.64 2.14 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.152 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.2 p -173.95 138.17 0.6 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.594 0.235 . . . . 0.0 110.766 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.618 ' HG2' HD22 ' A' ' 5' ' ' LEU . 3.2 tpm_? -131.02 17.65 5.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.75 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.8 p -96.95 122.29 39.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.652 0.263 . . . . 0.0 110.413 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.57 166.07 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.44 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.05 142.89 50.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.377 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.415 HG21 ' HE1' ' A' ' 3' ' ' TRP . 21.1 t -102.19 120.52 52.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.169 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.71 -54.44 0.77 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.23 154.52 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.274 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -117.15 122.04 42.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.33 -81.31 0.04 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.061 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.96 25.14 4.97 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.775 0.321 . . . . 0.0 111.211 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.19 116.93 25.85 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.803 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -108.4 174.57 5.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.042 HG21 ' HB3' ' A' ' 67' ' ' ALA . 54.9 t -73.3 -36.94 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -77.28 -33.39 44.52 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.86 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.8 -37.55 79.44 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.558 0.343 . . . . 0.0 110.988 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -86.54 -30.93 21.54 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.93 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -60.62 -58.69 7.39 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.524 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.68 -36.67 83.64 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 1.035 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -59.6 -51.56 69.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.585 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 31' ' ' ALA . 7.9 mp -67.39 -30.74 70.6 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.706 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 32' ' ' LEU . 58.2 t -62.78 -52.13 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.835 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.24 30.34 0.05 OUTLIER Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.748 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -105.24 -0.58 26.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.799 0.3 . . . . 0.0 111.565 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -123.62 69.39 44.13 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -44.24 -21.85 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.29 2.66 . . . . 0.0 113.627 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -50.82 -28.0 8.49 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -113.87 5.81 16.4 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -94.09 120.73 34.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.535 0.207 . . . . 0.0 111.08 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 t -97.1 -53.31 3.54 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.658 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.44 146.68 36.81 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.837 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -112.89 18.47 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.549 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 38.6 t80 69.67 -67.95 0.21 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 122.649 0.38 . . . . 0.0 111.567 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.39 -2.15 85.44 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.304 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.508 ' HA ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER 67.65 -75.55 0.06 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.033 0.417 . . . . 0.0 111.1 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -120.52 31.8 6.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.956 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.14 112.45 0.53 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.516 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.14 107.81 7.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.859 0.361 . . . . 0.0 111.19 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -107.6 -35.03 6.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.207 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -101.5 134.2 44.98 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.675 0.274 . . . . 0.0 111.145 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.4 129.28 56.15 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.058 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -147.1 129.27 15.61 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.5 tt -170.17 146.71 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.61 141.61 35.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.17 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.43 HG23 ' HG ' ' A' ' 80' ' ' LEU . 12.0 p -139.2 153.82 24.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.211 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.685 HD12 HD12 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -116.94 127.3 54.09 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.725 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 142.8 49.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -63.0 -21.29 66.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.691 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.56 5.58 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.7 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.7 165.99 12.64 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.609 0.242 . . . . 0.0 110.776 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.29 121.68 10.72 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.27 127.69 33.37 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.509 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 1.042 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -94.74 179.22 5.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.634 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 68' ' ' LEU . 4.7 tt -167.38 -54.31 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.904 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.86 19.75 43.59 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.096 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 27' ' ' THR . 9.3 pt-20 -174.47 101.17 0.09 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.987 0.394 . . . . 0.0 111.012 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.578 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -75.64 -5.15 44.09 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.785 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 t -91.29 33.89 0.96 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.044 0.449 . . . . 0.0 111.07 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.41 -173.7 3.67 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.74 -33.54 56.02 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.497 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.33 146.82 6.65 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.715 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' CG ' HG22 ' A' ' 28' ' ' VAL . 15.1 m-20 -89.24 -80.11 0.31 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.33 -173.54 4.62 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.39 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.685 HD12 HD12 ' A' ' 60' ' ' LEU . 11.3 mt -108.41 -40.15 5.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.632 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -169.79 169.68 8.28 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.869 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.543 ' HB3' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -139.79 105.94 5.24 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 110.983 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 84' ' ' VAL . 51.4 t80 -92.12 112.37 54.68 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.842 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' HG2' ' HB2' ' A' ' 8' ' ' ASP . 51.0 Cg_exo -54.14 167.73 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.047 2.498 . . . . 0.0 113.082 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.22 136.41 68.39 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.117 2.545 . . . . 0.0 112.836 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.497 HG21 ' CZ ' ' A' ' 81' ' ' PHE . 39.4 t -144.81 118.08 2.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.146 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.9 p -175.1 -64.81 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -106.05 -31.67 4.05 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.802 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.578 -1.124 . . . . 0.0 112.471 179.659 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptm . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 120.619 0.247 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -143.45 160.3 40.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -148.43 143.54 26.83 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.28 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.523 ' HG2' HG22 ' A' ' 17' ' ' THR . 0.6 OUTLIER -134.95 143.57 46.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.293 179.331 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.572 HD21 ' CB ' ' A' ' 9' ' ' LEU . 12.2 tp -133.08 157.8 44.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 111.308 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -89.14 162.6 15.86 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.76 62.11 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.762 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -55.2 -32.09 61.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.79 0.329 . . . . 0.0 110.525 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -110.9 -38.39 5.12 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.094 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -66.47 -13.25 60.57 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -72.16 -25.73 61.81 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG21 ' N ' ' A' ' 44' ' ' SER . 11.8 t -93.72 -44.18 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.509 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -84.21 -28.94 26.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.628 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.1 -21.53 44.69 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.726 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.26 130.23 55.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.755 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -109.5 -48.03 3.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.735 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.523 HG22 ' HG2' ' A' ' 4' ' ' LYS . 2.3 p -92.3 141.14 28.88 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.038 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.7 t -142.09 125.8 15.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -95.87 154.11 17.4 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.697 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 t -102.02 120.54 51.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.0 -73.99 0.66 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 p -98.53 146.22 8.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.001 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -88.12 137.71 32.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.52 -120.77 0.6 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.452 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -100.69 36.54 1.9 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 111.048 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.33 120.1 39.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.752 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -115.08 173.57 6.43 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.103 HG21 ' HB3' ' A' ' 67' ' ' ALA . 38.5 t -77.62 -39.59 27.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.973 0.416 . . . . 0.0 110.137 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -81.21 -32.04 32.78 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.75 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.98 -45.61 94.1 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.692 0.282 . . . . 0.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.43 -30.95 57.6 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.648 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.755 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -57.03 -58.29 8.82 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.928 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 38' ' ' ALA . 22.5 t0 -60.51 -39.31 87.31 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.413 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.788 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -58.57 -55.19 38.29 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.34 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.431 HD23 HD23 ' A' ' 80' ' ' LEU . 8.1 mp -62.28 -24.01 67.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.926 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 32' ' ' LEU . 94.4 t -83.87 -50.1 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.391 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.63 -27.87 0.03 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.557 -0.83 . . . . 0.0 114.529 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.788 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -65.96 -5.79 10.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -128.72 70.9 80.95 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.458 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 84.4 Cg_exo -49.38 -17.35 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.176 2.584 . . . . 0.0 113.388 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.69 7.34 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.673 ' HB2' HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -100.38 -19.33 16.34 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 2.1 pt-20 -107.57 126.94 53.16 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.121 -0.362 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.432 ' N ' HG21 ' A' ' 12' ' ' VAL . 15.7 m -79.31 -52.35 8.22 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.971 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.69 144.95 9.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.86 0.362 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -158.34 -41.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.523 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 81.51 -59.08 0.24 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.657 0.383 . . . . 0.0 110.321 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.41 57.41 4.93 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.495 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.13 -48.69 73.32 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.669 0.271 . . . . 0.0 110.781 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -27.61 54.71 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.78 -41.38 2.16 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.812 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.21 27.53 16.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.626 0.25 . . . . 0.0 111.453 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mt -175.02 -66.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.852 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -130.26 132.95 46.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.165 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -131.97 115.21 15.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.99 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.61 145.88 50.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.701 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -150.32 111.06 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -73.08 139.14 46.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -139.3 151.94 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.403 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.556 HD12 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -112.99 130.53 56.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.899 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.484 ' N ' HD13 ' A' ' 60' ' ' LEU . 2.9 mtm180 -115.16 145.47 42.34 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.501 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -89.76 15.32 9.9 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.681 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.43 23.15 12.9 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.645 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HG3' ' HB1' ' A' ' 74' ' ' ALA . 2.1 tp10 -115.65 163.5 15.7 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.707 0.289 . . . . 0.0 110.981 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.16 127.73 32.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.454 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.77 95.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.245 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 1.103 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -73.1 174.64 7.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.942 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 68' ' ' LEU . 5.7 tt -163.71 -59.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.913 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.63 23.57 34.64 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.887 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -172.51 88.79 0.09 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.83 0.348 . . . . 0.0 110.785 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -76.31 -7.02 54.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.547 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -91.74 11.32 24.98 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.548 0.213 . . . . 0.0 111.38 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.83 132.56 53.32 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.624 0.249 . . . . 0.0 111.283 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.542 ' HB1' ' HG3' ' A' ' 64' ' ' GLU . . . 65.06 -76.04 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.804 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.8 164.73 30.07 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.459 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.41 -83.37 0.13 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.601 0.238 . . . . 0.0 110.803 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 2.8 pt-20 -168.91 -169.24 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.556 HD13 HD12 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -110.28 -46.65 3.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.301 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.479 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -157.04 164.64 37.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 5' ' ' LEU . 47.4 tp -144.62 97.93 3.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 111.047 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -115.56 127.69 26.59 Favored Pre-proline 0 N--CA 1.463 0.184 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.207 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.77 172.59 1.07 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.851 2.367 . . . . 0.0 112.632 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.9 -173.0 1.09 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.687 2.258 . . . . 0.0 112.282 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.8 100.23 10.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.3 96.49 3.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.921 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.23 57.79 0.27 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.493 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.274 -1.292 . . . . 0.0 112.935 -179.922 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.777 ' SD ' HG11 ' A' ' 20' ' ' VAL . 14.2 mmt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.667 0.27 . . . . 0.0 111.514 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.41 ' HB3' ' HG3' ' A' ' 19' ' ' ARG . 1.7 mt-10 -156.08 174.79 14.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.961 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.478 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.96 139.42 23.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.588 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.653 ' C ' HD22 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -131.31 156.38 45.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.304 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.017 HD12 HD13 ' A' ' 9' ' ' LEU . 2.8 mm? -140.0 156.33 46.68 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.111 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.22 -178.67 3.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.761 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -49.32 -33.23 12.79 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -51.5 -36.8 46.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 110.232 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.017 HD13 HD12 ' A' ' 5' ' ' LEU . 4.8 mp -110.27 -8.88 14.68 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.089 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -93.48 -9.49 38.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -59.2 -39.34 82.31 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 25.8 t -97.85 -36.9 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.845 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . . . -88.6 -45.8 9.58 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.91 -32.01 7.06 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.916 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.3 107.03 0.07 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.698 0.285 . . . . 0.0 110.63 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.792 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.23 35.38 2.42 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.639 HG22 ' HG2' ' A' ' 4' ' ' LYS . 8.8 p -93.66 113.95 26.16 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.082 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.478 ' HB ' ' CD1' ' A' ' 3' ' ' TRP . 1.9 t -131.34 166.62 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.035 0.445 . . . . 0.0 111.934 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.43 ' H ' HG12 ' A' ' 18' ' ' VAL . 3.2 mpp_? -131.4 158.8 39.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.421 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.777 HG11 ' SD ' ' A' ' 1' ' ' MET . 11.9 p -102.03 120.43 51.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.095 0.474 . . . . 0.0 111.103 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.16 -45.02 1.25 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.172 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.83 113.73 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.15 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -116.21 139.12 50.68 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.8 37.0 1.46 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.716 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.22 -60.33 0.17 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.701 0.286 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.31 176.37 5.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.779 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.516 HG21 ' HA2' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -111.35 171.67 7.34 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.025 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.92 HG13 ' HA ' ' A' ' 71' ' ' ALA . 3.1 m -77.29 -39.46 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 120.765 0.317 . . . . 0.0 110.989 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -88.13 -27.68 25.12 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.417 -0.896 . . . . 0.0 112.32 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.57 -35.89 73.09 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.62 0.247 . . . . 0.0 110.911 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -91.64 -37.07 13.28 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.484 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.3 tt -51.31 -50.88 58.5 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 120.746 0.308 . . . . 0.0 110.369 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -58.91 -34.55 71.81 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.25 -52.89 11.01 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.773 0.321 . . . . 0.0 110.743 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -65.73 -22.84 66.63 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.451 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 32' ' ' LEU . 94.1 t -95.23 -40.32 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.817 -0.174 . . . . 0.0 111.052 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.78 -37.38 90.11 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.608 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.04 -34.25 9.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.609 0.242 . . . . 0.0 111.299 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.491 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 12.8 m-70 60.14 54.81 4.08 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.327 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 51.1 Cg_exo -52.44 -22.08 15.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.242 1.961 . . . . 0.0 111.993 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.845 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . . . -62.2 -35.14 77.97 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.497 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.547 HD22 ' HG ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -121.4 1.5 10.16 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.507 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -84.46 103.65 13.79 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 m -75.55 -28.95 59.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.42 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 60.28 76.03 0.38 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 111.004 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.23 -59.76 3.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.824 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -173.23 -58.23 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.78 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -134.22 95.79 0.28 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.261 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -63.44 160.42 16.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.927 0.394 . . . . 0.0 111.343 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -76.73 -29.05 56.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.203 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.55 -139.61 14.62 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.774 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -158.79 139.55 12.72 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.662 0.267 . . . . 0.0 110.913 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.21 -57.1 3.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.873 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -125.87 161.4 27.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.825 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.72 113.59 25.9 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.234 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.25 116.79 14.8 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.383 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.1 tp -172.52 143.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -120.15 156.36 31.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.809 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.7 HG23 ' HG ' ' A' ' 80' ' ' LEU . 8.3 p -139.58 144.9 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.516 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.12 118.4 36.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.422 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.14 145.62 47.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.103 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -61.42 -15.86 41.04 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.764 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.95 23.91 5.39 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.856 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' OE1' ' HB3' ' A' ' 74' ' ' ALA . 4.0 tm-20 -104.13 166.06 10.65 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.731 0.301 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.94 121.44 13.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.89 113.32 2.01 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.232 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.62 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -67.75 166.31 15.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.481 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -164.98 -50.68 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.399 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.516 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -101.36 28.96 13.61 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.125 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -164.04 102.44 0.87 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.788 0.294 . . . . 0.0 110.98 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.92 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -64.33 -26.82 68.65 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.241 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.3 t -95.99 37.18 1.24 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.07 0.462 . . . . 0.0 111.206 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.06 -173.68 4.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.473 ' HB3' ' OE1' ' A' ' 64' ' ' GLU . . . -61.09 -55.84 27.82 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.352 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.7 133.69 2.36 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.149 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -81.58 0.07 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.572 0.225 . . . . 0.0 110.535 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -160.14 179.89 8.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.489 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.6 mt -101.19 -41.13 6.84 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.777 0.323 . . . . 0.0 110.517 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.65 167.46 26.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.985 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.7 ' HG ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -138.46 100.9 4.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.324 179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -123.69 136.7 27.61 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 84' ' ' VAL . 73.8 Cg_endo -76.47 148.81 30.17 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.348 2.032 . . . . 0.0 112.042 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -57.35 92.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.839 2.359 . . . . 0.0 112.059 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 82' ' ' PRO . 12.7 p -148.69 134.02 10.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.417 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.33 35.55 0.65 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.95 -56.6 0.69 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.366 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.754 -1.026 . . . . 0.0 112.893 179.998 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.661 0.267 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -152.15 167.41 28.64 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.795 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.462 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -155.02 166.89 32.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.108 0.48 . . . . 0.0 111.372 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 35.0 mtpt -136.44 156.97 47.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.33 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.499 HD11 ' O ' ' A' ' 35' ' ' LEU . 6.8 tp -146.37 160.48 42.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.262 0.554 . . . . 0.0 112.229 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -97.66 172.96 7.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.332 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.19 -19.1 62.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.741 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.82 -42.33 25.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.807 0.337 . . . . 0.0 111.029 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.898 HD21 ' HA2' ' A' ' 37' ' ' GLY . 5.9 mp -108.66 -33.29 7.05 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.645 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.89 -10.76 41.52 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -56.43 -40.31 74.52 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 11.7 t -97.77 -53.07 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.77 -41.32 97.56 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.508 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.68 -15.15 62.25 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.416 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -116.77 128.68 55.53 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -109.58 -58.54 2.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.804 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 6.0 p -92.86 133.53 35.99 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.817 0.342 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.462 ' HB ' ' CD1' ' A' ' 3' ' ' TRP . 9.6 t -140.34 163.37 23.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.457 ' N ' HG12 ' A' ' 18' ' ' VAL . 15.6 ptt85 -130.52 149.87 51.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.58 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.9 t -101.97 120.22 51.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.939 0.4 . . . . 0.0 110.939 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.38 -50.84 0.75 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.73 154.56 3.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.23 133.06 56.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.067 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.5 -153.69 6.88 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.603 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -33.61 76.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.558 0.179 . . . . 0.0 111.288 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.08 116.15 4.31 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.137 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.696 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -78.82 178.08 8.2 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.781 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.638 HG13 ' HA ' ' A' ' 71' ' ' ALA . 2.8 m -77.98 -38.04 23.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.617 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.591 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -87.74 -27.51 26.56 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.23 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.31 -41.13 68.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.651 0.262 . . . . 0.0 110.768 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.14 -26.45 23.6 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.86 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.782 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.7 tp -62.24 -57.46 11.36 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.382 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -56.99 -40.4 76.5 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.982 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -64.95 -51.87 59.43 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.645 0.259 . . . . 0.0 110.36 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.654 ' O ' HD22 ' A' ' 9' ' ' LEU . 6.9 mp -62.52 -35.88 80.81 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 32' ' ' LEU . 57.6 t -60.86 -52.27 63.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.59 0.233 . . . . 0.0 110.69 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.898 ' HA2' HD21 ' A' ' 9' ' ' LEU . . . 158.02 52.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.638 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -77.35 -61.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.208 0.051 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.415 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 1.3 m-70 172.02 -62.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 123.442 0.464 . . . . 0.0 111.008 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 39' ' ' HIS . 8.0 Cg_endo -50.03 -27.76 17.43 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.626 2.217 . . . . 0.0 112.326 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.685 ' CB ' HD23 ' A' ' 9' ' ' LEU . . . -60.54 -31.67 70.76 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.772 HD22 ' HG ' ' A' ' 9' ' ' LEU . 1.6 pt? -136.65 29.76 2.9 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.28 155.77 0.12 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 111.251 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.1 p -78.35 -35.54 47.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.214 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -62.83 98.21 0.12 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.855 0.359 . . . . 0.0 110.994 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.434 HG21 ' CG ' ' A' ' 49' ' ' ASP . 17.3 m -58.03 -40.21 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.613 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.85 87.12 0.1 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 49' ' ' ASP . . . 100.32 -34.22 5.72 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.661 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 1.8 m-20 70.11 139.93 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.956 0.407 . . . . 0.0 111.383 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -111.03 -28.9 8.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.786 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.29 156.74 6.96 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.94 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.3 98.26 3.28 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.832 0.349 . . . . 0.0 111.362 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 54' ' ' TYR . 1.3 pt? -174.1 -42.8 0.01 OUTLIER 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.557 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.43 ' N ' ' HG ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -158.83 141.5 14.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.654 0.264 . . . . 0.0 111.234 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.06 142.05 29.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.176 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.467 ' CD2' ' HG2' ' A' ' 83' ' ' PRO . 2.0 t60 -110.68 135.06 51.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.636 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.499 HD13 ' CG1' ' A' ' 36' ' ' VAL . 1.5 pt -143.91 115.01 2.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -90.49 138.28 31.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.833 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.89 151.32 27.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.198 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -111.88 118.9 36.8 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.615 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HG2' ' CB ' ' A' ' 77' ' ' GLU . 2.0 mtt85 -121.69 145.52 47.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.909 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -67.9 -13.4 62.12 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.724 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.58 23.57 5.63 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.736 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -103.19 165.49 10.99 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.782 0.325 . . . . 0.0 110.793 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.33 125.08 25.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.54 95.45 0.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.83 149.03 25.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.101 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.591 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 8.1 tt -126.2 -61.13 1.24 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.203 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.659 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -86.11 44.81 3.38 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.129 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -151.11 72.93 1.08 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.761 0.28 . . . . 0.0 111.104 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.696 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -52.05 -28.01 15.76 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.635 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.22 34.78 0.93 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.756 0.313 . . . . 0.0 111.442 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.77 176.72 6.05 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.894 0.378 . . . . 0.0 111.242 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.67 32.05 3.54 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.668 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.63 158.82 10.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.557 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -76.39 0.59 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.743 0.306 . . . . 0.0 111.275 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.41 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 20.0 pt-20 -145.53 -162.65 1.55 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.972 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 78' ' ' LEU . 2.8 mm? -120.66 -45.12 2.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.487 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -156.61 169.14 25.35 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.61 HD11 HG22 ' A' ' 36' ' ' VAL . 2.5 tt -153.32 122.15 6.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.859 0.361 . . . . 0.0 110.605 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -150.7 135.84 10.11 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.285 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 6' ' ' PHE . 84.4 Cg_endo -78.94 146.55 20.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.671 2.248 . . . . 0.0 112.614 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.467 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 45.6 Cg_exo . . . . . 0 C--N 1.349 0.598 0 C-N-CA 122.808 2.339 . . . . 0.0 112.489 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.817 0.341 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -160.57 172.97 16.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.4 ' CE3' ' HG2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -151.7 140.84 21.26 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.417 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -137.62 151.9 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.388 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.733 ' CD1' HD22 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -147.45 151.11 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.095 0.474 . . . . 0.0 111.879 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.12 -175.61 5.92 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.049 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -58.48 -20.18 43.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.939 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.68 -43.14 12.38 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.979 0.418 . . . . 0.0 110.81 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.858 HD23 ' HB1' ' A' ' 41' ' ' ALA . 4.7 mp -105.17 -31.37 9.16 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.011 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -72.08 -4.3 28.11 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -36.67 84.7 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.668 0.27 . . . . 0.0 110.936 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.807 HG11 ' HB2' ' A' ' 43' ' ' GLU . 15.8 t -97.21 -46.11 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.813 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.25 -45.17 20.31 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.99 -29.55 7.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.114 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 t -167.49 117.14 0.82 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.669 0.271 . . . . 0.0 110.994 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.57 29.19 7.42 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.043 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.5 p -95.63 114.03 25.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.328 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 19' ' ' ARG . 3.6 t -122.7 161.72 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.215 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.409 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -126.81 152.58 46.77 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.744 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.574 HG21 ' OD2' ' A' ' 76' ' ' ASP . 19.2 t -102.3 120.33 51.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 0.0 110.776 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.33 -50.09 2.13 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.869 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.55 134.23 52.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.158 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -115.95 152.52 33.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.951 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.91 -81.62 0.15 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.963 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -82.71 -46.65 12.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.665 0.269 . . . . 0.0 111.125 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.64 116.16 4.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.443 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -83.66 172.86 11.88 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.085 HG11 ' HB1' ' A' ' 67' ' ' ALA . 39.0 t -76.71 -35.5 25.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.509 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.25 -32.44 9.64 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.353 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.84 -42.8 80.3 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.741 0.305 . . . . 0.0 110.775 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.62 -27.75 26.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.046 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.5 tp -62.45 -57.2 12.08 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.7 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.04 -40.42 76.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.237 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . . . -64.02 -52.1 61.07 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.794 0.33 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 3' ' ' TRP . 8.8 mp -68.88 -34.41 75.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.318 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 32' ' ' LEU . 21.2 t -57.4 -48.89 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.603 0.239 . . . . 0.0 111.023 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 9' ' ' LEU . . . 161.87 53.23 0.02 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.646 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 34' ' ' ALA . . . -65.83 -61.78 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.448 0.166 . . . . 0.0 110.744 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.413 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 2.5 m-70 -179.74 -62.92 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 39' ' ' HIS . 9.8 Cg_endo -52.27 -26.68 27.84 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.301 2.001 . . . . 0.0 112.064 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.858 ' HB1' HD23 ' A' ' 9' ' ' LEU . . . -62.41 -27.89 69.4 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -135.4 28.89 3.34 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.807 ' HB2' HG11 ' A' ' 12' ' ' VAL . 0.5 OUTLIER 71.16 150.34 0.09 Allowed 'General case' 0 C--N 1.342 0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 110.847 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.9 m -60.38 -43.09 96.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.523 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.62 148.33 29.19 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.805 0.335 . . . . 0.0 110.814 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 p -169.02 -43.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.417 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -172.9 106.79 0.16 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.673 0.273 . . . . 0.0 110.755 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.23 92.57 0.11 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.495 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -65.53 -52.15 54.73 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.572 0.225 . . . . 0.0 110.855 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.24 -28.9 69.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.079 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.25 -166.89 14.0 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.707 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.38 179.8 4.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.692 0.282 . . . . 0.0 110.927 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -35.84 59.86 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.134 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.15 128.97 48.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.72 0.295 . . . . 0.0 111.003 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.18 130.02 55.61 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -142.01 108.29 5.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.176 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.9 pp -150.29 127.72 2.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.49 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -100.51 162.56 12.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.063 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -135.62 152.64 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.649 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -107.86 131.04 54.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.427 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -112.4 145.46 40.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.202 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -3.63 25.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.895 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.77 23.57 5.57 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.902 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.27 157.71 16.01 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.817 0.342 . . . . 0.0 110.684 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.73 102.73 14.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.297 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.03 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.95 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 1.085 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -105.84 133.71 50.13 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.991 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.8 -69.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.107 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.03 64.26 1.73 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.479 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -140.73 47.29 1.75 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -51.7 -28.15 13.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.782 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.31 33.48 2.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.668 0.27 . . . . 0.0 111.258 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . . . -96.52 174.16 6.99 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.815 0.34 . . . . 0.0 111.461 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.54 -34.09 17.51 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.469 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.68 157.93 27.47 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.429 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.574 ' OD2' HG21 ' A' ' 20' ' ' VAL . 6.6 m-20 -109.32 -72.96 0.7 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.761 0.281 . . . . 0.0 110.644 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HG2' ' CE3' ' A' ' 3' ' ' TRP . 0.4 OUTLIER -139.53 -173.16 3.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.308 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -108.58 -53.22 2.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.611 0.243 . . . . 0.0 110.987 -179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -164.9 173.71 11.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 58' ' ' ASN . 1.0 OUTLIER -136.1 95.27 3.17 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.214 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -130.32 148.97 72.0 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.245 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.05 148.68 51.21 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.552 2.168 . . . . 0.0 112.545 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.348 0.508 0 C-N-CA 122.656 2.237 . . . . 0.0 112.479 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.838 0.352 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -160.3 173.33 15.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.667 ' CE3' HD22 ' A' ' 35' ' ' LEU . 3.1 t90 -155.85 146.17 21.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.44 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.433 ' HG2' HG22 ' A' ' 17' ' ' THR . 24.7 mttt -138.07 144.81 41.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.015 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.612 HD21 HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -135.34 164.35 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.042 0.449 . . . . 0.0 111.375 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 5' ' ' LEU . 6.4 t80 -89.5 170.08 10.81 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.816 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.57 -9.24 57.92 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.529 ' HB3' HD12 ' A' ' 9' ' ' LEU . 1.2 t0 -52.48 -44.06 65.37 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 111.224 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.651 HD23 HD22 ' A' ' 42' ' ' LEU . 5.0 mp -107.49 -32.84 7.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.177 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -69.68 -7.06 35.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -40.6 91.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.543 0.211 . . . . 0.0 111.005 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 21.1 t -95.08 -46.89 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.522 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.07 -46.51 80.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.752 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.52 11.81 70.87 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.901 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -139.08 92.96 2.64 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -91.22 -42.79 10.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.181 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.433 HG22 ' HG2' ' A' ' 4' ' ' LYS . 5.8 p -96.64 145.42 25.78 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 120.718 0.294 . . . . 0.0 111.216 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -142.87 108.58 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.24 152.32 21.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.779 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.84 120.23 51.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.748 0.309 . . . . 0.0 111.032 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.34 -72.79 0.38 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.049 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.0 p -94.88 148.54 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.213 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.27 116.07 22.25 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.04 -139.31 3.89 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.635 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -107.01 36.12 2.78 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.845 0.355 . . . . 0.0 111.193 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.89 123.03 41.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.741 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -109.03 169.32 8.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.766 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 71' ' ' ALA . 40.8 t -74.18 -33.55 35.28 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.132 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.72 -36.92 9.87 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.086 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.37 -38.68 74.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 110.666 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.39 -23.21 22.24 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.752 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 36' ' ' VAL . 23.8 tp -63.53 -52.53 60.79 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.499 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -58.54 -41.87 86.54 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.447 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.68 -49.68 61.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.753 0.311 . . . . 0.0 111.206 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.667 HD22 ' CE3' ' A' ' 3' ' ' TRP . 8.6 mp -68.19 -33.35 74.28 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.466 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 32' ' ' LEU . 12.4 t -62.51 -48.89 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-O 120.705 0.288 . . . . 0.0 110.418 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.91 54.84 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.612 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -62.49 -61.64 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.465 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . 1.1 m170 155.02 -66.47 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.646 0.778 . . . . 0.0 110.423 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 39' ' ' HIS . 11.0 Cg_endo -54.17 -24.74 34.76 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.511 2.141 . . . . 0.0 111.805 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.531 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -61.45 -28.28 69.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.054 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.651 HD22 HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -142.47 22.8 2.0 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.89 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 61.97 160.06 0.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.246 0.546 . . . . 0.0 111.875 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -14.15 22.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.515 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.466 ' O ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -78.69 150.74 32.49 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 45' ' ' ARG . 8.5 p 45.38 34.33 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.169 0.509 . . . . 0.0 111.981 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.95 -60.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.088 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.3 69.27 1.99 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.565 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -69.77 165.19 21.94 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.574 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -82.15 -20.97 36.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.756 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.14 -152.51 1.99 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.596 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.82 91.49 2.71 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.845 0.355 . . . . 0.0 111.192 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tp -97.59 142.7 29.08 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.626 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.03 127.54 53.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.104 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.94 146.97 48.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.075 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 57' ' ' ILE . 66.3 m-70 -111.42 152.76 27.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.637 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.561 HG22 ' HB3' ' A' ' 82' ' ' PRO . 1.7 pt -156.55 124.99 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.761 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -90.56 137.42 32.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -124.02 157.99 30.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.31 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.84 122.21 44.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.075 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 145.45 50.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.743 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.94 -19.42 65.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.663 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.28 23.5 5.74 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.743 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.94 165.74 23.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.603 0.24 . . . . 0.0 111.006 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.15 124.64 29.42 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.289 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 76' ' ' ASP . . . -92.22 146.79 23.43 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.368 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.1 -177.75 6.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.968 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -136.3 -45.02 0.62 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.225 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.409 ' N ' ' HG ' ' A' ' 68' ' ' LEU . . . -94.53 31.97 6.38 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.787 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -164.7 91.46 0.57 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.787 0.327 . . . . 0.0 111.221 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.66 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -64.83 -17.63 64.41 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.835 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 t -88.83 33.92 0.78 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 111.246 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.68 168.84 12.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.213 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.65 80.36 8.01 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.64 149.87 3.21 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.985 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 20.0 p-10 -133.3 -49.52 0.85 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.573 0.225 . . . . 0.0 111.335 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.459 ' HG3' ' CD1' ' A' ' 3' ' ' TRP . 0.5 OUTLIER -165.04 -172.43 2.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.56 179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.19 -45.18 2.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.516 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -170.35 174.02 5.43 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.343 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.641 ' HB2' HG12 ' A' ' 59' ' ' VAL . 6.0 tt -152.93 117.72 5.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.324 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -141.46 138.28 17.34 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.568 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.561 ' HB3' HG22 ' A' ' 57' ' ' ILE . 77.8 Cg_endo -77.71 169.55 20.61 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.712 2.274 . . . . 0.0 112.452 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 C--N 1.349 0.59 0 C-N-CA 122.817 2.345 . . . . 0.0 112.038 179.784 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.872 0.368 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.436 ' HG2' ' HG3' ' A' ' 19' ' ' ARG . 6.3 mt-10 -146.95 166.17 27.6 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.497 ' HE1' HD13 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -150.89 137.69 18.97 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.025 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.511 ' O ' HD22 ' A' ' 5' ' ' LEU . 34.7 mttt -134.92 148.86 50.16 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.839 HD11 HD23 ' A' ' 80' ' ' LEU . 3.1 mm? -130.9 152.44 50.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.742 0.306 . . . . 0.0 111.257 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -174.95 3.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 11' ' ' GLU . . . -57.03 -23.04 43.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.854 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.502 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -48.72 -37.8 19.76 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.715 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.74 HD22 HD13 ' A' ' 42' ' ' LEU . 10.3 mt -120.57 -34.96 3.49 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.623 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.06 -2.8 22.71 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -91.14 -29.16 17.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.797 0.332 . . . . 0.0 110.36 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 41' ' ' ALA . 97.3 t -93.11 -35.89 7.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.357 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -94.42 -43.5 8.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.62 0.247 . . . . 0.0 111.1 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.98 -40.34 1.75 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.356 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.34 141.12 2.43 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -137.57 27.04 2.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.45 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 p -96.45 112.01 23.91 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 110.401 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.97 157.99 41.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.408 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.436 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -129.61 148.91 51.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.584 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.3 120.22 56.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.907 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.35 -52.02 0.82 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.725 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -90.67 153.31 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.32 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.6 142.22 35.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.086 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.19 -111.54 0.27 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.689 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.98 38.25 4.18 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.054 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.03 133.13 56.35 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.981 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -113.29 167.94 10.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.22 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 71' ' ' ALA . 27.3 t -74.99 -39.18 44.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.943 0.401 . . . . 0.0 110.213 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -83.19 -34.38 20.83 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.221 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.24 -45.83 83.58 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.832 0.349 . . . . 0.0 110.405 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -77.12 -26.74 53.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.563 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.719 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.1 tp -63.37 -61.07 2.59 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.258 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.65 -34.25 72.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.114 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.943 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -69.05 -50.6 47.06 Favored 'General case' 0 C--N 1.335 -0.046 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.186 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 31' ' ' ALA . 11.1 mp -68.26 -19.5 64.73 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.703 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 32' ' ' LEU . 70.1 t -83.78 -44.81 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -133.42 -34.37 0.32 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.273 -0.965 . . . . 0.0 114.476 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.943 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -69.67 -0.94 7.69 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -121.81 64.87 18.11 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 120.738 0.304 . . . . 0.0 110.821 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 86.4 Cg_exo -50.64 -18.9 4.4 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.887 2.392 . . . . 0.0 112.942 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.767 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -49.47 -31.63 10.39 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.74 HD13 HD22 ' A' ' 9' ' ' LEU . 4.1 pp -106.68 -6.84 17.62 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -158.95 70.97 0.51 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.868 0.365 . . . . 0.0 110.524 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -31.6 66.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.346 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -134.85 125.03 26.01 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.392 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.22 37.88 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.87 0.367 . . . . 0.0 111.313 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 60.65 99.21 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.394 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.13 -36.03 4.48 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.508 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 70.52 -66.32 0.29 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.622 0.369 . . . . 0.0 111.101 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.27 31.4 3.4 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 111.154 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.85 -75.55 1.22 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.335 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.45 144.56 21.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 0.0 111.034 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tp -92.13 95.68 9.89 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.487 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -124.72 123.75 40.67 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.048 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -111.75 114.71 27.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.72 103.51 5.44 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.027 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 pt -149.35 121.76 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.831 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -82.81 153.32 25.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 80' ' ' LEU . 13.7 p -135.58 145.95 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.577 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.418 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -103.29 120.97 41.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.597 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.418 ' N ' HD13 ' A' ' 60' ' ' LEU . 62.1 mtt180 -132.17 142.47 49.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.717 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -62.74 -20.56 65.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.482 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.72 23.75 5.52 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.76 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.18 163.8 12.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 110.633 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.15 124.55 36.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.26 159.81 36.75 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.78 169.26 9.03 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.231 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.433 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -103.68 -35.3 8.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.173 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.45 28.37 8.36 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.077 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 27' ' ' THR . 2.1 mt-10 -173.44 103.16 0.12 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.826 0.313 . . . . 0.0 110.862 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -82.2 6.32 17.01 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.93 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.72 1.36 26.81 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.8 -176.2 1.03 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.787 0.327 . . . . 0.0 111.34 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.97 83.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.448 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.34 172.61 43.72 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.663 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.0 -70.22 0.73 Allowed 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.67 -165.83 1.1 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.529 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tp -108.57 -50.83 2.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.782 0.325 . . . . 0.0 110.751 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -155.38 171.57 19.66 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.339 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.839 HD23 HD11 ' A' ' 5' ' ' LEU . 11.5 tp -135.54 110.56 8.85 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.594 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -129.13 124.56 22.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.34 133.61 13.38 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.647 2.231 . . . . 0.0 112.52 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 122.726 2.284 . . . . 0.0 112.53 -179.785 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.738 0.304 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -148.03 167.05 25.93 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.07 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' THR . 54.4 m95 -145.96 138.59 25.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.942 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -138.51 136.19 35.86 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 80' ' ' LEU . 4.4 tp -130.91 153.7 48.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 111.23 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.13 173.29 8.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.48 -15.06 62.28 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.925 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.52 -35.38 72.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.933 0.397 . . . . 0.0 110.524 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -112.11 -40.56 4.17 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.763 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.75 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -64.74 -13.94 56.85 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -74.95 -27.12 60.06 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.505 -0.122 . . . . 0.0 111.232 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -90.79 -42.25 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.483 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -92.19 -42.85 9.66 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.76 -26.76 11.21 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.648 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.45 126.96 49.66 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.7 0.286 . . . . 0.0 111.244 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.75 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 1.7 ptt-85 -118.42 -58.4 1.98 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.53 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 3' ' ' TRP . 9.1 p -93.33 136.33 33.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -142.32 124.34 13.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.8 132.83 56.59 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 22' ' ' VAL . 19.0 t -148.68 121.31 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.338 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.61 32.64 2.76 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.07 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.516 ' H ' HG12 ' A' ' 20' ' ' VAL . 11.1 p -147.34 150.69 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.104 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -115.71 125.15 52.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.84 88.11 0.14 Allowed Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.397 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.41 26.02 13.64 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.692 0.282 . . . . 0.0 111.592 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.66 116.07 23.91 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.788 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -91.03 169.01 11.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.558 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.885 HG11 ' HB1' ' A' ' 67' ' ' ALA . 22.3 t -78.75 -33.53 16.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.642 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.615 ' HA3' HD13 ' A' ' 68' ' ' LEU . . . -86.06 -27.49 31.02 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.449 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.34 -42.69 82.44 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.672 0.272 . . . . 0.0 110.975 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -83.16 -38.16 22.74 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.635 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.3 tt -53.23 -54.98 28.15 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -59.32 -41.09 88.27 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.169 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -59.47 -56.5 21.17 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.58 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.6 mt -62.4 -20.56 64.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.167 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.801 HG13 HG21 ' A' ' 57' ' ' ILE . 65.5 t -88.59 -48.52 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 111.571 0.211 . . . . 0.0 111.571 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.56 -30.64 0.04 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.478 -0.867 . . . . 0.0 114.661 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.768 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -69.54 -1.38 8.56 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.591 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 8.7 t-80 -133.04 72.8 76.15 Favored Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -51.44 -15.25 2.37 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.32 2.68 . . . . 0.0 113.967 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.63 -28.92 23.45 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.581 ' HB2' HD23 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -100.07 -13.22 19.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -140.0 114.71 9.44 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.246 -0.284 . . . . 0.0 111.425 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -8.56 53.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.085 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 60.63 58.64 2.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.998 0.428 . . . . 0.0 111.017 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 m -96.44 34.92 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.553 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -167.15 -56.05 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.74 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.15 60.32 4.81 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.661 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.2 -49.27 11.88 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.708 0.29 . . . . 0.0 110.683 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.76 31.91 2.78 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.7 -100.22 0.19 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.675 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 56.77 -167.74 0.11 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.092 0.157 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 66.22 -75.69 0.05 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.455 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -111.9 125.52 54.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.031 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.67 158.37 31.72 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.179 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -137.21 113.39 9.9 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.414 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.801 HG21 HG13 ' A' ' 36' ' ' VAL . 1.6 pt -144.83 103.87 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.9 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -85.23 144.85 27.88 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.194 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 p -140.58 140.58 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.939 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -93.61 139.49 30.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.7 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.422 ' H ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -121.36 146.14 47.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.102 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.541 ' HB3' HD23 ' A' ' 78' ' ' LEU . 12.2 p-10 -84.96 19.28 2.17 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.181 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.32 23.72 5.65 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.885 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -108.42 155.8 20.16 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.737 0.303 . . . . 0.0 111.032 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 102.81 14.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.242 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.01 109.24 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.821 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.885 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -98.51 133.71 42.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.625 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.615 HD13 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -171.26 -68.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 27' ' ' THR . . . -100.4 49.19 1.14 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.573 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' HB2' HG21 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -108.66 31.35 5.7 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -54.59 -34.95 62.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.215 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.63 31.25 2.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.527 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.47 150.56 32.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.6 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.14 72.45 2.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 110.783 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.2 147.07 6.77 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.469 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.16 -73.25 0.69 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.689 0.28 . . . . 0.0 110.766 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 2.7 pt-20 -148.9 -169.58 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.543 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -112.11 -42.65 3.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.791 179.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.22 166.95 31.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.205 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 5' ' ' LEU . 6.1 tt -146.06 99.82 3.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.785 0.326 . . . . 0.0 110.842 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -151.47 143.23 15.91 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.413 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.56 153.47 23.36 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.855 2.37 . . . . 0.0 112.552 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.576 2.184 . . . . 0.0 112.551 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.403 ' HB3' ' HG2' ' A' ' 19' ' ' ARG . 3.7 pt-20 -146.17 164.33 32.56 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.915 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -147.4 118.58 7.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.974 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.474 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 23.3 mttm -106.16 141.96 36.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.642 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 11.6 tp -132.49 144.42 50.43 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.889 0.376 . . . . 0.0 111.412 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.48 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -82.57 172.43 12.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.265 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.05 66.36 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.008 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -34.46 53.31 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.573 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 3.9 mp -113.24 -38.05 4.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.978 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 -13.05 45.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -79.28 -27.28 42.26 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.439 ' HB ' ' C ' ' A' ' 42' ' ' LEU . 16.4 t -87.13 -39.44 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -96.43 -38.09 10.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.22 27.42 8.19 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.455 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.3 t -140.91 128.99 22.06 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.634 0.255 . . . . 0.0 110.758 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.642 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 3.2 ptm180 -113.79 -75.08 0.6 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.543 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 3.5 p -97.43 134.06 41.19 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.792 0.329 . . . . 0.0 111.409 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -145.27 129.83 12.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.843 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.403 ' HG2' ' HB3' ' A' ' 2' ' ' GLU . 67.0 mtm-85 -100.77 139.21 36.77 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.423 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.81 120.35 52.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.815 0.341 . . . . 0.0 111.261 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.57 -36.53 5.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.93 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.59 149.98 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.268 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -108.51 166.27 10.9 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.149 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.01 -124.29 0.87 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.633 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.51 34.52 2.19 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.939 0.399 . . . . 0.0 111.004 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.33 120.12 37.22 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.588 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.472 ' C ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -95.66 -176.94 3.89 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.009 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 67' ' ' ALA . 21.3 t -75.2 -42.22 44.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.518 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -75.64 -26.7 64.64 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.923 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -50.93 -45.24 60.41 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.489 0.316 . . . . 0.0 110.876 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.91 -32.23 20.28 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.6 tt -56.71 -60.73 3.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 110.098 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -60.87 -40.97 94.97 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.305 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -53.49 -56.02 20.51 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.228 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.57 -29.84 70.88 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.956 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 32' ' ' LEU . 92.0 t -73.62 -53.02 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.585 0.231 . . . . 0.0 110.827 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.02 20.58 0.06 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.248 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.742 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -105.15 -1.17 25.81 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.44 0.62 . . . . 0.0 111.579 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.516 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -129.32 72.65 81.96 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.44 -20.6 1.65 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.371 2.714 . . . . 0.0 113.551 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.52 -32.26 17.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.8 OUTLIER -99.7 -15.92 18.34 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.467 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -165.07 95.73 0.69 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.705 0.288 . . . . 0.0 111.161 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.78 -48.92 22.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.282 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -155.46 133.63 11.56 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.718 0.294 . . . . 0.0 110.839 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.49 -44.3 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.733 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -171.95 -67.41 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.964 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.42 99.57 1.01 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.595 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.36 -62.81 1.5 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.618 0.247 . . . . 0.0 111.146 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.87 -26.41 13.76 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.527 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.73 82.07 0.31 Allowed Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.767 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 59.85 80.0 0.21 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.985 0.421 . . . . 0.0 111.253 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.1 tp -96.0 97.5 9.65 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.692 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -147.9 116.99 6.83 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.277 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -147.17 149.7 33.49 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -87.49 157.64 19.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.594 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.637 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -153.5 124.23 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.67 0.272 . . . . 0.0 110.787 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -97.58 136.9 37.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 110.862 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 p -140.4 141.09 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.358 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 60' ' ' LEU . 9.8 tp -97.81 134.51 40.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 145.84 47.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -55.43 -21.26 15.12 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.7 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.81 23.76 5.49 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.41 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.85 165.93 13.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.369 0.267 . . . . 0.0 110.468 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.38 123.62 16.09 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.771 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.37 102.19 0.08 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.338 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.65 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -77.25 160.48 28.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.073 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.518 ' CD2' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -158.15 22.53 0.25 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.499 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.19 14.45 2.33 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.133 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.643 ' HG2' HG22 ' A' ' 72' ' ' THR . 2.0 tt0 178.54 96.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.717 0.294 . . . . 0.0 110.41 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.472 ' HB2' ' C ' ' A' ' 27' ' ' THR . . . -71.41 -6.66 41.94 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.894 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.643 HG22 ' HG2' ' A' ' 70' ' ' GLU . 13.4 t -75.23 1.52 13.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.89 -177.73 0.86 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.357 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 77.91 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.47 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.8 160.94 9.72 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.667 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.43 -78.79 0.59 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.674 0.273 . . . . 0.0 110.27 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -131.76 -177.01 4.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 110.823 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.76 -37.86 6.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.842 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -174.25 166.39 4.09 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.972 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.47 110.36 7.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.895 0.379 . . . . 0.0 110.602 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.459 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 23.3 m-85 -112.73 161.47 26.29 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.101 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 6' ' ' PHE . 96.6 Cg_endo -81.96 169.48 14.69 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.671 2.247 . . . . 0.0 112.584 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 C--N 1.348 0.516 0 C-N-CA 122.819 2.346 . . . . 0.0 112.547 179.887 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.788 0.328 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -160.68 163.64 32.32 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.166 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.516 ' CZ2' HD22 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -155.36 174.68 14.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.997 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 27.0 mttm -137.13 152.98 50.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.132 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.717 HD11 HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -141.51 132.38 25.91 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.811 0.338 . . . . 0.0 111.528 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.418 ' N ' HD13 ' A' ' 5' ' ' LEU . 1.1 t80 -81.35 175.77 10.3 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.112 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.82 -10.97 60.4 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.41 -46.31 62.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.901 0.381 . . . . 0.0 110.911 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -112.44 -36.03 5.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.121 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.95 -10.46 13.71 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -40.7 74.4 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.485 0.183 . . . . 0.0 111.067 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.834 HG11 ' HB2' ' A' ' 43' ' ' GLU . 4.2 t -94.51 -45.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.532 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 41' ' ' ALA . . . -65.34 -46.75 79.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.09 11.24 61.61 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.546 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.3 m -116.83 129.73 56.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.773 0.32 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -111.73 -85.91 0.56 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.728 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.7 p -102.66 134.37 46.14 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.571 0.224 . . . . 0.0 111.405 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 t -147.75 154.39 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.031 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 1.3 mtt85 -108.45 152.27 24.93 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.617 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.0 120.32 51.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.072 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.81 -46.43 0.95 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.388 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 m -87.37 122.15 38.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.444 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -116.45 129.36 56.17 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.096 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.21 -125.63 0.77 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.651 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.54 -45.67 91.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.581 0.229 . . . . 0.0 111.173 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.44 122.0 22.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.676 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -79.19 171.05 15.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.289 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.874 HG13 ' HA ' ' A' ' 71' ' ' ALA . 8.7 m -74.75 -37.08 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.502 ' HA3' HD23 ' A' ' 68' ' ' LEU . . . -80.27 -33.23 32.73 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.937 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -50.98 -47.5 61.38 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.78 0.324 . . . . 0.0 110.831 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.21 -25.8 33.89 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.886 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.797 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -63.1 -60.25 3.69 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.8 -36.57 72.38 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.091 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -62.61 -52.28 63.99 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.758 0.313 . . . . 0.0 110.267 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.516 HD22 ' CZ2' ' A' ' 3' ' ' TRP . 5.6 mp -68.9 -33.26 73.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.984 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 32' ' ' LEU . 41.6 t -55.66 -51.15 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.681 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' HD22 ' A' ' 9' ' ' LEU . . . 163.66 49.73 0.02 OUTLIER Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.959 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -82.19 -61.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.426 0.155 . . . . 0.0 110.588 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.432 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER 170.87 -58.78 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.78 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 39' ' ' HIS . 54.4 Cg_exo -50.67 -29.25 24.9 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.206 1.937 . . . . 0.0 111.914 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.62 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -61.98 -26.09 68.01 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.492 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.675 HD22 HD23 ' A' ' 9' ' ' LEU . 1.9 pt? -139.99 27.59 2.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.714 0.292 . . . . 0.0 110.765 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.834 ' HB2' HG11 ' A' ' 12' ' ' VAL . 3.3 tt0 64.78 165.61 0.16 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.201 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.1 p -69.68 -41.83 74.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.582 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.09 129.1 6.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.731 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.87 -37.87 11.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.995 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -154.05 35.64 0.43 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.204 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.91 97.6 0.38 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.221 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -61.37 142.94 56.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.827 0.346 . . . . 0.0 111.401 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.41 -28.87 65.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.631 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.62 62.76 0.63 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.784 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -123.98 118.23 26.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.564 0.221 . . . . 0.0 110.704 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.5 79.28 5.54 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.596 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.1 134.07 19.17 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.324 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.98 119.27 12.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -143.19 133.14 24.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.187 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.8 tt -169.88 146.9 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.46 155.33 16.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.871 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.556 HG23 ' HG ' ' A' ' 80' ' ' LEU . 11.6 p -140.54 149.02 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.365 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.59 123.11 49.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.814 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.546 ' NH1' ' HB2' ' A' ' 66' ' ' ALA . 3.6 tpp85 -114.16 144.41 43.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.818 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -74.12 -16.35 61.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.521 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.7 23.26 6.0 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.83 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.48 165.92 11.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.717 0.294 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.25 124.91 19.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.971 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.546 ' HB2' ' NH1' ' A' ' 61' ' ' ARG . . . -67.89 87.79 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.964 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.46 ' HB1' HG21 ' A' ' 28' ' ' VAL . . . -70.24 142.76 52.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.265 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.502 HD23 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -141.61 -59.24 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.005 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.594 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -94.36 36.69 3.66 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.67 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 73' ' ' ALA . 4.7 pt-20 -152.79 90.81 1.49 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.698 0.285 . . . . 0.0 111.285 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.874 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -59.12 -24.51 63.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.516 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.92 33.56 0.78 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.686 0.279 . . . . 0.0 111.571 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . . . -85.33 171.18 12.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.859 0.362 . . . . 0.0 111.674 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.1 92.97 3.93 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.023 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.07 122.41 3.81 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.892 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -107.18 -65.27 1.11 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.709 0.29 . . . . 0.0 111.003 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -162.95 -159.37 0.54 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.584 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.8 tp -123.29 -53.11 1.83 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.558 0.218 . . . . 0.0 110.951 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -152.8 153.54 33.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.196 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.597 HD11 HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -132.93 101.37 5.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.752 0.31 . . . . 0.0 110.73 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -146.81 145.13 21.66 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.469 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.16 150.42 65.9 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.668 2.245 . . . . 0.0 112.103 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--N 1.347 0.491 0 C-N-CA 122.589 2.193 . . . . 0.0 112.074 179.789 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -135.48 153.22 51.82 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 111.635 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.441 ' CZ2' HD13 ' A' ' 80' ' ' LEU . 1.9 t90 -155.48 148.28 24.29 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.112 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.452 ' HG2' HG22 ' A' ' 17' ' ' THR . 2.9 mttp -137.98 146.61 43.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.351 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.843 HD22 ' HB2' ' A' ' 9' ' ' LEU . 1.1 tt -135.54 165.1 26.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.974 0.416 . . . . 0.0 111.028 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.536 ' N ' HD23 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -80.79 -178.61 6.89 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.205 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.62 -8.73 50.0 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.29 -40.22 61.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.681 0.276 . . . . 0.0 111.431 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.843 ' HB2' HD22 ' A' ' 5' ' ' LEU . 4.7 mp -100.24 -33.23 10.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.596 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -71.52 -7.52 48.12 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -79.9 -29.57 39.89 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.383 0.135 . . . . 0.0 111.22 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 4.9 t -98.03 -49.19 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -104.48 -34.79 8.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.77 26.6 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.616 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.465 ' HB2' HD21 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -125.39 79.0 1.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.969 0.414 . . . . 0.0 110.772 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 5' ' ' LEU . 8.0 ptt85 -88.24 -43.82 11.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.98 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.452 HG22 ' HG2' ' A' ' 4' ' ' LYS . 6.1 p -92.99 139.28 30.68 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.824 0.345 . . . . 0.0 110.97 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -129.71 107.67 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.79 152.53 20.77 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.681 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.482 HG11 ' O ' ' A' ' 71' ' ' ALA . 29.0 t -102.08 120.28 51.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.39 -71.05 0.7 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -89.46 145.78 6.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.072 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HB2' HG21 ' A' ' 72' ' ' THR . 25.9 t0 -104.76 151.66 23.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.217 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.09 -102.97 0.18 Allowed Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.418 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.71 -27.35 11.36 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.603 0.224 . . . . 0.0 111.603 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 129.14 39.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.764 0.316 . . . . 0.0 111.336 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.468 HG22 ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -120.78 174.72 6.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.04 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.595 HG11 ' OD1' ' A' ' 76' ' ' ASP . 15.2 t -75.99 -39.59 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.126 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -76.41 -31.34 54.84 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.791 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -56.1 -48.38 76.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.716 0.293 . . . . 0.0 110.682 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.95 -26.84 39.89 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.125 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.1 tt -59.45 -58.76 7.19 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.84 -42.76 94.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.052 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.78 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -52.87 -56.15 17.99 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.24 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.546 ' O ' HD21 ' A' ' 9' ' ' LEU . 7.7 mp -62.14 -29.72 70.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.778 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 32' ' ' LEU . 84.0 t -74.44 -53.4 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.005 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.26 15.52 0.06 OUTLIER Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.056 -1.068 . . . . 0.0 114.806 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.78 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -105.16 -1.25 25.69 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.704 0.752 . . . . 0.0 111.655 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.516 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -137.77 75.31 43.39 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-O 120.945 0.403 . . . . 0.0 110.282 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -53.59 -14.22 4.77 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.981 2.454 . . . . 0.0 113.252 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.37 -28.59 20.17 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.503 HD13 HD23 ' A' ' 9' ' ' LEU . 1.2 mp -100.67 -12.99 18.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.99 109.88 12.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.647 0.26 . . . . 0.0 111.604 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -90.18 -41.31 11.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.241 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 62.67 77.22 0.34 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.606 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' HD1' ' A' ' 47' ' ' PHE . 20.0 t -92.41 -66.61 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.315 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.564 ' HD1' HG12 ' A' ' 46' ' ' VAL . 5.5 m-85 -136.14 76.67 1.62 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.933 0.397 . . . . 0.0 110.729 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.26 -86.1 0.5 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.377 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -147.05 164.05 34.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.739 0.304 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -115.51 31.67 6.56 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.962 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.18 83.62 0.06 OUTLIER Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.781 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.66 128.02 34.66 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.745 0.307 . . . . 0.0 111.357 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.53 161.42 7.75 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.023 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 112.72 25.52 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.961 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.51 154.48 43.67 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.195 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -135.35 102.86 5.29 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.302 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.85 -49.88 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.985 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.02 -167.06 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.212 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.638 ' CG1' HD12 ' A' ' 80' ' ' LEU . 3.7 m -90.61 151.58 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 111.131 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 60' ' ' LEU . 7.5 tp -129.81 150.56 51.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 111.309 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.516 ' HG3' ' HB3' ' A' ' 77' ' ' GLU . 3.5 mtt180 -143.14 146.34 33.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.962 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -52.44 -21.31 3.55 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.68 23.78 5.52 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.775 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -130.21 165.93 21.35 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.733 0.301 . . . . 0.0 110.739 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.52 121.65 10.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.252 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.08 144.56 56.04 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.387 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -92.52 -177.6 4.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HA ' ' HB ' ' A' ' 28' ' ' VAL . 5.2 tt -168.64 -50.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.652 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.51 25.39 21.1 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.869 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.468 ' N ' HG22 ' A' ' 27' ' ' THR . 1.2 tt0 -171.59 96.78 0.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.839 0.32 . . . . 0.0 110.979 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.482 ' O ' HG11 ' A' ' 20' ' ' VAL . . . -58.17 -26.82 63.2 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.694 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 23' ' ' ASP . 1.0 OUTLIER -91.11 34.03 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.721 0.296 . . . . 0.0 111.515 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.67 178.58 6.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.694 0.283 . . . . 0.0 111.478 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.41 72.0 9.47 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.937 0.398 . . . . 0.0 111.243 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.65 145.0 2.23 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.261 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.595 ' OD1' HG11 ' A' ' 28' ' ' VAL . 3.2 m-20 -124.12 -79.07 0.61 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.792 0.33 . . . . 0.0 110.852 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 1.4 pt-20 -141.15 -177.69 5.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.47 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.74 -52.94 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.632 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB1' ' CE2' ' A' ' 81' ' ' PHE . . . -159.34 174.35 14.88 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.638 HD12 ' CG1' ' A' ' 59' ' ' VAL . 3.1 tt -153.35 118.11 5.02 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.839 0.352 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.442 ' CE2' ' HB1' ' A' ' 79' ' ' ALA . 21.0 m-85 -139.76 108.11 7.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.886 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.72 158.17 50.9 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.831 2.354 . . . . 0.0 112.593 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 C--N 1.35 0.612 0 C-N-CA 123.074 2.516 . . . . 0.0 113.192 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.964 0.412 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -144.29 169.18 18.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.529 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.482 ' CZ3' HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -155.51 142.4 19.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.215 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.582 ' HG2' HG22 ' A' ' 17' ' ' THR . 8.2 mtmm -138.77 145.89 40.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.945 HD22 ' HB2' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -149.32 164.63 34.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 111.907 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.604 ' N ' HD23 ' A' ' 5' ' ' LEU . 2.1 t80 -85.79 179.79 6.98 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.496 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -63.04 -13.69 38.76 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.2 -34.69 23.57 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.716 0.293 . . . . 0.0 110.748 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.945 ' HB2' HD22 ' A' ' 5' ' ' LEU . 4.9 mp -105.07 -10.26 17.29 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.678 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.692 ' HB2' ' HG2' ' A' ' 16' ' ' ARG . . . -93.23 -2.24 55.34 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -35.83 73.66 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 56.1 t -97.65 -49.92 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.725 ' HB3' ' HA ' ' A' ' 41' ' ' ALA . . . -102.47 -34.38 9.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.99 25.79 28.27 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.313 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.17 98.33 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.874 0.369 . . . . 0.0 111.136 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.692 ' HG2' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -99.07 -45.3 5.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.075 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.582 HG22 ' HG2' ' A' ' 4' ' ' LYS . 11.8 p -93.47 147.7 22.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.144 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.24 113.74 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.168 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -105.7 141.83 36.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.836 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.56 120.5 56.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.085 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.28 -45.08 1.69 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.321 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.3 t -86.84 137.41 20.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -116.98 172.32 7.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.273 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.97 -91.13 0.13 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.24 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.91 -35.16 7.39 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.529 0.204 . . . . 0.0 111.115 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.59 135.81 55.54 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 111.14 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.874 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -110.07 -179.74 3.87 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.891 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.903 HG13 ' HA ' ' A' ' 71' ' ' ALA . 12.4 m -79.91 -35.2 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.785 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' HA3' HD23 ' A' ' 68' ' ' LEU . . . -91.29 -23.4 29.36 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.415 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.36 -40.27 96.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.704 0.288 . . . . 0.0 110.991 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -81.22 -39.67 25.02 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.707 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.616 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.6 tt -53.29 -57.13 11.64 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.74 0.305 . . . . 0.0 110.435 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.3 -34.75 75.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.47 -52.97 26.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.482 HD12 ' CZ3' ' A' ' 3' ' ' TRP . 12.4 mt -63.37 -26.22 68.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.317 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 32' ' ' LEU . 62.1 t -91.01 -42.6 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.58 0.229 . . . . 0.0 111.569 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.91 -34.54 90.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.102 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB3' ' HD3' ' A' ' 40' ' ' PRO . . . -104.95 -41.34 5.63 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.567 ' HB3' HD11 ' A' ' 42' ' ' LEU . 27.9 m170 63.16 49.17 1.07 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.345 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 39' ' ' HIS . 9.9 Cg_endo -53.57 -24.21 28.22 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.231 1.954 . . . . 0.0 112.109 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.725 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . . . -58.85 -36.17 74.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.532 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 39' ' ' HIS . 1.4 pp -120.59 1.86 10.63 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.276 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -132.8 78.14 1.78 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.794 0.33 . . . . 0.0 110.952 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.2 p -81.46 -44.28 17.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.706 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.86 99.44 0.77 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.001 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.17 -72.03 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.377 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -167.01 -46.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.409 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.52 -51.34 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.715 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -175.06 149.92 1.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.0 110.575 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.99 -28.99 63.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.51 111.31 0.29 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.778 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -102.84 136.2 43.1 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.744 0.307 . . . . 0.0 111.0 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -126.07 -46.01 1.69 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.462 ' HB2' HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -156.99 112.39 2.85 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.794 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -146.35 138.88 25.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -104.78 126.89 52.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.971 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 2.0 pp -151.24 132.09 4.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.334 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -90.83 143.29 26.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.795 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.491 ' CG2' HD12 ' A' ' 80' ' ' LEU . 14.7 p -140.83 150.43 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 111.771 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -115.37 128.93 56.41 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.826 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.49 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -101.78 145.92 28.49 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.059 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -20.98 59.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.713 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.48 23.66 5.62 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.891 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -95.84 162.19 13.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.082 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.66 102.5 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.974 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 49.91 75.88 0.15 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.983 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.32 133.99 33.62 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.805 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.43 HD23 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -161.27 -71.3 0.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.318 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.67 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -90.0 53.78 3.62 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.769 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 10.9 tt0 -159.4 72.94 0.56 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.752 0.31 . . . . 0.0 111.279 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.903 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -60.35 -28.66 68.35 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.339 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.31 36.38 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.345 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . . . -92.77 -178.39 4.83 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.956 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.12 68.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.485 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.94 157.76 9.11 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.505 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.518 ' OD2' HD12 ' A' ' 32' ' ' LEU . 15.4 t70 -95.49 -67.52 0.85 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.561 0.22 . . . . 0.0 110.871 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.73 -179.88 6.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.231 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 60' ' ' LEU . 11.0 mt -113.67 -47.72 2.97 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.602 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.16 169.87 22.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.102 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD12 ' CG2' ' A' ' 59' ' ' VAL . 7.6 tt -153.89 95.44 1.87 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.055 0.455 . . . . 0.0 110.645 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -131.12 144.96 55.66 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.254 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 59.8 Cg_endo -72.2 154.7 56.84 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.519 2.146 . . . . 0.0 112.109 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 39.7 Cg_exo . . . . . 0 C--N 1.349 0.56 0 C-N-CA 122.872 2.381 . . . . 0.0 112.497 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -146.52 159.97 42.73 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.496 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 41.8 m95 -143.51 128.34 18.33 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.643 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.517 ' C ' HD22 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -129.4 149.83 51.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.482 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 16' ' ' ARG . 4.0 mm? -126.66 144.95 50.75 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.644 0.259 . . . . 0.0 111.051 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -82.44 176.67 9.23 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 11' ' ' GLU . . . -52.34 -31.97 35.98 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.564 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.441 ' C ' HD13 ' A' ' 9' ' ' LEU . 1.1 t0 -49.45 -35.17 18.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 110.776 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.764 HD12 HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -109.24 -32.85 7.04 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.393 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.37 -2.51 49.56 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 28.1 tt0 -68.38 -34.89 76.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.775 0.322 . . . . 0.0 110.724 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' CG1' ' HB2' ' A' ' 44' ' ' SER . 20.5 t -94.87 -49.36 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.727 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 -38.25 63.0 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.27 -24.24 29.87 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.701 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.02 96.13 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.767 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.6 28.18 6.27 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.143 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 4' ' ' LYS . 11.1 p -92.09 132.76 36.34 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.647 0.261 . . . . 0.0 110.924 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.31 159.82 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.245 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -124.89 138.05 54.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.591 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.13 123.45 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.948 0.404 . . . . 0.0 111.424 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.27 -47.11 1.76 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.219 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.17 152.72 3.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.463 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.455 ' OD1' ' HB3' ' A' ' 71' ' ' ALA . 35.3 t0 -112.12 160.29 17.69 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.209 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.15 -130.22 1.54 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.423 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.91 -33.22 63.91 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.735 0.267 . . . . 0.0 111.145 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.0 134.74 49.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.255 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -111.28 175.84 5.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.002 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.698 HG23 ' HA ' ' A' ' 71' ' ' ALA . 58.5 t -75.64 -42.32 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 120.956 0.407 . . . . 0.0 110.032 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -82.54 -32.95 26.39 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.893 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.56 -41.07 96.55 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.721 0.296 . . . . 0.0 110.791 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.95 -31.57 51.01 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.805 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.6 tt -61.6 -58.78 6.75 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.33 -32.74 74.24 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.87 -51.97 34.72 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.106 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.9 -34.62 73.43 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.176 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 32' ' ' LEU . 40.9 t -85.08 -43.69 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.334 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.62 6.88 75.81 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.423 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.473 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -62.97 -58.32 7.73 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.191 0.496 . . . . 0.0 110.712 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.691 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 13.9 m-70 103.79 -57.52 0.0 OUTLIER Pre-proline 0 C--N 1.345 0.403 0 C-N-CA 124.637 1.175 . . . . 0.0 112.073 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 39' ' ' HIS . 61.2 Cg_exo -50.98 -22.93 11.14 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.028 1.818 . . . . 0.0 112.434 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -58.44 -32.55 68.8 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.622 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.764 HD22 HD12 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -136.75 25.11 3.1 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.146 179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.03 66.26 1.4 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.783 0.325 . . . . 0.0 110.985 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.406 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 3.3 m -82.41 -44.74 15.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.627 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -163.62 111.07 1.17 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.895 0.379 . . . . 0.0 111.227 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 47' ' ' PHE . 8.9 p -157.08 -48.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.236 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.437 ' N ' HG13 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -170.75 -165.65 0.45 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.72 43.86 3.29 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.897 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 67.87 133.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.092 0.472 . . . . 0.0 111.665 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -88.1 -28.15 21.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.373 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.27 -60.89 2.21 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.256 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.77 118.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.682 0.393 . . . . 0.0 111.936 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.9 mt -91.71 -32.28 15.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.684 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.11 122.52 34.46 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.71 0.29 . . . . 0.0 111.477 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.29 129.68 43.56 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.887 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.34 135.2 52.21 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.964 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HB ' HD21 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -151.87 131.2 3.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.851 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -91.42 164.82 13.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.782 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 p -138.76 147.36 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.435 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -106.05 128.0 53.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.953 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.435 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -126.62 145.89 50.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.016 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -59.31 -21.0 59.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.675 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.91 23.72 5.47 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.747 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.2 166.29 12.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.746 0.308 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.33 112.57 11.76 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.81 123.79 42.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.47 165.57 18.01 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.681 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.436 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -108.16 -38.88 5.65 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.13 24.9 13.79 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.142 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -162.54 96.06 0.93 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.84 0.32 . . . . 0.0 110.953 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.698 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -70.33 -6.65 36.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.708 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 t -75.86 1.28 15.47 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.8 -178.48 1.54 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 111.398 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.6 86.91 6.84 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.477 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.67 159.17 28.05 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.116 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -109.58 -77.4 0.6 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -157.4 -175.16 5.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.793 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.7 mt -108.12 -37.69 5.98 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.99 172.0 10.6 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.087 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.427 HD21 ' HB ' ' A' ' 57' ' ' ILE . 7.4 tt -136.65 97.3 3.51 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.274 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.86 136.49 20.74 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.68 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 66.2 Cg_endo -74.22 150.83 42.87 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.409 2.073 . . . . 0.0 112.451 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 52.7 Cg_exo . . . . . 0 C--N 1.351 0.677 0 C-N-CA 122.819 2.346 . . . . 0.0 112.106 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ttt . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.618 0.247 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -147.56 138.79 23.68 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.061 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.48 ' CE2' HD12 ' A' ' 32' ' ' LEU . 2.8 m0 -135.59 118.45 16.22 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.717 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 39.8 mtpt -116.91 139.78 50.23 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.589 ' HG ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -123.45 142.45 50.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.634 0.254 . . . . 0.0 110.796 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.484 ' H ' HD13 ' A' ' 5' ' ' LEU . 20.7 p90 -81.11 -173.19 4.16 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.173 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -41.09 -26.18 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.456 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -39.95 -47.27 2.2 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.884 0.373 . . . . 0.0 111.292 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.589 HD13 ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -113.23 -23.17 10.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.422 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.44 -3.01 38.18 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.15 -34.28 65.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.652 0.263 . . . . 0.0 111.073 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.425 HG21 ' C ' ' A' ' 42' ' ' LEU . 12.6 t -95.82 -53.6 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.719 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.64 -40.48 49.02 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.78 -30.33 7.23 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.455 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.2 p -156.95 124.96 5.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.632 0.253 . . . . 0.0 111.23 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.437 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.69 34.51 5.19 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.951 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.423 ' CG2' ' HG2' ' A' ' 4' ' ' LYS . 21.5 p -104.34 126.67 51.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -139.37 151.66 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -120.07 158.34 27.06 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.885 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 t -102.26 120.38 51.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.886 0.374 . . . . 0.0 111.215 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.99 -46.02 0.65 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.065 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.0 p -86.76 147.7 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.422 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -99.17 136.41 39.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.936 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.56 175.65 35.6 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.635 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.9 -31.49 68.67 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.548 0.213 . . . . 0.0 111.35 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 117.97 6.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.824 0.345 . . . . 0.0 111.049 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.855 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -68.28 179.52 1.58 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.876 HG13 ' HA ' ' A' ' 71' ' ' ALA . 2.6 m -74.54 -42.53 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.252 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -88.38 -28.49 22.21 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.276 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.78 -34.74 73.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.785 0.326 . . . . 0.0 110.728 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.601 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -92.09 -30.57 15.93 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.503 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 36' ' ' VAL . 4.0 tt -62.21 -53.69 51.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.781 0.324 . . . . 0.0 110.612 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -65.96 -31.76 72.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.245 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.0 -44.86 53.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.111 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 31' ' ' ALA . 8.1 mp -62.98 -32.78 74.21 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.928 0.394 . . . . 0.0 110.655 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 32' ' ' LEU . 47.0 t -87.97 -34.62 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.286 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.23 19.45 51.33 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.295 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -63.68 -52.2 61.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.053 0.426 . . . . 0.0 111.072 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.768 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 28.9 m170 104.63 -59.87 0.0 OUTLIER Pre-proline 0 C--N 1.345 0.391 0 C-N-CA 124.527 1.131 . . . . 0.0 112.071 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.768 ' HD3' ' HB2' ' A' ' 39' ' ' HIS . 42.6 Cg_exo -55.69 -22.06 34.63 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.691 1.594 . . . . 0.0 111.992 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.425 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -62.31 -29.25 70.3 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.645 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.528 HD22 ' CD2' ' A' ' 9' ' ' LEU . 2.3 pt? -135.69 26.81 3.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.838 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 70.95 136.02 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.5 m -58.45 -39.41 79.79 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.489 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 59.85 76.07 0.38 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.894 0.378 . . . . 0.0 111.244 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.3 68.56 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.508 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -141.18 -46.73 0.39 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.148 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.3 -63.34 1.51 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.049 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.92 155.53 1.64 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.792 0.33 . . . . 0.0 110.816 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -120.15 31.19 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.956 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.93 -99.63 2.63 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.512 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.14 93.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.832 0.348 . . . . 0.0 111.432 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 mp -94.82 18.66 11.37 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.527 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -133.24 128.85 36.76 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.618 0.247 . . . . 0.0 111.196 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.25 147.47 41.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -140.17 121.82 15.28 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.5 tt -173.6 145.39 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.404 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.6 m-80 -97.47 168.4 10.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.612 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' A' ' 80' ' ' LEU . 10.9 p -139.33 141.98 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.552 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.49 118.32 31.48 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.609 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -126.51 145.76 50.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.715 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.34 -10.59 56.01 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.895 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.56 5.58 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.945 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -118.8 166.08 13.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.631 0.253 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.11 125.78 27.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.64 130.3 46.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.24 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.476 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -98.27 134.54 41.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -128.59 -63.96 0.96 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.897 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.06 43.84 2.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.835 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -165.37 94.25 0.62 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.703 0.287 . . . . 0.0 111.236 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.876 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -71.56 -10.13 59.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.809 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.1 35.88 1.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 111.413 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.94 165.69 11.8 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.865 0.364 . . . . 0.0 111.327 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.3 80.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.15 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.76 -177.47 48.15 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.538 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.77 -74.9 0.59 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.792 0.33 . . . . 0.0 110.701 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -148.68 -177.61 5.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.39 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.59 -32.74 7.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.343 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB2' ' HD3' ' A' ' 4' ' ' LYS . . . -167.48 169.77 11.86 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.439 ' HG ' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -138.41 97.74 3.44 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.555 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -140.14 153.65 69.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.253 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HD3' ' CD1' ' A' ' 6' ' ' PHE . 24.6 Cg_endo -61.74 156.18 49.69 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.632 2.222 . . . . 0.0 112.31 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 C--N 1.347 0.463 0 C-N-CA 122.676 2.251 . . . . 0.0 112.421 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.759 ' HG3' HG12 ' A' ' 28' ' ' VAL . 2.8 ttp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.056 0.455 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -120.04 147.13 45.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.087 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.617 ' CH2' HD12 ' A' ' 32' ' ' LEU . 2.1 t90 -150.04 125.16 10.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.727 0.299 . . . . 0.0 111.168 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.652 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -122.23 148.47 44.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.297 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.668 HD13 ' HB3' ' A' ' 16' ' ' ARG . 7.6 mp -140.18 152.62 46.18 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.75 0.31 . . . . 0.0 111.334 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -98.27 179.15 4.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.62 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -53.67 -29.88 40.78 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.94 -37.73 33.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.004 0.431 . . . . 0.0 110.19 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.654 ' CB ' HD23 ' A' ' 5' ' ' LEU . 2.5 mp -110.73 -9.75 14.49 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.187 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.62 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -93.81 -4.9 49.34 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.99 -36.84 75.49 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 14.6 t -93.47 -33.51 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.797 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . . . -92.58 -45.03 8.3 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.38 -35.58 4.28 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.842 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.9 t -172.43 126.4 0.52 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.565 0.221 . . . . 0.0 110.824 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.668 ' HB3' HD13 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -123.05 28.2 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.291 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 5' ' ' LEU . 19.8 p -99.33 112.55 24.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.571 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.5 144.5 28.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.221 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -130.25 158.48 39.64 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.701 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.447 HG11 ' HB3' ' A' ' 1' ' ' MET . 13.4 p -103.95 136.97 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.893 0.378 . . . . 0.0 111.632 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.04 -48.62 1.11 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.918 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -86.65 165.67 2.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.284 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.09 118.07 33.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.08 -139.33 3.89 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.491 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.48 30.95 6.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.62 0.248 . . . . 0.0 111.302 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.46 146.3 25.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.898 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.533 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -121.08 167.75 12.28 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.83 0.348 . . . . 0.0 111.213 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.889 HG23 ' HA ' ' A' ' 68' ' ' LEU . 2.5 m -78.2 -36.88 21.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.435 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -79.21 -31.28 42.93 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.879 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -50.84 -42.17 58.31 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.885 0.374 . . . . 0.0 110.556 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.49 -30.89 17.02 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.126 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.617 HD12 ' CH2' ' A' ' 3' ' ' TRP . 0.7 OUTLIER -58.34 -56.07 26.85 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.829 -0.168 . . . . 0.0 110.96 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -57.18 -36.26 70.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.628 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.15 -53.95 9.71 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 110.469 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 39' ' ' HIS . 7.8 mp -61.43 -25.3 67.12 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.244 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 32' ' ' LEU . 90.4 t -91.92 -45.89 14.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.432 0.158 . . . . 0.0 111.336 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.28 -40.53 94.09 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.861 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.14 -56.35 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.652 0.263 . . . . 0.0 111.053 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.474 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER 72.52 55.5 0.34 Allowed Pre-proline 0 C--O 1.231 0.106 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.75 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 52.7 Cg_exo -53.12 -17.71 8.66 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.22 1.947 . . . . 0.0 112.06 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . . . -57.13 -40.49 77.23 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.189 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -134.5 13.17 3.78 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.642 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.14 118.64 26.55 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.842 0.354 . . . . 0.0 111.442 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.9 m -94.97 7.46 46.0 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.694 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 71.49 31.7 2.23 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.683 0.277 . . . . 0.0 111.063 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 46' ' ' VAL . 7.5 p -168.47 87.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.172 0.511 . . . . 0.0 111.37 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -157.57 104.67 2.0 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.183 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.42 -80.2 0.64 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.383 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.76 -62.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.814 0.34 . . . . 0.0 110.499 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.71 -28.94 51.04 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.465 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.09 -63.42 0.55 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.383 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.54 156.07 40.69 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.771 0.319 . . . . 0.0 111.059 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.56 -67.89 0.96 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -151.67 134.27 15.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.005 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.15 164.31 29.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.2 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -108.62 126.4 52.92 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.061 HD13 HD21 ' A' ' 80' ' ' LEU . 1.7 pp -148.87 120.09 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.553 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -77.27 151.31 35.12 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.868 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.684 HG23 HD12 ' A' ' 80' ' ' LEU . 11.0 p -136.92 146.7 27.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.678 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.34 124.3 49.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.732 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.71 145.61 51.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -61.09 -25.19 66.79 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.653 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.43 23.49 5.99 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.916 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.24 166.07 12.03 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.653 0.263 . . . . 0.0 110.772 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.03 114.29 2.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.982 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.03 111.54 10.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.075 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.54 -175.89 3.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.251 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.889 ' HA ' HG23 ' A' ' 28' ' ' VAL . 0.7 OUTLIER -141.16 -42.35 0.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.562 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.73 35.94 3.88 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.855 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HG2' HG22 ' A' ' 72' ' ' THR . 4.8 tt0 -167.94 91.28 0.33 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -83.88 -0.97 53.47 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.716 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.524 HG22 ' HG2' ' A' ' 70' ' ' GLU . 12.8 t -84.82 -26.56 27.38 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.436 0.16 . . . . 0.0 111.092 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.26 139.45 53.37 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.747 0.308 . . . . 0.0 110.913 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.94 -74.68 0.06 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.88 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.624 ' C ' HG11 ' A' ' 28' ' ' VAL . . . 113.99 -151.21 18.45 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.505 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 28' ' ' VAL . 25.3 p-10 -111.63 -50.77 2.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.406 0.146 . . . . 0.0 110.74 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -171.35 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.741 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.1 mt -107.66 -36.79 6.34 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.215 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 4' ' ' LYS . . . -165.22 170.93 14.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.631 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.061 HD21 HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -145.64 100.1 3.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.899 0.38 . . . . 0.0 110.545 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 12.5 m-85 -114.09 133.95 22.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.009 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 81' ' ' PHE . 37.1 Cg_exo -57.33 170.72 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.797 2.331 . . . . 0.0 112.403 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 C--N 1.349 0.573 0 C-N-CA 122.771 2.314 . . . . 0.0 112.362 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.579 0.228 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.44 160.14 40.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.882 0.372 . . . . 0.0 110.887 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.69 ' CH2' HD13 ' A' ' 80' ' ' LEU . 6.1 t-105 -155.27 144.83 21.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.02 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -137.63 141.16 41.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.938 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.617 HD21 ' HB2' ' A' ' 9' ' ' LEU . 11.7 tp -133.08 158.24 43.26 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.991 0.425 . . . . 0.0 111.893 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -91.14 177.93 6.13 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.716 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.495 ' HB1' ' HG3' ' A' ' 11' ' ' GLU . . . -72.93 -10.24 59.58 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.588 ' C ' HD13 ' A' ' 9' ' ' LEU . 6.2 t70 -56.65 -39.72 74.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.617 ' HB2' HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -111.66 -39.6 4.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.417 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -61.43 -14.23 26.62 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.495 ' HG3' ' HB1' ' A' ' 7' ' ' ALA . 35.1 mt-10 -73.37 -26.9 61.2 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.364 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 41' ' ' ALA . 16.5 t -89.66 -41.63 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.77 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -90.12 -43.55 10.39 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.68 -20.31 22.69 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.828 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.9 m -111.64 130.68 55.69 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.882 0.341 . . . . 0.0 110.665 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.623 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -113.81 -49.08 2.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 p -93.1 146.68 23.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.92 0.39 . . . . 0.0 111.435 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.0 t -145.36 119.33 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.24 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -102.42 138.59 39.14 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.358 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.75 123.21 65.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.438 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.08 -31.86 11.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.19 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 p -91.81 151.34 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -116.88 121.97 43.01 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.98 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.91 45.07 1.18 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.467 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.3 t0 55.48 33.57 21.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.868 0.365 . . . . 0.0 111.295 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.57 127.08 33.46 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.654 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.628 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -78.08 168.07 20.46 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.796 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.49 HG11 ' HG3' ' A' ' 61' ' ' ARG . 22.6 t -75.25 -34.43 30.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.451 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -85.07 -28.64 30.49 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.304 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.83 -41.44 74.25 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.559 0.218 . . . . 0.0 110.955 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.51 -32.29 19.5 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -61.43 -61.86 2.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.645 0.259 . . . . 0.0 110.54 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -62.06 -33.17 73.9 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.672 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -66.08 -54.5 24.93 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.291 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.54 -19.22 64.61 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.459 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 32' ' ' LEU . 88.2 t -91.99 -47.81 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.31 -34.22 2.55 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.789 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -80.61 -1.23 41.36 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.424 ' O ' HD12 ' A' ' 42' ' ' LEU . 7.8 m170 -127.1 65.69 65.28 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.781 0.324 . . . . 0.0 110.675 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 53.3 Cg_exo -54.01 -19.11 14.81 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.779 2.319 . . . . 0.0 112.469 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -52.72 -26.43 14.01 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.631 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.77 HD23 ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -95.91 -23.76 16.73 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.679 0.275 . . . . 0.0 110.99 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 78.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.084 0.469 . . . . 0.0 111.022 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.8 t -80.42 -53.38 6.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.813 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -176.49 107.47 0.07 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.61 -55.71 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.655 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -172.25 48.05 0.02 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.609 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.34 -45.23 2.6 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.528 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.06 156.76 45.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.723 0.297 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.37 -28.84 9.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.242 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.4 158.87 22.63 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.623 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.57 97.31 3.71 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.677 0.275 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 mt 70.93 -63.72 0.41 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.26 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -113.45 138.49 50.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.77 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -103.6 126.45 50.75 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 141.12 46.04 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.193 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.4 mt -146.86 130.83 9.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.285 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -101.65 146.53 27.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.957 0.408 . . . . 0.0 111.143 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.78 154.08 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tp -124.61 120.92 33.29 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.017 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HG3' HG11 ' A' ' 28' ' ' VAL . 2.5 tmm_? -127.5 88.42 2.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.619 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 57.54 18.68 4.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.851 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.48 23.66 39.11 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.642 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -102.01 166.0 10.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.951 0.405 . . . . 0.0 111.199 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.52 102.9 14.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.533 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 63.2 105.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.066 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.416 ' CB ' ' HG3' ' A' ' 61' ' ' ARG . . . -109.95 162.57 14.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.225 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.451 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 2.6 tt -169.9 -65.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.602 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.483 ' HA2' HG22 ' A' ' 27' ' ' THR . . . -93.45 63.39 1.97 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.137 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -123.82 30.48 6.16 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -58.32 -22.9 54.82 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -76.74 -25.0 53.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.243 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.84 154.52 41.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.69 0.281 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.4 66.74 3.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.825 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.53 -173.93 27.46 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.549 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -117.36 -72.74 0.67 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.582 0.229 . . . . 0.0 110.694 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.455 ' HA ' ' HG2' ' A' ' 61' ' ' ARG . 1.3 pt-20 -149.41 -169.21 3.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.716 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -113.52 -48.74 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.407 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -162.5 166.74 24.49 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.249 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.69 HD13 ' CH2' ' A' ' 3' ' ' TRP . 4.8 tt -146.55 111.88 5.49 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.83 0.348 . . . . 0.0 110.942 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -151.44 156.7 34.93 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.485 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.0 153.06 76.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.543 2.162 . . . . 0.0 112.383 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 C--N 1.347 0.469 0 C-N-CA 122.609 2.206 . . . . 0.0 112.703 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG3' ' HA2' ' A' ' 75' ' ' GLY . 6.4 mtm . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.621 0.248 . . . . 0.0 111.434 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -116.71 159.22 22.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.815 0.34 . . . . 0.0 111.28 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.709 ' CH2' HD13 ' A' ' 80' ' ' LEU . 7.2 t-105 -151.27 143.05 23.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.627 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.541 ' HG2' HG22 ' A' ' 17' ' ' THR . 2.1 mtmm -138.24 145.91 41.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.774 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.478 HD11 HD13 ' A' ' 9' ' ' LEU . 10.5 tp -138.48 159.76 41.26 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.044 0.449 . . . . 0.0 111.683 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -87.13 173.39 9.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.327 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 11' ' ' GLU . . . -65.52 -25.5 67.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.746 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.48 -39.52 23.31 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.865 0.364 . . . . 0.0 110.675 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.729 ' HB3' HD22 ' A' ' 42' ' ' LEU . 1.3 mp -101.1 -34.26 9.79 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.337 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -70.29 -12.01 61.29 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -71.1 -34.4 71.07 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 121.289 -0.164 . . . . 0.0 111.361 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.698 HG21 ' HB2' ' A' ' 43' ' ' GLU . 5.1 t -98.3 -37.79 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.655 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -88.15 -45.83 9.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.586 0.232 . . . . 0.0 111.437 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.34 -25.57 27.81 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.534 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 t -106.14 111.58 24.25 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.857 0.36 . . . . 0.0 110.814 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.597 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 1.7 ptt-85 -102.66 -45.77 4.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.709 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.541 HG22 ' HG2' ' A' ' 4' ' ' LYS . 4.8 p -99.73 140.64 33.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 111.436 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.09 129.59 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.927 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -110.52 136.0 50.32 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.519 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.51 137.43 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.861 0.362 . . . . 0.0 111.652 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.71 -21.25 11.77 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.584 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.87 152.21 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.875 0.369 . . . . 0.0 111.615 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.7 153.53 26.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.132 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.68 -155.08 9.02 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.784 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.56 30.36 5.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.725 0.298 . . . . 0.0 111.492 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.13 123.7 29.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.044 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.711 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -76.72 164.25 26.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.781 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.878 HG11 ' HB3' ' A' ' 67' ' ' ALA . 38.7 t -73.76 -30.08 27.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.536 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.676 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -87.21 -29.48 22.4 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.425 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.44 -41.84 77.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.589 0.233 . . . . 0.0 111.077 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -84.27 -32.31 24.48 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.373 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.4 tt -56.48 -61.22 2.56 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.346 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.68 -37.74 88.49 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.403 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -59.83 -53.58 56.26 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.618 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.1 mt -64.88 -20.62 66.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.007 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 32' ' ' LEU . 57.3 t -86.34 -48.47 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.57 -39.47 1.21 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.804 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -72.85 -0.49 13.6 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.484 ' HD2' ' HB3' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -120.79 68.73 16.18 Favored Pre-proline 0 N--CA 1.453 -0.301 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.487 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 85.9 Cg_exo -48.63 -19.11 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.123 2.549 . . . . 0.0 113.362 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB3' ' HD2' ' A' ' 39' ' ' HIS . . . -51.36 -38.72 54.67 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -83.79 -19.81 34.38 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.698 ' HB2' HG21 ' A' ' 12' ' ' VAL . 1.8 mm-40 64.48 118.89 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.7 t -94.94 -26.64 16.04 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.046 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.48 174.16 10.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.016 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.22 39.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.885 0.374 . . . . 0.0 111.543 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -175.3 83.49 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.928 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.93 -97.67 0.11 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.36 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -156.75 141.73 17.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.718 0.294 . . . . 0.0 111.029 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -100.49 -28.92 12.65 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.365 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.99 -159.54 21.73 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.222 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -160.31 145.03 14.55 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.755 0.312 . . . . 0.0 111.465 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -172.4 -49.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.075 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -146.23 141.15 27.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -106.19 119.47 39.31 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.586 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -93.89 97.25 10.25 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 56' ' ' HIS . 0.8 OUTLIER -163.07 126.19 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.991 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -85.87 144.02 27.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.515 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.51 ' CG2' HD12 ' A' ' 80' ' ' LEU . 14.4 p -139.99 147.9 23.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.338 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tp -107.46 118.3 36.37 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.849 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.31 85.8 1.81 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.297 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 63.8 16.32 9.7 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.917 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.6 23.75 27.72 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.536 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.98 162.67 14.61 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.831 0.348 . . . . 0.0 110.858 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.31 102.48 13.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.42 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.75 109.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.305 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.878 ' HB3' HG11 ' A' ' 28' ' ' VAL . . . -104.75 148.66 26.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.028 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.676 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 6.2 tt -139.11 -67.37 0.45 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.045 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.02 52.75 3.69 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.844 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.49 24.77 7.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.63 0.252 . . . . 0.0 111.621 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -58.06 -29.65 65.57 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.308 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.68 1.38 56.88 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.97 175.28 6.77 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.833 0.349 . . . . 0.0 111.363 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.68 53.59 2.76 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.215 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA2' ' HG3' ' A' ' 1' ' ' MET . . . 138.34 163.54 9.62 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.878 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.71 -67.9 0.76 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 110.531 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.57 -172.32 2.87 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.739 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.11 -52.47 2.76 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.69 0.281 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.16 170.13 22.97 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.949 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.709 HD13 ' CH2' ' A' ' 3' ' ' TRP . 1.1 tt -147.99 112.23 5.23 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.837 0.351 . . . . 0.0 111.083 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -130.9 136.32 28.71 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.054 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 6' ' ' PHE . 57.7 Cg_endo -71.31 146.19 50.23 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.628 2.219 . . . . 0.0 112.531 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--N 1.35 0.636 0 C-N-CA 122.805 2.337 . . . . 0.0 112.603 -179.915 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.042 0.449 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 77' ' ' GLU . 19.9 mt-10 -141.04 175.44 9.63 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.438 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.765 ' CZ3' HD22 ' A' ' 35' ' ' LEU . 1.5 t90 -155.41 118.62 4.38 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.986 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 7.0 mtpp -102.55 145.79 29.09 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -136.5 137.21 40.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.722 0.296 . . . . 0.0 111.723 -179.111 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.58 163.39 14.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.632 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -53.08 -29.19 28.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.518 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.705 ' HB3' HD12 ' A' ' 9' ' ' LEU . 4.3 t70 -47.62 -38.5 14.79 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.958 0.409 . . . . 0.0 110.667 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.707 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 4.2 mp -119.19 -3.18 10.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.481 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -92.99 -9.18 40.79 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.55 -44.37 76.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.578 0.228 . . . . 0.0 111.108 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 15.4 t -94.26 -29.96 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.074 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.926 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . . . -69.43 -41.67 76.02 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.582 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.62 -6.78 81.75 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.479 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.39 152.17 51.57 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 110.998 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -110.7 -76.81 0.6 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.474 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.7 p -95.93 136.65 36.08 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.854 0.359 . . . . 0.0 111.428 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.21 121.33 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.763 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.41 151.19 21.81 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.955 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 20' ' ' VAL . 11.5 p -118.16 120.74 65.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.84 0.353 . . . . 0.0 111.275 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -33.52 6.02 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.17 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 m -87.41 134.23 28.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.15 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -117.01 134.21 55.03 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.82 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.45 -109.17 0.29 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.649 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.15 25.8 6.47 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 111.454 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.32 141.97 49.55 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.753 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.65 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -117.5 177.38 4.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 68' ' ' LEU . 42.2 t -78.1 -50.32 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.055 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.495 ' HA3' HD13 ' A' ' 68' ' ' LEU . . . -78.67 -25.63 60.27 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.146 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.69 -39.86 85.95 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.645 0.26 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.94 -33.1 18.58 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.815 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.565 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -60.27 -57.47 12.66 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.457 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.29 -33.97 73.11 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.382 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.86 -52.35 15.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.096 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.765 HD22 ' CZ3' ' A' ' 3' ' ' TRP . 8.8 mp -61.8 -27.76 68.99 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.428 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 32' ' ' LEU . 42.4 t -94.24 -41.07 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.54 0.21 . . . . 0.0 111.365 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.2 -37.0 91.15 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.045 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.08 -25.07 13.55 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.582 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 17.0 m80 63.19 44.78 0.59 Allowed Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 122.675 0.39 . . . . 0.0 111.324 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 53.6 Cg_exo -51.77 -31.31 41.3 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.942 1.761 . . . . 0.0 111.71 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.926 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . . . -56.46 -32.1 64.63 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.389 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.59 HD21 HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -121.94 -3.12 9.15 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -79.47 87.47 5.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.832 0.348 . . . . 0.0 111.041 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.0 -53.6 3.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.26 103.87 0.07 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.526 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 46' ' ' VAL . 63.6 t 56.59 70.12 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.994 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.17 -59.58 1.39 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.936 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.48 62.68 0.54 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.487 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.65 -70.23 0.25 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.485 0.183 . . . . 0.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -109.89 -29.48 8.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.295 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.02 123.77 0.22 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.909 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -127.37 33.75 4.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.682 0.277 . . . . 0.0 111.273 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.45 163.3 36.96 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.89 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -101.82 112.24 24.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.97 147.89 44.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.413 ' HB3' ' HG2' ' A' ' 83' ' ' PRO . 3.5 t60 -117.25 149.79 39.85 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 pt -136.8 104.45 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.29 151.4 33.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.8 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.502 HG23 ' OE2' ' A' ' 77' ' ' GLU . 9.1 p -133.98 151.81 33.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.714 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.533 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -114.35 130.07 56.67 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.663 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.533 ' N ' HD13 ' A' ' 60' ' ' LEU . 18.8 mtt180 -123.18 145.6 48.49 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.741 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -52.09 -38.4 57.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.371 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.04 22.64 6.79 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.807 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.82 164.63 19.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.726 0.263 . . . . 0.0 110.715 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.27 105.76 0.97 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.23 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.31 153.46 46.98 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.375 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -113.7 179.85 3.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.293 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD13 ' HA3' ' A' ' 29' ' ' GLY . 3.2 pp -111.67 -33.16 6.43 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.989 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.477 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -85.5 32.22 3.69 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.854 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -153.28 90.96 1.46 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.813 0.306 . . . . 0.0 111.269 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.65 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -67.66 -12.7 61.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.97 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 t -88.2 34.14 0.74 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.953 0.406 . . . . 0.0 111.056 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.56 167.38 11.97 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.11 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.48 40.56 1.84 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.699 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.58 67.0 0.02 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.59 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -69.17 -71.16 0.23 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.711 0.291 . . . . 0.0 110.57 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.502 ' OE2' HG23 ' A' ' 59' ' ' VAL . 34.7 tt0 -140.45 156.36 46.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.554 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -100.62 -42.99 6.31 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.766 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -169.44 163.18 10.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.425 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -136.26 113.24 10.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.994 0.426 . . . . 0.0 110.439 179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -146.22 140.57 15.57 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.303 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 73.2 Cg_endo -75.46 151.46 37.53 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.36 2.04 . . . . 0.0 111.857 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' A' ' 56' ' ' HIS . 34.7 Cg_exo . . . . . 0 C--N 1.348 0.529 0 C-N-CA 122.673 2.248 . . . . 0.0 112.068 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.893 0.378 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 17.3 mt-10 -142.58 163.76 31.95 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.03 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.736 ' CZ2' HD22 ' A' ' 80' ' ' LEU . 5.3 t-105 -153.99 141.54 19.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.103 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -138.43 143.1 39.55 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.644 HD21 HD22 ' A' ' 9' ' ' LEU . 13.2 tp -136.73 156.48 48.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 111.646 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.563 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -81.27 -177.73 6.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.359 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.38 -12.29 60.23 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -54.03 -38.12 64.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.781 0.324 . . . . 0.0 111.044 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.796 HD23 HD13 ' A' ' 42' ' ' LEU . 2.2 mp -105.48 -38.22 6.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.326 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -64.73 -17.83 64.48 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -67.13 -26.85 66.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.429 0.156 . . . . 0.0 111.166 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 41' ' ' ALA . 8.9 t -98.19 -44.37 12.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.9 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -91.62 -42.55 10.13 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.48 -28.14 14.46 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.84 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 t -100.45 108.25 20.18 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.826 0.346 . . . . 0.0 111.043 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.816 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -98.62 -42.43 7.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.531 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -93.75 147.5 22.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.068 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -142.11 113.24 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.191 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.13 136.24 37.95 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.441 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.56 124.88 66.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 111.407 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.78 -34.41 7.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.054 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.62 145.3 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 120.813 0.339 . . . . 0.0 111.257 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -116.66 121.72 42.48 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.99 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.84 -107.93 1.62 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.395 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.33 -10.64 16.88 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.21 145.34 51.54 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.744 0.307 . . . . 0.0 111.39 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.03 170.92 7.92 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.084 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.571 HG22 ' HA ' ' A' ' 76' ' ' ASP . 24.6 t -75.01 -37.64 41.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.462 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.68 ' HA3' HD12 ' A' ' 68' ' ' LEU . . . -88.78 -33.87 9.58 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.17 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -55.49 -45.22 77.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.665 0.269 . . . . 0.0 111.139 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -76.75 -24.68 52.98 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.934 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.744 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.4 tt -66.72 -58.17 5.63 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -62.63 -31.6 72.48 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.832 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' CA ' ' HB3' ' A' ' 38' ' ' ALA . . . -71.62 -48.3 48.83 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.938 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 31' ' ' ALA . 8.9 mp -64.31 -21.45 66.61 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.011 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 32' ' ' LEU . 97.9 t -84.4 -49.26 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.82 -35.41 1.38 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.826 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HB3' ' CA ' ' A' ' 34' ' ' ALA . . . -74.47 -1.21 20.18 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 5.7 m80 -126.11 65.63 57.22 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 110.471 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 77.6 Cg_exo -52.28 -19.64 9.77 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.825 2.35 . . . . 0.0 112.576 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -53.03 -29.03 27.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.576 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.9 HD23 ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -96.21 -16.25 21.56 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.597 0.237 . . . . 0.0 111.453 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' C ' HG21 ' A' ' 12' ' ' VAL . 4.4 mt-10 -73.25 131.56 42.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.708 0.29 . . . . 0.0 111.394 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -89.67 -32.84 16.86 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.214 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -145.61 164.46 31.66 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.7 0.286 . . . . 0.0 111.129 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.56 59.28 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -151.79 93.53 1.87 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.848 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.09 32.32 83.74 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.825 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -90.41 -35.45 15.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.631 0.215 . . . . 0.0 111.101 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -28.74 66.98 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.588 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.57 105.45 0.22 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.526 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -84.36 75.36 10.24 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.802 0.334 . . . . 0.0 111.109 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' A' ' 54' ' ' TYR . 9.8 tt 68.19 -70.51 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.193 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HB2' HD23 ' A' ' 53' ' ' LEU . 1.5 t80 -117.72 123.68 46.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.655 0.264 . . . . 0.0 110.569 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -149.61 143.65 25.68 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.241 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -97.84 144.46 27.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.52 HG22 ' HD3' ' A' ' 83' ' ' PRO . 8.2 pt -152.51 125.33 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.743 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -99.94 135.39 41.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.437 HG23 HD12 ' A' ' 80' ' ' LEU . 13.8 p -140.6 153.96 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.256 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mp -132.18 133.09 43.81 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.965 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -146.11 84.29 1.64 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.424 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 54.11 18.96 1.91 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.076 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.36 23.06 59.36 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.711 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -138.1 166.99 22.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.08 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.39 127.86 34.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.744 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.16 157.52 13.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.508 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 28' ' ' VAL . . . -110.25 174.54 5.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.403 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.68 HD12 ' HA3' ' A' ' 29' ' ' GLY . 2.1 tt -149.58 20.23 0.92 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.445 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.31 19.38 1.35 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.588 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 178.27 85.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.139 0.469 . . . . 0.0 111.417 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB2' ' N ' ' A' ' 28' ' ' VAL . . . -82.71 6.97 16.22 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.779 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 t -83.91 -14.9 49.84 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.53 0.205 . . . . 0.0 111.254 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.08 131.26 54.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.707 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.82 23.73 11.59 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.975 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.71 -129.82 22.27 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.346 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.571 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -121.34 -72.85 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.52 0.2 . . . . 0.0 110.859 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -162.53 -166.85 1.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 78' ' ' LEU . 11.2 mt -111.75 -55.47 2.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.708 0.289 . . . . 0.0 110.958 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.89 164.37 38.96 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.225 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.736 HD22 ' CZ2' ' A' ' 3' ' ' TRP . 0.5 OUTLIER -139.29 115.29 10.23 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.004 0.43 . . . . 0.0 110.741 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -107.77 108.26 61.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 6' ' ' PHE . 58.7 Cg_endo -71.67 171.48 16.31 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.777 2.318 . . . . 0.0 112.492 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.52 ' HD3' HG22 ' A' ' 57' ' ' ILE . 70.6 Cg_endo . . . . . 0 C--N 1.349 0.598 0 C-N-CA 122.651 2.234 . . . . 0.0 112.583 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.609 0.242 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.94 154.14 44.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.046 0.45 . . . . 0.0 111.497 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -145.8 143.85 29.92 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.412 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.47 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 12.9 mttp -135.03 136.43 42.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.525 0.202 . . . . 0.0 110.654 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.742 HD21 ' CB ' ' A' ' 9' ' ' LEU . 3.9 tp -129.95 135.21 48.06 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.798 0.332 . . . . 0.0 111.07 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -81.8 176.35 9.67 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.414 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.545 ' HB1' ' CD ' ' A' ' 11' ' ' GLU . . . -63.79 -16.16 60.52 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -55.51 -30.43 60.65 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.739 0.304 . . . . 0.0 110.906 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.742 ' CB ' HD21 ' A' ' 5' ' ' LEU . 3.3 mp -119.31 -36.26 3.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.335 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.47 -15.48 50.13 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.545 ' CD ' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -71.63 -26.79 62.71 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -95.7 -39.14 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.888 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -93.19 -42.4 9.38 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.18 23.19 10.72 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.736 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.71 136.96 49.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.553 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -113.5 -81.63 0.6 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.428 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 5.0 p -92.69 149.0 21.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.872 0.368 . . . . 0.0 111.464 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.16 118.29 6.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.976 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 148.17 28.18 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.467 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -103.14 120.2 52.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.97 -15.88 14.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.541 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.79 150.81 3.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.594 0.235 . . . . 0.0 110.968 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.86 172.48 0.95 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.433 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.15 85.13 0.91 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.937 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.59 -44.09 4.77 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.472 0.177 . . . . 0.0 111.402 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.55 165.82 12.15 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.751 0.31 . . . . 0.0 111.246 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.672 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -80.16 165.17 22.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 179.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.45 -24.3 14.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.731 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.474 ' N ' ' HA ' ' A' ' 68' ' ' LEU . . . -88.95 -27.52 23.52 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.051 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.18 -47.78 68.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.687 0.279 . . . . 0.0 110.912 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -79.61 -34.59 40.54 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.605 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -53.12 -60.06 3.77 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.393 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.2 -35.48 80.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.13 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.887 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -57.87 -55.38 35.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.646 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.52 HD23 ' ND1' ' A' ' 39' ' ' HIS . 17.9 mt -66.77 -23.16 66.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.875 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 32' ' ' LEU . 56.1 t -80.21 -47.58 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -125.41 -37.8 0.51 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.201 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.887 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -71.48 -1.54 13.62 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.52 ' ND1' HD23 ' A' ' 35' ' ' LEU . 15.7 m80 -129.29 67.03 78.09 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 120.816 0.341 . . . . 0.0 110.667 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.33 -16.82 14.31 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.715 2.277 . . . . 0.0 112.588 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.45 -25.59 16.77 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.888 HD23 ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -99.5 -22.43 15.49 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.634 0.254 . . . . 0.0 111.365 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -98.85 163.61 12.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.917 0.389 . . . . 0.0 111.363 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -97.81 -49.52 4.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.71 135.66 23.6 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.732 0.301 . . . . 0.0 111.176 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 46' ' ' VAL . 9.5 p -154.71 31.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.132 0.491 . . . . 0.0 111.287 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.2 -75.21 0.6 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.864 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.26 74.59 0.38 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.263 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.52 167.67 5.37 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.782 0.325 . . . . 0.0 111.343 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -96.86 31.58 2.32 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.441 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.11 57.79 0.03 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.903 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -163.94 132.72 3.75 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.794 0.331 . . . . 0.0 111.317 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.37 -38.15 5.06 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 135.54 46.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.603 0.24 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.29 168.82 11.06 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.145 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -114.5 111.23 21.07 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.087 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.546 HD12 HG13 ' A' ' 36' ' ' VAL . 7.6 mt -149.74 126.42 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.074 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.24 163.4 16.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 32' ' ' LEU . 10.8 p -140.64 149.6 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.372 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.61 118.31 33.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.717 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.3 85.53 2.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.556 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 61.44 16.87 7.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.736 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.62 23.62 33.04 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.31 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -101.99 163.16 12.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.859 0.361 . . . . 0.0 110.82 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 102.91 14.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.424 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 54.7 96.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.884 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.73 143.69 32.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.438 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.474 ' HA ' ' N ' ' A' ' 29' ' ' GLY . 9.0 tt -143.79 -52.49 0.34 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.014 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.88 53.04 4.04 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.1 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.31 22.15 8.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.62 0.248 . . . . 0.0 111.533 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -55.89 -30.01 60.87 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.169 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.88 31.13 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.338 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.22 -175.39 2.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.75 0.31 . . . . 0.0 111.105 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.86 -32.42 67.47 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.514 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.14 -124.62 1.54 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.559 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.21 -79.05 0.39 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.684 0.278 . . . . 0.0 110.737 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -147.23 -165.38 2.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.606 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 78' ' ' LEU . 3.3 tp -112.69 -51.95 2.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.628 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -153.95 167.22 30.48 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.171 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.04 97.69 3.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.699 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.467 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 34.9 p90 -149.58 149.64 29.03 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-O 120.638 0.256 . . . . 0.0 111.603 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.509 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 39.1 Cg_exo -55.39 -49.45 16.14 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.871 2.381 . . . . 0.0 112.915 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 82' ' ' PRO . 76.5 Cg_exo . . . . . 0 C--N 1.355 0.902 0 C-N-CA 122.689 2.259 . . . . 0.0 112.974 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttm . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -146.84 171.98 14.36 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.814 0.34 . . . . 0.0 111.193 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.415 ' HE1' HG21 ' A' ' 20' ' ' VAL . 59.1 m95 -145.82 131.84 19.27 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.091 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -136.8 158.41 44.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.504 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HD12 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -150.1 163.0 39.32 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.879 0.371 . . . . 0.0 111.588 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.96 179.99 4.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.338 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.57 -11.84 47.71 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.236 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.471 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -52.81 -36.78 58.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.88 0.371 . . . . 0.0 110.357 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.056 HD12 HD21 ' A' ' 5' ' ' LEU . 7.8 mt -122.03 -39.44 2.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.469 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.73 -13.96 38.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -82.84 -28.12 30.36 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.844 0.354 . . . . 0.0 110.503 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 74.8 t -85.73 -30.88 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.355 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -99.22 -39.52 8.41 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.891 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.61 -37.64 2.14 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.152 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.2 p -173.95 138.17 0.6 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.594 0.235 . . . . 0.0 110.766 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.618 ' HG2' HD22 ' A' ' 5' ' ' LEU . 3.2 tpm_? -131.02 17.65 5.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.75 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.8 p -96.95 122.29 39.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.652 0.263 . . . . 0.0 110.413 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.57 166.07 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.44 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.05 142.89 50.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.377 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.415 HG21 ' HE1' ' A' ' 3' ' ' TRP . 21.1 t -102.19 120.52 52.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.169 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.71 -54.44 0.77 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.23 154.52 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.274 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -117.15 122.04 42.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.33 -81.31 0.04 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.061 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.96 25.14 4.97 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.775 0.321 . . . . 0.0 111.211 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.19 116.93 25.85 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.803 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -108.4 174.57 5.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.042 HG21 ' HB3' ' A' ' 67' ' ' ALA . 54.9 t -73.3 -36.94 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.413 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -77.28 -33.39 44.52 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.86 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.8 -37.55 79.44 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.558 0.343 . . . . 0.0 110.988 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -86.54 -30.93 21.54 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.93 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -60.62 -58.69 7.39 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.524 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.68 -36.67 83.64 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 1.035 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -59.6 -51.56 69.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.585 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 31' ' ' ALA . 7.9 mp -67.39 -30.74 70.6 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.706 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 32' ' ' LEU . 58.2 t -62.78 -52.13 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.835 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.24 30.34 0.05 OUTLIER Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.748 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -105.24 -0.58 26.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.799 0.3 . . . . 0.0 111.565 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -123.62 69.39 44.13 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -44.24 -21.85 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.29 2.66 . . . . 0.0 113.627 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -50.82 -28.0 8.49 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -113.87 5.81 16.4 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -94.09 120.73 34.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.535 0.207 . . . . 0.0 111.08 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 t -97.1 -53.31 3.54 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.658 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.44 146.68 36.81 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.837 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -112.89 18.47 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.549 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 38.6 t80 69.67 -67.95 0.21 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 122.649 0.38 . . . . 0.0 111.567 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.39 -2.15 85.44 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.304 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.508 ' HA ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER 67.65 -75.55 0.06 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.033 0.417 . . . . 0.0 111.1 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -120.52 31.8 6.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.956 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.14 112.45 0.53 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.516 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.14 107.81 7.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.859 0.361 . . . . 0.0 111.19 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -107.6 -35.03 6.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.207 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -101.5 134.2 44.98 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.675 0.274 . . . . 0.0 111.145 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.4 129.28 56.15 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.058 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -147.1 129.27 15.61 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.5 tt -170.17 146.71 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.61 141.61 35.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.17 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.43 HG23 ' HG ' ' A' ' 80' ' ' LEU . 12.0 p -139.2 153.82 24.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.211 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.685 HD12 HD12 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -116.94 127.3 54.09 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.725 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 142.8 49.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -63.0 -21.29 66.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.691 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.56 5.58 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.7 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.7 165.99 12.64 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.609 0.242 . . . . 0.0 110.776 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.29 121.68 10.72 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.27 127.69 33.37 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.509 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 1.042 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -94.74 179.22 5.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.634 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 68' ' ' LEU . 4.7 tt -167.38 -54.31 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.904 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.86 19.75 43.59 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.096 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 27' ' ' THR . 9.3 pt-20 -174.47 101.17 0.09 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.987 0.394 . . . . 0.0 111.012 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.578 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -75.64 -5.15 44.09 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.785 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 t -91.29 33.89 0.96 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.044 0.449 . . . . 0.0 111.07 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.41 -173.7 3.67 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.74 -33.54 56.02 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.497 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.33 146.82 6.65 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.715 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' CG ' HG22 ' A' ' 28' ' ' VAL . 15.1 m-20 -89.24 -80.11 0.31 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.33 -173.54 4.62 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.39 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.685 HD12 HD12 ' A' ' 60' ' ' LEU . 11.3 mt -108.41 -40.15 5.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.632 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -169.79 169.68 8.28 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.869 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.543 ' HB3' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -139.79 105.94 5.24 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 110.983 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -92.12 112.37 54.68 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.842 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.417 ' HG2' ' HB2' ' A' ' 8' ' ' ASP . 51.0 Cg_exo -54.14 167.73 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.047 2.498 . . . . 0.0 113.082 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo . . . . . 0 C--N 1.35 0.646 0 C-N-CA 123.117 2.545 . . . . 0.0 112.836 -179.622 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptm . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 120.619 0.247 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -143.45 160.3 40.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -148.43 143.54 26.83 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.28 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.523 ' HG2' HG22 ' A' ' 17' ' ' THR . 0.6 OUTLIER -134.95 143.57 46.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.293 179.331 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.572 HD21 ' CB ' ' A' ' 9' ' ' LEU . 12.2 tp -133.08 157.8 44.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 111.308 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -89.14 162.6 15.86 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.76 62.11 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.762 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -55.2 -32.09 61.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.79 0.329 . . . . 0.0 110.525 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -110.9 -38.39 5.12 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.094 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -66.47 -13.25 60.57 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -72.16 -25.73 61.81 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG21 ' N ' ' A' ' 44' ' ' SER . 11.8 t -93.72 -44.18 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.509 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -84.21 -28.94 26.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.628 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.1 -21.53 44.69 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.726 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.26 130.23 55.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.755 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -109.5 -48.03 3.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.735 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.523 HG22 ' HG2' ' A' ' 4' ' ' LYS . 2.3 p -92.3 141.14 28.88 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.038 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.7 t -142.09 125.8 15.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -95.87 154.11 17.4 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.697 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 t -102.02 120.54 51.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.0 -73.99 0.66 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 p -98.53 146.22 8.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.001 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -88.12 137.71 32.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.52 -120.77 0.6 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.452 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -100.69 36.54 1.9 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 111.048 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.33 120.1 39.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.752 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -115.08 173.57 6.43 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.103 HG21 ' HB3' ' A' ' 67' ' ' ALA . 38.5 t -77.62 -39.59 27.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.973 0.416 . . . . 0.0 110.137 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -81.21 -32.04 32.78 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.75 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.98 -45.61 94.1 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.692 0.282 . . . . 0.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.43 -30.95 57.6 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.648 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.755 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -57.03 -58.29 8.82 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.928 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 38' ' ' ALA . 22.5 t0 -60.51 -39.31 87.31 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.413 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.788 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -58.57 -55.19 38.29 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.34 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.431 HD23 HD23 ' A' ' 80' ' ' LEU . 8.1 mp -62.28 -24.01 67.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.926 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 32' ' ' LEU . 94.4 t -83.87 -50.1 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.391 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.63 -27.87 0.03 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.557 -0.83 . . . . 0.0 114.529 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.788 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -65.96 -5.79 10.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -128.72 70.9 80.95 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.458 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 84.4 Cg_exo -49.38 -17.35 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.176 2.584 . . . . 0.0 113.388 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.69 7.34 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.673 ' HB2' HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -100.38 -19.33 16.34 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 2.1 pt-20 -107.57 126.94 53.16 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.121 -0.362 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.432 ' N ' HG21 ' A' ' 12' ' ' VAL . 15.7 m -79.31 -52.35 8.22 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.971 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.69 144.95 9.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.86 0.362 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -158.34 -41.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.523 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 81.51 -59.08 0.24 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.657 0.383 . . . . 0.0 110.321 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.41 57.41 4.93 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.495 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.13 -48.69 73.32 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.669 0.271 . . . . 0.0 110.781 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -27.61 54.71 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.78 -41.38 2.16 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.812 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.21 27.53 16.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.626 0.25 . . . . 0.0 111.453 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mt -175.02 -66.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.852 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -130.26 132.95 46.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.165 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -131.97 115.21 15.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.99 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.61 145.88 50.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.701 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -150.32 111.06 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -73.08 139.14 46.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -139.3 151.94 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.403 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.556 HD12 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -112.99 130.53 56.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.899 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.484 ' N ' HD13 ' A' ' 60' ' ' LEU . 2.9 mtm180 -115.16 145.47 42.34 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.501 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -89.76 15.32 9.9 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.681 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.43 23.15 12.9 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.645 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HG3' ' HB1' ' A' ' 74' ' ' ALA . 2.1 tp10 -115.65 163.5 15.7 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.707 0.289 . . . . 0.0 110.981 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.16 127.73 32.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.454 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.77 95.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.245 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 1.103 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -73.1 174.64 7.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.942 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 68' ' ' LEU . 5.7 tt -163.71 -59.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.913 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.63 23.57 34.64 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.887 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -172.51 88.79 0.09 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.83 0.348 . . . . 0.0 110.785 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -76.31 -7.02 54.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.547 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -91.74 11.32 24.98 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.548 0.213 . . . . 0.0 111.38 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.83 132.56 53.32 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.624 0.249 . . . . 0.0 111.283 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.542 ' HB1' ' HG3' ' A' ' 64' ' ' GLU . . . 65.06 -76.04 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.804 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.8 164.73 30.07 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.459 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.41 -83.37 0.13 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.601 0.238 . . . . 0.0 110.803 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 2.8 pt-20 -168.91 -169.24 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.556 HD13 HD12 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -110.28 -46.65 3.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.301 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.479 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -157.04 164.64 37.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 5' ' ' LEU . 47.4 tp -144.62 97.93 3.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 111.047 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -115.56 127.69 26.59 Favored Pre-proline 0 N--CA 1.463 0.184 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.207 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.77 172.59 1.07 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.851 2.367 . . . . 0.0 112.632 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--N 1.348 0.516 0 C-N-CA 122.687 2.258 . . . . 0.0 112.282 179.801 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.777 ' SD ' HG11 ' A' ' 20' ' ' VAL . 14.2 mmt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.667 0.27 . . . . 0.0 111.514 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.41 ' HB3' ' HG3' ' A' ' 19' ' ' ARG . 1.7 mt-10 -156.08 174.79 14.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.961 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.478 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.96 139.42 23.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.588 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.653 ' C ' HD22 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -131.31 156.38 45.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.304 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.017 HD12 HD13 ' A' ' 9' ' ' LEU . 2.8 mm? -140.0 156.33 46.68 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.111 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.22 -178.67 3.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.761 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -49.32 -33.23 12.79 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -51.5 -36.8 46.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 110.232 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.017 HD13 HD12 ' A' ' 5' ' ' LEU . 4.8 mp -110.27 -8.88 14.68 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.089 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -93.48 -9.49 38.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -59.2 -39.34 82.31 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 25.8 t -97.85 -36.9 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.845 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . . . -88.6 -45.8 9.58 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.91 -32.01 7.06 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.916 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.3 107.03 0.07 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.698 0.285 . . . . 0.0 110.63 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.792 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.23 35.38 2.42 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.639 HG22 ' HG2' ' A' ' 4' ' ' LYS . 8.8 p -93.66 113.95 26.16 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.082 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.478 ' HB ' ' CD1' ' A' ' 3' ' ' TRP . 1.9 t -131.34 166.62 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.035 0.445 . . . . 0.0 111.934 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.43 ' H ' HG12 ' A' ' 18' ' ' VAL . 3.2 mpp_? -131.4 158.8 39.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.421 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.777 HG11 ' SD ' ' A' ' 1' ' ' MET . 11.9 p -102.03 120.43 51.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.095 0.474 . . . . 0.0 111.103 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.16 -45.02 1.25 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.172 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.83 113.73 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.15 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -116.21 139.12 50.68 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.8 37.0 1.46 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.716 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.22 -60.33 0.17 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.701 0.286 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.31 176.37 5.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.779 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.516 HG21 ' HA2' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -111.35 171.67 7.34 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.025 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.92 HG13 ' HA ' ' A' ' 71' ' ' ALA . 3.1 m -77.29 -39.46 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 120.765 0.317 . . . . 0.0 110.989 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -88.13 -27.68 25.12 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.417 -0.896 . . . . 0.0 112.32 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.57 -35.89 73.09 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.62 0.247 . . . . 0.0 110.911 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -91.64 -37.07 13.28 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.484 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.3 tt -51.31 -50.88 58.5 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 120.746 0.308 . . . . 0.0 110.369 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -58.91 -34.55 71.81 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.25 -52.89 11.01 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.773 0.321 . . . . 0.0 110.743 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -65.73 -22.84 66.63 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.451 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 32' ' ' LEU . 94.1 t -95.23 -40.32 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.817 -0.174 . . . . 0.0 111.052 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.78 -37.38 90.11 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.608 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.04 -34.25 9.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.609 0.242 . . . . 0.0 111.299 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.491 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 12.8 m-70 60.14 54.81 4.08 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.327 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 51.1 Cg_exo -52.44 -22.08 15.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.242 1.961 . . . . 0.0 111.993 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.845 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . . . -62.2 -35.14 77.97 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.497 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.547 HD22 ' HG ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -121.4 1.5 10.16 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.507 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -84.46 103.65 13.79 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 m -75.55 -28.95 59.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.42 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 60.28 76.03 0.38 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 111.004 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.23 -59.76 3.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.824 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -173.23 -58.23 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.78 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -134.22 95.79 0.28 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.261 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -63.44 160.42 16.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.927 0.394 . . . . 0.0 111.343 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -76.73 -29.05 56.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.203 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.55 -139.61 14.62 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.774 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -158.79 139.55 12.72 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.662 0.267 . . . . 0.0 110.913 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.21 -57.1 3.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.873 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -125.87 161.4 27.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.825 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.72 113.59 25.9 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.234 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.25 116.79 14.8 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.383 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.1 tp -172.52 143.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -120.15 156.36 31.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.809 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.7 HG23 ' HG ' ' A' ' 80' ' ' LEU . 8.3 p -139.58 144.9 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.516 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.12 118.4 36.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.422 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.14 145.62 47.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.103 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -61.42 -15.86 41.04 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.764 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.95 23.91 5.39 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.856 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' OE1' ' HB3' ' A' ' 74' ' ' ALA . 4.0 tm-20 -104.13 166.06 10.65 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.731 0.301 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.94 121.44 13.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.89 113.32 2.01 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.232 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.62 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -67.75 166.31 15.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.481 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -164.98 -50.68 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.399 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.516 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -101.36 28.96 13.61 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.125 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -164.04 102.44 0.87 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.788 0.294 . . . . 0.0 110.98 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.92 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -64.33 -26.82 68.65 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.241 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.3 t -95.99 37.18 1.24 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.07 0.462 . . . . 0.0 111.206 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.06 -173.68 4.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.473 ' HB3' ' OE1' ' A' ' 64' ' ' GLU . . . -61.09 -55.84 27.82 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.352 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.7 133.69 2.36 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.149 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -81.58 0.07 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.572 0.225 . . . . 0.0 110.535 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -160.14 179.89 8.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.489 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.6 mt -101.19 -41.13 6.84 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.777 0.323 . . . . 0.0 110.517 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.65 167.46 26.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.985 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.7 ' HG ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -138.46 100.9 4.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.324 179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -123.69 136.7 27.61 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.47 148.81 30.17 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.348 2.032 . . . . 0.0 112.042 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 122.839 2.359 . . . . 0.0 112.059 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.661 0.267 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -152.15 167.41 28.64 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.795 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.462 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -155.02 166.89 32.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.108 0.48 . . . . 0.0 111.372 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 35.0 mtpt -136.44 156.97 47.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.33 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.499 HD11 ' O ' ' A' ' 35' ' ' LEU . 6.8 tp -146.37 160.48 42.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.262 0.554 . . . . 0.0 112.229 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -97.66 172.96 7.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.332 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.19 -19.1 62.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.741 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.82 -42.33 25.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.807 0.337 . . . . 0.0 111.029 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.898 HD21 ' HA2' ' A' ' 37' ' ' GLY . 5.9 mp -108.66 -33.29 7.05 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.645 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.89 -10.76 41.52 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -56.43 -40.31 74.52 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 11.7 t -97.77 -53.07 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.77 -41.32 97.56 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.508 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.68 -15.15 62.25 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.416 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -116.77 128.68 55.53 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -109.58 -58.54 2.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.804 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 6.0 p -92.86 133.53 35.99 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.817 0.342 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.462 ' HB ' ' CD1' ' A' ' 3' ' ' TRP . 9.6 t -140.34 163.37 23.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.457 ' N ' HG12 ' A' ' 18' ' ' VAL . 15.6 ptt85 -130.52 149.87 51.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.58 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.9 t -101.97 120.22 51.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.939 0.4 . . . . 0.0 110.939 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.38 -50.84 0.75 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.73 154.56 3.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.23 133.06 56.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.067 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.5 -153.69 6.88 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.603 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -33.61 76.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.558 0.179 . . . . 0.0 111.288 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.08 116.15 4.31 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.137 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.696 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -78.82 178.08 8.2 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.781 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.638 HG13 ' HA ' ' A' ' 71' ' ' ALA . 2.8 m -77.98 -38.04 23.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.617 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.591 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -87.74 -27.51 26.56 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.23 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.31 -41.13 68.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.651 0.262 . . . . 0.0 110.768 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.14 -26.45 23.6 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.86 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.782 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.7 tp -62.24 -57.46 11.36 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.382 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -56.99 -40.4 76.5 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.982 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -64.95 -51.87 59.43 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.645 0.259 . . . . 0.0 110.36 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.654 ' O ' HD22 ' A' ' 9' ' ' LEU . 6.9 mp -62.52 -35.88 80.81 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 32' ' ' LEU . 57.6 t -60.86 -52.27 63.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.59 0.233 . . . . 0.0 110.69 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.898 ' HA2' HD21 ' A' ' 9' ' ' LEU . . . 158.02 52.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.638 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -77.35 -61.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.208 0.051 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.415 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 1.3 m-70 172.02 -62.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 123.442 0.464 . . . . 0.0 111.008 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 39' ' ' HIS . 8.0 Cg_endo -50.03 -27.76 17.43 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.626 2.217 . . . . 0.0 112.326 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.685 ' CB ' HD23 ' A' ' 9' ' ' LEU . . . -60.54 -31.67 70.76 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.772 HD22 ' HG ' ' A' ' 9' ' ' LEU . 1.6 pt? -136.65 29.76 2.9 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.28 155.77 0.12 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 111.251 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.1 p -78.35 -35.54 47.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.214 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -62.83 98.21 0.12 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.855 0.359 . . . . 0.0 110.994 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.434 HG21 ' CG ' ' A' ' 49' ' ' ASP . 17.3 m -58.03 -40.21 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.613 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.85 87.12 0.1 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 49' ' ' ASP . . . 100.32 -34.22 5.72 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.661 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 1.8 m-20 70.11 139.93 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.956 0.407 . . . . 0.0 111.383 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -111.03 -28.9 8.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.786 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.29 156.74 6.96 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.94 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.3 98.26 3.28 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.832 0.349 . . . . 0.0 111.362 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 54' ' ' TYR . 1.3 pt? -174.1 -42.8 0.01 OUTLIER 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.557 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.43 ' N ' ' HG ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -158.83 141.5 14.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.654 0.264 . . . . 0.0 111.234 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.06 142.05 29.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.176 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.467 ' CD2' ' HG2' ' A' ' 83' ' ' PRO . 2.0 t60 -110.68 135.06 51.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.636 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.499 HD13 ' CG1' ' A' ' 36' ' ' VAL . 1.5 pt -143.91 115.01 2.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -90.49 138.28 31.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.833 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.89 151.32 27.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.198 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -111.88 118.9 36.8 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.615 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HG2' ' CB ' ' A' ' 77' ' ' GLU . 2.0 mtt85 -121.69 145.52 47.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.909 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -67.9 -13.4 62.12 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.724 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.58 23.57 5.63 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.736 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -103.19 165.49 10.99 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.782 0.325 . . . . 0.0 110.793 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.33 125.08 25.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.54 95.45 0.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.83 149.03 25.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.101 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.591 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 8.1 tt -126.2 -61.13 1.24 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.203 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.659 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -86.11 44.81 3.38 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.129 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -151.11 72.93 1.08 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.761 0.28 . . . . 0.0 111.104 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.696 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -52.05 -28.01 15.76 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.635 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.22 34.78 0.93 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.756 0.313 . . . . 0.0 111.442 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.77 176.72 6.05 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.894 0.378 . . . . 0.0 111.242 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.67 32.05 3.54 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.668 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.63 158.82 10.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.557 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -76.39 0.59 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.743 0.306 . . . . 0.0 111.275 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.41 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 20.0 pt-20 -145.53 -162.65 1.55 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.972 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 78' ' ' LEU . 2.8 mm? -120.66 -45.12 2.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.487 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -156.61 169.14 25.35 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.61 HD11 HG22 ' A' ' 36' ' ' VAL . 2.5 tt -153.32 122.15 6.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.859 0.361 . . . . 0.0 110.605 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -150.7 135.84 10.11 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.285 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 6' ' ' PHE . 84.4 Cg_endo -78.94 146.55 20.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.671 2.248 . . . . 0.0 112.614 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.467 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 45.6 Cg_exo -56.32 145.36 78.52 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.808 2.339 . . . . 0.0 112.489 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 84' ' ' VAL . 12.5 p -165.74 119.99 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.977 0.418 . . . . 0.0 111.192 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m -142.66 135.86 28.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.853 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.14 -44.31 1.51 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.483 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.341 -1.255 . . . . 0.0 112.374 179.923 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.817 0.341 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -160.57 172.97 16.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.4 ' CE3' ' HG2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -151.7 140.84 21.26 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.417 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -137.62 151.9 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.388 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.733 ' CD1' HD22 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -147.45 151.11 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.095 0.474 . . . . 0.0 111.879 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.12 -175.61 5.92 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.049 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -58.48 -20.18 43.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.939 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.68 -43.14 12.38 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.979 0.418 . . . . 0.0 110.81 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.858 HD23 ' HB1' ' A' ' 41' ' ' ALA . 4.7 mp -105.17 -31.37 9.16 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.011 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -72.08 -4.3 28.11 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -36.67 84.7 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.668 0.27 . . . . 0.0 110.936 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.807 HG11 ' HB2' ' A' ' 43' ' ' GLU . 15.8 t -97.21 -46.11 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.813 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.25 -45.17 20.31 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.99 -29.55 7.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.114 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 t -167.49 117.14 0.82 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.669 0.271 . . . . 0.0 110.994 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.57 29.19 7.42 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.043 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.5 p -95.63 114.03 25.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.328 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 19' ' ' ARG . 3.6 t -122.7 161.72 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.215 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.409 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -126.81 152.58 46.77 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.744 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.574 HG21 ' OD2' ' A' ' 76' ' ' ASP . 19.2 t -102.3 120.33 51.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 0.0 110.776 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.33 -50.09 2.13 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.869 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.55 134.23 52.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.158 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -115.95 152.52 33.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.951 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.91 -81.62 0.15 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.963 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -82.71 -46.65 12.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.665 0.269 . . . . 0.0 111.125 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.64 116.16 4.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.443 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -83.66 172.86 11.88 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.085 HG11 ' HB1' ' A' ' 67' ' ' ALA . 39.0 t -76.71 -35.5 25.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.509 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.25 -32.44 9.64 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.353 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.84 -42.8 80.3 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.741 0.305 . . . . 0.0 110.775 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.62 -27.75 26.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.046 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.5 tp -62.45 -57.2 12.08 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.7 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.04 -40.42 76.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.237 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . . . -64.02 -52.1 61.07 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.794 0.33 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 3' ' ' TRP . 8.8 mp -68.88 -34.41 75.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.318 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 32' ' ' LEU . 21.2 t -57.4 -48.89 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.603 0.239 . . . . 0.0 111.023 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 9' ' ' LEU . . . 161.87 53.23 0.02 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.646 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 34' ' ' ALA . . . -65.83 -61.78 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.448 0.166 . . . . 0.0 110.744 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.413 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 2.5 m-70 -179.74 -62.92 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 39' ' ' HIS . 9.8 Cg_endo -52.27 -26.68 27.84 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.301 2.001 . . . . 0.0 112.064 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.858 ' HB1' HD23 ' A' ' 9' ' ' LEU . . . -62.41 -27.89 69.4 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -135.4 28.89 3.34 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.807 ' HB2' HG11 ' A' ' 12' ' ' VAL . 0.5 OUTLIER 71.16 150.34 0.09 Allowed 'General case' 0 C--N 1.342 0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 110.847 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.9 m -60.38 -43.09 96.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.523 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.62 148.33 29.19 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.805 0.335 . . . . 0.0 110.814 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 p -169.02 -43.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.417 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -172.9 106.79 0.16 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.673 0.273 . . . . 0.0 110.755 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.23 92.57 0.11 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.495 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -65.53 -52.15 54.73 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.572 0.225 . . . . 0.0 110.855 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.24 -28.9 69.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.079 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.25 -166.89 14.0 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.707 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.38 179.8 4.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.692 0.282 . . . . 0.0 110.927 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -35.84 59.86 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.134 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.15 128.97 48.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.72 0.295 . . . . 0.0 111.003 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.18 130.02 55.61 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -142.01 108.29 5.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.176 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.9 pp -150.29 127.72 2.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.49 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -100.51 162.56 12.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.063 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -135.62 152.64 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.649 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -107.86 131.04 54.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.427 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -112.4 145.46 40.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.202 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -3.63 25.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.895 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.77 23.57 5.57 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.902 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.27 157.71 16.01 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.817 0.342 . . . . 0.0 110.684 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.73 102.73 14.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.297 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.03 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.95 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 1.085 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -105.84 133.71 50.13 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.991 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.8 -69.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.107 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.03 64.26 1.73 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.479 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -140.73 47.29 1.75 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -51.7 -28.15 13.99 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.782 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.31 33.48 2.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.668 0.27 . . . . 0.0 111.258 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . . . -96.52 174.16 6.99 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.815 0.34 . . . . 0.0 111.461 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.54 -34.09 17.51 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.469 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -148.68 157.93 27.47 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.429 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.574 ' OD2' HG21 ' A' ' 20' ' ' VAL . 6.6 m-20 -109.32 -72.96 0.7 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.761 0.281 . . . . 0.0 110.644 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HG2' ' CE3' ' A' ' 3' ' ' TRP . 0.4 OUTLIER -139.53 -173.16 3.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.308 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -108.58 -53.22 2.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.611 0.243 . . . . 0.0 110.987 -179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -164.9 173.71 11.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 58' ' ' ASN . 1.0 OUTLIER -136.1 95.27 3.17 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.214 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -130.32 148.97 72.0 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.245 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.05 148.68 51.21 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.552 2.168 . . . . 0.0 112.545 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.53 134.01 19.83 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.656 2.237 . . . . 0.0 112.479 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 m -65.45 141.16 18.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.41 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.8 p -133.33 -72.04 0.51 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.83 -168.52 38.4 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.735 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.495 -1.17 . . . . 0.0 112.684 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.838 0.352 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -160.3 173.33 15.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.667 ' CE3' HD22 ' A' ' 35' ' ' LEU . 3.1 t90 -155.85 146.17 21.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.44 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.433 ' HG2' HG22 ' A' ' 17' ' ' THR . 24.7 mttt -138.07 144.81 41.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.015 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.612 HD21 HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -135.34 164.35 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.042 0.449 . . . . 0.0 111.375 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 5' ' ' LEU . 6.4 t80 -89.5 170.08 10.81 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.816 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.57 -9.24 57.92 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.529 ' HB3' HD12 ' A' ' 9' ' ' LEU . 1.2 t0 -52.48 -44.06 65.37 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 111.224 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.651 HD23 HD22 ' A' ' 42' ' ' LEU . 5.0 mp -107.49 -32.84 7.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.177 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -69.68 -7.06 35.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -40.6 91.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.543 0.211 . . . . 0.0 111.005 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 21.1 t -95.08 -46.89 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.522 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.07 -46.51 80.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.752 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.52 11.81 70.87 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.901 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -139.08 92.96 2.64 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -91.22 -42.79 10.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.181 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.433 HG22 ' HG2' ' A' ' 4' ' ' LYS . 5.8 p -96.64 145.42 25.78 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 120.718 0.294 . . . . 0.0 111.216 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -142.87 108.58 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.24 152.32 21.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.779 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.84 120.23 51.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.748 0.309 . . . . 0.0 111.032 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.34 -72.79 0.38 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.049 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.0 p -94.88 148.54 4.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.213 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.27 116.07 22.25 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.04 -139.31 3.89 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.635 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -107.01 36.12 2.78 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.845 0.355 . . . . 0.0 111.193 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.89 123.03 41.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.741 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -109.03 169.32 8.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.766 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 71' ' ' ALA . 40.8 t -74.18 -33.55 35.28 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.132 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.72 -36.92 9.87 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.086 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.37 -38.68 74.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 110.666 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.39 -23.21 22.24 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.752 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 36' ' ' VAL . 23.8 tp -63.53 -52.53 60.79 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.499 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -58.54 -41.87 86.54 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.447 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.68 -49.68 61.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.753 0.311 . . . . 0.0 111.206 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.667 HD22 ' CE3' ' A' ' 3' ' ' TRP . 8.6 mp -68.19 -33.35 74.28 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.466 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 32' ' ' LEU . 12.4 t -62.51 -48.89 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-O 120.705 0.288 . . . . 0.0 110.418 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.91 54.84 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.612 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -62.49 -61.64 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.465 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . 1.1 m170 155.02 -66.47 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.646 0.778 . . . . 0.0 110.423 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 39' ' ' HIS . 11.0 Cg_endo -54.17 -24.74 34.76 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.511 2.141 . . . . 0.0 111.805 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.531 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -61.45 -28.28 69.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.054 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.651 HD22 HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -142.47 22.8 2.0 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.89 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 61.97 160.06 0.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.246 0.546 . . . . 0.0 111.875 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -14.15 22.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.515 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.466 ' O ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -78.69 150.74 32.49 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 45' ' ' ARG . 8.5 p 45.38 34.33 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.169 0.509 . . . . 0.0 111.981 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.95 -60.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.088 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.3 69.27 1.99 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.565 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -69.77 165.19 21.94 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.574 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -82.15 -20.97 36.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.756 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.14 -152.51 1.99 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.596 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.82 91.49 2.71 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.845 0.355 . . . . 0.0 111.192 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tp -97.59 142.7 29.08 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.626 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.03 127.54 53.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.104 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.94 146.97 48.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.075 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 57' ' ' ILE . 66.3 m-70 -111.42 152.76 27.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.637 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.561 HG22 ' HB3' ' A' ' 82' ' ' PRO . 1.7 pt -156.55 124.99 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.761 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -90.56 137.42 32.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -124.02 157.99 30.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.31 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.84 122.21 44.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.075 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 145.45 50.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.743 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.94 -19.42 65.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.663 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.28 23.5 5.74 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.743 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.94 165.74 23.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.603 0.24 . . . . 0.0 111.006 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.15 124.64 29.42 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.289 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 76' ' ' ASP . . . -92.22 146.79 23.43 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.368 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.1 -177.75 6.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.968 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -136.3 -45.02 0.62 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.225 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.409 ' N ' ' HG ' ' A' ' 68' ' ' LEU . . . -94.53 31.97 6.38 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.787 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -164.7 91.46 0.57 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.787 0.327 . . . . 0.0 111.221 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.66 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -64.83 -17.63 64.41 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.835 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 t -88.83 33.92 0.78 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 111.246 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.68 168.84 12.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.213 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.65 80.36 8.01 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.64 149.87 3.21 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.985 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 20.0 p-10 -133.3 -49.52 0.85 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.573 0.225 . . . . 0.0 111.335 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.459 ' HG3' ' CD1' ' A' ' 3' ' ' TRP . 0.5 OUTLIER -165.04 -172.43 2.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.56 179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.19 -45.18 2.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.516 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -170.35 174.02 5.43 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.343 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.641 ' HB2' HG12 ' A' ' 59' ' ' VAL . 6.0 tt -152.93 117.72 5.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.324 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -141.46 138.28 17.34 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.568 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.561 ' HB3' HG22 ' A' ' 57' ' ' ILE . 77.8 Cg_endo -77.71 169.55 20.61 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.712 2.274 . . . . 0.0 112.452 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.8 131.97 42.7 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.817 2.345 . . . . 0.0 112.038 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.6 t -62.87 133.67 28.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.177 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.07 170.27 7.97 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.958 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.75 -36.61 0.12 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.44 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.615 -1.103 . . . . 0.0 112.692 179.929 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.872 0.368 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.436 ' HG2' ' HG3' ' A' ' 19' ' ' ARG . 6.3 mt-10 -146.95 166.17 27.6 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.497 ' HE1' HD13 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -150.89 137.69 18.97 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.025 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.511 ' O ' HD22 ' A' ' 5' ' ' LEU . 34.7 mttt -134.92 148.86 50.16 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.839 HD11 HD23 ' A' ' 80' ' ' LEU . 3.1 mm? -130.9 152.44 50.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.742 0.306 . . . . 0.0 111.257 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -174.95 3.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 11' ' ' GLU . . . -57.03 -23.04 43.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.854 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.502 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -48.72 -37.8 19.76 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.715 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.74 HD22 HD13 ' A' ' 42' ' ' LEU . 10.3 mt -120.57 -34.96 3.49 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.623 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.06 -2.8 22.71 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -91.14 -29.16 17.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.797 0.332 . . . . 0.0 110.36 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 41' ' ' ALA . 97.3 t -93.11 -35.89 7.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.357 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -94.42 -43.5 8.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.62 0.247 . . . . 0.0 111.1 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.98 -40.34 1.75 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.356 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.34 141.12 2.43 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -137.57 27.04 2.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.45 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 p -96.45 112.01 23.91 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 110.401 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.97 157.99 41.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.408 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.436 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -129.61 148.91 51.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.584 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.3 120.22 56.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.907 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.35 -52.02 0.82 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.725 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -90.67 153.31 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.32 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.6 142.22 35.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.086 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.19 -111.54 0.27 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.689 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.98 38.25 4.18 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.054 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.03 133.13 56.35 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.981 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -113.29 167.94 10.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.22 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 71' ' ' ALA . 27.3 t -74.99 -39.18 44.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.943 0.401 . . . . 0.0 110.213 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -83.19 -34.38 20.83 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.221 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.24 -45.83 83.58 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.832 0.349 . . . . 0.0 110.405 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -77.12 -26.74 53.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.563 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.719 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.1 tp -63.37 -61.07 2.59 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.258 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.65 -34.25 72.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.114 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.943 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -69.05 -50.6 47.06 Favored 'General case' 0 C--N 1.335 -0.046 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.186 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 31' ' ' ALA . 11.1 mp -68.26 -19.5 64.73 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.703 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 32' ' ' LEU . 70.1 t -83.78 -44.81 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -133.42 -34.37 0.32 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.273 -0.965 . . . . 0.0 114.476 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.943 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -69.67 -0.94 7.69 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -121.81 64.87 18.11 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 120.738 0.304 . . . . 0.0 110.821 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 86.4 Cg_exo -50.64 -18.9 4.4 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.887 2.392 . . . . 0.0 112.942 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.767 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -49.47 -31.63 10.39 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.74 HD13 HD22 ' A' ' 9' ' ' LEU . 4.1 pp -106.68 -6.84 17.62 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -158.95 70.97 0.51 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.868 0.365 . . . . 0.0 110.524 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -31.6 66.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.346 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -134.85 125.03 26.01 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.392 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.22 37.88 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.87 0.367 . . . . 0.0 111.313 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 60.65 99.21 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.394 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.13 -36.03 4.48 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.508 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 70.52 -66.32 0.29 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.622 0.369 . . . . 0.0 111.101 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.27 31.4 3.4 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 111.154 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.85 -75.55 1.22 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.335 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.45 144.56 21.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 0.0 111.034 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tp -92.13 95.68 9.89 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.487 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -124.72 123.75 40.67 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.048 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -111.75 114.71 27.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.72 103.51 5.44 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.027 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 pt -149.35 121.76 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.831 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -82.81 153.32 25.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 80' ' ' LEU . 13.7 p -135.58 145.95 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.577 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.418 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -103.29 120.97 41.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.597 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.418 ' N ' HD13 ' A' ' 60' ' ' LEU . 62.1 mtt180 -132.17 142.47 49.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.717 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -62.74 -20.56 65.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.482 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.72 23.75 5.52 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.76 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.18 163.8 12.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 110.633 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.15 124.55 36.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.26 159.81 36.75 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.78 169.26 9.03 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.231 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.433 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -103.68 -35.3 8.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.173 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.45 28.37 8.36 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.077 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 27' ' ' THR . 2.1 mt-10 -173.44 103.16 0.12 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.826 0.313 . . . . 0.0 110.862 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -82.2 6.32 17.01 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.93 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.72 1.36 26.81 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.8 -176.2 1.03 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.787 0.327 . . . . 0.0 111.34 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.97 83.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.448 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.34 172.61 43.72 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.663 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.0 -70.22 0.73 Allowed 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.67 -165.83 1.1 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.529 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tp -108.57 -50.83 2.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.782 0.325 . . . . 0.0 110.751 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -155.38 171.57 19.66 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.339 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.839 HD23 HD11 ' A' ' 5' ' ' LEU . 11.5 tp -135.54 110.56 8.85 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.594 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -129.13 124.56 22.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.34 133.61 13.38 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.647 2.231 . . . . 0.0 112.52 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.72 134.2 18.01 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.726 2.284 . . . . 0.0 112.53 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 84' ' ' VAL . 11.9 p -91.61 112.72 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 110.98 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 m -92.15 -51.68 5.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.356 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.7 -135.39 1.58 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.331 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.231 179.826 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.738 0.304 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -148.03 167.05 25.93 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.07 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' THR . 54.4 m95 -145.96 138.59 25.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.942 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -138.51 136.19 35.86 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 80' ' ' LEU . 4.4 tp -130.91 153.7 48.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 111.23 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.13 173.29 8.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.48 -15.06 62.28 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.925 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.52 -35.38 72.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.933 0.397 . . . . 0.0 110.524 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -112.11 -40.56 4.17 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.763 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.75 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -64.74 -13.94 56.85 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -74.95 -27.12 60.06 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.505 -0.122 . . . . 0.0 111.232 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -90.79 -42.25 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.483 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -92.19 -42.85 9.66 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.76 -26.76 11.21 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.648 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.45 126.96 49.66 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.7 0.286 . . . . 0.0 111.244 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.75 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 1.7 ptt-85 -118.42 -58.4 1.98 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.53 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 3' ' ' TRP . 9.1 p -93.33 136.33 33.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -142.32 124.34 13.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.8 132.83 56.59 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 22' ' ' VAL . 19.0 t -148.68 121.31 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.338 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.61 32.64 2.76 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.07 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.516 ' H ' HG12 ' A' ' 20' ' ' VAL . 11.1 p -147.34 150.69 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.104 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -115.71 125.15 52.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.84 88.11 0.14 Allowed Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.397 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.41 26.02 13.64 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.692 0.282 . . . . 0.0 111.592 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.66 116.07 23.91 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.788 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -91.03 169.01 11.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.558 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.885 HG11 ' HB1' ' A' ' 67' ' ' ALA . 22.3 t -78.75 -33.53 16.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.642 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.615 ' HA3' HD13 ' A' ' 68' ' ' LEU . . . -86.06 -27.49 31.02 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.449 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.34 -42.69 82.44 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.672 0.272 . . . . 0.0 110.975 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -83.16 -38.16 22.74 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.635 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.3 tt -53.23 -54.98 28.15 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -59.32 -41.09 88.27 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.169 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -59.47 -56.5 21.17 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.58 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.6 mt -62.4 -20.56 64.59 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.167 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.801 HG13 HG21 ' A' ' 57' ' ' ILE . 65.5 t -88.59 -48.52 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 111.571 0.211 . . . . 0.0 111.571 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.56 -30.64 0.04 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.478 -0.867 . . . . 0.0 114.661 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.768 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -69.54 -1.38 8.56 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.591 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 8.7 t-80 -133.04 72.8 76.15 Favored Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -51.44 -15.25 2.37 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.32 2.68 . . . . 0.0 113.967 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.63 -28.92 23.45 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.581 ' HB2' HD23 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -100.07 -13.22 19.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -140.0 114.71 9.44 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.246 -0.284 . . . . 0.0 111.425 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -8.56 53.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.085 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 60.63 58.64 2.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.998 0.428 . . . . 0.0 111.017 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 m -96.44 34.92 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.553 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -167.15 -56.05 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.74 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.15 60.32 4.81 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.661 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.2 -49.27 11.88 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.708 0.29 . . . . 0.0 110.683 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.76 31.91 2.78 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.7 -100.22 0.19 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.675 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 56.77 -167.74 0.11 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.092 0.157 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 66.22 -75.69 0.05 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.455 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -111.9 125.52 54.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.031 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.67 158.37 31.72 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.179 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -137.21 113.39 9.9 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.414 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.801 HG21 HG13 ' A' ' 36' ' ' VAL . 1.6 pt -144.83 103.87 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.9 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -85.23 144.85 27.88 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.194 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 p -140.58 140.58 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.939 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -93.61 139.49 30.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.7 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.422 ' H ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -121.36 146.14 47.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.102 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.541 ' HB3' HD23 ' A' ' 78' ' ' LEU . 12.2 p-10 -84.96 19.28 2.17 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.181 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.32 23.72 5.65 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.885 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -108.42 155.8 20.16 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.737 0.303 . . . . 0.0 111.032 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 102.81 14.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.242 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.01 109.24 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.821 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.885 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -98.51 133.71 42.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.625 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.615 HD13 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -171.26 -68.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 27' ' ' THR . . . -100.4 49.19 1.14 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.573 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' HB2' HG21 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -108.66 31.35 5.7 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -54.59 -34.95 62.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.215 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.63 31.25 2.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.527 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.47 150.56 32.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.6 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.14 72.45 2.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 110.783 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.2 147.07 6.77 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.469 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.16 -73.25 0.69 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.689 0.28 . . . . 0.0 110.766 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 2.7 pt-20 -148.9 -169.58 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.543 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -112.11 -42.65 3.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.791 179.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.22 166.95 31.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.205 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 5' ' ' LEU . 6.1 tt -146.06 99.82 3.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.785 0.326 . . . . 0.0 110.842 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -151.47 143.23 15.91 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.413 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.56 153.47 23.36 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.855 2.37 . . . . 0.0 112.552 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.67 -45.25 2.44 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.576 2.184 . . . . 0.0 112.551 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.53 118.92 4.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.588 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.2 p -85.66 123.99 31.69 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.723 0.297 . . . . 0.0 110.879 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.91 55.19 0.52 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.61 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.242 -1.31 . . . . 0.0 112.894 -179.844 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.403 ' HB3' ' HG2' ' A' ' 19' ' ' ARG . 3.7 pt-20 -146.17 164.33 32.56 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.915 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -147.4 118.58 7.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.974 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.474 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 23.3 mttm -106.16 141.96 36.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.642 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 11.6 tp -132.49 144.42 50.43 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.889 0.376 . . . . 0.0 111.412 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.48 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -82.57 172.43 12.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.265 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.05 66.36 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.008 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -34.46 53.31 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.573 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 3.9 mp -113.24 -38.05 4.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.978 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 -13.05 45.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -79.28 -27.28 42.26 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.439 ' HB ' ' C ' ' A' ' 42' ' ' LEU . 16.4 t -87.13 -39.44 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -96.43 -38.09 10.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.22 27.42 8.19 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.455 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.3 t -140.91 128.99 22.06 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.634 0.255 . . . . 0.0 110.758 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.642 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 3.2 ptm180 -113.79 -75.08 0.6 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.543 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 3.5 p -97.43 134.06 41.19 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.792 0.329 . . . . 0.0 111.409 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -145.27 129.83 12.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.843 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.403 ' HG2' ' HB3' ' A' ' 2' ' ' GLU . 67.0 mtm-85 -100.77 139.21 36.77 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.423 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.81 120.35 52.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.815 0.341 . . . . 0.0 111.261 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.57 -36.53 5.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.93 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.59 149.98 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.268 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -108.51 166.27 10.9 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.149 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.01 -124.29 0.87 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.633 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.51 34.52 2.19 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.939 0.399 . . . . 0.0 111.004 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.33 120.12 37.22 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.588 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.472 ' C ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -95.66 -176.94 3.89 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.009 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 67' ' ' ALA . 21.3 t -75.2 -42.22 44.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.518 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -75.64 -26.7 64.64 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.923 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -50.93 -45.24 60.41 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.489 0.316 . . . . 0.0 110.876 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.91 -32.23 20.28 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.6 tt -56.71 -60.73 3.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 110.098 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -60.87 -40.97 94.97 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.305 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -53.49 -56.02 20.51 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.228 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.57 -29.84 70.88 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.956 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 32' ' ' LEU . 92.0 t -73.62 -53.02 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.585 0.231 . . . . 0.0 110.827 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.02 20.58 0.06 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.248 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.742 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -105.15 -1.17 25.81 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.44 0.62 . . . . 0.0 111.579 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.516 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -129.32 72.65 81.96 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.44 -20.6 1.65 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.371 2.714 . . . . 0.0 113.551 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.52 -32.26 17.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.8 OUTLIER -99.7 -15.92 18.34 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.467 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -165.07 95.73 0.69 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.705 0.288 . . . . 0.0 111.161 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.78 -48.92 22.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.282 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -155.46 133.63 11.56 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.718 0.294 . . . . 0.0 110.839 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.49 -44.3 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.733 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -171.95 -67.41 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.964 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.42 99.57 1.01 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.595 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.36 -62.81 1.5 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.618 0.247 . . . . 0.0 111.146 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.87 -26.41 13.76 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.527 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.73 82.07 0.31 Allowed Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.767 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 59.85 80.0 0.21 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.985 0.421 . . . . 0.0 111.253 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.1 tp -96.0 97.5 9.65 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.692 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -147.9 116.99 6.83 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.277 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -147.17 149.7 33.49 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -87.49 157.64 19.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.594 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.637 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -153.5 124.23 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.67 0.272 . . . . 0.0 110.787 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -97.58 136.9 37.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 110.862 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 p -140.4 141.09 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.358 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 60' ' ' LEU . 9.8 tp -97.81 134.51 40.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 145.84 47.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -55.43 -21.26 15.12 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.7 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.81 23.76 5.49 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.41 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.85 165.93 13.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.369 0.267 . . . . 0.0 110.468 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.38 123.62 16.09 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.771 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.37 102.19 0.08 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.338 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.65 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -77.25 160.48 28.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.073 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.518 ' CD2' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -158.15 22.53 0.25 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.499 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.19 14.45 2.33 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.133 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.643 ' HG2' HG22 ' A' ' 72' ' ' THR . 2.0 tt0 178.54 96.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.717 0.294 . . . . 0.0 110.41 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.472 ' HB2' ' C ' ' A' ' 27' ' ' THR . . . -71.41 -6.66 41.94 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.894 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.643 HG22 ' HG2' ' A' ' 70' ' ' GLU . 13.4 t -75.23 1.52 13.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.89 -177.73 0.86 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.357 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 77.91 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.47 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.8 160.94 9.72 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.667 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.43 -78.79 0.59 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.674 0.273 . . . . 0.0 110.27 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -131.76 -177.01 4.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 110.823 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.76 -37.86 6.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.842 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -174.25 166.39 4.09 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.972 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.47 110.36 7.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.895 0.379 . . . . 0.0 110.602 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.459 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 23.3 m-85 -112.73 161.47 26.29 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.101 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 6' ' ' PHE . 96.6 Cg_endo -81.96 169.48 14.69 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.671 2.247 . . . . 0.0 112.584 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.9 -42.54 6.24 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.819 2.346 . . . . 0.0 112.547 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.2 t -82.54 114.52 23.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.156 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 p -103.47 -34.62 8.64 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.158 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.47 173.55 54.95 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.856 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.29 -1.283 . . . . 0.0 112.606 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.788 0.328 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -160.68 163.64 32.32 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.166 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.516 ' CZ2' HD22 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -155.36 174.68 14.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.997 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 27.0 mttm -137.13 152.98 50.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.132 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.717 HD11 HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -141.51 132.38 25.91 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.811 0.338 . . . . 0.0 111.528 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.418 ' N ' HD13 ' A' ' 5' ' ' LEU . 1.1 t80 -81.35 175.77 10.3 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.112 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.82 -10.97 60.4 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.41 -46.31 62.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.901 0.381 . . . . 0.0 110.911 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -112.44 -36.03 5.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.121 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.95 -10.46 13.71 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -40.7 74.4 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.485 0.183 . . . . 0.0 111.067 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.834 HG11 ' HB2' ' A' ' 43' ' ' GLU . 4.2 t -94.51 -45.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.532 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 41' ' ' ALA . . . -65.34 -46.75 79.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.09 11.24 61.61 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.546 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.3 m -116.83 129.73 56.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.773 0.32 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -111.73 -85.91 0.56 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.728 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.7 p -102.66 134.37 46.14 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.571 0.224 . . . . 0.0 111.405 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 t -147.75 154.39 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.031 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 2' ' ' GLU . 1.3 mtt85 -108.45 152.27 24.93 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.617 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.0 120.32 51.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.072 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.81 -46.43 0.95 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.388 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 m -87.37 122.15 38.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.444 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -116.45 129.36 56.17 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.096 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.21 -125.63 0.77 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.651 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.54 -45.67 91.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.581 0.229 . . . . 0.0 111.173 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.44 122.0 22.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.676 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -79.19 171.05 15.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.289 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.874 HG13 ' HA ' ' A' ' 71' ' ' ALA . 8.7 m -74.75 -37.08 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.502 ' HA3' HD23 ' A' ' 68' ' ' LEU . . . -80.27 -33.23 32.73 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.937 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -50.98 -47.5 61.38 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.78 0.324 . . . . 0.0 110.831 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.21 -25.8 33.89 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.886 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.797 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -63.1 -60.25 3.69 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.8 -36.57 72.38 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.091 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -62.61 -52.28 63.99 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.758 0.313 . . . . 0.0 110.267 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.516 HD22 ' CZ2' ' A' ' 3' ' ' TRP . 5.6 mp -68.9 -33.26 73.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.984 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 32' ' ' LEU . 41.6 t -55.66 -51.15 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.681 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' HD22 ' A' ' 9' ' ' LEU . . . 163.66 49.73 0.02 OUTLIER Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.959 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -82.19 -61.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.426 0.155 . . . . 0.0 110.588 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.432 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER 170.87 -58.78 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.78 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 39' ' ' HIS . 54.4 Cg_exo -50.67 -29.25 24.9 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.206 1.937 . . . . 0.0 111.914 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.62 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -61.98 -26.09 68.01 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.492 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.675 HD22 HD23 ' A' ' 9' ' ' LEU . 1.9 pt? -139.99 27.59 2.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.714 0.292 . . . . 0.0 110.765 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.834 ' HB2' HG11 ' A' ' 12' ' ' VAL . 3.3 tt0 64.78 165.61 0.16 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.201 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.1 p -69.68 -41.83 74.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.582 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.09 129.1 6.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.731 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.87 -37.87 11.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.995 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -154.05 35.64 0.43 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.204 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.91 97.6 0.38 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.221 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -61.37 142.94 56.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.827 0.346 . . . . 0.0 111.401 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.41 -28.87 65.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.631 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.62 62.76 0.63 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.784 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -123.98 118.23 26.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.564 0.221 . . . . 0.0 110.704 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.5 79.28 5.54 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.596 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.1 134.07 19.17 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.324 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.98 119.27 12.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -143.19 133.14 24.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.187 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.8 tt -169.88 146.9 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.46 155.33 16.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.871 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.556 HG23 ' HG ' ' A' ' 80' ' ' LEU . 11.6 p -140.54 149.02 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.365 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.59 123.11 49.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.814 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.546 ' NH1' ' HB2' ' A' ' 66' ' ' ALA . 3.6 tpp85 -114.16 144.41 43.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.818 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -74.12 -16.35 61.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.521 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.7 23.26 6.0 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.83 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.48 165.92 11.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.717 0.294 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.25 124.91 19.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.971 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.546 ' HB2' ' NH1' ' A' ' 61' ' ' ARG . . . -67.89 87.79 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.964 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.46 ' HB1' HG21 ' A' ' 28' ' ' VAL . . . -70.24 142.76 52.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.265 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.502 HD23 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -141.61 -59.24 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.005 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.594 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -94.36 36.69 3.66 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.67 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 73' ' ' ALA . 4.7 pt-20 -152.79 90.81 1.49 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.698 0.285 . . . . 0.0 111.285 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.874 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -59.12 -24.51 63.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.516 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.92 33.56 0.78 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.686 0.279 . . . . 0.0 111.571 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . . . -85.33 171.18 12.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.859 0.362 . . . . 0.0 111.674 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.1 92.97 3.93 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.023 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.07 122.41 3.81 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.892 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -107.18 -65.27 1.11 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.709 0.29 . . . . 0.0 111.003 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -162.95 -159.37 0.54 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.584 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.8 tp -123.29 -53.11 1.83 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.558 0.218 . . . . 0.0 110.951 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -152.8 153.54 33.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.196 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.597 HD11 HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -132.93 101.37 5.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.752 0.31 . . . . 0.0 110.73 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -146.81 145.13 21.66 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.469 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.16 150.42 65.9 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.668 2.245 . . . . 0.0 112.103 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.78 60.75 6.81 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.589 2.193 . . . . 0.0 112.074 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.33 135.7 61.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.02 -57.8 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.094 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.97 125.02 7.42 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.289 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 CA-C-O 118.654 -1.081 . . . . 0.0 112.854 179.889 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -135.48 153.22 51.82 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 111.635 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.441 ' CZ2' HD13 ' A' ' 80' ' ' LEU . 1.9 t90 -155.48 148.28 24.29 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.112 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.452 ' HG2' HG22 ' A' ' 17' ' ' THR . 2.9 mttp -137.98 146.61 43.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.351 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.843 HD22 ' HB2' ' A' ' 9' ' ' LEU . 1.1 tt -135.54 165.1 26.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.974 0.416 . . . . 0.0 111.028 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.536 ' N ' HD23 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -80.79 -178.61 6.89 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.205 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.62 -8.73 50.0 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.29 -40.22 61.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.681 0.276 . . . . 0.0 111.431 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.843 ' HB2' HD22 ' A' ' 5' ' ' LEU . 4.7 mp -100.24 -33.23 10.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.596 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -71.52 -7.52 48.12 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -79.9 -29.57 39.89 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.383 0.135 . . . . 0.0 111.22 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 4.9 t -98.03 -49.19 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -104.48 -34.79 8.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.77 26.6 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.616 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.465 ' HB2' HD21 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -125.39 79.0 1.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.969 0.414 . . . . 0.0 110.772 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 5' ' ' LEU . 8.0 ptt85 -88.24 -43.82 11.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.98 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.452 HG22 ' HG2' ' A' ' 4' ' ' LYS . 6.1 p -92.99 139.28 30.68 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.824 0.345 . . . . 0.0 110.97 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -129.71 107.67 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.79 152.53 20.77 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.681 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.482 HG11 ' O ' ' A' ' 71' ' ' ALA . 29.0 t -102.08 120.28 51.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.39 -71.05 0.7 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -89.46 145.78 6.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.072 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HB2' HG21 ' A' ' 72' ' ' THR . 25.9 t0 -104.76 151.66 23.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.217 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.09 -102.97 0.18 Allowed Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.418 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.71 -27.35 11.36 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.603 0.224 . . . . 0.0 111.603 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 129.14 39.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.764 0.316 . . . . 0.0 111.336 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.468 HG22 ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -120.78 174.72 6.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.04 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.595 HG11 ' OD1' ' A' ' 76' ' ' ASP . 15.2 t -75.99 -39.59 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.126 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' A' ' 68' ' ' LEU . . . -76.41 -31.34 54.84 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.791 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -56.1 -48.38 76.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.716 0.293 . . . . 0.0 110.682 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.95 -26.84 39.89 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.125 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.1 tt -59.45 -58.76 7.19 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.84 -42.76 94.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.052 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.78 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -52.87 -56.15 17.99 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.24 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.546 ' O ' HD21 ' A' ' 9' ' ' LEU . 7.7 mp -62.14 -29.72 70.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.778 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 32' ' ' LEU . 84.0 t -74.44 -53.4 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.005 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.26 15.52 0.06 OUTLIER Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.056 -1.068 . . . . 0.0 114.806 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.78 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -105.16 -1.25 25.69 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.704 0.752 . . . . 0.0 111.655 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.516 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -137.77 75.31 43.39 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-O 120.945 0.403 . . . . 0.0 110.282 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -53.59 -14.22 4.77 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.981 2.454 . . . . 0.0 113.252 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.37 -28.59 20.17 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.503 HD13 HD23 ' A' ' 9' ' ' LEU . 1.2 mp -100.67 -12.99 18.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.99 109.88 12.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.647 0.26 . . . . 0.0 111.604 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -90.18 -41.31 11.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.241 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 62.67 77.22 0.34 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.606 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' HD1' ' A' ' 47' ' ' PHE . 20.0 t -92.41 -66.61 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.315 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.564 ' HD1' HG12 ' A' ' 46' ' ' VAL . 5.5 m-85 -136.14 76.67 1.62 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.933 0.397 . . . . 0.0 110.729 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.26 -86.1 0.5 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.377 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -147.05 164.05 34.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.739 0.304 . . . . 0.0 110.867 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -115.51 31.67 6.56 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.962 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.18 83.62 0.06 OUTLIER Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.781 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.66 128.02 34.66 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.745 0.307 . . . . 0.0 111.357 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.53 161.42 7.75 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.023 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 112.72 25.52 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.961 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.51 154.48 43.67 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.195 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -135.35 102.86 5.29 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.302 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.85 -49.88 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.985 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.02 -167.06 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.212 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.638 ' CG1' HD12 ' A' ' 80' ' ' LEU . 3.7 m -90.61 151.58 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 111.131 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 60' ' ' LEU . 7.5 tp -129.81 150.56 51.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 111.309 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.516 ' HG3' ' HB3' ' A' ' 77' ' ' GLU . 3.5 mtt180 -143.14 146.34 33.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.962 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -52.44 -21.31 3.55 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.68 23.78 5.52 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.775 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -130.21 165.93 21.35 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.733 0.301 . . . . 0.0 110.739 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.52 121.65 10.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.252 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.08 144.56 56.04 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.387 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -92.52 -177.6 4.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HA ' ' HB ' ' A' ' 28' ' ' VAL . 5.2 tt -168.64 -50.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.652 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.51 25.39 21.1 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.869 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.468 ' N ' HG22 ' A' ' 27' ' ' THR . 1.2 tt0 -171.59 96.78 0.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.839 0.32 . . . . 0.0 110.979 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.482 ' O ' HG11 ' A' ' 20' ' ' VAL . . . -58.17 -26.82 63.2 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.694 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 23' ' ' ASP . 1.0 OUTLIER -91.11 34.03 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.721 0.296 . . . . 0.0 111.515 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.67 178.58 6.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.694 0.283 . . . . 0.0 111.478 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.41 72.0 9.47 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.937 0.398 . . . . 0.0 111.243 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.65 145.0 2.23 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.261 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.595 ' OD1' HG11 ' A' ' 28' ' ' VAL . 3.2 m-20 -124.12 -79.07 0.61 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.792 0.33 . . . . 0.0 110.852 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 1.4 pt-20 -141.15 -177.69 5.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.47 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.74 -52.94 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.632 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB1' ' CE2' ' A' ' 81' ' ' PHE . . . -159.34 174.35 14.88 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.638 HD12 ' CG1' ' A' ' 59' ' ' VAL . 3.1 tt -153.35 118.11 5.02 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.839 0.352 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.442 ' CE2' ' HB1' ' A' ' 79' ' ' ALA . 21.0 m-85 -139.76 108.11 7.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.886 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.72 158.17 50.9 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.831 2.354 . . . . 0.0 112.593 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -87.42 32.27 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.074 2.516 . . . . 0.0 113.192 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p 38.43 84.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.239 0.616 . . . . 0.0 112.295 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 t -85.42 128.73 34.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.32 -162.83 54.32 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.719 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.068 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.964 0.412 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -144.29 169.18 18.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.529 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.482 ' CZ3' HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -155.51 142.4 19.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.215 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.582 ' HG2' HG22 ' A' ' 17' ' ' THR . 8.2 mtmm -138.77 145.89 40.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.945 HD22 ' HB2' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -149.32 164.63 34.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 111.907 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.604 ' N ' HD23 ' A' ' 5' ' ' LEU . 2.1 t80 -85.79 179.79 6.98 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.496 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -63.04 -13.69 38.76 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.2 -34.69 23.57 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.716 0.293 . . . . 0.0 110.748 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.945 ' HB2' HD22 ' A' ' 5' ' ' LEU . 4.9 mp -105.07 -10.26 17.29 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.678 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.692 ' HB2' ' HG2' ' A' ' 16' ' ' ARG . . . -93.23 -2.24 55.34 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -35.83 73.66 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 56.1 t -97.65 -49.92 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.725 ' HB3' ' HA ' ' A' ' 41' ' ' ALA . . . -102.47 -34.38 9.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.99 25.79 28.27 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.313 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.17 98.33 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.874 0.369 . . . . 0.0 111.136 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.692 ' HG2' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -99.07 -45.3 5.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.075 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.582 HG22 ' HG2' ' A' ' 4' ' ' LYS . 11.8 p -93.47 147.7 22.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.144 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.24 113.74 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.168 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -105.7 141.83 36.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.836 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.56 120.5 56.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.085 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.28 -45.08 1.69 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.321 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.3 t -86.84 137.41 20.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -116.98 172.32 7.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.273 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.97 -91.13 0.13 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.24 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.91 -35.16 7.39 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.529 0.204 . . . . 0.0 111.115 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.59 135.81 55.54 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 111.14 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.874 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -110.07 -179.74 3.87 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.891 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.903 HG13 ' HA ' ' A' ' 71' ' ' ALA . 12.4 m -79.91 -35.2 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.785 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' HA3' HD23 ' A' ' 68' ' ' LEU . . . -91.29 -23.4 29.36 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.415 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.36 -40.27 96.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.704 0.288 . . . . 0.0 110.991 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -81.22 -39.67 25.02 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.707 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.616 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.6 tt -53.29 -57.13 11.64 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.74 0.305 . . . . 0.0 110.435 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.3 -34.75 75.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.47 -52.97 26.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.482 HD12 ' CZ3' ' A' ' 3' ' ' TRP . 12.4 mt -63.37 -26.22 68.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.317 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 32' ' ' LEU . 62.1 t -91.01 -42.6 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.58 0.229 . . . . 0.0 111.569 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.91 -34.54 90.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.102 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB3' ' HD3' ' A' ' 40' ' ' PRO . . . -104.95 -41.34 5.63 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.567 ' HB3' HD11 ' A' ' 42' ' ' LEU . 27.9 m170 63.16 49.17 1.07 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.345 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 39' ' ' HIS . 9.9 Cg_endo -53.57 -24.21 28.22 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.231 1.954 . . . . 0.0 112.109 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.725 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . . . -58.85 -36.17 74.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.532 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 39' ' ' HIS . 1.4 pp -120.59 1.86 10.63 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.276 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -132.8 78.14 1.78 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.794 0.33 . . . . 0.0 110.952 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.2 p -81.46 -44.28 17.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.706 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.86 99.44 0.77 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.001 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.17 -72.03 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.377 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -167.01 -46.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.409 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.52 -51.34 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.715 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -175.06 149.92 1.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.0 110.575 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.99 -28.99 63.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.51 111.31 0.29 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.778 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -102.84 136.2 43.1 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.744 0.307 . . . . 0.0 111.0 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -126.07 -46.01 1.69 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.462 ' HB2' HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -156.99 112.39 2.85 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.794 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -146.35 138.88 25.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -104.78 126.89 52.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.971 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 2.0 pp -151.24 132.09 4.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.334 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -90.83 143.29 26.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.795 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.491 ' CG2' HD12 ' A' ' 80' ' ' LEU . 14.7 p -140.83 150.43 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 111.771 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -115.37 128.93 56.41 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.826 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.49 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -101.78 145.92 28.49 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.059 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -20.98 59.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.713 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.48 23.66 5.62 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.891 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -95.84 162.19 13.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.082 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.66 102.5 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.974 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 49.91 75.88 0.15 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.983 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.32 133.99 33.62 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.805 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.43 HD23 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -161.27 -71.3 0.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.318 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.67 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -90.0 53.78 3.62 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.769 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 10.9 tt0 -159.4 72.94 0.56 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.752 0.31 . . . . 0.0 111.279 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.903 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -60.35 -28.66 68.35 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.339 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.31 36.38 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.345 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . . . -92.77 -178.39 4.83 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.956 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.12 68.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.485 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.94 157.76 9.11 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.505 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.518 ' OD2' HD12 ' A' ' 32' ' ' LEU . 15.4 t70 -95.49 -67.52 0.85 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.561 0.22 . . . . 0.0 110.871 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.73 -179.88 6.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.231 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 60' ' ' LEU . 11.0 mt -113.67 -47.72 2.97 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.602 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.16 169.87 22.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.102 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD12 ' CG2' ' A' ' 59' ' ' VAL . 7.6 tt -153.89 95.44 1.87 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.055 0.455 . . . . 0.0 110.645 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -131.12 144.96 55.66 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.254 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 59.8 Cg_endo -72.2 154.7 56.84 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.519 2.146 . . . . 0.0 112.109 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 39.7 Cg_exo -60.85 -172.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.872 2.381 . . . . 0.0 112.497 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 84' ' ' VAL . 9.9 p -141.88 112.06 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.973 0.415 . . . . 0.0 111.579 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.58 -174.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.418 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.72 32.66 26.6 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.834 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.639 -1.09 . . . . 0.0 112.852 179.866 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -146.52 159.97 42.73 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.496 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 41.8 m95 -143.51 128.34 18.33 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.643 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.517 ' C ' HD22 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -129.4 149.83 51.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.482 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 16' ' ' ARG . 4.0 mm? -126.66 144.95 50.75 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.644 0.259 . . . . 0.0 111.051 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -82.44 176.67 9.23 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 11' ' ' GLU . . . -52.34 -31.97 35.98 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.564 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.441 ' C ' HD13 ' A' ' 9' ' ' LEU . 1.1 t0 -49.45 -35.17 18.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 110.776 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.764 HD12 HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -109.24 -32.85 7.04 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.393 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.37 -2.51 49.56 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 28.1 tt0 -68.38 -34.89 76.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.775 0.322 . . . . 0.0 110.724 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' CG1' ' HB2' ' A' ' 44' ' ' SER . 20.5 t -94.87 -49.36 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.727 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 -38.25 63.0 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.27 -24.24 29.87 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.701 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.02 96.13 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.767 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.6 28.18 6.27 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.143 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 4' ' ' LYS . 11.1 p -92.09 132.76 36.34 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.647 0.261 . . . . 0.0 110.924 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.31 159.82 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.245 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -124.89 138.05 54.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.591 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.13 123.45 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.948 0.404 . . . . 0.0 111.424 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.27 -47.11 1.76 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.219 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.17 152.72 3.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.463 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.455 ' OD1' ' HB3' ' A' ' 71' ' ' ALA . 35.3 t0 -112.12 160.29 17.69 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.209 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.15 -130.22 1.54 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.423 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -73.91 -33.22 63.91 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.735 0.267 . . . . 0.0 111.145 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.0 134.74 49.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.255 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -111.28 175.84 5.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.002 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.698 HG23 ' HA ' ' A' ' 71' ' ' ALA . 58.5 t -75.64 -42.32 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 120.956 0.407 . . . . 0.0 110.032 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -82.54 -32.95 26.39 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.893 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.56 -41.07 96.55 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.721 0.296 . . . . 0.0 110.791 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.95 -31.57 51.01 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.805 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.6 tt -61.6 -58.78 6.75 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.33 -32.74 74.24 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.87 -51.97 34.72 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.106 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.9 -34.62 73.43 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.176 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 32' ' ' LEU . 40.9 t -85.08 -43.69 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.334 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.62 6.88 75.81 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.423 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.473 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -62.97 -58.32 7.73 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.191 0.496 . . . . 0.0 110.712 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.691 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 13.9 m-70 103.79 -57.52 0.0 OUTLIER Pre-proline 0 C--N 1.345 0.403 0 C-N-CA 124.637 1.175 . . . . 0.0 112.073 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 39' ' ' HIS . 61.2 Cg_exo -50.98 -22.93 11.14 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.028 1.818 . . . . 0.0 112.434 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -58.44 -32.55 68.8 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.622 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.764 HD22 HD12 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -136.75 25.11 3.1 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.146 179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.03 66.26 1.4 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.783 0.325 . . . . 0.0 110.985 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.406 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 3.3 m -82.41 -44.74 15.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.627 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -163.62 111.07 1.17 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.895 0.379 . . . . 0.0 111.227 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 47' ' ' PHE . 8.9 p -157.08 -48.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.236 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.437 ' N ' HG13 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -170.75 -165.65 0.45 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.72 43.86 3.29 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.897 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 67.87 133.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.092 0.472 . . . . 0.0 111.665 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -88.1 -28.15 21.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.373 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.27 -60.89 2.21 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.256 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.77 118.2 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.682 0.393 . . . . 0.0 111.936 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.9 mt -91.71 -32.28 15.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.684 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.11 122.52 34.46 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.71 0.29 . . . . 0.0 111.477 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.29 129.68 43.56 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.887 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.34 135.2 52.21 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.964 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HB ' HD21 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -151.87 131.2 3.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.851 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -91.42 164.82 13.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.782 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 p -138.76 147.36 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.435 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -106.05 128.0 53.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.953 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.435 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -126.62 145.89 50.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.016 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -59.31 -21.0 59.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.675 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.91 23.72 5.47 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.747 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.2 166.29 12.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.746 0.308 . . . . 0.0 110.844 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.33 112.57 11.76 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.81 123.79 42.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.47 165.57 18.01 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.681 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.436 ' HB2' ' HA3' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -108.16 -38.88 5.65 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.13 24.9 13.79 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.142 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -162.54 96.06 0.93 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.84 0.32 . . . . 0.0 110.953 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.698 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -70.33 -6.65 36.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.708 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.1 t -75.86 1.28 15.47 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.8 -178.48 1.54 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 111.398 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.6 86.91 6.84 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.477 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.67 159.17 28.05 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.116 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -109.58 -77.4 0.6 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -157.4 -175.16 5.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.793 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.7 mt -108.12 -37.69 5.98 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.99 172.0 10.6 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.087 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.427 HD21 ' HB ' ' A' ' 57' ' ' ILE . 7.4 tt -136.65 97.3 3.51 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.274 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.86 136.49 20.74 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.68 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 66.2 Cg_endo -74.22 150.83 42.87 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.409 2.073 . . . . 0.0 112.451 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 52.7 Cg_exo -54.73 159.25 9.26 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.819 2.346 . . . . 0.0 112.106 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 m -65.97 82.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.991 0.424 . . . . 0.0 111.427 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 t -92.48 161.4 14.64 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.214 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.42 85.99 0.11 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.55 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.202 -1.332 . . . . 0.0 112.904 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ttt . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.618 0.247 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -147.56 138.79 23.68 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.061 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.48 ' CE2' HD12 ' A' ' 32' ' ' LEU . 2.8 m0 -135.59 118.45 16.22 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.717 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 39.8 mtpt -116.91 139.78 50.23 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.589 ' HG ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -123.45 142.45 50.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.634 0.254 . . . . 0.0 110.796 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.484 ' H ' HD13 ' A' ' 5' ' ' LEU . 20.7 p90 -81.11 -173.19 4.16 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.173 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -41.09 -26.18 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.456 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -39.95 -47.27 2.2 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.884 0.373 . . . . 0.0 111.292 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.589 HD13 ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -113.23 -23.17 10.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.422 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.44 -3.01 38.18 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.15 -34.28 65.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.652 0.263 . . . . 0.0 111.073 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.425 HG21 ' C ' ' A' ' 42' ' ' LEU . 12.6 t -95.82 -53.6 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.719 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.64 -40.48 49.02 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.78 -30.33 7.23 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.455 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.2 p -156.95 124.96 5.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.632 0.253 . . . . 0.0 111.23 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.69 34.51 5.19 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.951 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.423 ' CG2' ' HG2' ' A' ' 4' ' ' LYS . 21.5 p -104.34 126.67 51.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -139.37 151.66 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -120.07 158.34 27.06 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.885 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 t -102.26 120.38 51.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.886 0.374 . . . . 0.0 111.215 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.99 -46.02 0.65 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.065 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.0 p -86.76 147.7 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.422 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -99.17 136.41 39.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.936 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.56 175.65 35.6 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.635 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.9 -31.49 68.67 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.548 0.213 . . . . 0.0 111.35 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 117.97 6.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.824 0.345 . . . . 0.0 111.049 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.855 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -68.28 179.52 1.58 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.876 HG13 ' HA ' ' A' ' 71' ' ' ALA . 2.6 m -74.54 -42.53 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.252 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -88.38 -28.49 22.21 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.276 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.78 -34.74 73.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.785 0.326 . . . . 0.0 110.728 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.601 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -92.09 -30.57 15.93 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.503 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 36' ' ' VAL . 4.0 tt -62.21 -53.69 51.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.781 0.324 . . . . 0.0 110.612 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -65.96 -31.76 72.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.245 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.0 -44.86 53.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.111 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 31' ' ' ALA . 8.1 mp -62.98 -32.78 74.21 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.928 0.394 . . . . 0.0 110.655 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 32' ' ' LEU . 47.0 t -87.97 -34.62 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.286 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.23 19.45 51.33 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.295 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 39' ' ' HIS . . . -63.68 -52.2 61.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.053 0.426 . . . . 0.0 111.072 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.768 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 28.9 m170 104.63 -59.87 0.0 OUTLIER Pre-proline 0 C--N 1.345 0.391 0 C-N-CA 124.527 1.131 . . . . 0.0 112.071 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.768 ' HD3' ' HB2' ' A' ' 39' ' ' HIS . 42.6 Cg_exo -55.69 -22.06 34.63 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.691 1.594 . . . . 0.0 111.992 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.425 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -62.31 -29.25 70.3 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.645 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.528 HD22 ' CD2' ' A' ' 9' ' ' LEU . 2.3 pt? -135.69 26.81 3.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.838 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 70.95 136.02 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.5 m -58.45 -39.41 79.79 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.489 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 59.85 76.07 0.38 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.894 0.378 . . . . 0.0 111.244 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.3 68.56 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.508 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -141.18 -46.73 0.39 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.148 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.3 -63.34 1.51 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.049 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.92 155.53 1.64 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.792 0.33 . . . . 0.0 110.816 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -120.15 31.19 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.956 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.93 -99.63 2.63 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.512 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.14 93.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.832 0.348 . . . . 0.0 111.432 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 mp -94.82 18.66 11.37 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.527 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -133.24 128.85 36.76 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.618 0.247 . . . . 0.0 111.196 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.25 147.47 41.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -140.17 121.82 15.28 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.5 tt -173.6 145.39 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.404 ' O ' HD23 ' A' ' 80' ' ' LEU . 1.6 m-80 -97.47 168.4 10.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.612 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.439 HG23 ' HG ' ' A' ' 80' ' ' LEU . 10.9 p -139.33 141.98 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.552 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.49 118.32 31.48 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.609 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -126.51 145.76 50.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.715 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.34 -10.59 56.01 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.895 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.56 5.58 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.945 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -118.8 166.08 13.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.631 0.253 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.11 125.78 27.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.64 130.3 46.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.24 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.476 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -98.27 134.54 41.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -128.59 -63.96 0.96 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.897 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.06 43.84 2.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.835 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -165.37 94.25 0.62 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.703 0.287 . . . . 0.0 111.236 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.876 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -71.56 -10.13 59.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.809 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.1 35.88 1.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 111.413 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.94 165.69 11.8 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.865 0.364 . . . . 0.0 111.327 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.3 80.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.15 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.76 -177.47 48.15 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.538 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.77 -74.9 0.59 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.792 0.33 . . . . 0.0 110.701 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -148.68 -177.61 5.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.39 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.59 -32.74 7.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.343 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB2' ' HD3' ' A' ' 4' ' ' LYS . . . -167.48 169.77 11.86 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.439 ' HG ' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -138.41 97.74 3.44 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.555 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -140.14 153.65 69.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.253 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HD3' ' CD1' ' A' ' 6' ' ' PHE . 24.6 Cg_endo -61.74 156.18 49.69 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.632 2.222 . . . . 0.0 112.31 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.42 -41.29 6.78 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.676 2.251 . . . . 0.0 112.421 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.38 122.66 53.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.734 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.29 155.27 40.88 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.84 70.83 0.34 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.749 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.64 -1.089 . . . . 0.0 112.643 179.807 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.759 ' HG3' HG12 ' A' ' 28' ' ' VAL . 2.8 ttp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.056 0.455 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -120.04 147.13 45.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.087 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.617 ' CH2' HD12 ' A' ' 32' ' ' LEU . 2.1 t90 -150.04 125.16 10.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.727 0.299 . . . . 0.0 111.168 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.652 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -122.23 148.47 44.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.297 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.668 HD13 ' HB3' ' A' ' 16' ' ' ARG . 7.6 mp -140.18 152.62 46.18 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.75 0.31 . . . . 0.0 111.334 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -98.27 179.15 4.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.113 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.62 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -53.67 -29.88 40.78 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.94 -37.73 33.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.004 0.431 . . . . 0.0 110.19 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.654 ' CB ' HD23 ' A' ' 5' ' ' LEU . 2.5 mp -110.73 -9.75 14.49 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.187 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.62 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -93.81 -4.9 49.34 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.99 -36.84 75.49 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 14.6 t -93.47 -33.51 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.797 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . . . -92.58 -45.03 8.3 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.38 -35.58 4.28 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.842 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.9 t -172.43 126.4 0.52 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.565 0.221 . . . . 0.0 110.824 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.668 ' HB3' HD13 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -123.05 28.2 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.291 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 5' ' ' LEU . 19.8 p -99.33 112.55 24.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.571 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.5 144.5 28.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.221 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -130.25 158.48 39.64 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.701 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.447 HG11 ' HB3' ' A' ' 1' ' ' MET . 13.4 p -103.95 136.97 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.893 0.378 . . . . 0.0 111.632 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.04 -48.62 1.11 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.918 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -86.65 165.67 2.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.284 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.09 118.07 33.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.08 -139.33 3.89 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.491 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.48 30.95 6.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.62 0.248 . . . . 0.0 111.302 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.46 146.3 25.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.898 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.533 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -121.08 167.75 12.28 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.83 0.348 . . . . 0.0 111.213 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.889 HG23 ' HA ' ' A' ' 68' ' ' LEU . 2.5 m -78.2 -36.88 21.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.435 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 68' ' ' LEU . . . -79.21 -31.28 42.93 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.879 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -50.84 -42.17 58.31 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.885 0.374 . . . . 0.0 110.556 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.49 -30.89 17.02 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.126 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.617 HD12 ' CH2' ' A' ' 3' ' ' TRP . 0.7 OUTLIER -58.34 -56.07 26.85 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.829 -0.168 . . . . 0.0 110.96 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -57.18 -36.26 70.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.628 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.15 -53.95 9.71 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 110.469 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 39' ' ' HIS . 7.8 mp -61.43 -25.3 67.12 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.244 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 32' ' ' LEU . 90.4 t -91.92 -45.89 14.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.432 0.158 . . . . 0.0 111.336 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.28 -40.53 94.09 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.861 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.14 -56.35 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.652 0.263 . . . . 0.0 111.053 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.474 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER 72.52 55.5 0.34 Allowed Pre-proline 0 C--O 1.231 0.106 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.75 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 52.7 Cg_exo -53.12 -17.71 8.66 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.22 1.947 . . . . 0.0 112.06 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . . . -57.13 -40.49 77.23 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.189 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -134.5 13.17 3.78 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.642 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.14 118.64 26.55 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.842 0.354 . . . . 0.0 111.442 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.9 m -94.97 7.46 46.0 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.694 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 71.49 31.7 2.23 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.683 0.277 . . . . 0.0 111.063 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 46' ' ' VAL . 7.5 p -168.47 87.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.172 0.511 . . . . 0.0 111.37 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -157.57 104.67 2.0 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.183 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.42 -80.2 0.64 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.383 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.76 -62.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.814 0.34 . . . . 0.0 110.499 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.71 -28.94 51.04 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.465 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.09 -63.42 0.55 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.383 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.54 156.07 40.69 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.771 0.319 . . . . 0.0 111.059 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.56 -67.89 0.96 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -151.67 134.27 15.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.005 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.15 164.31 29.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.2 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -108.62 126.4 52.92 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.061 HD13 HD21 ' A' ' 80' ' ' LEU . 1.7 pp -148.87 120.09 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.553 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -77.27 151.31 35.12 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.868 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.684 HG23 HD12 ' A' ' 80' ' ' LEU . 11.0 p -136.92 146.7 27.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.678 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.34 124.3 49.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.732 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.71 145.61 51.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -61.09 -25.19 66.79 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.653 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.43 23.49 5.99 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.916 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.24 166.07 12.03 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.653 0.263 . . . . 0.0 110.772 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.03 114.29 2.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.982 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.03 111.54 10.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.075 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.54 -175.89 3.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.251 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.889 ' HA ' HG23 ' A' ' 28' ' ' VAL . 0.7 OUTLIER -141.16 -42.35 0.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.562 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.73 35.94 3.88 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.855 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HG2' HG22 ' A' ' 72' ' ' THR . 4.8 tt0 -167.94 91.28 0.33 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -83.88 -0.97 53.47 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.716 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.524 HG22 ' HG2' ' A' ' 70' ' ' GLU . 12.8 t -84.82 -26.56 27.38 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.436 0.16 . . . . 0.0 111.092 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.26 139.45 53.37 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.747 0.308 . . . . 0.0 110.913 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.94 -74.68 0.06 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.88 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.624 ' C ' HG11 ' A' ' 28' ' ' VAL . . . 113.99 -151.21 18.45 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.505 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 28' ' ' VAL . 25.3 p-10 -111.63 -50.77 2.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.406 0.146 . . . . 0.0 110.74 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -171.35 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.741 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.1 mt -107.66 -36.79 6.34 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.215 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 4' ' ' LYS . . . -165.22 170.93 14.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.631 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.061 HD21 HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -145.64 100.1 3.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.899 0.38 . . . . 0.0 110.545 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 12.5 m-85 -114.09 133.95 22.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.009 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 81' ' ' PHE . 37.1 Cg_exo -57.33 170.72 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.797 2.331 . . . . 0.0 112.403 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.19 74.23 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.771 2.314 . . . . 0.0 112.362 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -95.71 144.02 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.34 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.5 m -104.91 153.05 21.9 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.47 -166.51 26.91 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.769 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.688 -1.062 . . . . 0.0 112.851 179.845 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.579 0.228 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.44 160.14 40.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.882 0.372 . . . . 0.0 110.887 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.69 ' CH2' HD13 ' A' ' 80' ' ' LEU . 6.1 t-105 -155.27 144.83 21.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.02 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -137.63 141.16 41.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.938 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.617 HD21 ' HB2' ' A' ' 9' ' ' LEU . 11.7 tp -133.08 158.24 43.26 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.991 0.425 . . . . 0.0 111.893 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -91.14 177.93 6.13 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.716 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.495 ' HB1' ' HG3' ' A' ' 11' ' ' GLU . . . -72.93 -10.24 59.58 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.588 ' C ' HD13 ' A' ' 9' ' ' LEU . 6.2 t70 -56.65 -39.72 74.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.617 ' HB2' HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -111.66 -39.6 4.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.417 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -61.43 -14.23 26.62 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.495 ' HG3' ' HB1' ' A' ' 7' ' ' ALA . 35.1 mt-10 -73.37 -26.9 61.2 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.364 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 41' ' ' ALA . 16.5 t -89.66 -41.63 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.77 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -90.12 -43.55 10.39 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.68 -20.31 22.69 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.828 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.9 m -111.64 130.68 55.69 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.882 0.341 . . . . 0.0 110.665 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.623 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -113.81 -49.08 2.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 p -93.1 146.68 23.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.92 0.39 . . . . 0.0 111.435 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.0 t -145.36 119.33 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.24 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -102.42 138.59 39.14 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.358 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.75 123.21 65.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.438 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.08 -31.86 11.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.19 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 p -91.81 151.34 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -116.88 121.97 43.01 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.98 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.91 45.07 1.18 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.467 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.3 t0 55.48 33.57 21.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.868 0.365 . . . . 0.0 111.295 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.57 127.08 33.46 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.654 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.628 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -78.08 168.07 20.46 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.796 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.49 HG11 ' HG3' ' A' ' 61' ' ' ARG . 22.6 t -75.25 -34.43 30.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.318 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.451 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -85.07 -28.64 30.49 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.304 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.83 -41.44 74.25 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.559 0.218 . . . . 0.0 110.955 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.51 -32.29 19.5 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -61.43 -61.86 2.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.645 0.259 . . . . 0.0 110.54 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -62.06 -33.17 73.9 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.672 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -66.08 -54.5 24.93 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.291 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.54 -19.22 64.61 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.459 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 32' ' ' LEU . 88.2 t -91.99 -47.81 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.31 -34.22 2.55 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.789 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -80.61 -1.23 41.36 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.424 ' O ' HD12 ' A' ' 42' ' ' LEU . 7.8 m170 -127.1 65.69 65.28 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.781 0.324 . . . . 0.0 110.675 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 53.3 Cg_exo -54.01 -19.11 14.81 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.779 2.319 . . . . 0.0 112.469 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -52.72 -26.43 14.01 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.631 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.77 HD23 ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -95.91 -23.76 16.73 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.679 0.275 . . . . 0.0 110.99 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 78.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.084 0.469 . . . . 0.0 111.022 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.8 t -80.42 -53.38 6.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.813 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -176.49 107.47 0.07 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.61 -55.71 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.655 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -172.25 48.05 0.02 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.609 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.34 -45.23 2.6 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.528 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.06 156.76 45.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.723 0.297 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.37 -28.84 9.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.242 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.4 158.87 22.63 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.623 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.57 97.31 3.71 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.677 0.275 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 mt 70.93 -63.72 0.41 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.26 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -113.45 138.49 50.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.77 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -103.6 126.45 50.75 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 141.12 46.04 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.193 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.4 mt -146.86 130.83 9.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.285 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -101.65 146.53 27.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.957 0.408 . . . . 0.0 111.143 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.78 154.08 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tp -124.61 120.92 33.29 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.017 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HG3' HG11 ' A' ' 28' ' ' VAL . 2.5 tmm_? -127.5 88.42 2.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.619 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 57.54 18.68 4.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.851 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.48 23.66 39.11 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.642 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -102.01 166.0 10.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.951 0.405 . . . . 0.0 111.199 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.52 102.9 14.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.533 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 63.2 105.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.066 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.416 ' CB ' ' HG3' ' A' ' 61' ' ' ARG . . . -109.95 162.57 14.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.225 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.451 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 2.6 tt -169.9 -65.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.602 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.483 ' HA2' HG22 ' A' ' 27' ' ' THR . . . -93.45 63.39 1.97 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.137 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -123.82 30.48 6.16 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -58.32 -22.9 54.82 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -76.74 -25.0 53.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.243 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.84 154.52 41.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.69 0.281 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.4 66.74 3.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.825 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.53 -173.93 27.46 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.549 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -117.36 -72.74 0.67 Allowed 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.582 0.229 . . . . 0.0 110.694 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.455 ' HA ' ' HG2' ' A' ' 61' ' ' ARG . 1.3 pt-20 -149.41 -169.21 3.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.716 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.0 mt -113.52 -48.74 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.407 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -162.5 166.74 24.49 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.249 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.69 HD13 ' CH2' ' A' ' 3' ' ' TRP . 4.8 tt -146.55 111.88 5.49 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.83 0.348 . . . . 0.0 110.942 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -151.44 156.7 34.93 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.485 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.0 153.06 76.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.543 2.162 . . . . 0.0 112.383 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.37 -42.66 3.59 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.609 2.206 . . . . 0.0 112.703 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.2 149.36 32.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.933 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.5 t -103.71 102.41 12.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.727 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.48 170.48 36.47 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.673 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.236 -1.313 . . . . 0.0 112.868 179.893 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG3' ' HA2' ' A' ' 75' ' ' GLY . 6.4 mtm . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.621 0.248 . . . . 0.0 111.434 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -116.71 159.22 22.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.815 0.34 . . . . 0.0 111.28 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.709 ' CH2' HD13 ' A' ' 80' ' ' LEU . 7.2 t-105 -151.27 143.05 23.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.627 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.541 ' HG2' HG22 ' A' ' 17' ' ' THR . 2.1 mtmm -138.24 145.91 41.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.774 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.478 HD11 HD13 ' A' ' 9' ' ' LEU . 10.5 tp -138.48 159.76 41.26 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.044 0.449 . . . . 0.0 111.683 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -87.13 173.39 9.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.327 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 11' ' ' GLU . . . -65.52 -25.5 67.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.746 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.48 -39.52 23.31 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.865 0.364 . . . . 0.0 110.675 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.729 ' HB3' HD22 ' A' ' 42' ' ' LEU . 1.3 mp -101.1 -34.26 9.79 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.337 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -70.29 -12.01 61.29 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -71.1 -34.4 71.07 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 121.289 -0.164 . . . . 0.0 111.361 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.698 HG21 ' HB2' ' A' ' 43' ' ' GLU . 5.1 t -98.3 -37.79 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.655 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -88.15 -45.83 9.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.586 0.232 . . . . 0.0 111.437 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.34 -25.57 27.81 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.534 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 t -106.14 111.58 24.25 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.857 0.36 . . . . 0.0 110.814 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.597 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 1.7 ptt-85 -102.66 -45.77 4.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.709 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.541 HG22 ' HG2' ' A' ' 4' ' ' LYS . 4.8 p -99.73 140.64 33.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 111.436 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.09 129.59 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.927 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -110.52 136.0 50.32 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.519 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.51 137.43 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.861 0.362 . . . . 0.0 111.652 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.71 -21.25 11.77 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.584 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.87 152.21 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.875 0.369 . . . . 0.0 111.615 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.7 153.53 26.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.132 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.68 -155.08 9.02 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.784 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.56 30.36 5.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.725 0.298 . . . . 0.0 111.492 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.13 123.7 29.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.044 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.711 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -76.72 164.25 26.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.781 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.878 HG11 ' HB3' ' A' ' 67' ' ' ALA . 38.7 t -73.76 -30.08 27.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.536 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.676 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -87.21 -29.48 22.4 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.425 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.44 -41.84 77.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.589 0.233 . . . . 0.0 111.077 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -84.27 -32.31 24.48 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.373 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.4 tt -56.48 -61.22 2.56 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.346 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.68 -37.74 88.49 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.403 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -59.83 -53.58 56.26 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.618 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 12.1 mt -64.88 -20.62 66.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.007 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 32' ' ' LEU . 57.3 t -86.34 -48.47 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.57 -39.47 1.21 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.804 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -72.85 -0.49 13.6 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.484 ' HD2' ' HB3' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -120.79 68.73 16.18 Favored Pre-proline 0 N--CA 1.453 -0.301 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.487 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 85.9 Cg_exo -48.63 -19.11 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.123 2.549 . . . . 0.0 113.362 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB3' ' HD2' ' A' ' 39' ' ' HIS . . . -51.36 -38.72 54.67 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -83.79 -19.81 34.38 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.698 ' HB2' HG21 ' A' ' 12' ' ' VAL . 1.8 mm-40 64.48 118.89 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.7 t -94.94 -26.64 16.04 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.046 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.48 174.16 10.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.016 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.22 39.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.885 0.374 . . . . 0.0 111.543 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -175.3 83.49 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.928 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.93 -97.67 0.11 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.36 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -156.75 141.73 17.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.718 0.294 . . . . 0.0 111.029 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -100.49 -28.92 12.65 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.365 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.99 -159.54 21.73 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.222 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -160.31 145.03 14.55 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.755 0.312 . . . . 0.0 111.465 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -172.4 -49.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.075 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -146.23 141.15 27.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -106.19 119.47 39.31 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.586 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -93.89 97.25 10.25 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 56' ' ' HIS . 0.8 OUTLIER -163.07 126.19 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.991 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -85.87 144.02 27.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.515 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.51 ' CG2' HD12 ' A' ' 80' ' ' LEU . 14.4 p -139.99 147.9 23.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.338 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tp -107.46 118.3 36.37 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.849 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.31 85.8 1.81 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.297 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 63.8 16.32 9.7 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.917 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.6 23.75 27.72 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.536 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.98 162.67 14.61 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.831 0.348 . . . . 0.0 110.858 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.31 102.48 13.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.42 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.75 109.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.305 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.878 ' HB3' HG11 ' A' ' 28' ' ' VAL . . . -104.75 148.66 26.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.028 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.676 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 6.2 tt -139.11 -67.37 0.45 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.045 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.02 52.75 3.69 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.844 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.49 24.77 7.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.63 0.252 . . . . 0.0 111.621 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -58.06 -29.65 65.57 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.308 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.68 1.38 56.88 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.97 175.28 6.77 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.833 0.349 . . . . 0.0 111.363 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.68 53.59 2.76 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.215 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA2' ' HG3' ' A' ' 1' ' ' MET . . . 138.34 163.54 9.62 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.878 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.71 -67.9 0.76 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 110.531 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.57 -172.32 2.87 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.739 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.11 -52.47 2.76 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.69 0.281 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.16 170.13 22.97 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.949 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.709 HD13 ' CH2' ' A' ' 3' ' ' TRP . 1.1 tt -147.99 112.23 5.23 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.837 0.351 . . . . 0.0 111.083 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -130.9 136.32 28.71 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.054 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 6' ' ' PHE . 57.7 Cg_endo -71.31 146.19 50.23 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.628 2.219 . . . . 0.0 112.531 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.55 137.22 27.4 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.805 2.337 . . . . 0.0 112.603 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 m -95.69 37.81 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.404 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 t -121.71 95.8 4.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.396 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.98 -53.01 0.38 Allowed Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.548 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.361 -1.244 . . . . 0.0 112.815 -179.869 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.042 0.449 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 77' ' ' GLU . 19.9 mt-10 -141.04 175.44 9.63 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.438 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.765 ' CZ3' HD22 ' A' ' 35' ' ' LEU . 1.5 t90 -155.41 118.62 4.38 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.986 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 7.0 mtpp -102.55 145.79 29.09 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -136.5 137.21 40.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.722 0.296 . . . . 0.0 111.723 -179.111 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.58 163.39 14.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.632 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -53.08 -29.19 28.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.518 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.705 ' HB3' HD12 ' A' ' 9' ' ' LEU . 4.3 t70 -47.62 -38.5 14.79 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.958 0.409 . . . . 0.0 110.667 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.707 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 4.2 mp -119.19 -3.18 10.6 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.481 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -92.99 -9.18 40.79 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.55 -44.37 76.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.578 0.228 . . . . 0.0 111.108 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 15.4 t -94.26 -29.96 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.074 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.926 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . . . -69.43 -41.67 76.02 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.582 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.62 -6.78 81.75 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.479 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.39 152.17 51.57 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 110.998 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -110.7 -76.81 0.6 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.474 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.7 p -95.93 136.65 36.08 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.854 0.359 . . . . 0.0 111.428 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.21 121.33 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.763 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.41 151.19 21.81 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.955 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 20' ' ' VAL . 11.5 p -118.16 120.74 65.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.84 0.353 . . . . 0.0 111.275 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -33.52 6.02 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.17 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 m -87.41 134.23 28.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.15 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -117.01 134.21 55.03 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.82 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.45 -109.17 0.29 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.649 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.15 25.8 6.47 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 111.454 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -120.32 141.97 49.55 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.753 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.65 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -117.5 177.38 4.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 68' ' ' LEU . 42.2 t -78.1 -50.32 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.055 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.495 ' HA3' HD13 ' A' ' 68' ' ' LEU . . . -78.67 -25.63 60.27 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.146 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.69 -39.86 85.95 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.645 0.26 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.94 -33.1 18.58 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.815 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.565 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -60.27 -57.47 12.66 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.457 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.29 -33.97 73.11 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.382 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.86 -52.35 15.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.096 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.765 HD22 ' CZ3' ' A' ' 3' ' ' TRP . 8.8 mp -61.8 -27.76 68.99 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.428 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 32' ' ' LEU . 42.4 t -94.24 -41.07 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.54 0.21 . . . . 0.0 111.365 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.2 -37.0 91.15 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.045 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.08 -25.07 13.55 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.582 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 17.0 m80 63.19 44.78 0.59 Allowed Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 122.675 0.39 . . . . 0.0 111.324 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 53.6 Cg_exo -51.77 -31.31 41.3 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.942 1.761 . . . . 0.0 111.71 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.926 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . . . -56.46 -32.1 64.63 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.389 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.59 HD21 HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -121.94 -3.12 9.15 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -79.47 87.47 5.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.832 0.348 . . . . 0.0 111.041 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.0 -53.6 3.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.26 103.87 0.07 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.526 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 46' ' ' VAL . 63.6 t 56.59 70.12 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.994 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.17 -59.58 1.39 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.936 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.48 62.68 0.54 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.487 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.65 -70.23 0.25 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.485 0.183 . . . . 0.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -109.89 -29.48 8.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.295 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.02 123.77 0.22 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.909 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -127.37 33.75 4.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.682 0.277 . . . . 0.0 111.273 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.45 163.3 36.96 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.89 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -101.82 112.24 24.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.97 147.89 44.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.413 ' HB3' ' HG2' ' A' ' 83' ' ' PRO . 3.5 t60 -117.25 149.79 39.85 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 pt -136.8 104.45 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.29 151.4 33.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.8 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.502 HG23 ' OE2' ' A' ' 77' ' ' GLU . 9.1 p -133.98 151.81 33.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.714 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.533 HD13 ' N ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -114.35 130.07 56.67 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.663 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.533 ' N ' HD13 ' A' ' 60' ' ' LEU . 18.8 mtt180 -123.18 145.6 48.49 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.741 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -52.09 -38.4 57.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.371 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.04 22.64 6.79 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.807 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.82 164.63 19.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.726 0.263 . . . . 0.0 110.715 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.27 105.76 0.97 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.23 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.31 153.46 46.98 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.375 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -113.7 179.85 3.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.293 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD13 ' HA3' ' A' ' 29' ' ' GLY . 3.2 pp -111.67 -33.16 6.43 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.989 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.477 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -85.5 32.22 3.69 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.854 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -153.28 90.96 1.46 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.813 0.306 . . . . 0.0 111.269 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.65 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -67.66 -12.7 61.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.97 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 t -88.2 34.14 0.74 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.953 0.406 . . . . 0.0 111.056 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.56 167.38 11.97 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.11 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.48 40.56 1.84 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.699 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.58 67.0 0.02 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.59 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -69.17 -71.16 0.23 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.711 0.291 . . . . 0.0 110.57 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.502 ' OE2' HG23 ' A' ' 59' ' ' VAL . 34.7 tt0 -140.45 156.36 46.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.554 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -100.62 -42.99 6.31 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.766 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -169.44 163.18 10.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.425 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -136.26 113.24 10.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.994 0.426 . . . . 0.0 110.439 179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -146.22 140.57 15.57 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.303 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 73.2 Cg_endo -75.46 151.46 37.53 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.36 2.04 . . . . 0.0 111.857 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' A' ' 56' ' ' HIS . 34.7 Cg_exo -60.83 90.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.673 2.248 . . . . 0.0 112.068 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 m -60.78 134.99 26.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.516 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.67 156.29 23.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.327 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.23 -161.47 8.74 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.868 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.328 -179.891 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.893 0.378 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 17.3 mt-10 -142.58 163.76 31.95 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.03 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.736 ' CZ2' HD22 ' A' ' 80' ' ' LEU . 5.3 t-105 -153.99 141.54 19.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.103 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -138.43 143.1 39.55 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.644 HD21 HD22 ' A' ' 9' ' ' LEU . 13.2 tp -136.73 156.48 48.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 111.646 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.563 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -81.27 -177.73 6.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.359 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.38 -12.29 60.23 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -54.03 -38.12 64.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.781 0.324 . . . . 0.0 111.044 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.796 HD23 HD13 ' A' ' 42' ' ' LEU . 2.2 mp -105.48 -38.22 6.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.326 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -64.73 -17.83 64.48 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -67.13 -26.85 66.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.429 0.156 . . . . 0.0 111.166 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 41' ' ' ALA . 8.9 t -98.19 -44.37 12.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.9 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -91.62 -42.55 10.13 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.48 -28.14 14.46 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.84 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 t -100.45 108.25 20.18 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.826 0.346 . . . . 0.0 111.043 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.816 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -98.62 -42.43 7.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.531 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -93.75 147.5 22.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.068 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -142.11 113.24 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.191 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.13 136.24 37.95 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.441 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.56 124.88 66.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 111.407 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.78 -34.41 7.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.054 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.62 145.3 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 120.813 0.339 . . . . 0.0 111.257 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -116.66 121.72 42.48 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.99 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.84 -107.93 1.62 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.395 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.33 -10.64 16.88 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.21 145.34 51.54 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.744 0.307 . . . . 0.0 111.39 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.03 170.92 7.92 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.084 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.571 HG22 ' HA ' ' A' ' 76' ' ' ASP . 24.6 t -75.01 -37.64 41.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.462 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.68 ' HA3' HD12 ' A' ' 68' ' ' LEU . . . -88.78 -33.87 9.58 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.17 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -55.49 -45.22 77.06 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.665 0.269 . . . . 0.0 111.139 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -76.75 -24.68 52.98 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.934 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.744 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.4 tt -66.72 -58.17 5.63 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -62.63 -31.6 72.48 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.832 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.528 ' CA ' ' HB3' ' A' ' 38' ' ' ALA . . . -71.62 -48.3 48.83 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.938 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 31' ' ' ALA . 8.9 mp -64.31 -21.45 66.61 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.011 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 32' ' ' LEU . 97.9 t -84.4 -49.26 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.82 -35.41 1.38 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.826 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HB3' ' CA ' ' A' ' 34' ' ' ALA . . . -74.47 -1.21 20.18 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 5.7 m80 -126.11 65.63 57.22 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 110.471 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 38' ' ' ALA . 77.6 Cg_exo -52.28 -19.64 9.77 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.825 2.35 . . . . 0.0 112.576 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -53.03 -29.03 27.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.576 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.9 HD23 ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -96.21 -16.25 21.56 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.597 0.237 . . . . 0.0 111.453 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' C ' HG21 ' A' ' 12' ' ' VAL . 4.4 mt-10 -73.25 131.56 42.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.708 0.29 . . . . 0.0 111.394 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -89.67 -32.84 16.86 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.214 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -145.61 164.46 31.66 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.7 0.286 . . . . 0.0 111.129 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.56 59.28 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -151.79 93.53 1.87 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.848 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.09 32.32 83.74 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.825 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -90.41 -35.45 15.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.631 0.215 . . . . 0.0 111.101 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -28.74 66.98 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.588 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.57 105.45 0.22 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.526 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -84.36 75.36 10.24 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.802 0.334 . . . . 0.0 111.109 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' A' ' 54' ' ' TYR . 9.8 tt 68.19 -70.51 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.193 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HB2' HD23 ' A' ' 53' ' ' LEU . 1.5 t80 -117.72 123.68 46.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.655 0.264 . . . . 0.0 110.569 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -149.61 143.65 25.68 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.241 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -97.84 144.46 27.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.52 HG22 ' HD3' ' A' ' 83' ' ' PRO . 8.2 pt -152.51 125.33 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.743 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -99.94 135.39 41.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.437 HG23 HD12 ' A' ' 80' ' ' LEU . 13.8 p -140.6 153.96 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.256 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mp -132.18 133.09 43.81 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.965 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -146.11 84.29 1.64 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.424 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 54.11 18.96 1.91 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.076 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.36 23.06 59.36 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.711 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -138.1 166.99 22.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.08 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.39 127.86 34.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.744 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.16 157.52 13.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.508 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 28' ' ' VAL . . . -110.25 174.54 5.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.403 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.68 HD12 ' HA3' ' A' ' 29' ' ' GLY . 2.1 tt -149.58 20.23 0.92 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.445 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.31 19.38 1.35 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.588 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 178.27 85.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.139 0.469 . . . . 0.0 111.417 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB2' ' N ' ' A' ' 28' ' ' VAL . . . -82.71 6.97 16.22 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.779 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 t -83.91 -14.9 49.84 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.53 0.205 . . . . 0.0 111.254 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.08 131.26 54.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.707 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.82 23.73 11.59 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.975 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.71 -129.82 22.27 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.346 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.571 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -121.34 -72.85 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.52 0.2 . . . . 0.0 110.859 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -162.53 -166.85 1.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 78' ' ' LEU . 11.2 mt -111.75 -55.47 2.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.708 0.289 . . . . 0.0 110.958 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.89 164.37 38.96 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.225 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.736 HD22 ' CZ2' ' A' ' 3' ' ' TRP . 0.5 OUTLIER -139.29 115.29 10.23 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.004 0.43 . . . . 0.0 110.741 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -107.77 108.26 61.28 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 6' ' ' PHE . 58.7 Cg_endo -71.67 171.48 16.31 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.777 2.318 . . . . 0.0 112.492 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.52 ' HD3' HG22 ' A' ' 57' ' ' ILE . 70.6 Cg_endo -74.96 -177.1 3.23 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.651 2.234 . . . . 0.0 112.583 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.48 139.17 17.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.989 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.4 t -146.89 151.59 37.3 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.77 0.319 . . . . 0.0 111.498 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.39 -158.28 11.71 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.438 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.709 -1.05 . . . . 0.0 112.434 -179.5 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.609 0.242 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.94 154.14 44.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.046 0.45 . . . . 0.0 111.497 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -145.8 143.85 29.92 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.412 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.47 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 12.9 mttp -135.03 136.43 42.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.525 0.202 . . . . 0.0 110.654 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.742 HD21 ' CB ' ' A' ' 9' ' ' LEU . 3.9 tp -129.95 135.21 48.06 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.798 0.332 . . . . 0.0 111.07 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -81.8 176.35 9.67 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.414 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.545 ' HB1' ' CD ' ' A' ' 11' ' ' GLU . . . -63.79 -16.16 60.52 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -55.51 -30.43 60.65 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.739 0.304 . . . . 0.0 110.906 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.742 ' CB ' HD21 ' A' ' 5' ' ' LEU . 3.3 mp -119.31 -36.26 3.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.335 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.47 -15.48 50.13 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.545 ' CD ' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -71.63 -26.79 62.71 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -95.7 -39.14 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.888 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -93.19 -42.4 9.38 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.18 23.19 10.72 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.736 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.71 136.96 49.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.553 ' HA ' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -113.5 -81.63 0.6 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.428 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 5.0 p -92.69 149.0 21.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.872 0.368 . . . . 0.0 111.464 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.16 118.29 6.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.976 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 148.17 28.18 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.467 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -103.14 120.2 52.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.97 -15.88 14.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.541 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.79 150.81 3.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.594 0.235 . . . . 0.0 110.968 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.86 172.48 0.95 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.433 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.15 85.13 0.91 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.937 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.59 -44.09 4.77 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.472 0.177 . . . . 0.0 111.402 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.55 165.82 12.15 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.751 0.31 . . . . 0.0 111.246 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.672 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -80.16 165.17 22.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 179.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.45 -24.3 14.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.731 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.474 ' N ' ' HA ' ' A' ' 68' ' ' LEU . . . -88.95 -27.52 23.52 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.051 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.18 -47.78 68.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.687 0.279 . . . . 0.0 110.912 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -79.61 -34.59 40.54 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.605 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -53.12 -60.06 3.77 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.393 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.2 -35.48 80.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.13 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.887 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -57.87 -55.38 35.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.646 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.52 HD23 ' ND1' ' A' ' 39' ' ' HIS . 17.9 mt -66.77 -23.16 66.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.875 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 32' ' ' LEU . 56.1 t -80.21 -47.58 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -125.41 -37.8 0.51 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.201 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.887 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -71.48 -1.54 13.62 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.52 ' ND1' HD23 ' A' ' 35' ' ' LEU . 15.7 m80 -129.29 67.03 78.09 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 120.816 0.341 . . . . 0.0 110.667 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.33 -16.82 14.31 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.715 2.277 . . . . 0.0 112.588 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.45 -25.59 16.77 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.888 HD23 ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -99.5 -22.43 15.49 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.634 0.254 . . . . 0.0 111.365 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -98.85 163.61 12.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.917 0.389 . . . . 0.0 111.363 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -97.81 -49.52 4.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.71 135.66 23.6 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.732 0.301 . . . . 0.0 111.176 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 46' ' ' VAL . 9.5 p -154.71 31.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.132 0.491 . . . . 0.0 111.287 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.2 -75.21 0.6 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.864 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.26 74.59 0.38 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.263 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.52 167.67 5.37 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.782 0.325 . . . . 0.0 111.343 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -96.86 31.58 2.32 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.441 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.11 57.79 0.03 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.903 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -163.94 132.72 3.75 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.794 0.331 . . . . 0.0 111.317 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.37 -38.15 5.06 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 135.54 46.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.603 0.24 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.29 168.82 11.06 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.145 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -114.5 111.23 21.07 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.087 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.546 HD12 HG13 ' A' ' 36' ' ' VAL . 7.6 mt -149.74 126.42 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.074 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.24 163.4 16.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 32' ' ' LEU . 10.8 p -140.64 149.6 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.372 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.61 118.31 33.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.717 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.3 85.53 2.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.556 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 61.44 16.87 7.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.736 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.62 23.62 33.04 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.31 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -101.99 163.16 12.4 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.859 0.361 . . . . 0.0 110.82 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.88 102.91 14.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.424 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 54.7 96.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.884 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.73 143.69 32.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.438 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.474 ' HA ' ' N ' ' A' ' 29' ' ' GLY . 9.0 tt -143.79 -52.49 0.34 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.014 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.88 53.04 4.04 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.1 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.31 22.15 8.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.62 0.248 . . . . 0.0 111.533 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -55.89 -30.01 60.87 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.169 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.88 31.13 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.338 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.22 -175.39 2.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.75 0.31 . . . . 0.0 111.105 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.86 -32.42 67.47 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.514 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.14 -124.62 1.54 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.559 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.21 -79.05 0.39 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.684 0.278 . . . . 0.0 110.737 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -147.23 -165.38 2.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.606 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 78' ' ' LEU . 3.3 tp -112.69 -51.95 2.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.628 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 4' ' ' LYS . . . -153.95 167.22 30.48 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.171 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.04 97.69 3.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.699 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.467 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 34.9 p90 -149.58 149.64 29.03 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-O 120.638 0.256 . . . . 0.0 111.603 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.509 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 39.1 Cg_exo -55.39 -49.45 16.14 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.871 2.381 . . . . 0.0 112.915 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 82' ' ' PRO . 76.5 Cg_exo -50.4 160.08 1.74 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.689 2.259 . . . . 0.0 112.974 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 84' ' ' VAL . 11.0 p -151.67 116.95 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.385 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m 64.21 110.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.454 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.74 -74.73 0.05 OUTLIER Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.584 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.506 -1.163 . . . . 0.0 112.664 -179.891 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttm . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -146.84 171.98 14.36 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.814 0.34 . . . . 0.0 111.193 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.415 ' HE1' HG21 ' A' ' 20' ' ' VAL . 59.1 m95 -145.82 131.84 19.27 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.091 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -136.8 158.41 44.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.504 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HD12 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -150.1 163.0 39.32 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.879 0.371 . . . . 0.0 111.588 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.96 179.99 4.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.338 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.57 -11.84 47.71 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.236 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.471 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -52.81 -36.78 58.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.88 0.371 . . . . 0.0 110.357 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.056 HD12 HD21 ' A' ' 5' ' ' LEU . 7.8 mt -122.03 -39.44 2.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.469 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.73 -13.96 38.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -82.84 -28.12 30.36 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.844 0.354 . . . . 0.0 110.503 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 42' ' ' LEU . 74.8 t -85.73 -30.88 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.355 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -99.22 -39.52 8.41 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.891 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.61 -37.64 2.14 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.152 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.2 p -173.95 138.17 0.6 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.594 0.235 . . . . 0.0 110.766 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.618 ' HG2' HD22 ' A' ' 5' ' ' LEU . 3.2 tpm_? -131.02 17.65 5.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.75 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.8 p -96.95 122.29 39.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.652 0.263 . . . . 0.0 110.413 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.57 166.07 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.44 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.05 142.89 50.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.377 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.415 HG21 ' HE1' ' A' ' 3' ' ' TRP . 21.1 t -102.19 120.52 52.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.169 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.71 -54.44 0.77 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.23 154.52 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.274 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -117.15 122.04 42.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.33 -81.31 0.04 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.061 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.96 25.14 4.97 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.775 0.321 . . . . 0.0 111.211 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.19 116.93 25.85 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.803 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -108.4 174.57 5.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.042 HG21 ' HB3' ' A' ' 67' ' ' ALA . 54.9 t -73.3 -36.94 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -77.28 -33.39 44.52 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.86 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.8 -37.55 79.44 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.558 0.343 . . . . 0.0 110.988 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -86.54 -30.93 21.54 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.93 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -60.62 -58.69 7.39 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.524 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.68 -36.67 83.64 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 1.035 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -59.6 -51.56 69.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.585 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 31' ' ' ALA . 7.9 mp -67.39 -30.74 70.6 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.706 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 32' ' ' LEU . 58.2 t -62.78 -52.13 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.835 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.24 30.34 0.05 OUTLIER Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.748 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -105.24 -0.58 26.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.799 0.3 . . . . 0.0 111.565 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -123.62 69.39 44.13 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -44.24 -21.85 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.29 2.66 . . . . 0.0 113.627 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 12' ' ' VAL . . . -50.82 -28.0 8.49 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -113.87 5.81 16.4 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -94.09 120.73 34.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.535 0.207 . . . . 0.0 111.08 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 t -97.1 -53.31 3.54 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.658 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.44 146.68 36.81 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.837 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -112.89 18.47 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.549 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 38.6 t80 69.67 -67.95 0.21 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 122.649 0.38 . . . . 0.0 111.567 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.39 -2.15 85.44 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.304 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.508 ' HA ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER 67.65 -75.55 0.06 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.033 0.417 . . . . 0.0 111.1 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -120.52 31.8 6.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.956 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.14 112.45 0.53 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.516 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.14 107.81 7.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.859 0.361 . . . . 0.0 111.19 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -107.6 -35.03 6.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.207 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -101.5 134.2 44.98 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.675 0.274 . . . . 0.0 111.145 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.4 129.28 56.15 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.058 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -147.1 129.27 15.61 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.5 tt -170.17 146.71 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.61 141.61 35.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.17 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.43 HG23 ' HG ' ' A' ' 80' ' ' LEU . 12.0 p -139.2 153.82 24.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.211 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.685 HD12 HD12 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -116.94 127.3 54.09 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.725 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 142.8 49.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -63.0 -21.29 66.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.691 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.56 5.58 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.7 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.7 165.99 12.64 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.609 0.242 . . . . 0.0 110.776 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.29 121.68 10.72 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.27 127.69 33.37 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.509 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 1.042 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -94.74 179.22 5.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.634 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 68' ' ' LEU . 4.7 tt -167.38 -54.31 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.904 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.86 19.75 43.59 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.096 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 27' ' ' THR . 9.3 pt-20 -174.47 101.17 0.09 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.987 0.394 . . . . 0.0 111.012 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.578 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -75.64 -5.15 44.09 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.785 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 t -91.29 33.89 0.96 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.044 0.449 . . . . 0.0 111.07 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.41 -173.7 3.67 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.74 -33.54 56.02 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.497 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.33 146.82 6.65 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.715 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' CG ' HG22 ' A' ' 28' ' ' VAL . 15.1 m-20 -89.24 -80.11 0.31 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.33 -173.54 4.62 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.39 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.685 HD12 HD12 ' A' ' 60' ' ' LEU . 11.3 mt -108.41 -40.15 5.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.632 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -169.79 169.68 8.28 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.869 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.543 ' HB3' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -139.79 105.94 5.24 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 110.983 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 84' ' ' VAL . 51.4 t80 -92.12 112.37 54.68 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.842 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' HG2' ' HB2' ' A' ' 8' ' ' ASP . 51.0 Cg_exo -54.14 167.73 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.047 2.498 . . . . 0.0 113.082 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.22 136.41 68.39 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.117 2.545 . . . . 0.0 112.836 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.497 HG21 ' CZ ' ' A' ' 81' ' ' PHE . 39.4 t -144.81 118.08 2.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.146 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.9 p -175.1 -64.81 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -106.05 -31.67 4.05 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.802 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.578 -1.124 . . . . 0.0 112.471 179.659 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptm . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 120.619 0.247 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -143.45 160.3 40.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -148.43 143.54 26.83 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.28 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.523 ' HG2' HG22 ' A' ' 17' ' ' THR . 0.6 OUTLIER -134.95 143.57 46.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.293 179.331 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.572 HD21 ' CB ' ' A' ' 9' ' ' LEU . 12.2 tp -133.08 157.8 44.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 111.308 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -89.14 162.6 15.86 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.76 62.11 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.762 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -55.2 -32.09 61.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.79 0.329 . . . . 0.0 110.525 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -110.9 -38.39 5.12 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.094 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . . . -66.47 -13.25 60.57 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -72.16 -25.73 61.81 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG21 ' N ' ' A' ' 44' ' ' SER . 11.8 t -93.72 -44.18 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.509 ' HB3' HD23 ' A' ' 42' ' ' LEU . . . -84.21 -28.94 26.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.628 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.1 -21.53 44.69 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.726 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.26 130.23 55.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.755 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -109.5 -48.03 3.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.735 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.523 HG22 ' HG2' ' A' ' 4' ' ' LYS . 2.3 p -92.3 141.14 28.88 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.038 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.7 t -142.09 125.8 15.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -95.87 154.11 17.4 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.697 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 t -102.02 120.54 51.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.0 -73.99 0.66 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 p -98.53 146.22 8.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.001 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -88.12 137.71 32.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.52 -120.77 0.6 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.452 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -100.69 36.54 1.9 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 111.048 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.33 120.1 39.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.752 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -115.08 173.57 6.43 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.103 HG21 ' HB3' ' A' ' 67' ' ' ALA . 38.5 t -77.62 -39.59 27.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.973 0.416 . . . . 0.0 110.137 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -81.21 -32.04 32.78 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.75 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.98 -45.61 94.1 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.692 0.282 . . . . 0.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.43 -30.95 57.6 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.648 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.755 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -57.03 -58.29 8.82 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.928 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 38' ' ' ALA . 22.5 t0 -60.51 -39.31 87.31 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.413 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.788 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . . . -58.57 -55.19 38.29 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.34 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.431 HD23 HD23 ' A' ' 80' ' ' LEU . 8.1 mp -62.28 -24.01 67.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.926 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 32' ' ' LEU . 94.4 t -83.87 -50.1 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.391 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.63 -27.87 0.03 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.557 -0.83 . . . . 0.0 114.529 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.788 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . . . -65.96 -5.79 10.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -128.72 70.9 80.95 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.458 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 84.4 Cg_exo -49.38 -17.35 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.176 2.584 . . . . 0.0 113.388 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.69 7.34 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.673 ' HB2' HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -100.38 -19.33 16.34 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 2.1 pt-20 -107.57 126.94 53.16 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.121 -0.362 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.432 ' N ' HG21 ' A' ' 12' ' ' VAL . 15.7 m -79.31 -52.35 8.22 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.971 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.69 144.95 9.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.86 0.362 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -158.34 -41.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.523 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 81.51 -59.08 0.24 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.657 0.383 . . . . 0.0 110.321 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.41 57.41 4.93 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.495 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.13 -48.69 73.32 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.669 0.271 . . . . 0.0 110.781 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -27.61 54.71 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.78 -41.38 2.16 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.812 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.21 27.53 16.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.626 0.25 . . . . 0.0 111.453 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mt -175.02 -66.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.852 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -130.26 132.95 46.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.165 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -131.97 115.21 15.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.99 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.61 145.88 50.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.701 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -150.32 111.06 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -73.08 139.14 46.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -139.3 151.94 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.403 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.556 HD12 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -112.99 130.53 56.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.899 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.484 ' N ' HD13 ' A' ' 60' ' ' LEU . 2.9 mtm180 -115.16 145.47 42.34 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.501 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -89.76 15.32 9.9 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.681 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.43 23.15 12.9 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.645 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HG3' ' HB1' ' A' ' 74' ' ' ALA . 2.1 tp10 -115.65 163.5 15.7 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.707 0.289 . . . . 0.0 110.981 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.16 127.73 32.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.454 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.77 95.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.245 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 1.103 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -73.1 174.64 7.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.942 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 68' ' ' LEU . 5.7 tt -163.71 -59.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.913 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.63 23.57 34.64 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.887 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -172.51 88.79 0.09 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.83 0.348 . . . . 0.0 110.785 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 27' ' ' THR . . . -76.31 -7.02 54.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.547 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -91.74 11.32 24.98 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.548 0.213 . . . . 0.0 111.38 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.83 132.56 53.32 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.624 0.249 . . . . 0.0 111.283 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.542 ' HB1' ' HG3' ' A' ' 64' ' ' GLU . . . 65.06 -76.04 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.804 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.8 164.73 30.07 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.459 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.41 -83.37 0.13 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.601 0.238 . . . . 0.0 110.803 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 2.8 pt-20 -168.91 -169.24 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.556 HD13 HD12 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -110.28 -46.65 3.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.301 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.479 ' CB ' ' HB2' ' A' ' 4' ' ' LYS . . . -157.04 164.64 37.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 5' ' ' LEU . 47.4 tp -144.62 97.93 3.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 111.047 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -115.56 127.69 26.59 Favored Pre-proline 0 N--CA 1.463 0.184 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.207 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.77 172.59 1.07 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.851 2.367 . . . . 0.0 112.632 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.9 -173.0 1.09 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.687 2.258 . . . . 0.0 112.282 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.8 100.23 10.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.3 96.49 3.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.921 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.23 57.79 0.27 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.493 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.274 -1.292 . . . . 0.0 112.935 -179.922 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.777 ' SD ' HG11 ' A' ' 20' ' ' VAL . 14.2 mmt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.667 0.27 . . . . 0.0 111.514 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.41 ' HB3' ' HG3' ' A' ' 19' ' ' ARG . 1.7 mt-10 -156.08 174.79 14.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.961 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.478 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.96 139.42 23.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.588 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.653 ' C ' HD22 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -131.31 156.38 45.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.304 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.017 HD12 HD13 ' A' ' 9' ' ' LEU . 2.8 mm? -140.0 156.33 46.68 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.111 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.22 -178.67 3.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.761 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . . . -49.32 -33.23 12.79 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -51.5 -36.8 46.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 110.232 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.017 HD13 HD12 ' A' ' 5' ' ' LEU . 4.8 mp -110.27 -8.88 14.68 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.089 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -93.48 -9.49 38.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -59.2 -39.34 82.31 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 41' ' ' ALA . 25.8 t -97.85 -36.9 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.845 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . . . -88.6 -45.8 9.58 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.91 -32.01 7.06 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.916 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.3 107.03 0.07 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.698 0.285 . . . . 0.0 110.63 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.792 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.23 35.38 2.42 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.639 HG22 ' HG2' ' A' ' 4' ' ' LYS . 8.8 p -93.66 113.95 26.16 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.082 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.478 ' HB ' ' CD1' ' A' ' 3' ' ' TRP . 1.9 t -131.34 166.62 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.035 0.445 . . . . 0.0 111.934 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.43 ' H ' HG12 ' A' ' 18' ' ' VAL . 3.2 mpp_? -131.4 158.8 39.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.421 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.777 HG11 ' SD ' ' A' ' 1' ' ' MET . 11.9 p -102.03 120.43 51.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.095 0.474 . . . . 0.0 111.103 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.16 -45.02 1.25 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.172 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.83 113.73 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.15 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -116.21 139.12 50.68 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.8 37.0 1.46 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.716 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.22 -60.33 0.17 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.701 0.286 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.31 176.37 5.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.779 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.516 HG21 ' HA2' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -111.35 171.67 7.34 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.025 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.92 HG13 ' HA ' ' A' ' 71' ' ' ALA . 3.1 m -77.29 -39.46 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 120.765 0.317 . . . . 0.0 110.989 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' HA3' ' HG ' ' A' ' 68' ' ' LEU . . . -88.13 -27.68 25.12 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.417 -0.896 . . . . 0.0 112.32 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.57 -35.89 73.09 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.62 0.247 . . . . 0.0 110.911 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -91.64 -37.07 13.28 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.484 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.3 tt -51.31 -50.88 58.5 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 120.746 0.308 . . . . 0.0 110.369 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -58.91 -34.55 71.81 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.25 -52.89 11.01 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.773 0.321 . . . . 0.0 110.743 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -65.73 -22.84 66.63 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.451 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 32' ' ' LEU . 94.1 t -95.23 -40.32 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.817 -0.174 . . . . 0.0 111.052 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.78 -37.38 90.11 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.608 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.04 -34.25 9.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.609 0.242 . . . . 0.0 111.299 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.491 ' N ' ' HD3' ' A' ' 40' ' ' PRO . 12.8 m-70 60.14 54.81 4.08 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.327 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 39' ' ' HIS . 51.1 Cg_exo -52.44 -22.08 15.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.242 1.961 . . . . 0.0 111.993 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.845 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . . . -62.2 -35.14 77.97 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.497 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.547 HD22 ' HG ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -121.4 1.5 10.16 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.507 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -84.46 103.65 13.79 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 m -75.55 -28.95 59.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.42 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 60.28 76.03 0.38 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 111.004 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.23 -59.76 3.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.824 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -173.23 -58.23 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.78 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -134.22 95.79 0.28 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.261 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -63.44 160.42 16.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.927 0.394 . . . . 0.0 111.343 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -76.73 -29.05 56.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.203 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.55 -139.61 14.62 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.774 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -158.79 139.55 12.72 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.662 0.267 . . . . 0.0 110.913 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.21 -57.1 3.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.873 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -125.87 161.4 27.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.825 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.72 113.59 25.9 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.234 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.25 116.79 14.8 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.383 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.1 tp -172.52 143.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -120.15 156.36 31.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.809 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.7 HG23 ' HG ' ' A' ' 80' ' ' LEU . 8.3 p -139.58 144.9 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.516 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.12 118.4 36.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.422 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.14 145.62 47.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.103 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -61.42 -15.86 41.04 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.764 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.95 23.91 5.39 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.856 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' OE1' ' HB3' ' A' ' 74' ' ' ALA . 4.0 tm-20 -104.13 166.06 10.65 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.731 0.301 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.94 121.44 13.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.89 113.32 2.01 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.232 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.62 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -67.75 166.31 15.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.481 ' HG ' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -164.98 -50.68 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.399 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.516 ' HA2' HG21 ' A' ' 27' ' ' THR . . . -101.36 28.96 13.61 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.125 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -164.04 102.44 0.87 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.788 0.294 . . . . 0.0 110.98 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.92 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -64.33 -26.82 68.65 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.241 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.3 t -95.99 37.18 1.24 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.07 0.462 . . . . 0.0 111.206 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.06 -173.68 4.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.473 ' HB3' ' OE1' ' A' ' 64' ' ' GLU . . . -61.09 -55.84 27.82 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.352 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.7 133.69 2.36 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.149 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -81.58 0.07 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.572 0.225 . . . . 0.0 110.535 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -160.14 179.89 8.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.489 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.6 mt -101.19 -41.13 6.84 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.777 0.323 . . . . 0.0 110.517 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.65 167.46 26.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.985 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.7 ' HG ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -138.46 100.9 4.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.324 179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -123.69 136.7 27.61 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 84' ' ' VAL . 73.8 Cg_endo -76.47 148.81 30.17 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.348 2.032 . . . . 0.0 112.042 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -57.35 92.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.839 2.359 . . . . 0.0 112.059 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 82' ' ' PRO . 12.7 p -148.69 134.02 10.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.417 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.33 35.55 0.65 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.95 -56.6 0.69 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.366 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.754 -1.026 . . . . 0.0 112.893 179.998 . . . . . . . . 0 0 . 1 stop_ save_